<SEC-DOCUMENT>0001193125-21-257913.txt : 20210827
<SEC-HEADER>0001193125-21-257913.hdr.sgml : 20210827
<ACCEPTANCE-DATETIME>20210826213905
ACCESSION NUMBER:		0001193125-21-257913
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		51
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210827
DATE AS OF CHANGE:		20210826

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ascendis Pharma A/S
		CENTRAL INDEX KEY:			0001612042
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			G7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36815
		FILM NUMBER:		211213963

	BUSINESS ADDRESS:	
		STREET 1:		TUBORG BOULEVARD 12
		CITY:			HELLERUP
		STATE:			G7
		ZIP:			DK-2900
		BUSINESS PHONE:		45 70 22 22 44

	MAIL ADDRESS:	
		STREET 1:		TUBORG BOULEVARD 12
		CITY:			HELLERUP
		STATE:			G7
		ZIP:			DK-2900
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d206395d6k.htm
<DESCRIPTION>6-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:asnd="http://ascendispharma.com/20210630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>6-K</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="">
 <div style='display: none'><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_01_2021To06_30_2021">false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="P01_01_2021To06_30_2021">2021-06-30</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="P01_01_2021To06_30_2021">Q2</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_01_2021To06_30_2021">0001612042</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="P01_01_2021To06_30_2021">--12-31</ix:nonNumeric><ix:footnote id="FN_86136" xml:lang="en-US">A total of 6,065,823 warrants outstanding as of June 30, 2021 can potentially dilute earnings per share in the future but have not been included in the calculation of diluted earnings per share because they are antidilutive for the periods presented. Similarly, a total of 5,788,390 warrants outstanding as of June 30, 2020 are also considered antidilutive for the periods presented and have not been included in the calculation. </ix:footnote ></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="asnd-20210630.xsd" /><link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /></ix:references><ix:resources><xbrli:context id="P04_01_2021To06_30_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-04-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2020To06_30_2020" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-04-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To06_30_2020" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P06_30_2021To06_30_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-06-30</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To03_31_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2019" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2020" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis" >asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-04-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2021To06_30_2021_OtherCollaborationPartnersMemberifrsfullMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis" >asnd:OtherCollaborationPartnersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-04-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2021To06_30_2021_NorthAmericaMemberifrsfullGeographicalAreasAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis" >srt:NorthAmericaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-04-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2021To06_30_2021_CNifrsfullGeographicalAreasAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis" >country:CN</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-04-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis" >asnd:Warrant1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-04-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2020To06_30_2020_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis" >asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-04-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2020To06_30_2020_NorthAmericaMemberifrsfullGeographicalAreasAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis" >srt:NorthAmericaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-04-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2020To06_30_2020_CNifrsfullGeographicalAreasAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis" >country:CN</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-04-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2020To06_30_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis" >asnd:Warrant1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-04-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis" >asnd:Warrant1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis" >asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_OtherCollaborationPartnersMemberifrsfullMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis" >asnd:OtherCollaborationPartnersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_NorthAmericaMemberifrsfullGeographicalAreasAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis" >srt:NorthAmericaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_CNifrsfullGeographicalAreasAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis" >country:CN</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_SharePremiumMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:SharePremiumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_BottomOfRangeMemberifrsfullRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:RangeAxis" >ifrs-full:BottomOfRangeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_TopOfRangeMemberifrsfullRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:RangeAxis" >ifrs-full:TopOfRangeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To06_30_2021_Warrant1MemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >asnd:Warrant1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To06_30_2020_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis" >asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To06_30_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To06_30_2020_NorthAmericaMemberifrsfullGeographicalAreasAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis" >srt:NorthAmericaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To06_30_2020_CNifrsfullGeographicalAreasAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis" >country:CN</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To06_30_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To06_30_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To06_30_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To06_30_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:SharePremiumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To06_30_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis" >asnd:Warrant1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To06_30_2020_Warrant1MemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >asnd:Warrant1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis" >ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="asnd:LeaseLiabilitiesAxis" >ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanOneYearAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis" >ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="asnd:LeaseLiabilitiesAxis" >ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanFiveYearsMemberifrsfullMaturityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis" >ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="asnd:LeaseLiabilitiesAxis" >ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="asnd:LeaseLiabilitiesAxis" >ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_GrossCarryingAmountMemberASNDLeaseLiabilitiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="asnd:LeaseLiabilitiesAxis" >ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis" >asnd:Warrant1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_BottomOfRangeMemberifrsfullRangeAxis_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis" >asnd:Warrant1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangeAxis" >ifrs-full:BottomOfRangeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_TopOfRangeMemberifrsfullRangeAxis_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis" >asnd:Warrant1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangeAxis" >ifrs-full:TopOfRangeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:UsTreasuryBillsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:UsTreasuryBillsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:UsGovernmentBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:UsGovernmentBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:CommercialPapersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:CommercialPapersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:CorporateBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:CorporateBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:AgencyBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:AgencyBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:UpperMediumGradeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:UpperMediumGradeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_LowerMediumGradeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:LowerMediumGradeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_LowerMediumGradeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:LowerMediumGradeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >ifrs-full:FixedInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >ifrs-full:FixedInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >asnd:ZeroCouponMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >asnd:ZeroCouponMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:PrimeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:PrimeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:HighGradeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:HighGradeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis" >asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:UsTreasuryBillsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:UsTreasuryBillsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:UsGovernmentBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:UsGovernmentBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:CommercialPapersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:CommercialPapersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:CorporateBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:CorporateBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:AgencyBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis" >asnd:AgencyBondsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:UpperMediumGradeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:UpperMediumGradeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >ifrs-full:FixedInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >ifrs-full:FixedInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >asnd:ZeroCouponMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis" >asnd:ZeroCouponMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:PrimeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:PrimeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:HighGradeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis" >ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis" >asnd:HighGradeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_08_2021To01_08_2021_VisenSeriesBFinancingMemberifrsfullLiabilitiesArisingFromFinancingActivitiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis" >asnd:VisenSeriesBFinancingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-08</xbrli:startDate> <xbrli:endDate>2021-01-08</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_08_2021To01_08_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis" >asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-08</xbrli:startDate> <xbrli:endDate>2021-01-08</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_08_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis" >asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-08</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P08_25_2021To08_25_2021_NonadjustingEventsAfterReportingPeriodMemberifrsfullNonadjustingEventsAfterReportingPeriodAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis" >asnd:NonadjustingEventsAfterReportingPeriodMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-08-25</xbrli:startDate> <xbrli:endDate>2021-08-25</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis" >asnd:Warrant1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:SharePremiumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_SharePremiumMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:SharePremiumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2019_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2019_SharePremiumMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:SharePremiumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2019_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2019_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2019_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:SharePremiumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612042</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis" >ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_EUR" > <xbrli:measure>iso4217:EUR</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_shares" > <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_USD" > <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_pure" > <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Month" > <xbrli:measure>utr:Month</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Year" > <xbrli:measure>utr:Year</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Segment" > <xbrli:measure>asnd:Segment</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_DKK_per_Share" > <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:DKK</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit><xbrli:unit id="Unit_EUR_per_Share" > <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:EUR</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit><ix:relationship fromRefs="Fact_25469810" toRefs="FN_86136"/><ix:relationship fromRefs="Fact_25469811" toRefs="FN_86136"/><ix:relationship fromRefs="Fact_25469854" toRefs="FN_86136"/><ix:relationship fromRefs="Fact_25469855" toRefs="FN_86136"/></ix:resources></ix:header></div><div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="line-height: 1pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 18pt; margin-top: 4pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">UNITED STATES </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">SECURITIES AND EXCHANGE COMMISSION </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">Washington, D.C. 20549 </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 18pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">FORM <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:DocumentType" contextRef="P01_01_2021To06_30_2021">6-K</ix:nonNumeric></div> </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 12pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">REPORT OF FOREIGN PRIVATE ISSUER </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">PURSUANT TO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">SECTION&#160;13a-16</div> OR <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">15d-16</div> </div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">UNDER THE SECURITIES EXCHANGE ACT OF 1934 </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the month of <div style="letter-spacing: 0px; top: 0px;;display:inline;">August, <ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="P01_01_2021To06_30_2021">2021</ix:nonNumeric></div> </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Commission File Number: <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">001-36815</div> </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 24pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 24pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_01_2021To06_30_2021">Ascendis Pharma A/S</ix:nonNumeric> </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Exact Name of Registrant as Specified in Its Charter) </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tuborg Boulevard 12 </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">DK-2900</div> Hellerup </div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denmark </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">(Address of principal executive offices) </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">20-F</div> or Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">40-F.</div> </div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">20-F&#160;&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">40-F&#160;&#160;&#9744;</div> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Indicate by check mark if the registrant is submitting the Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">6-K</div> in paper as permitted by Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-T</div> Rule 101(b)(1):&#160;&#160;&#9744; </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Indicate by check mark if the registrant is submitting the Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">6-K</div> in paper as permitted by Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-T</div> Rule 101(b)(7):&#160;&#160;&#9744; </div> <div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="line-height: 1pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">INCORPORATION BY REFERENCE </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">This report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">6-K</div> shall be deemed to be incorporated by reference into the registration statements on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-8</div> (Registration Numbers <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-203040,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-210810,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-211512,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-213412,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-214843,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-216883,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-228576</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-254101)</div> and Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">F-3</div> (Registration Numbers <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-209336,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-211511,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-216882,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-223134,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-225284</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">333-256571)</div> of Ascendis Pharma A/S (the &#8220;Company&#8221;) (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Furnished as exhibits to this Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">6-K</div> is information regarding the Company&#8217;s financial results for the fiscal quarter ended June&#160;30, 2021. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exhibits </div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td style="width: 90%;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exhibit&#160;No.</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: inline-block; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div></div> </td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"></td>
<td colspan="2" style="height: 6pt;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">99.1</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><a href="d206395dex991.htm">Unaudited Condensed Consolidated Interim Financial Statements.</a></div></td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"></td>
<td colspan="2" style="height: 6pt;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">99.2</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><a href="d206395dex992.htm">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. </a></div></td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"></td>
<td colspan="2" style="height: 6pt;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">101.INS</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">XBRL Instance Document.</div></td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"></td>
<td colspan="2" style="height: 6pt;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">101.SCH</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">XBRL Taxonomy Extension Schema Document.</div></td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"></td>
<td colspan="2" style="height: 6pt;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">101.CAL</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">XBRL Taxonomy Extension Calculation Linkbase Document.</div></td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"></td>
<td colspan="2" style="height: 6pt;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">101.DEF</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">XBRL Taxonomy Extension Definition Linkbase Document.</div></td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"></td>
<td colspan="2" style="height: 6pt;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">101.IAB</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">XBRL Taxonomy Extension Labels Linkbase Document.</div></td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"></td>
<td colspan="2" style="height: 6pt;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap; font-size: 6pt;">101.PRE <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">104</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: top; font-size: 6pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">XBRL Taxonomy Extension Presentation Linkbase Document.</div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2 </div></div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> </div> </div> </div> <div style="text-align: center;"> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></div> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SIGNATURES </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 45%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td style="width: 4%;"></td>
<td style="vertical-align: bottom;"></td>
<td style="width: 3%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td style="width: 45%;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;"></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="3" style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ascendis Pharma A/S</div></div></div></td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt;"></td>
<td colspan="2" style="height: 12pt;"></td>
<td colspan="2" style="height: 12pt;"></td>
<td colspan="2" style="height: 12pt;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Date: August&#160;26, 2021</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;"></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">By:</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/ Michael Wolff Jensen</div></div></div> </td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;"></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="3" style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Michael Wolff Jensen</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;"></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="3" style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Senior Vice President, Chief Legal Officer</div></td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3 </div></div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> </div> </div> </div> <div style="text-align: center;"> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></div> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"></div> </div> </div> </div> </div> </div> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"></div> </div> </div> </div> </div> </div>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d206395dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:asnd="http://ascendispharma.com/20210630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>EX-99.1</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="">
 <div style='display: none'><ix:header><ix:hidden><ix:nonNumeric name="asnd:LeaseTerm" id="hidden25486367" contextRef="P01_01_2021To06_30_2021_BottomOfRangeMemberifrsfullRangeAxis">P2Y</ix:nonNumeric><ix:nonNumeric name="asnd:LeasesOptionToExtendAndTerminationTerm" id="hidden25486370" contextRef="P01_01_2021To06_30_2021_BottomOfRangeMemberifrsfullRangeAxis">P2Y</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="asnd-20210630.xsd" /><link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /></ix:references></ix:header></div><div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exhibit 99.1 </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASCENDIS PHARMA A/S </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">INDEX TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 96%;"></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 1pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Page</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unaudited Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income / (Loss) for the Three and Six Months Ended June&#160;30, 2021 and 2020</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unaudited Condensed Consolidated Interim Statements of Financial Position as of June&#160;30, 2021 and December&#160;31, 2020</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unaudited Condensed Consolidated Interim Statements of Changes in Equity at June&#160;30, 2021 and 2020</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unaudited Condensed Consolidated Interim Cash Flow Statements for the Six Months Ended June&#160;30, 2021 and 2020</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Notes to the Unaudited Condensed Consolidated Interim Financial Statements</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"></div> </div> </div> <div> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unaudited Condensed Consolidated Interim Statements of Profit or Loss </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">and Comprehensive Income / (Loss) for the Three and Six Months Ended June&#160;30 </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;margin-left : auto;margin-right : auto;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 58%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 1pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 1pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 1pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three&#160;Months&#160;Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 1pt;">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;">&#160;</td> </tr>
<tr>
<td style="padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="line-height: 1pt; font-size: 1pt;;text-align:center;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="line-height: 1pt; font-size: 1pt;;text-align:center;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="line-height: 1pt; font-size: 1pt;;text-align:center;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="line-height: 1pt; font-size: 1pt;;text-align:center;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="line-height: 1pt; font-size: 1pt;;text-align:center;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;;vertical-align:bottom;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td>
<td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Notes</div></td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td>
<td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2021</div></td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2021</div></td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></td>
<td style="vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255);;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Consolidated Interim Statement of Profit or Loss</div></div></div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">5</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,022</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,436</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,767</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">3,661</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Research and development costs</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">7</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">83,306</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">63,578</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">171,455</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">121,093</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Selling, general&#160;and administrative expenses</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">7</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">35,345</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">20,805</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">72,591</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">38,720</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Operating profit / (loss)</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">117,629</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">82,947</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">242,279</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">156,152</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Share of profit / (loss) of associate</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,817</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,885</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">23,289</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,400</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255);;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Finance income</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">145</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">86</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">23,268</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,996</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance expenses</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">12,141</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">10,292</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,703</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">876</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Profit / (loss) before tax</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">134,442</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">95,038</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">197,425</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">158,432</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tax on profit / (loss) for the period</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">68</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">106</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">259</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">183</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Net profit / (loss) for the period</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">134,374</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">94,932</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">197,166</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">158,249</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Attributable to owners of the Company</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">134,374</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">94,932</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">197,166</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">158,249</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255);;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Basic and diluted earnings / (loss) per share</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8364;(<ix:nonFraction name="ifrs-full:BasicAndDilutedEarningsLossPerShare" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">2.50</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8364;(<ix:nonFraction name="ifrs-full:BasicAndDilutedEarningsLossPerShare" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">1.97</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8364;(<ix:nonFraction name="ifrs-full:BasicAndDilutedEarningsLossPerShare" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">3.66</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8364;(<ix:nonFraction name="ifrs-full:BasicAndDilutedEarningsLossPerShare" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">3.29</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Number of shares used for calculation (basic and diluted)<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">&#160;(1)</div></div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal" id="Fact_25469810">53,848,166</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal" id="Fact_25469811">48,207,661</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal" id="Fact_25469854">53,804,300</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal" id="Fact_25469855">48,096,749</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-size: 1pt;">
<td style="font-family: &quot;Times New Roman&quot;;;height:16;">&#160;</td>
<td colspan="4" style="font-family: &quot;Times New Roman&quot;;;height:16;">&#160;</td>
<td colspan="8" style="font-family: &quot;Times New Roman&quot;;;height:16;">&#160;</td>
<td colspan="8" style="font-family: &quot;Times New Roman&quot;;;height:16;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></td>
<td style="vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255);;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Consolidated Interim Statement of Comprehensive Income</div></div></div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net profit / (loss) for the period</div></div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">134,374</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">94,932</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">197,166</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">158,249</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255);;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Other comprehensive income / (loss)</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Items that may be reclassified subsequently to profit or loss:</div></div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255);;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exchange differences on translating foreign operations</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">77</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">147</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,765</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">61</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other comprehensive income / (loss) for the period, net of tax</div></div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">77</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">147</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,765</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">61</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total comprehensive income / (loss) for the period, net of tax</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">134,297</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">95,079</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">195,401</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">158,310</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Attributable to owners of the Company</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">134,297</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">95,079</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">195,401</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">158,310</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;">
<tr style="page-break-inside: avoid;">
<td style="text-align:left;;vertical-align:top;;width:4%;">(1)</td>
<td style="text-align:left;;vertical-align:top;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A total of <ix:nonFraction name="ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullComponentsOfEquityAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">6,065,823</ix:nonFraction> warrants outstanding as of June 30, 2021 can potentially dilute earnings per share in the future but have not been included in the calculation of diluted earnings per share because they are antidilutive for the periods presented. Similarly, a total of <ix:nonFraction name="ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" contextRef="P01_01_2020To06_30_2020_Warrant1MemberifrsfullComponentsOfEquityAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">5,788,390</ix:nonFraction> warrants outstanding as of June&#160;30, 2020 are also considered antidilutive for the periods presented and have not been included in the calculation. </div></div> </td> </tr> </table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2 </div></div></div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="text-align: center;"></div> </div> <div> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; padding-top: 0pt; padding-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unaudited Condensed Consolidated Interim Statements of Financial Position </div></div></div> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; padding-top: 0pt; padding-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;margin-left : auto;margin-right : auto;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 75%;"></td>
<td style="vertical-align: bottom;"></td>
<td></td>
<td></td>
<td style="width: 1%;"></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td>
<td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Notes</div></td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td>
<td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/> 2021</div></td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td>
<td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2020</div></td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></td>
<td style="vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Assets</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Non-current</div> assets</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Intangible assets</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="asnd:GoodwillAndOtherIntangibleAssets" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">5,495</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="asnd:GoodwillAndOtherIntangibleAssets" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">5,717</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Property, plant and equipment</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">123,924</ix:nonFraction></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">108,112</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Investment in associate</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">45,783</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">9,176</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Deposits</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:LongtermDeposits" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,702</ix:nonFraction></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:LongtermDeposits" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,375</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Marketable securities</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">8</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">90,693</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">115,280</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">267,597</ix:nonFraction></div></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">239,660</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Current assets</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Trade receivables</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">394</ix:nonFraction></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">387</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Other receivables</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:OtherCurrentReceivables" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">11,398</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:OtherCurrentReceivables" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">6,957</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Prepayments</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentPrepayments" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">21,826</ix:nonFraction></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentPrepayments" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">13,994</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Marketable securities</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">8</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">166,094</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">134,278</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Cash and cash equivalents</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">384,539</ix:nonFraction></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">584,517</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">584,251</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">740,133</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Total assets</div></div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Assets" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">851,848</ix:nonFraction></div></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Assets" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">979,793</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Equity and liabilities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Share capital</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">9</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">7,237</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">7,217</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Distributable equity</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="asnd:DistributableEquity" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">680,250</ix:nonFraction></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="asnd:DistributableEquity" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">831,494</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">687,487</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">838,711</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Non-current</div> liabilities</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Lease liabilities</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">10</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">94,059</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">85,116</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Other payables</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:OtherNoncurrentPayables" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">3,162</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">94,059</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">88,278</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Current liabilities</div></div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Lease liabilities</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">10</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">6,950</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">6,859</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Contract liabilities</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentContractLiabilities" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">145</ix:nonFraction></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentContractLiabilities" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">363</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Trade payables and accrued expenses</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">44,207</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">21,897</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Other payables</div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">18,623</ix:nonFraction></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">23,384</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Income taxes payable</div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">377</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">301</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">70,302</ix:nonFraction></div></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">52,804</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Total liabilities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Liabilities" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">164,361</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Liabilities" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">141,082</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="text-align: right;">&#160;</td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 75%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Total equity and liabilities</div></div></div> </td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">851,848</ix:nonFraction></div></td>
<td style="white-space: nowrap; text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align: right; width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align: right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">979,793</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3 </div></div></div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> </div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="text-align: center;"></div> </div> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;;text-align:center;"><div style="font-size: 10pt;;font-weight:bold;display:inline;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unaudited Condensed Consolidated Interim Statements of Changes in Equity</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;;text-align:center;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;;text-align:center;"></div> </div> </div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"></div> </div> </div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"></div> </div> </div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 47%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="14" style="vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distributable Equity</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share<br/> Capital</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share<br/> Premium</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign</div></div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Currency<br/> Translation<br/> Reserve</div></div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share-based<br/> Payment<br/> Reserve</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/> Deficit</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="22" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="22" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 47%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Equity at January&#160;1, 2021</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">7,217</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,728,747</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">76</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">133,101</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,030,278</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">838,711</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Loss for the period</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2021To06_30_2021_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">197,166</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">197,166</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Other comprehensive income / (loss), net of tax</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2021To06_30_2021_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,765</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,765</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 47%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap;;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total comprehensive income / (loss)</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2021To06_30_2021_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,765</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2021To06_30_2021_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">197,166</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">195,401</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 47%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap;;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 47%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Transactions with Owners</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Share-based payment (Note 7)</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="P01_01_2021To06_30_2021_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">39,396</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align: bottom; width: 1%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">39,396</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Capital increase</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners" contextRef="P01_01_2021To06_30_2021_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">20</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners" contextRef="P01_01_2021To06_30_2021_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">4,761</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">4,781</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 47%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap;;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="background-color: rgba(255, 255, 255, 0); width: 47%; white-space: nowrap; padding-bottom: 2.5pt;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">Equity at June&#160;30, 2021</div></div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%; white-space: nowrap; padding-bottom: 2.5pt;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap; border-bottom: 2.5pt double black;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap; border-bottom: 2.5pt double black;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2021_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">7,237</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0); padding-bottom: 2.5pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%; white-space: nowrap; padding-bottom: 2.5pt;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap; border-bottom: 2.5pt double black;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap; border-bottom: 2.5pt double black;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2021_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,733,508</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0); padding-bottom: 2.5pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%; white-space: nowrap; padding-bottom: 2.5pt;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); padding: 0px; white-space: nowrap; border-bottom: 2.5pt double black;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap; border-bottom: 2.5pt double black;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2021_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,689</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0); padding-bottom: 2.5pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%; white-space: nowrap; padding-bottom: 2.5pt;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap; border-bottom: 2.5pt double black;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap; border-bottom: 2.5pt double black;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2021_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">172,497</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0); padding-bottom: 2.5pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%; white-space: nowrap; padding-bottom: 2.5pt;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); padding: 0px; white-space: nowrap; border-bottom: 2.5pt double black;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap; border-bottom: 2.5pt double black;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2021_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,227,444</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 2.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%; white-space: nowrap; padding-bottom: 2.5pt;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap; border-bottom: 2.5pt double black;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap; border-bottom: 2.5pt double black;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">687,487</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0); padding-bottom: 2.5pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt;">&#160;</td>
<td colspan="4" style="height: 12pt;">&#160;</td>
<td colspan="16" style="height: 12pt;">&#160;</td>
<td colspan="4" style="height: 12pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="14" style="vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distributable Equity</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="2" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share<br/> Capital</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share<br/> Premium</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign</div></div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Currency<br/> Translation<br/> Reserve</div></div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share-based<br/> Payment<br/> Reserve</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/> Deficit</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td colspan="22" style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:center;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="22" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 10pt; break-inside: avoid;">
<td style="background-color: rgb(204, 238, 255); width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity at January&#160;1, 2020</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2019_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">6,443</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2019_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,122,097</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2019_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">34</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2019_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">79,931</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2019_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">611,323</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">597,114</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 10pt; break-inside: avoid;">
<td style="background-color: rgba(255, 255, 255, 0); width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Loss for the period</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2020To06_30_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">158,249</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">158,249</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size: 10pt; break-inside: avoid;">
<td style="background-color: rgb(204, 238, 255); width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other comprehensive income / (loss), net of tax</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2020To06_30_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">61</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">61</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="background-color: rgba(255, 255, 255, 0); width: 47%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap;;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-size: 10pt; break-inside: avoid;">
<td style="background-color: rgba(255, 255, 255, 0); width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total comprehensive income / (loss)</div></div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2020To06_30_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">61</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2020To06_30_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">158,249</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">158,310</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="background-color: rgba(255, 255, 255, 0); width: 47%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap;;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-size: 10pt; break-inside: avoid;">
<td style="background-color: rgb(204, 238, 255); width: 47%;;vertical-align:top;"> <div style="text-indent: -1em; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transactions with Owners</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 10pt; break-inside: avoid;">
<td style="background-color: rgba(255, 255, 255, 0); width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Share-based payment (Note 7)</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="P01_01_2020To06_30_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">28,364</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">28,364</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 10pt; break-inside: avoid;">
<td style="background-color: rgb(204, 238, 255); width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Capital increase</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners" contextRef="P01_01_2020To06_30_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">48</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners" contextRef="P01_01_2020To06_30_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">9,928</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" xsi:nil="true"></ix:nonFraction>9,976</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="background-color: rgba(255, 255, 255, 0); width: 47%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap;;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-size: 10pt; break-inside: avoid;">
<td style="background-color: rgba(255, 255, 255, 0); width: 47%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity at June&#160;30, 2020</div></div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">6,491</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,132,025</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">95</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">108,295</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">769,572</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">477,144</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="background-color: rgba(255, 255, 255, 0); width: 47%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr> </table> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="clear: both; max-height: 0px;"></div> </div> </div> </div> </div> </div> </div> </div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4 </div></div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"></div> </div> <div> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; padding-top: 0pt; padding-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unaudited Condensed Consolidated Interim Cash Flow Statements for the </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; padding-top: 0pt; padding-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended June&#160;30 </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; padding-top: 0pt; padding-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;margin-left : auto;margin-right : auto;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 80%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Six Months Ended<br/> June&#160;30,</div></td>
<td style="vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td>
<td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2021</div></td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td>
<td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;&#160;</td>
<td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></td>
<td style="vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Operating activities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Net profit / (loss) for the period</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">197,166</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">158,249</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Reversal of finance income</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">23,268</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,996</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Reversal of finance expenses</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,703</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">876</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Reversal of tax charge</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">259</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">183</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;">Adjustments for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">non-cash</div> items:</div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;">Reversal of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">non-cash</div> consideration relating to revenue</div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="asnd:NoncashConsideration" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,155</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="asnd:NoncashConsideration" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">2,215</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Reversal of share of profit / (loss) of associate</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">23,289</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,400</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Share-based payment</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">39,396</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">28,364</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Depreciation</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">7,112</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">4,192</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Amortization</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">222</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Changes in working capital:</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Receivables</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="asnd:AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,035</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="asnd:AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">944</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Prepayments</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="asnd:AdjustmentsForIncreaseDecreaseInPrepayments" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">7,832</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="asnd:AdjustmentsForIncreaseDecreaseInPrepayments" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">5,385</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Contract liabilities (deferred income)</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">218</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">858</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Trade payables and other payables</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">10,902</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">8,008</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Cash flows generated from / (used in) operations</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">197,887</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">124,990</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Finance income received</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,915</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,776</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Finance expenses paid</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">699</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">798</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Income taxes re<div style="letter-spacing: 0px; top: 0px;;display:inline;">c</div>eived / (paid)</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">149</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">615</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Cash flows from / (used in) operating activities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">196,820</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">123,397</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Investing activities</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Investment in associate</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:PurchaseOfInterestsInAssociates" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">10,187</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Acquisition of property, plant and equipment</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">7,607</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">10,725</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Development expenditures (software)</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:PaymentsForDevelopmentProjectExpenditure" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">530</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:PaymentsForDevelopmentProjectExpenditure" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">311</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Purchase of marketable securities</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:PurchaseOfAvailableforsaleFinancialAssets" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">76,358</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:PurchaseOfAvailableforsaleFinancialAssets" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">233,446</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Settlement of marketable securities</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">75,600</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Cash flows from / (used in) investing activities</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">19,082</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">244,482</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Financing activities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Payment of principal portion of lease liabilities</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">3,371</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">2,306</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Proceeds from exercise of warrants</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="asnd:ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">4,782</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="asnd:ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">9,976</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Cash flows from / (used in) financing activities</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,411</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">7,670</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Increase / (decrease) in cash and cash equivalents</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">214,491</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">360,209</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Cash and cash equivalents at January&#160;1</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">584,517</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">598,106</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Effect of exchange rate changes on balances held in foreign currencies</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">14,513</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">2,708</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Cash and cash equivalents at June&#160;30</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">384,539</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">240,605</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Cash and cash equivalents include:</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">Bank deposits</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="asnd:CashDeposits" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">383,073</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="asnd:CashDeposits" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">183,153</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 80%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255); margin-bottom: 0pt;;display:inline;">Short-term marketable securities</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="asnd:ShortTermMarketableSecurities" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,466</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="asnd:ShortTermMarketableSecurities" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">57,452</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 80%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;"><div style="font-weight:bold;display:inline;">Cash and cash equivalents at June&#160;30</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">384,539</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">240,605</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 80%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); padding-top: 0pt; padding-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px; margin-bottom: 0pt;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5 </div></div></div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="width: 8.5in; margin-left: auto; margin-right: auto;"> <div style="width: 8.5in; margin-left: auto; margin-right: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;;text-align:center;"></div> </div> <div style="clear: both; max-height: 0px;"></div> </div> </div> <div> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Notes to the Unaudited Condensed Consolidated Interim Financial Statements </div></div></div> <ix:nonNumeric name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 1&#8212;General Information </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ascendis Pharma A/S, together with its subsidiaries, is a biopharmaceutical company applying its innovative TransCon technologies to build a leading, fully integrated biopharmaceutical company. Ascendis Pharma A/S was incorporated in 2006 and is headquartered in Hellerup, Denmark. Unless the context otherwise requires, references to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Ascendis Pharma A/S and its subsidiaries. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The address of the Company&#8217;s registered office is Tuborg Boulevard 12, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">DK-2900,</div> Hellerup, Denmark. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 2, 2015, the Company completed an initial public offering which resulted in the listing of American Depositary Shares, or ADSs, representing the Company&#8217;s ordinary shares, under the symbol &#8220;ASND&#8221; in the United States on The Nasdaq Global Select Market. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s Board of Directors approved these unaudited condensed consolidated interim financial statements on August&#160;25, 2021. </div></div></ix:nonNumeric> <ix:nonNumeric name="ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 2&#8212;Summary of Significant Accounting Policies </div></div></div> <ix:nonNumeric name="ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Basis of Preparation </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The unaudited condensed consolidated interim financial statements of the Company are prepared in accordance with International Accounting Standard 34, &#8220;Interim Financial Reporting.&#8221; Certain information and disclosures normally included in the annual consolidated financial statements prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;) have been condensed or omitted. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with the Company&#8217;s audited annual consolidated financial statements for the year ended December 31, 2020 and accompanying notes, which have been prepared in accordance with IFRS as issued by the International Accounting Standards Board, and as adopted by the European Union. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accounting policies applied are consistent with those of the previous financial year. A description of our accounting policies is provided in the </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Policies section of the audited consolidated financial statements as of and for the year ended December 31, 2020. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with IFRS requires the use of certain significant accounting estimates and requires management to exercise its judgement in the process of applying the Company&#8217;s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the unaudited condensed consolidated interim financial statements are disclosed in Note 3. </div></div></ix:nonNumeric> <ix:nonNumeric name="asnd:DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">New and Amended IFRS Standards Adopted by the Company </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Several new amendments and interpretations became applicable for the current reporting period, but do not have an impact on the accounting policies applied by the Company. </div></div></ix:nonNumeric></ix:nonNumeric> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6 </div></div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Notes to the Unaudited Condensed Consolidated Interim Financial Statements </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 3&#8212;Critical Accounting Judgements and Key Sources of Estimation Uncertainty </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the application of the Company&#8217;s accounting policies, management is required to make judgements, estimates and assumptions about the carrying amount&#160;of assets and liabilities that are not readily apparent from other sources. Judgements and estimates applied are based on historical experience and other factors that are relevant, and which are available at the reporting date. Uncertainty concerning judgements and estimates could result in outcomes, that require a material adjustment to assets and liabilities in future periods. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. While the application of significant accounting estimates is subject to material estimation uncertainties, management&#8217;s ongoing revisions of significant accounting estimates have not revealed any material impact in the consolidated interim statements of profit or loss for any of the periods presented. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The unaudited condensed consolidated interim financial statements do not include all disclosures for significant accounting judgements, estimates and assumptions, that are required in the annual consolidated financial statements, and therefore, should be read in conjunction with the Company&#8217;s audited consolidated financial statements as of and for the year ended December 31, 2020. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Significant judgements made in the process of applying our accounting policies and that have the most significant effect on the amounts recognized in the unaudited condensed consolidated interim financial statements relate to revenue recognition, share-based payment, internally generated intangible assets related to drug development, classification of collaboration agreements and recognition principles related to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-launch</div> inventories. For the six months ended June 30, 2021, the Company has for the first time, in connection with determining the grant date fair value of warrants and accordingly, warrant compensation costs, applied its own share price as input for expected volatility. Details are provided in section &#8220;Warrant Compensation Costs&#8221;. Until December 31, 2020, the expected volatility was calculated using a simple average of daily historical data of comparable publicly traded companies, as the Company did not have sufficient data for the volatility of the Company&#8217;s own share price. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The key sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities within the next financial year, primarily relate to recognition and measurement of accruals and prepayments for manufacturing and clinical trial activities. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other than as set out below, there have been no other changes to the application of significant accounting judg<div style="letter-spacing: 0px; top: 0px;;display:inline;">e</div>ments, or estimation uncertainties regarding accounting estimates compared to December&#160;31, 2020. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant Compensation Costs </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">IFRS 2, &#8220;Share-Based Payment&#8221; requires an entity to reflect in its consolidated statement of profit or loss and financial position, the effects of share-based payment transactions. Warrant compensation costs are recognized over the vesting period as research and development costs or selling, general and administrative expenses, as appropriate, based on management&#8217;s best estimate of the number of warrants that will ultimately vest, which is subject to uncertainty. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant compensation costs are measured according to the grant date fair values of the warrants granted. Estimating fair values requires the Company to apply generally accepted valuation models and apply these models consistently according to the terms and conditions of the specific warrant program. Under all warrant programs, the Black-Scholes option-pricing model has been applied to determine the fair value of warrants granted. Subjective judgements and assumptions, which are subject to estimation uncertainties, need to be exercised in determining the appropriate input to the valuation model. These inputs include expected volatility of the Company&#8217;s share price for a historic period equaling the expected lifetime of the warrants, reflecting the assumption that the historical volatility over a period similar to the life of the warrants is indicative of future trends. For the six months ended June&#160;30, 2021, the expected volatility has been calculated using the Company&#8217;s own share price. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></ix:nonNumeric> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7 </div></div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="width: 8.5in; margin-left: auto; margin-right: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;;text-align:center;"></div> </div> </div> <div> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Notes to the Unaudited Condensed Consolidated Interim Financial Statements </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="asnd:SignificantEventsInTheReportingPeriodTextBlock" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 4&#8212;Significant Events in the Reporting Period </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Impact from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">A novel strain of coronavirus, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(&#8220;COVID-19&#8221;)</div> was reported to have surfaced in Wuhan, China, in December 2019. Since then, COVID-19 has spread around the world into a pandemic, including into countries where we are operating, where we have planned or have ongoing clinical trials, and where we rely on third-parties to manufacture preclinical and clinical supplies, as well as commercial supply. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">We monitor these risks closely, and work with relevant stakeholders to avoid disruptions, and to develop and establish working measures. However, while <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> continues to impact global societies, the uncertainty related to the duration and direction of the pandemic makes the future impact from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19,</div> including the magnitude of any impact on our operational results, highly uncertain and unpredictable. At the reporting date, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> did not have a direct impact on the <div style="letter-spacing: 0px; top: 0px;;display:inline;">consolidated </div>interim financial statements<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">VISEN Pharmaceuticals Investment </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On January 8, 2021, the Company entered into an equity investment of $<ix:nonFraction name="ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod" contextRef="PAsOn01_08_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">12.5</ix:nonFraction>&#160;million in its associate, VISEN Pharmaceuticals, or VISEN, as part of VISEN&#8217;s $<ix:nonFraction name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="P01_08_2021To01_08_2021_VisenSeriesBFinancingMemberifrsfullLiabilitiesArisingFromFinancingActivitiesAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:numdotdecimal">150</ix:nonFraction>&#160;million Series B financing. Following VISEN&#8217;s Series B financing, the Company retains approximately <ix:nonFraction name="asnd:ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" contextRef="P01_08_2021To01_08_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">44</ix:nonFraction>% of VISEN&#8217;s issued and outstanding shares. As a result, the Company has recognized a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain in the first quarter of 2021 of &#8364;<ix:nonFraction name="asnd:ExpectedNonCashGainTowardsShares" contextRef="P01_01_2021To03_31_2021" unitRef="Unit_EUR" decimals="-5" scale="6" format="ixt:numdotdecimal">42.3</ix:nonFraction>&#160;million, which is presented as part of &#8220;Share of profit / (loss) of associate&#8221; in the consolidated interim statement of profit or loss. The Series B financing has not changed the Company&#8217;s accounting treatment of VISEN. </div></ix:nonNumeric> <ix:nonNumeric name="ifrs-full:DisclosureOfRevenueExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 5&#8212;Revenue </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company&#8217;s revenue is primarily generated from three license agreements, which were entered into in 2018. The licenses grant VISEN exclusive rights to develop and commercialize TransCon hGH, TransCon PTH and TransCon CNP in Greater China. As consideration for the granting of such rights, the Company has received <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">up-front,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> consideration of $<ix:nonFraction name="asnd:UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" contextRef="P01_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">40.0</ix:nonFraction>&#160;million in the form of <ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInAssociate" contextRef="P01_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>% ownership in VISEN. At the reporting date, the Company retains approximately <ix:nonFraction name="asnd:RetainedPercentageOfIssuedAndOutstandingShares" contextRef="PAsOn06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">44</ix:nonFraction>% of VISEN&#8217;s issued and outstanding shares. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Consideration received is recognized partly as license revenue, and partly as rendering of services over time. In addition to granting exclusive rights, the Company will provide clinical trial supply and development services to VISEN. </div></div></div> <ix:nonNumeric name="asnd:DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 68%;"></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three&#160;Months&#160;Ended<br/> June&#160;30,</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30,</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue from external customers</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"></td>
<td style="vertical-align: bottom;"></td>
<td style="vertical-align: bottom;"></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"></td>
<td style="vertical-align: bottom;"></td>
<td style="vertical-align: bottom;"></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"></td>
<td style="vertical-align: bottom;"></td>
<td style="vertical-align: bottom;"></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"></td>
<td style="vertical-align: bottom;"></td>
<td style="vertical-align: bottom;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue from the rendering of services (recognized over time)</div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:RevenueFromRenderingOfServices" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">226</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:RevenueFromRenderingOfServices" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">779</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:RevenueFromRenderingOfServices" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">395</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:RevenueFromRenderingOfServices" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">2,091</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Sale of clinical supply (recognized at a point in time)</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="asnd:RevenueFromSaleOfClinicalSupply" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">217</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="asnd:RevenueFromSaleOfClinicalSupply" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">217</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="asnd:RevenueFromSaleOfClinicalSupply" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">246</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Right-to-use&#8221;</div></div> licenses (recognized at a point in time)</div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:LicenceFeeIncome" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">579</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:LicenceFeeIncome" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">657</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:LicenceFeeIncome" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,155</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:LicenceFeeIncome" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,324</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total revenue <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,022</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,436</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,767</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">3,661</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Attributable to</div></div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">VISEN Pharmaceuticals</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">913</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2020To06_30_2020_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,436</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,550</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2020To06_30_2020_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">3,661</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other collaboration partners</div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2021To06_30_2021_OtherCollaborationPartnersMemberifrsfullMajorCustomersAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">109</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2021To06_30_2021_OtherCollaborationPartnersMemberifrsfullMajorCustomersAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">217</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total revenue</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,022</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,436</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,767</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">3,661</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Revenue by geographical location</div></div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">North America</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2021To06_30_2021_NorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">688</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2020To06_30_2020_NorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">657</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2021To06_30_2021_NorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,373</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2020To06_30_2020_NorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,324</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">China</div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2021To06_30_2021_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">334</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2020To06_30_2020_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">779</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2021To06_30_2021_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">394</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2020To06_30_2020_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">2,337</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total revenue</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,022</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,436</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,767</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Revenue" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">3,661</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="margin-top: 1em; margin-bottom: 1em"></div> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;">
<tr style="page-break-inside: avoid;">
<td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div>&#160;</td>
<td style="text-align:left;;vertical-align:top;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended June&#160;30, 2021 and 2020, and for the six months ended June&#160;30, 2021 and 2020, &#8220;Total revenue&#8221; includes recognition of previously deferred revenue/internal profit from associate of &#8364;<ix:nonFraction name="asnd:DeferredRevenueFromAssociate" contextRef="P04_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">579</ix:nonFraction>&#160;thousand and &#8364;<ix:nonFraction name="asnd:DeferredRevenueFromAssociate" contextRef="P04_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,013</ix:nonFraction>&#160;thousand, and of &#8364;<ix:nonFraction name="asnd:DeferredRevenueFromAssociate" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">1,155</ix:nonFraction>&#160;thousand and &#8364;<ix:nonFraction name="asnd:DeferredRevenueFromAssociate" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">2,215</ix:nonFraction>&#160;thousand, respectively. </div></div> </td> </tr> </table> </ix:nonNumeric> </ix:nonNumeric> <ix:nonNumeric name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 6&#8212;Segment Information </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is managed and operated as <ix:nonFraction name="asnd:NumberOfReportableOperatingSegments" contextRef="P01_01_2021To06_30_2021" unitRef="Unit_Segment" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> business unit. No separate business areas or separate business units have been identified in relation to product candidates or geographical markets. Accordingly, no additional information on business segments or geographical areas is disclosed. </div></div></ix:nonNumeric> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">8 </div></div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Notes to the Unaudited Condensed Consolidated Interim Financial Statements </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="ifrs-full:DisclosureOfEmployeeBenefitsExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 7&#8212;Warrants and Share-based Payment </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Share-based</div> Payment </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ascendis Pharma A/S has established warrant programs and equity-settled share-based payment transactions, as an incentive for all its employees, members of its Board of Directors and select external consultants. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants are granted by the Company&#8217;s Board of Directors in accordance with authorizations given to it by the shareholders of the Company. As of June&#160;30, 2021, <ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:numdotdecimal">11,023,308</ix:nonFraction> warrants have been granted, of which <ix:nonFraction name="asnd:AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">19,580</ix:nonFraction> warrants have been cancelled, <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:numdotdecimal">4,327,249</ix:nonFraction> warrants have been exercised, <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:numdotdecimal">2,168</ix:nonFraction> warrants have expired without being exercised, and <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:numdotdecimal">608,488</ix:nonFraction> warrants have been forfeited. As of June&#160;30, 2021, the Company&#8217;s Board of Directors was authorized to grant up to <ix:nonFraction name="asnd:NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:numdotdecimal">2,603,979</ix:nonFraction> additional warrants to employees, board members and select consultants without preemptive subscription rights for the shareholders of the Company. Each warrant carries the right to subscribe for one ordinary share of a nominal value of DKK <ix:nonFraction name="ifrs-full:ParValuePerShare" contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_DKK_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">1</ix:nonFraction>. The exercise price is fixed at the fair market value of the Company&#8217;s ordinary shares at the time of grant as determined by the Company&#8217;s Board of Directors. The exercise prices of outstanding warrants under the Company&#8217;s warrant programs range from &#8364;<ix:nonFraction name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" contextRef="PAsOn06_30_2021_BottomOfRangeMemberifrsfullRangeAxis_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">6.48</ix:nonFraction> to &#8364;<ix:nonFraction name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" contextRef="PAsOn06_30_2021_TopOfRangeMemberifrsfullRangeAxis_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">145.5</ix:nonFraction> depending on the grant dates. Vested warrants may be exercised in two or four annual exercise periods. Apart from exercise prices and exercise periods, the programs are similar. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; font-size: 10pt;;font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant Activity</div></div></div></div> <ix:nonNumeric name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" escape="true"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table specifies the warrant activity during the six months ended June&#160;30, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 74%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;Average<br/> Exercise Price<br/> EUR</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="color: white; line-height: 0pt; visibility: hidden;">
<td style="width: 74%; font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding at January&#160;1, 2021</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" contextRef="PAsOn12_31_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:numdotdecimal">6,148,004</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" contextRef="PAsOn12_31_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">69.97</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 74%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted during the period</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:numdotdecimal">158,590</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">120.15</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercised during the period</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:numdotdecimal">150,604</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">33.51</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 74%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited during the period</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(<ix:nonFraction name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:numdotdecimal">90,167</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">121.80</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 74%;">&#160;</td>
<td style="vertical-align: bottom; width: 1%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 1%;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding at June&#160;30, 2021</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:numdotdecimal">6,065,823</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">71.04</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Vested at June&#160;30, 2021</div></div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="asnd:NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:numdotdecimal">3,565,573</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="asnd:WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">46.23</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr> </table> </ix:nonNumeric> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Warrant Compensation Costs </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant compensation costs are determined with a basis in the grant date fair value of the warrants granted and recognized over the vesting period as research and development costs or as selling, general and administrative expenses. For the three months ended June <div style="letter-spacing: 0px; top: 0px;;display:inline;">30</div>, 2021 and 2020, and for the six months ended June&#160;30, 2021 and 2020, warrant compensation costs recognized in the consolidated interim statement of profit or loss was &#8364;<ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="P04_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">16,320</ix:nonFraction>&#160;thousand and &#8364;<ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="P04_01_2020To06_30_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">13,415</ix:nonFraction>&#160;thousand, and &#8364;<ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">39,396</ix:nonFraction>&#160;thousand and &#8364;<ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="P01_01_2020To06_30_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">28,364</ix:nonFraction>&#160;thousand, respectively. </div></div></ix:nonNumeric> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">9 </div></div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></div> <div> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Notes to the Unaudited Condensed Consolidated Interim Financial Statements </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 8&#8212;Marketable Securities </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable securities are measured at amortized cost, and fair values are determined based on quoted market prices (Level 1 in the fair value hierarchy). </div></div> <ix:nonNumeric name="asnd:DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The composition of the portfolio is specified in the following table<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 48%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2020</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying&#160;amount</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying&#160;amount</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="14" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable securities</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U.S. Treasury bills</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">46,243</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">46,245</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">U.S. Government bonds</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">85,049</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">85,049</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">62,088</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">62,101</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Commercial papers</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">8,832</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">8,833</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">10,583</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">10,581</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Corporate bonds</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">144,830</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">144,734</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">121,282</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">121,234</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Agency bonds</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">18,076</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">18,077</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">9,362</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">9,369</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">256,787</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">256,693</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">249,558</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">249,530</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Classified based on maturity profiles</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Non-current</div> assets</div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">90,693</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">90,623</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">115,280</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">115,277</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current assets</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">166,094</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">166,070</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">134,278</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">134,253</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">256,787</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">256,693</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">249,558</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssetsAvailableforsale" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">249,530</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Specified by rate structure</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Fixed rate</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">231,342</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">231,249</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">175,757</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">175,732</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Floating rate</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">16,613</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">16,611</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">16,975</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">16,972</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Zero-coupon</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">8,832</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">8,833</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">56,826</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">56,826</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">256,787</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">256,693</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">249,558</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">249,530</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Specified by investment grade credit rating</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prime</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">6,398</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">6,398</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">7,716</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">7,714</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">High grade</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">127,690</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">127,678</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">142,339</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">142,352</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upper medium grade</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">119,785</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">119,706</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">99,503</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">99,464</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Lower medium grade</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_LowerMediumGradeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">2,914</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_LowerMediumGradeMemberifrsfullExternalCreditGradesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">2,911</ix:nonFraction></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">256,787</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">256,693</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">249,558</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">249,530</ix:nonFraction></div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </ix:nonNumeric> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company&#8217;s marketable securities are all denominated in U.S. Dollars. At June&#160;30, 2021, the portfolio has a weighted average duration of <ix:nonNumeric name="asnd:WeightedAverageDurationOfMarketableSecuritiesCurrent" contextRef="P06_30_2021To06_30_2021" format="ixt-sec:durmonth">6.6</ix:nonNumeric> and <ix:nonNumeric name="asnd:WeightedAverageDurationOfMarketableSecuritiesNoncurrent" contextRef="P06_30_2021To06_30_2021" format="ixt-sec:durmonth">17.5</ix:nonNumeric> months, for current and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> positions, respectively. The entire portfolio has a weighted average duration of <ix:nonNumeric name="asnd:WeightedAverageDurationOfMarketableSecurities" contextRef="P06_30_2021To06_30_2021" format="ixt-sec:durmonth">10.4</ix:nonNumeric> months. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All marketable securities have investment grade ratings, and accordingly, the risk from probability of default is low. The risk of expected credit loss over marketable securities has been considered, including the hypothetical impact arising from the probability of default which is considered in conjunction with the expected loss given default from securities with similar credit ratings and attributes. This assessment did not reveal a material expected credit loss, and accordingly, no provision for expected credit loss has been recognized. </div></div></ix:nonNumeric> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">10 </div></div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="width: 8.5in; margin-left: auto; margin-right: auto;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Notes to the Unaudited Condensed Consolidated Interim Financial Statements </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 9&#8212;Share Capital </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The share capital of Ascendis Pharma A/S consists of <ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="PAsOn06_30_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">53,900,990</ix:nonFraction> outstanding shares at a nominal value of DKK <ix:nonFraction name="ifrs-full:ParValuePerShare" contextRef="PAsOn06_30_2021" unitRef="Unit_DKK_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">1</ix:nonFraction>, all in the same share class. </div></div></ix:nonNumeric> <ix:nonNumeric name="ifrs-full:DisclosureOfLeasesExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 10 &#8212;Lease Liabilities </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;">The Company primarily leases office and laboratory facilities. Lease arrangements contain a range of different terms and conditions and are typically entered into for fixed periods. Generally, the lease terms are determined according to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancellable</div> period and are between <span style="-sec-ix-hidden:hidden25486367">two</span> and <ix:nonNumeric name="asnd:LeaseTerm" contextRef="P01_01_2021To06_30_2021_TopOfRangeMemberifrsfullRangeAxis" format="ixt-sec:durwordsen">twelve years</ix:nonNumeric>. In addition, in order to improve flexibility to the Company&#8217;s operations, lease terms may provide the Company with options to extend the lease or to terminate the lease within the enforceable lease term. In the Company&#8217;s current lease portfolio, extension and termination options range between <span style="-sec-ix-hidden:hidden25486370">two</span> to <ix:nonNumeric name="asnd:LeasesOptionToExtendAndTerminationTerm" contextRef="P01_01_2021To06_30_2021_TopOfRangeMemberifrsfullRangeAxis" format="ixt-sec:durwordsen">ten years</ix:nonNumeric>, in addition to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancellable</div> period. </div> <ix:nonNumeric name="asnd:DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Maturity analysis for lease liabilities recognized in the consolidated statements of financial position at June&#160;30, 2021 is specified below. </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="color: white; line-height: 0pt; visibility: hidden;">
<td style="width: 69%;">&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td> </tr>
<tr style="font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&lt;&#160;1&#160;year</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1-5&#160;years</div></div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&gt;5&#160;years</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total<br/> contractual<br/> cash-flows</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying<br/> amount</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="18" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">June&#160;30, 2021</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 69%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lease liabilities</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">7,051</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanOneYearAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">45,162</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">71,397</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">123,610</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="PAsOn06_30_2021_GrossCarryingAmountMemberASNDLeaseLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">101,009</ix:nonFraction></td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 69%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total lease liabilities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">7,051</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanOneYearAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">45,162</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">71,397</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">123,610</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="PAsOn06_30_2021_GrossCarryingAmountMemberASNDLeaseLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3" scale="3" format="ixt:numdotdecimal">101,009</ix:nonFraction></div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 69%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory" contextRef="P01_01_2021To06_30_2021" escape="true"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 11&#8212;Subsequent Events </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="display:inline;">O</div>n August&#160;25, 2021, the Company announced that the U.S. Food and Drug Administration, or FDA, has approved SKYTROFA (lonapegsomatropin-tcgd) for the treatment of pediatric patients one year and older who weigh at least 11.5&#160;kg (25.4&#160;lb) and have growth failure due to inadequate secretion of endogenous growth hormone (GH). In order to accommodate market demands, the Company has initiated manufacturing of inventories prior to obtaining marketing approval, or pre-launch inventories, for SKYTROFA. However, since pre-launch inventories are not realizable prior to obtaining marketing approval, pre-launch inventories are immediately written down to zero through research and development costs. As a result of the marketing approval received on August&#160;25, 2021, the Company will reverse prior periods&#8217; write-downs of pre-launch inventories through research and development costs, at the lower of cost and net-realizable value. Subsequent to the reporting date, reversal of prior periods&#8217; write-downs is expected to have a positive impact on research and development costs of approximately &#8364;</div></div><ix:nonFraction name="asnd:ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" contextRef="P08_25_2021To08_25_2021_NonadjustingEventsAfterReportingPeriodMemberifrsfullNonadjustingEventsAfterReportingPeriodAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:numdotdecimal">50</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">No other events have occurred after the reporting date that would influence the evaluation of these unaudited condensed consolidated interim financial statements. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></ix:nonNumeric> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">11 </div></div> </div> </div>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d206395dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASCENDIS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PHARMA A/S
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND RESULTS OF OPERATIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>You should
read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated interim financial statements, including the notes thereto, included with this report and the
section contained in our Annual Report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> for the year ended December&nbsp;31, 2020 &#150; &#147;Item 5. Operating and Financial Review and Prospects&#148;. The following discussion is based on our
financial information prepared in accordance with International Accounting Standard 34, &#147;Interim Financial Reporting.&#148; Certain information and disclosures normally included in the consolidated financial statements prepared in accordance
with International Financial Reporting Standards (&#147;IFRS&#148;) have been condensed or omitted. IFRS as issued by the International Accounting Standards Board, and as adopted by the European Union, might differ in material respects from
generally accepted accounting principles in other jurisdictions. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Special Note Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This report contains forward-looking statements concerning our business, operations and financial performance and conditions, as well as our plans, objectives
and expectations for our business operations and financial performance and conditions. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. In some cases, you can identify
forward-looking statements by terminology such as &#147;aim,&#148; &#147;anticipate,&#148; &#147;assume,&#148; &#147;believe,&#148; &#147;contemplate,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;due,&#148; &#147;estimate,&#148;
&#147;expect,&#148; &#147;goal,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;objective,&#148; &#147;plan,&#148; &#147;predict,&#148; &#147;potential,&#148; &#147;positioned,&#148; &#147;seek,&#148; &#147;should,&#148; &#147;target,&#148;
&#147;will,&#148; &#147;would,&#148; and other similar expressions that are predictions or indicate future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements include, but are
not limited to, statements about: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing or likelihood of regulatory filings and approvals for our product candidates, including our
expectations regarding approval of our Marketing Authorization Application for TransCon Growth Hormone, or TransCon hGH or lonapegsomatropin-tcgd; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the commercial availability of lonapegsomatropin-tcgd in the United States and related
patient support services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope, progress, results and costs of developing our product candidates or any other future product
candidates, and conducting preclinical studies and clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our pursuit of oncology as our second of three independent therapeutic areas of focus, and our development of a
pipeline of product candidates related to oncology; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the potential market size and the size of the patient populations for
lonapegsomatropin-tcgd and our other product candidates, if approved for commercial use; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the potential advantages of lonapegsomatropin-tcgd and our other product candidates
over existing therapies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to enter into new collaborations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations with regard to the ability to develop additional product candidates using our TransCon
technologies and file Investigational New Drug Applications, or INDs, or similar for such product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations with regard to the ability to seek expedited regulatory approval pathways for our product
candidates, including the potential ability to rely on the parent drug&#146;s clinical and safety data with regard to our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations with regard to our current and future collaboration partners to pursue the development of our
product candidates and file INDs or similar for such product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our development plans with respect to lonapegsomatropin-tcgd and our other product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to develop, acquire and advance product candidates into, and successfully complete, clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the commercialization of lonapegsomatropin-tcgd and our other product candidates, if approved;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our commercialization, marketing and manufacturing capabilities of lonapegsomatropin-tcgd and our other product
candidates and associated devices; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the implementation of our business model and strategic plans for our business, lonapegsomatropin-tcgd and our
other product candidates and technologies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope of protection we are able to establish and maintain for intellectual property rights covering
lonapegsomatropin-tcgd and our other product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">estimates of our expenses, future revenue, capital requirements, our needs for additional financing and our
ability to obtain additional capital; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial performance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments and projections relating to our competitors and our industry; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effects on our business of the worldwide <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These forward-looking statements are based on senior management&#146;s current expectations, estimates, forecasts and projections about
our business and the industry in which we operate and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking statements in this report may turn out
to be inaccurate. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under the section in our Annual Report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> for the year
ended December&nbsp;31, 2020 &#151; &#147;Item 3.D. Risk Factors&#148;. You are urged to consider these factors carefully in evaluating the forward-looking statements. These forward-looking statements speak only as of the date of this report. Except
as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future. Given these risks and uncertainties, you are cautioned not to rely on such
forward-looking statements as predictions of future events. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should read this report and the documents that we reference in this report and have filed
as exhibits to this report completely and with the understanding that our actual future results may be materially different from what we expect. You should also review the factors and risks we describe in the reports we will file or submit from time
to time with the Securities and Exchange Commission after the date of this report. We qualify all of our forward-looking statements by these cautionary statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are applying our innovative TransCon technologies to build a leading, fully integrated biopharmaceutical company and develop a pipeline of product
candidates with potential best-in-class profiles to address unmet medical needs. We currently have a pipeline of multiple independent endocrinology rare disease and oncology product candidates in development. We are also working to apply our
TransCon technology platform in additional therapeutic areas to address unmet medical needs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August 25, 2021, the U.S. Food and Drug Administration,
or the FDA, approved SKYTROFA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (lonapegsomatropin-tcgd) for the treatment of pediatric patients one year and older who weigh at least 11.5&nbsp;kg (25.4&nbsp;lb) and have growth failure due to
inadequate secretion of endogenous growth hormone. We also have submitted a regulatory application for marketing approval for lonapegsomatropin-tcgd for the treatment of pediatric growth hormone deficiency, or GHD, during 2020 to the European
Medicines Agency. Our initial U.S. commercial organization is in place to enable the U.S. launch of SKYTROFA and we are beginning to build up our commercial organization outside of the U.S. for territories we plan to commercialize with our own sales
organization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2018, we co-founded VISEN Pharmaceuticals, or VISEN, a company established to develop and commercialize our endocrinology rare disease
therapies in the People&#146;s Republic of China, Hong Kong, Macau and Taiwan, or Greater China. We received 50% ownership in the outstanding shares of VISEN and concurrently with the rights we granted to VISEN for lonapegsomatropin-tcgd, TransCon
PTH (palopegteriparatide) and TransCon CNP, entities affiliated with Vivo Capital and Sofinnova Ventures purchased shares in VISEN for an aggregate purchase price of $40&nbsp;million in cash. On January&nbsp;8, 2021, we completed an equity
investment of $12.5&nbsp;million in VISEN as part of VISEN&#146;s $150&nbsp;million Series&nbsp;B financing. Following VISEN&#146;s Series&nbsp;B financing, we retained approximately 44% of VISEN&#146;s issued and outstanding shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We had a net loss of &#128;197.2&nbsp;million for the six months ended June&nbsp;30, 2021, and a net loss of &#128;419.0&nbsp;million for the year ended
December&nbsp;31, 2020. Our total equity was &#128;687.5&nbsp;million as of June&nbsp;30, 2021 compared to &#128;838.7&nbsp;million as of December&nbsp;31, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TransCon Technologies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our TransCon technologies are
designed to solve the fundamental limitations of previous approaches applied to extend duration of a drug&#146;s action in the body, and to enhance the overall benefit of a given therapeutic. Many drugs suffer from suboptimal pharmacokinetics, short
residence time in the body, poor tolerability at the administration site and/or systemic side effects that result from initial drug concentrations that are too high. Frequent administration and poor tolerability negatively impact patient compliance,
potentially leading to suboptimal treatment outcomes. To address these issues, several approaches are currently being applied to improve drug characteristics, such as prodrug and sustained release technologies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our TransCon technologies combine the benefits of conventional prodrug and sustained release technologies to create new therapies with potentially optimized
therapeutic effect, including efficacy, safety and dosing frequency. We believe the technologies can be applied broadly to a protein, peptide, antibody or small molecule in multiple therapeutic areas. TransCon molecules have three components: an
existing parent drug, an inert carrier that protects it, and a linker that temporarily binds the two. When bound, the carrier inactivates and shields the parent drug from clearance. When injected into the body, physiologic pH and temperature
conditions initiate the release of the active, unmodified parent drug in a predictable release manner. Because the parent drug is unmodified, its original mode of action is expected to be maintained. Depending upon the type of TransCon carrier we
employ, we can design our TransCon prodrugs to act systemically or locally in areas that are difficult to treat with conventional therapies. In addition to retaining the original mode of action of the unmodified parent drug, we believe this
predictable release may improve the likelihood of clinical development success. We refer to our systemic and localized applications of TransCon as individual technologies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Lonapegsomatropin-tcgd </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lonapegsomatropin-tcgd is an
investigational once-weekly prodrug designed to deliver somatropin over a one-week period. The released somatropin has the same 191 amino acid sequence as daily somatropin. Lonapegsomatropin-tcgd is approved in the U.S. under the brand name SKYTROFA
for the treatment of pediatric patients one year and older who weigh at least 11.5&nbsp;kg (25.4&nbsp;lb) and have growth failure due to inadequate secretion of endogenous. Lonapegsomatropin-tcgd is under review by the European Medicines Agency as a
once-weekly treatment for pediatric GHD. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SKYTROFA single-use, prefilled cartridges will be available in the U.S. in nine dosage strengths, allowing for
convenient dosing flexibility. They are designed for use only with the SKYTROFA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Auto-Injector and may be stored at room temperature for up to six months. The recommended dose of SKYTROFA for
treatment-na&iuml;ve patients and patients switching from daily somatropin is 0.24&nbsp;mg/kg body weight, administered once weekly. Somatropin released from SKYTROFA produces a dose linear IGF-1 response and the dosage of SKYTROFA may be
individualized and titrated based on response. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the body, a similar distribution pattern to that from daily somatropin is expected once somatropin is
released from lonapegsomatropin-tcgd. We used daily growth hormone as an active comparator in our clinical studies, allowing us to directly compare the activity of lonapegsomatropin-tcgd to daily growth hormone in an identical clinical setting. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our phase 3 pediatric program for lonapegsomatropin-tcgd consists of the heiGHt, fliGHt and enliGHten
Trials. The heiGHt Trial was a randomized, open label, active-controlled phase 3 registrational trial that enrolled 161 children with GHD who had not previously been treated. The fliGHt Trial was designed to evaluate lonapegsomatropin-tcgd in
subjects who were primarily treatment experienced with daily somatropin, although a subgroup of younger subjects were treatment-na&iuml;ve. Nearly all subjects who completed the heiGHt or fliGHt Trials have enrolled in the open-label extension
study, or the enliGHten Trial, which is designed to provide long-term safety data to support the regulatory submissions for lonapegsomatropin-tcgd. We initiated the enliGHten Trial in 2017 as the first subjects began to roll over from the heiGHt
Trial, and we have enrolled approximately 300&nbsp;pediatric subjects. Data from enliGHten formed the long-term safety database supporting our Biologics License Application submission to the FDA for lonapegsomatropin-tcgd for the treatment of
pediatric GHD which was approved in August 2021, as well as submission of an MAA to the European Medicines Agency, or EMA, which occurred in September 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, in January 2021, we announced 104-week analysis of data from the ongoing enliGHten Trial, including follow-up on subjects from height who
continued into enliGHten. The data showed maintenance of a treatment advantage in subjects initially treated with lonapegsomatropin-tcgd beyond the first year of therapy. The safety results, which were comparable to Genotropin in the phase 3 heiGHt
Trial, were consistent across the phase&nbsp;3 clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In September 2020, we filed a Clinical Trial Notification, or CTN, with the
Pharmaceuticals and Medical Devices Agency, or PMDA in Japan, to initiate our phase 3 riGHt Trial of lonapegsomatropin-tcgd for the treatment for pediatric GHD. The primary objective of the riGHt Trial is to evaluate and compare the AHV of 40
Japanese prepubertal treatment-na&iuml;ve children with GHD treated with weekly lonapegsomatropin-tcgd to that of a commercially available daily somatropin formulation at 52&nbsp;weeks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2020, the EMA adopted a decision agreeing with the positive opinion from the Paediatric Development Committee, or PDCO, which approved the proposed
Paediatric Investigation Plan, or PIP, for lonapegsomatropin-tcgd. The PDCO endorsed the lonapegsomatropin-tcgd program as acceptable for assessment of safety and efficacy for the use of lonapegsomatropin-tcgd as a treatment for GHD in children from
six months to less than 18 years of age, mirroring the population covered by the studies conducted in the program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2020, we received orphan drug
designation from the FDA for lonapegsomatropin-tcgd in the United States for the treatment of GHD. The FDA grants orphan designation to drugs that are intended for the treatment, diagnosis, or prevention of rare diseases or disorders that affect
fewer than 200,000 people in the United States, and potentially may be safer or more effective than already approved products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2019, we
received orphan designation from the European Commission, or EC, for lonapegsomatropin-tcgd for GHD. Orphan designation is granted to therapies aimed at the treatment, prevention or diagnosis of a disease that is life-threatening or chronically
debilitating, affects no more than five in 10,000 persons in the European Union and for which no satisfactory method of diagnosis, prevention, or treatment has been authorized (or the product would provide significant additional benefit over
existing therapies). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, we have initiated the foresiGHt Trial, a global phase&nbsp;3 study with the aim to demonstrate the metabolic benefits
of lonapegsomatropin-tcgd in adults with GHD, and in Greater China, VISEN Pharmaceuticals completed the patient enrollment of 154&nbsp;treatment-na&iuml;ve, prepubertal children for the ongoing phase&nbsp;3 pivotal trial of lonapegsomatropin-tcgd in
patients with pediatric GHD in March 2021. We intend to pursue other indications for lonapegsomatropin-tcgd consistent with our strategy to create sustainable growth. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Palopegteriparatide </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are using our TransCon technology
platform to develop palopegteriparatide, an investigational once-daily long-acting prodrug of parathyroid hormone, or PTH, as a potential treatment for adult hypoparathyroidism, or HP, a rare endocrine disorder of calcium and phosphate metabolism.
Palopegteriparatide is designed to replace PTH at physiologic levels for 24 hours each day to address both the short-term symptoms and long-term complications of HP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Current standard of care (SoC) for HP patients primarily consists of active vitamin D and oral calcium supplementation. However, since PTH is not present at
the kidney to facilitate calcium reabsorption from the urine, the goal of SoC is to maintain serum calcium (sCa) levels just below or within the lower part of the normal range and thereby limit as much as possible the damage from excess urinary
calcium. Nonetheless, SoC frequently leads to significant sCa fluctuations accompanied by symptomatic hyper- or hypocalcemia. SoC with active vitamin D and calcium have been shown to contribute to the risk of renal disease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HP also poses a high burden on the healthcare system despite current SoC. For example, one survey of 374 patients showed that 72% experienced more than ten
symptoms in the preceding twelve months, with symptoms experienced for a mean of 13 &plusmn; 9 hours a day. Other studies showed that 79% of HP cases require hospitalizations and that patients with the disease have a four-fold increase in the risk
of renal disease compared to healthy controls. Patients often experience decreased quality of life. We conducted a survey of 42 patients which found that 100&nbsp;percent of subjects reported negative psychological impacts, interference with daily
life and impact on physical functioning from HP, and that 76&nbsp;percent were either no longer able to work or experienced interference with work productivity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Palopegteriparatide is currently in phase 3 development as a treatment for adult HP. In September 2020, we submitted an amendment to our IND to initiate
PaTHway, our North American and European phase 3 double-blinded, placebo controlled clinical trial evaluating the safety, tolerability and efficacy of palopegteriparatide in adults with HP following discussions with FDA and European regulatory
authorities. On July&nbsp;6, 2021, we announced that the PaTHway Trial reached the target enrollment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, on July&nbsp;6, 2021, we announced the
receipt of orphan drug designation for palopegteriparatide from the Japanese Ministry of Health, Labor, and Welfare. Furthermore, we announced the acceptance of the CTN for the PaTHway Japan Trial, a
<FONT STYLE="white-space:nowrap">single-arm,</FONT> phase 3 trial of palopegteriparatide in a minimum of 12 Japanese subjects with HP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;2,
2021, VISEN announced IND approval from the Center for Drug Evaluation on the National Medical Products Administration for the phase&nbsp;3 clinical trial of palopegteriparatide in adult subjects with HP, the PaTHway China Trial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&nbsp;10, 2021, we announced preliminary <FONT STYLE="white-space:nowrap">58-week</FONT> results from the continuing open-label extension, or OLE,
portion of the PaTH Forward Trial, a global phase 2 trial evaluating the safety, tolerability, and efficacy of its investigational product candidate, palopegteriparatide, in adult subjects with HP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Key Findings of the Preliminary OLE Results of PaTH Forward Trial at 58 weeks </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">58 subjects continued in the open-label extension beyond 58 weeks </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Continued treatment with palopegteriparatide demonstrated that: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">91% of subjects were off standard of care therapy defined as no active vitamin D and less than or equal to 600
mg/day of calcium supplements </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Urinary calcium maintained in the normal range </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Bone markers trended towards the <FONT STYLE="white-space:nowrap">mid-normal</FONT> levels </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quality of life benefits measured by <FONT STYLE="white-space:nowrap">SF-36</FONT> continued within normal range
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Palopegteriparatide was well-tolerated at all doses administered </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">No treatment-related serious or severe adverse events occurred, and no treatment-emergent adverse events led to
discontinuation of study drug </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">No change to the safety profile in the OLE portion of the study </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of August 23, 2021, 58 subjects continue in the OLE portion of the PaTH Forward Trial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2020, the EC granted orphan designation to TransCon PTH for the treatment of HP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2020, we reported data from the four-week fixed dose, blinded portion of PaTH Forward Trial on <FONT STYLE="white-space:nowrap">SF-36</FONT><SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Health Survey which demonstrated that palopegteriparatide significantly improved quality of life and restored physical and mental functioning toward a normal level compared to placebo. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2020, we reported positive <FONT STYLE="white-space:nowrap">top-line</FONT> results from the four-week fixed dose, blinded portion of our phase 2
PaTH Forward Trial, which evaluated the safety, tolerability and efficacy of three fixed doses of palopegteriparatide using a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ready-to-use</FONT></FONT> prefilled pen injector planned
for commercial presentation. The goal of PaTH Forward was to identify a starting dose for a pivotal phase 3 trial, establish a titration regimen for complete withdrawal of standard of care (i.e., active vitamin D and calcium supplements), and
evaluate palopegteriparatide control of serum and urinary calcium. A total of 59 subjects were randomized in a blinded manner to receive fixed doses of palopegteriparatide at 15, 18 or 21 &micro;g/day or placebo for four weeks. All doses of
palopegteriparatide were well-tolerated, and no serious or severe adverse events were shown during this period. No treatment-emergent adverse events, or TEAEs, led to discontinuation of study drug, and the overall incidence of TEAEs was comparable
between palopegteriparatide and placebo. Additionally, there were no drop-outs during the four-week fixed dose period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2018, we were granted
orphan drug designation by the FDA for palopegteriparatide for the treatment of hypoparathyroidism. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TransCon
<FONT STYLE="white-space:nowrap">C-Type</FONT> Natriuretic Peptide </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TransCon C-Type Natriuetic Peptide, or TransCon CNP, is an investigational
long-acting prodrug of CNP designed to provide continuous CNP exposure at therapeutic levels with a well-tolerated and convenient once-weekly dose. It is being developed for the treatment of children with achondroplasia. TransCon CNP is designed to
provide effective shielding of CNP from neutral endopeptidase degradation in subcutaneous tissue and the blood compartment, minimize binding of CNP to the <FONT STYLE="white-space:nowrap">NPR-C</FONT> receptor to decrease clearance, reduce binding
of CNP to the <FONT STYLE="white-space:nowrap">NPR-B</FONT> receptor in the cardiovascular system to avoid hypotension, and release unmodified CNP, which is small enough in size to allow effective penetration into growth plates. We believe TransCon
CNP offers advantages over short-acting CNP and CNP analogs in development that result in high Cmax levels which may cause adverse cardiovascular events. In addition, we expect a more constant CNP exposure at lower Cmax to correlate with better
therapeutic outcomes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2019, we initiated the phase 2 ACcomplisH Trial to evaluate safety and efficacy of TransCon CNP in children (ages <FONT
STYLE="white-space:nowrap">2-10</FONT> years) with achondroplasia. In collaboration with VISEN, we are sponsoring the ACcomplisH China Trial, a randomized, double-blind, placebo-controlled, phase 2 dose expansion trial to evaluate the safety and
efficacy of TransCon CNP in subjects with achondroplasia. The primary endpoint is to evaluate the safety of treatment and its effect on <FONT STYLE="white-space:nowrap">12-month</FONT> annualized height velocity. In January 2021, China Center for
Drug Evaluation of National Medical Products Administration approved VISEN&#146;s IND application to conduct the ACcomplisH China Trial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2020, we
received orphan designation from the EC for TransCon CNP for treatment of achondroplasia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In February 2019, we were granted orphan drug designation by
the FDA for TransCon CNP for the treatment of achondroplasia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2018, we reported preliminary results from a phase 1 trial in healthy adult
subjects, which we believe supported our target product profile for TransCon CNP. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TransCon Product Candidates within Oncology </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2019, we established oncology as our second independent therapeutic area of focus for our TransCon technologies. Our goal is to improve treatment
efficacy while limiting or reducing toxicity by applying TransCon technologies to clinically validated drugs, using our unique algorithm for product innovation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are conducting preclinical studies within the field of oncology to explore multiple potential product
candidates and evaluate systemic as well as localized delivery systems using our TransCon technologies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are currently advancing two product
candidates: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">TransCon TLR7/8 Agonist is designed for sustained release of TLR7/8 agonist, resiquimod, and intended for
intratumoral administration. This product candidate is designed to provide potent activation of the innate immune system in the tumor and draining lymph nodes and to have low risk of systemic toxicity. In December 2020, we filed an IND with the FDA
to initiate the clinical program of TransCon TLR7/8 Agonist with the <FONT STYLE="white-space:nowrap">transcendIT-101</FONT> Trial. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">TransCon <FONT STYLE="white-space:nowrap">IL-2</FONT> &szlig;/<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT> is
designed for prolonged exposure of an <FONT STYLE="white-space:nowrap">IL-2</FONT> variant that selectively activates the <FONT STYLE="white-space:nowrap">IL-2R&szlig;/</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT>, with minimal binding to <FONT
STYLE="white-space:nowrap">IL-2R&#945;.</FONT> This product candidate is designed to provide potent anti-tumor activity and to have reduced risk of toxicity, such as vascular leak syndrome. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are evaluating additional TransCon product candidates in nonclinical research studies for the treatment of a variety of tumor types. Examples of TransCon
product candidates under evaluation include stimulators of innate and adaptive immunity, as well as modulators of the tumor environment. We are exploring systemic and intratumoral administration both as a monotherapy and as a component of
combination regimens. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TransCon Product Candidate Pipeline </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g206395g20i18.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Impact from <FONT STYLE="white-space:nowrap">COVID-19</FONT> Pandemic </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A novel strain of coronavirus <FONT STYLE="white-space:nowrap">(&#147;COVID-19&#148;)</FONT> was reported to have surfaced in Wuhan, China, in December 2019.
Since then, <FONT STYLE="white-space:nowrap">COVID-19</FONT> has spread around the world into a pandemic, including into countries where we are operating, where we have planned or have ongoing clinical trials, and where we rely on third-parties to
manufacture preclinical and clinical supplies, as well as commercial supply. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since <FONT STYLE="white-space:nowrap">COVID-19</FONT> started to spread
around the world, we have closely monitored the development, and implemented several measures to accommodate any potential negative impact on our business, and to ensure the safety of our employees, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Encouraging employees to work remotely, reduce travel activity and minimize <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">face-to-face</FONT></FONT> meetings; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Establishing home offices, and ensuring proper and secure IT infrastructure, enabling a safe and efficient remote
work environment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Implementing remote visits for patients enrolled in our clinical trials, including ensuring safe delivery of
clinical drugs; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Addressing <FONT STYLE="white-space:nowrap">COVID-19</FONT> in relation to logistics and manufacturing at Joint
Steering Committees with manufacturing partners. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While <FONT STYLE="white-space:nowrap">COVID-19</FONT> has an impact on how we work
and conduct our activities, we have managed to avoid significant disruptions to our operations. Further, while <FONT STYLE="white-space:nowrap">COVID-19</FONT> continues to remain in the global society, we will keep working with <FONT
STYLE="white-space:nowrap">COVID-19</FONT> measures to accommodate any business disruptions and to achieve our strategic objectives. Further, as a participant in the global fight against spreading the virus, we will maintain and further develop
precautionary measures within our organization, including encouraging our employees to work remotely, reduce travel activity and minimize <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">face-to-face</FONT></FONT> meetings. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, to accommodate efficient procedures for financial reporting, including internal controls, we have, also before the pandemic, structured our work
environment, enabling our employees to perform their tasks remotely. Accordingly, it has not been necessary to make material changes to our internal control over financial reporting due to the pandemic. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While <FONT STYLE="white-space:nowrap">COVID-19</FONT> did not have a significant negative impact on our business, we foresee elevated <FONT
STYLE="white-space:nowrap">COVID-19</FONT> related risks in certain areas, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In conducting our clinical trials, there is a risk that suppliers experience delays in providing necessary
equipment, consumables and services, which potentially could cause temporary delays in clinical trial activities. In addition, there is a risk that patients will elect not to enroll in trials to limit their exposure to medical institutions, which
could potentially have a negative impact on clinical trial timelines; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Global demand for <FONT STYLE="white-space:nowrap">COVID-19</FONT> vaccines could result in contract
manufacturers not having sufficient capacity to meet scheduled manufacturing. In addition, sourcing of certain types of raw materials, consumables and equipment could result in scheduled manufacturing being delayed or postponed; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our commercial launch strategy could be negatively impacted by patients not being able to see their physicians,
and similarly, our commercial team not being able to meet with physicians, which could both have a negative impact on the commercial launch strategy. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We monitor these risks closely, and work with relevant stakeholders to avoid disruptions, and to develop and establish working measures. However, while <FONT
STYLE="white-space:nowrap">COVID-19</FONT> continues to impact global societies, the uncertainty related to the duration and direction of the pandemic makes the future impact from <FONT STYLE="white-space:nowrap">COVID-19,</FONT> including the
magnitude of any impact on our operational results, highly uncertain and unpredictable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For additional description related to <FONT
STYLE="white-space:nowrap">COVID-19</FONT> related risks, please refer to &#147;Item 3D. Risk Factors&#148;, set forth in our 2020 Annual Report on Form <FONT STYLE="white-space:nowrap">20-F.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Three Months Ended June&nbsp;20, 2021 and 2020 (unaudited): </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended</B><br><B>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(EUR&#146;000)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,436</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(83,306</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(63,578</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(35,345</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(20,805</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating profit / (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>(117,629</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>(82,947</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of profit / (loss) of associate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,817</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,885</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(12,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(10,292</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Profit / (loss) before tax</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>(134,442</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>(95,038</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax on profit / (loss) for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net profit / (loss) for the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>(134,374</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>(94,932</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Revenue </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue
for the three months ended June&nbsp;30, 2021 was &#128;1.0&nbsp;million, a decrease of &#128;0.4&nbsp;million, compared to &#128;1.4&nbsp;million for the three months ended June&nbsp;30, 2020, and primarily comprised sale of clinical supplies,
rendering of services, and recognition of internal profit deferred from November 2018 when we entered into the collaboration with VISEN. The decrease was due to a lower amount of license revenue being recognized, partly offset by increased sale of
clinical supplies and services to VISEN and recognition of revenue from services rendered to another collaboration partner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development costs were &#128;83.3&nbsp;million for the three months ended June&nbsp;30, 2021, an increase of &#128;19.7&nbsp;million, or 31%,
compared to &#128;63.6&nbsp;million for the three months ended June&nbsp;30, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">External development costs related to lonapegsomatropin-tcgd increased
by &#128;10.4&nbsp;million compared to the same period last year, reflecting higher costs for manufacturing of product supply, but also reflecting higher costs for the ongoing clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">External development costs related to palopegteriparatide increased by &#128;1.2&nbsp;million, primarily reflecting increased costs for clinical trials and
clinical supplies as well as costs related to device development, compared to the same period last year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">External development costs related to TransCon
CNP increased by &#128;3.3&nbsp;million, primarily reflecting an increase in clinical trial costs and clinical supplies, but also increasing manufacturing costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">External development costs related to our oncology product candidates, primarily TransCon TLR7/8 Agonist and TransCon
<FONT STYLE="white-space:nowrap">IL-2</FONT> &szlig;/<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT> increased by &#128;1.2&nbsp;million, reflecting an increase in costs for clinical trials and clinical supplies as these product candidates progress
through the development stages and into manufacturing and clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other research and development costs increased by &#128;3.6&nbsp;million,
primarily driven by an increase in personnel costs of &#128;3.3&nbsp;million and <FONT STYLE="white-space:nowrap">non-cash</FONT> share- based payment of &#128;0.5&nbsp;million due to a higher number of employees in research and development
functions. Facility costs increased by &#128;1.6&nbsp;million, whereas other costs allocated to research and development functions decreased by a total of &#128;1.8&nbsp;million, primarily relating to IT and professional fees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development costs included <FONT STYLE="white-space:nowrap">non-cash</FONT> share-based payment of &#128;8.6&nbsp;million for the three months
ended June&nbsp;30, 2021, compared to &#128;8.1&nbsp;million for the three months ended June&nbsp;30, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Selling, General and Administrative
Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expenses were &#128;35.3&nbsp;million for the three months ended June&nbsp;30, 2021, an increase of
&#128;14.5&nbsp;million, or 70%, compared to &#128;20.8&nbsp;million for the three months ended June&nbsp;30, 2020. The higher expenses were primarily due to an increase in personnel costs of &#128;4.1&nbsp;million and
<FONT STYLE="white-space:nowrap">non-cash</FONT> share-based payment of &#128;2.5&nbsp;million for additional commercial and administrative personnel, and an increase in IT costs, including the implementation of a new
<FONT STYLE="white-space:nowrap">ERP-system,</FONT> of &#128;5.5&nbsp;million. Other costs allocated to selling, general and administrative functions increased by a total of &#128;2.4&nbsp;million, primarily reflecting increasing professional fees
of &#128;1.6&nbsp;million, facility costs of &#128;0.3&nbsp;million and insurance costs of &#128;0.3&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Selling, general and administrative
expenses included <FONT STYLE="white-space:nowrap">non-cash</FONT> share-based payment of &#128;7.7&nbsp;million for the three months ended June&nbsp;30, 2021, compared to &#128;5.2&nbsp;million for the three months ended June&nbsp;30, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Profit / (Loss) of Associate </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net loss of
associate was &#128;4.8&nbsp;million for the three months ended June&nbsp;30, 2021, compared to a net loss of &#128;1.9&nbsp;million for the three months ended June&nbsp;30, 2020. The net loss represents our share of net result from VISEN. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Finance Income and Finance Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finance
income was &#128;0.1&nbsp;million for the three months ended June&nbsp;30, 2021 compared to &#128;0.1&nbsp;million for the three months ended June&nbsp;30, 2020. Finance expenses were &#128;12.1&nbsp;million for the three months ended June&nbsp;30,
2021 compared to &#128;10.3&nbsp;million for the same period in 2020. As we hold positions of marketable securities and cash and cash equivalents in U.S. Dollars, we are affected by exchange rate fluctuations when reporting our financial results in
Euro. For the three months ended June&nbsp;30, 2021, as well as for the same period last year, we recognized net exchange rate losses when reporting our U.S.&nbsp;Dollar positions in Euro, reflecting negative exchange rate fluctuations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We did not have any interest-bearing debt for any of the periods presented. However, IFRS 16, &#147;Leases,&#148; requires interest expenses to be accrued on
lease liabilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tax for the Period </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tax
for the three months ended June&nbsp;30, 2021 was a net tax credit of &#128;0.1&nbsp;million compared to a net tax credit of &#128;0.1&nbsp;million for the three months ended June&nbsp;30, 2020. Taxes for the three months ended June&nbsp;30, 2021
comprised an estimated tax credit of &#128;0.2&nbsp;million in the group of Danish companies, partly offset by a tax provision of &#128;0.1&nbsp;million in our German subsidiary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Six Months Ended June&nbsp;20, 2021 and 2020 (unaudited): </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six&nbsp;Months&nbsp;Ended</B><br><B>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(EUR&#146;000)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(171,455</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(121,093</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(72,591</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(38,720</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating profit / (loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(242,279</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(156,152</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share of profit / (loss) in associates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,400</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,703</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Profit / (loss) before tax</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(197,425</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(158,432</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax on profit / (loss) for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net profit / (loss) for the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(197,166</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(158,249</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Revenue </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue
for the six months ended June&nbsp;30, 2021 was &#128;1.8&nbsp;million, a decrease of &#128;1.9&nbsp;million, compared to &#128;3.7&nbsp;million for the six months ended June&nbsp;30, 2020, and primarily comprised sale of clinical supplies,
rendering of services, and recognition of internal profit deferred from November 2018 when we entered into the collaboration with VISEN. The decrease was due to a lower amount of license revenue being recognized, as well as lower sale of services to
VISEN, partly offset by recognition of revenue from services rendered to another collaboration partner. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development costs were &#128;171.5&nbsp;million for the six months ended June&nbsp;30, 2021, an increase of &#128;50.4&nbsp;million, or 42%,
compared to &#128;121.1&nbsp;million for the six months ended June&nbsp;30, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">External development costs related to lonapegsomatropin-tcgd increased
by &#128;20.4&nbsp;million compared to the same period last year, primarily reflecting higher costs for manufacturing of product supply, but also reflecting higher costs for the ongoing clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">External development costs related to palopegteriparatide increased by &#128;3.0&nbsp;million, primarily reflecting increased costs related to manufacturing
of validation batches, device development, and increasing costs for clinical trials and clinical supplies, compared to the same period last year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">External development costs related to TransCon CNP increased by &#128;9.2&nbsp;million, primarily reflecting an increase in clinical trial costs and clinical
supplies, but also increasing manufacturing costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">External development costs related to our oncology product candidates, primarily TransCon TLR7/8
Agonist and TransCon <FONT STYLE="white-space:nowrap">IL-2</FONT> &szlig;/<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT> increased by &#128;6.8&nbsp;million, reflecting increases in preclinical and manufacturing costs, as well as increasing costs
for clinical trials and clinical supplies as these product candidates progress through the development stages and into manufacturing and clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other research and development costs increased by &#128;11.0&nbsp;million, primarily driven by an increase in personnel costs of &#128;8.3&nbsp;million and <FONT
STYLE="white-space:nowrap">non-cash</FONT> share-based payment of &#128;5.8&nbsp;million due to a higher number of employees in research and development functions. Facility costs increased by &#128;2.5&nbsp;million, whereas other costs allocated to
research and development functions decreased by a total of &#128;5.7&nbsp;million, primarily relating to IT, travel costs and professional fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research
and development costs included <FONT STYLE="white-space:nowrap">non-cash</FONT> share-based payment of &#128;22.8&nbsp;million for the six months ended June&nbsp;30, 2021, compared to &#128;17.0&nbsp;million for the six months ended June&nbsp;30,
2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Selling, General and Administrative Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expenses were &#128;72.6&nbsp;million for the six months ended June&nbsp;30, 2021, an increase of &#128;33.9&nbsp;million,
or 87%, compared to &#128;38.7&nbsp;million for the six months ended June&nbsp;30, 2020. The higher expenses were primarily due to an increase in personnel costs of &#128;8.9&nbsp;million and <FONT STYLE="white-space:nowrap">non-cash</FONT>
share-based payment of &#128;5.3&nbsp;million for additional commercial and administrative personnel, and an increase in IT costs of &#128;10.5&nbsp;million, primarily related to the implementation of new
<FONT STYLE="white-space:nowrap">ERP-system.</FONT> Other costs allocated to selling, general and administrative functions increased by a total of &#128;9.2&nbsp;million, primarily reflecting increasing insurance costs of &#128;2.5&nbsp;million,
professional fees of &#128;3.2&nbsp;million, facility costs of &#128;1.3&nbsp;million, and costs related to building our commercial business of &#128;1.6&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expenses included <FONT STYLE="white-space:nowrap">non-cash</FONT>
share-based payment of &#128;16.6&nbsp;million for the six months ended June&nbsp;30, 2021, compared to &#128;11.3&nbsp;million for the six months ended June&nbsp;30, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Profit / (Loss) of Associate </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net profit of
associate was &#128;23.3&nbsp;million for the six months ended June&nbsp;30, 2021, compared to a net loss of &#128;3.4&nbsp;million for the six months ended June&nbsp;30, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the six months ended June&nbsp;30, 2021, the net profit of associate comprises a <FONT STYLE="white-space:nowrap">non-cash</FONT> gain of
&#128;42.3&nbsp;million as a result of the Series B financing in VISEN on January&nbsp;8, 2021, and our share of loss of &#128;19.0&nbsp;million. The Series B financing has not changed our accounting treatment of VISEN. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Finance Income and Finance Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finance
income was &#128;23.3&nbsp;million for the six months ended June&nbsp;30, 2021 compared to &#128;2.0&nbsp;million for the six months ended June&nbsp;30, 2020. Finance expenses were &#128;1.7&nbsp;million for the six months ended June&nbsp;30, 2021
compared to &#128;0.9&nbsp;million for the same period in 2020. As we hold positions of marketable securities and cash and cash equivalents in U.S.&nbsp;Dollar, we are affected by exchange rate fluctuations when reporting our financial results in
Euro. For the six months ended June&nbsp;30, 2021, as well as for the same period last year, we recognized net exchange rate gains when reporting our U.S.&nbsp;Dollar positions in Euro, reflecting positive exchange rate fluctuations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We did not have any interest-bearing debt for any of the periods presented. However, IFRS 16, &#147;Leases&#148;, requires interest expenses to be accrued on
lease liabilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tax for the Period </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tax
for the six months ended June&nbsp;30, 2021 was a net tax credit of &#128;0.3&nbsp;million compared to a net tax credit of &#128;0.2&nbsp;million for the six months ended June&nbsp;30, 2020. Taxes for the six months ended June&nbsp;30, 2021
comprised an estimated tax credit of &#128;0.4&nbsp;million in the group of Danish companies and a tax credit of &#128;0.1&nbsp;million in our U.S. subsidiaries, partly offset by a tax provision of &#128;0.2&nbsp;million in our German subsidiary.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our liquidity and
capital resources comprise cash, cash equivalents and marketable securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2021, these amounted to &#128;641.3&nbsp;million, and
are specified as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair<BR>value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(EUR&#146;000)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>June&nbsp;30, 2021</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="5" VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liquidity and capital resources</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">256,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">256,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">384,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">384,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total liquidity and capital resources</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>641,326</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>641,232</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Classification in consolidated statement of financial position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,633</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total liquidity and capital resources</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>641,326</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>641,232</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marketable securities have a weighted average duration of 6.6 and 17.5 months, for current (i.e., those maturing within twelve
months after the reporting date) and <FONT STYLE="white-space:nowrap">non-current</FONT> positions, respectively. The entire portfolio of marketable securities (current and <FONT STYLE="white-space:nowrap">non-current)</FONT> has a weighted average
duration of 10.4 months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have historically funded our operations primarily through issuance of preference shares, ordinary shares, including our
initial public offering, <FONT STYLE="white-space:nowrap">follow-on</FONT> offerings and exercise of warrants, convertible debt securities, and payments to us under collaboration agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In February 2015, we announced the closing of our initial public offering, with net proceeds of $111.5&nbsp;million (or &#128;101.4 million). In addition, we
have completed <FONT STYLE="white-space:nowrap">follow-on</FONT> public offerings of American Depositary Shares (&#147;ADSs&#148;) as specified below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In 2016, with net proceeds of $127.1&nbsp;million (or &#128;116.6 million); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In 2017, with net proceeds of $145.2&nbsp;million (or &#128;123.1 million); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In 2018, with net proceeds of $242.5&nbsp;million (or &#128;198.6 million); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In 2019, with net proceeds of $539.4&nbsp;million (or &#128;480.3 million); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In 2020, with net proceeds of $654.6&nbsp;million (or &#128;580.5 million). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our expenditures are primarily related to research and development activities and general and administrative activities to support research and development,
as well as activities for building our sales and marketing capabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We manage our liquidity risk by maintaining adequate cash reserves and banking
facilities, and by matching the maturity profiles of financial assets including marketable securities, with cash-forecasts including payment profiles on liabilities. We monitor the risk of a shortage of funds using a liquidity planning tool, to
ensure sufficient funds available to settle liabilities as they fall due. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on our current operating plan, we believe that our existing cash, cash
equivalents and marketable securities as of June&nbsp;30, 2021, will be sufficient to meet our projected cash requirements for at least twelve months from the date of this report. However, our operating plan may change as a result of many factors
currently unknown to us, and we may need to seek additional funds sooner than planned. Our future funding requirements will depend on many factors, including, but not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the manufacturing, selling and marketing costs associated with product candidates, including the cost and timing
of building our sales and marketing capabilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing, receipt, and amount of sales of, or royalties on, our future products, if any; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sales price and the availability of adequate third-party coverage and reimbursement for our product
candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to establish and maintain strategic partnerships, licensing or other arrangements and the financial
terms of such agreements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to collect payments which are due to us from collaboration partners (if any), which in turn is
impacted by the financial standing of any such collaboration partners; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the progress, timing, scope, results and costs of our preclinical studies and clinical trials and manufacturing
activities for our product candidates that have not been licensed, including the ability to enroll patients in a timely manner for clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the time and cost necessary to obtain regulatory approvals for our product candidates that have not been licensed
and the costs of post-marketing studies that could be required by regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cash requirements of any future acquisitions or discovery of product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number and scope of preclinical and discovery programs that we decide to pursue or initiate;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential acquisition and <FONT STYLE="white-space:nowrap">in-licensing</FONT> of other technologies,
products or assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the time and cost necessary to respond to technological and market developments, including further development of
our TransCon technologies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the achievement of development, regulatory and commercial milestones resulting in the payment to us from
collaboration partners of contractual milestone payments and the timing of receipt of such payments, if any; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our progress in the successful commercialization and <FONT STYLE="white-space:nowrap">co-promotion</FONT> of our
most advanced product candidates and our efforts to develop and commercialize our other existing product candidates; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of filing, prosecuting, maintaining, defending and enforcing any patent claims and other intellectual
property rights, including litigation costs and the outcome of such litigation, including costs of defending any claims of infringement brought by others in connection with the development, manufacture or commercialization of our product candidates.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional funds may not be available when we need them on terms that are acceptable to us, or at all. If adequate funds are not
available to us on a timely basis, we may be required to delay, limit, scale back or cease our research and development activities, preparing for potential commercialization, preclinical studies and clinical trials for our product candidates for
which we retain such responsibility and our establishment and maintenance of sales and marketing capabilities or other activities that may be necessary to commercialize our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our cash flows for each of the unaudited six month periods ended June&nbsp;30, 2021 and 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six&nbsp;Months&nbsp;Ended</B><br><B>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(EUR&#146;000)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from / (used in) operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(196,820</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(123,397</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from / (used in) investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(19,082</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(244,482</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from / (used in) financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,411</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net increase / (decrease) in cash and cash equivalents</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(214,491</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(360,209</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows from / (Used in) Operating Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities for the six months ended June&nbsp;30, 2021 was &#128;196.8&nbsp;million compared to &#128;123.4&nbsp;million for the six
months ended June&nbsp;30, 2020. The net loss for the six months ended June&nbsp;30, 2021 of &#128;197.2&nbsp;million included <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of &#128;46.7&nbsp;million, comprising share-based payment,
depreciation and amortization, and <FONT STYLE="white-space:nowrap">non-cash</FONT> net income, including <FONT STYLE="white-space:nowrap">non-cash</FONT> revenue, net financial income and taxes, of &#128;45.2&nbsp;million. The net change in working
capital contributed negatively to cash flows by &#128;1.2&nbsp;million, primarily due to an increase in prepayments and receivables of &#128;11.9&nbsp;million, a decrease in deferred income of &#128;0.2&nbsp;million, partly offset by a net increase
in trade payables, accrued expenses and other payables of &#128;10.9&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities for the six months ended
June&nbsp;30, 2020 was &#128;123.4&nbsp;million. The net loss for the six months ended June&nbsp;30, 2020 of &#128;158.2&nbsp;million included <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of &#128;32.6&nbsp;million, comprising
share-based payment and depreciation, and <FONT STYLE="white-space:nowrap">non-cash</FONT> net charges, including net financial income and taxes, of &#128;1.4&nbsp;million. The net change in working capital contributed positively to cash flows by
&#128;0.8&nbsp;million, primarily due to a net increase in trade payables and other payables of &#128;8.0&nbsp;million, partly offset by an increase in receivables and prepayments of &#128;6.3&nbsp;million and a decrease in deferred income of
&#128;0.9&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows from / (Used in) Investing Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash flows used in investing activities for the six months ended June&nbsp;30, 2021 of &#128;19.1&nbsp;million were related to the acquisition of marketable
securities of &#128;76.4&nbsp;million and the settlement of marketable securities of &#128;75.6&nbsp;million, to Series B investment in VISEN of &#128;10.2&nbsp;million, to the acquisition of property, plant and equipment of &#128;7.6&nbsp;million,
primarily related to leasehold improvements and equipment for use in the United States, and to the acquisition of software of &#128;0.5&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash flows used in investing activities for the six months ended June&nbsp;30, 2020 of &#128;244.5&nbsp;million were related to acquisition of marketable
securities of &#128;233.4&nbsp;million, to acquisition of property, plant and equipment of &#128;10.8&nbsp;million, primarily related to our oncology laboratories in the United States and for use in the laboratories of our German facility, and to
acquisition of software of &#128;0.3&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows from / (Used in) Financing Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash flows from financing activities for the six months ended June&nbsp;30, 2021 of &#128;1.4&nbsp;million were comprised of &#128;4.8&nbsp;million in net
proceeds from warrant exercises in March, May and June 2021, partly offset by payments on principal portion of lease liabilities of &#128;3.4&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash flows from financing activities for the six months ended June&nbsp;30, 2020 of &#128;7.7&nbsp;million were comprised of &#128;10.0&nbsp;million in net
proceeds from warrant exercises in April, May and June 2020, partly offset by payments on lease liabilities of &#128;2.3&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">Off-balance</FONT> Sheet Arrangements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not entered into any <FONT STYLE="white-space:nowrap">off-balance</FONT>
sheet arrangements or any holdings in variable interest entities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Qualitative Disclosures about Market Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our activities expose us to the financial risks of changes in foreign currency exchange rates and interest rates. We do not enter into derivative financial
instruments to manage our exposure to such risks. Further, we are exposed to credit risk and liquidity risk. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Foreign Currency Risk </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are exposed to foreign exchange risk arising from various currency exposures, primarily with respect to the U.S.&nbsp;Dollar, the British Pound and the
Danish Krone. We have received payments in U.S. Dollars under our collaborations, and the proceeds from our series D financing in November 2014, our initial public offering in February 2015, and our <FONT STYLE="white-space:nowrap">follow-on</FONT>
offerings, the latest being in July 2020, were in U.S. Dollars. We seek to minimize our exchange rate risk by maintaining cash positions in the currencies in which we expect to incur the majority of our future expenses and we make payments from
those positions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Rate Risk </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have
no interest-bearing debt to third parties. In addition, while we hold no derivatives or financial assets and liabilities measured at fair value, the exposure to interest rate risk primarily relates to the interest rates for cash, cash equivalents
and marketable securities. Future interest income from interest-bearing bank deposits and marketable securities may fall short of expectations due to changes in interest rates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Credit Risk </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have adopted an investment policy
with the primary purpose of preserving capital, fulfilling our liquidity needs and diversifying the risks associated with cash, cash equivalents and marketable securities. Our investment policy establishes minimum ratings for institutions with which
the we hold cash, cash equivalents and marketable securities, as well as rating and concentration limits for marketable securities held. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All material counterparties are considered creditworthy. While the concentration of credit risk may be
significant, the credit risk for each individual counterpart is considered to be low. Our exposure to credit risk primarily relates to cash, cash equivalents and marketable securities. The credit risk on our bank deposits is limited because the
counterparties, holding significant deposits, are banks with high credit rating (minimum <FONT STYLE="white-space:nowrap">A3/A-)</FONT> assigned by international credit ratings agencies. The banks are reviewed on a regular basis and deposits may be
transferred during the year to mitigate credit risk. On each reporting date, we consider the risk of expected credit loss on bank deposits, including the hypothetical impact arising from the probability of default, in conjunction with the expected
loss caused by default by banks with similar credit ratings and attributes. In line with previous periods, this assessment did not reveal a material impairment loss, and accordingly no provision for expected credit loss has been recognized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since March 2020, in order to mitigate the concentration of credit risks on bank deposits and to preserve capital, a portion of our bank deposits have been
placed into primarily U.S. government bonds, treasury bills, corporate bonds and commercial papers. Our investment policy, approved by the Board of Directors, only allows investment in marketable securities having investment grade credit ratings,
assigned by international credit rating agencies. Accordingly, the risk and probability of default is considered low. The risk of expected credit loss on marketable securities has been considered, including the hypothetical impact arising from the
probability of default, in conjunction with the expected loss caused by default on securities with similar credit ratings and attributes. This assessment did not reveal a material expected credit loss, and accordingly no provision for expected
credit loss has been recognized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For our receivables the credit risk is considered low and no provision for expected credit loss has been recognized.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>asnd-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 27-August-2021 [01:11:57] {AM}-->
<schema targetNamespace="http://ascendispharma.com/20210630" elementFormDefault="qualified" xmlns:asnd="http://ascendispharma.com/20210630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31">
<annotation>
<appinfo>
<link:roleType roleURI="http://ascendispharma.com/role/CoverPage" id="CoverPage">
<link:definition>1001 - Document - Cover Page</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss" id="CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss">
<link:definition>1002 - Statement - Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical" id="CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical">
<link:definition>1003 - Statement - Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss) (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition" id="CondensedConsolidatedInterimStatementsOfFinancialPosition">
<link:definition>1004 - Statement - Condensed Consolidated Interim Statements of Financial Position</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity" id="CondensedConsolidatedInterimStatementsOfChangesInEquity">
<link:definition>1005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements" id="CondensedConsolidatedInterimCashFlowStatements">
<link:definition>1006 - Statement - Condensed Consolidated Interim Cash Flow Statements</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/GeneralInformation" id="GeneralInformation">
<link:definition>1007 - Disclosure - General Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition>1008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty" id="CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty">
<link:definition>1009 - Disclosure - Critical Accounting Judgements and Key Sources of Estimation Uncertainty</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SignificantEventsInTheReportingPeriod" id="SignificantEventsInTheReportingPeriod">
<link:definition>1010 - Disclosure - Significant Events In The Reporting Period</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/Revenue" id="Revenue">
<link:definition>1011 - Disclosure - Revenue</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SegmentInformation" id="SegmentInformation">
<link:definition>1012 - Disclosure - Segment Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPayment" id="WarrantsAndShareBasedPayment">
<link:definition>1013 - Disclosure - Warrants and Share-based Payment</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/MarketableSecurities" id="MarketableSecurities">
<link:definition>1014 - Disclosure - Marketable Securities</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ShareCapital" id="ShareCapital">
<link:definition>1015 - Disclosure - Share Capital</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/LeaseLiabilities" id="LeaseLiabilities">
<link:definition>1016 - Disclosure - Lease Liabilities</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition>1017 - Disclosure - Subsequent Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition>1018 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/RevenueTables" id="RevenueTables">
<link:definition>1019 - Disclosure - Revenue (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables" id="WarrantsAndShareBasedPaymentTables">
<link:definition>1020 - Disclosure - Warrants and Share-based Payment (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/MarketableSecuritiesTables" id="MarketableSecuritiesTables">
<link:definition>1021 - Disclosure - Marketable Securities (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/LeaseLiabilitiesTables" id="LeaseLiabilitiesTables">
<link:definition>1022 - Disclosure - Lease Liabilities (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail" id="SignificantEventsInTheReportingPeriodAdditionalInformationDetail">
<link:definition>1023 - Disclosure - Significant Events in the Reporting Period - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/RevenueAdditionalInformationDetail" id="RevenueAdditionalInformationDetail">
<link:definition>1024 - Disclosure - Revenue - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail" id="RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail">
<link:definition>1025 - Disclosure - Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail" id="RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail">
<link:definition>1026 - Disclosure - Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Parenthetical) (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SegmentInformationAdditionalInformationDetail" id="SegmentInformationAdditionalInformationDetail">
<link:definition>1027 - Disclosure - Segment Information - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail" id="WarrantsAndShareBasedPaymentAdditionalInformationDetail">
<link:definition>1028 - Disclosure - Warrants and Share-based Payment - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail" id="WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail">
<link:definition>1029 - Disclosure - Warrants and Share-based Payment - Schedule of Warrant Activity (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/MarketableSecuritiesAdditionalInformationDetail" id="MarketableSecuritiesAdditionalInformationDetail">
<link:definition>1030 - Disclosure - Marketable Securities - Additional information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail" id="MarketableSecuritiesSummaryOfMarketableSecuritiesDetail">
<link:definition>1031 - Disclosure - Marketable Securities - Summary of Marketable Securities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail" id="ShareCapitalAdditionalInformationDetail">
<link:definition>1032 - Disclosure - Share Capital - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail" id="LeaseLiabilitiesAdditionalInformationDetail">
<link:definition>1033 - Disclosure - Lease Liabilities - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail" id="LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail">
<link:definition>1034 - Disclosure - Lease Liabilities - Summary of Maturity Analysis for Lease Liabilities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail" id="SubsequentEventsAdditionalInformationDetail">
<link:definition>1035 - Disclosure - Subsequent Events - Additional information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossAlternate1" id="CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossAlternate1">
<link:definition>1036 - Statement - Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss) Alternate 1</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
<import namespace="http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd" />
<import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
<import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
<import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
<element name="StatementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="Warrant1Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_Warrant1Member" substitutionGroup="xbrli:item" />
<element name="StatementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementLineItems" substitutionGroup="xbrli:item" />
<element name="NonCurrentAssetsFinanceLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" substitutionGroup="xbrli:item" />
<element name="DistributableEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_DistributableEquity" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="GoodwillAndOtherIntangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_GoodwillAndOtherIntangibleAssets" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TransactionsWithOwnersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_TransactionsWithOwnersAbstract" substitutionGroup="xbrli:item" />
<element name="ChangesInWorkingCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ChangesInWorkingCapitalAbstract" substitutionGroup="xbrli:item" />
<element name="AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="AdjustmentsForIncreaseDecreaseInPrepayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_AdjustmentsForIncreaseDecreaseInPrepayments" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NoncashConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_NoncashConsideration" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CashDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_CashDeposits" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ShortTermMarketableSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_ShortTermMarketableSecurities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_TextBlockAbstract" substitutionGroup="xbrli:item" />
<element name="SignificantEventsInTheReportingPeriodTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_SignificantEventsInTheReportingPeriodTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfSummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" substitutionGroup="xbrli:item" />
<element name="ExpectedNonCashGainTowardsShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_ExpectedNonCashGainTowardsShares" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" substitutionGroup="xbrli:item" />
<element name="SaleOfStockAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_SaleOfStockAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="SaleOfStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_SaleOfStockMember" substitutionGroup="xbrli:item" />
<element name="StatementOfComprehensiveIncomeProfitOrLossLocationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="StatementOfComprehensiveIncomeProfitOrLossLocationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" substitutionGroup="xbrli:item" />
<element name="VisenPharmaceuticalsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_VisenPharmaceuticalsMember" substitutionGroup="xbrli:item" />
<element name="VisenSeriesBFinancingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_VisenSeriesBFinancingMember" substitutionGroup="xbrli:item" />
<element name="UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="RetainedPercentageOfIssuedAndOutstandingShares" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_RetainedPercentageOfIssuedAndOutstandingShares" substitutionGroup="xbrli:item" />
<element name="RevenueFromSaleOfClinicalSupply" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_RevenueFromSaleOfClinicalSupply" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="OtherCollaborationPartnersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_OtherCollaborationPartnersMember" substitutionGroup="xbrli:item" />
<element name="DeferredRevenueFromAssociate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DeferredRevenueFromAssociate" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NumberOfReportableOperatingSegments" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_NumberOfReportableOperatingSegments" substitutionGroup="xbrli:item" />
<element name="AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="DisclosureOfEmployeeCompensationCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfEmployeeCompensationCostsAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfWarrantActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfWarrantActivityLineItems" substitutionGroup="xbrli:item" />
<element name="WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="MarketableSecuritiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_MarketableSecuritiesAbstract" substitutionGroup="xbrli:item" />
<element name="WeightedAverageDurationOfMarketableSecuritiesNoncurrent" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent" substitutionGroup="xbrli:item" />
<element name="WeightedAverageDurationOfMarketableSecurities" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_WeightedAverageDurationOfMarketableSecurities" substitutionGroup="xbrli:item" />
<element name="WeightedAverageDurationOfMarketableSecuritiesCurrent" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent" substitutionGroup="xbrli:item" />
<element name="DisclosureDetailedInformationAboutMarketableSecuritiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="UsTreasuryBillsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_UsTreasuryBillsMember" substitutionGroup="xbrli:item" />
<element name="CommercialPapersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_CommercialPapersMember" substitutionGroup="xbrli:item" />
<element name="CorporateBondsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_CorporateBondsMember" substitutionGroup="xbrli:item" />
<element name="AgencyBondsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_AgencyBondsMember" substitutionGroup="xbrli:item" />
<element name="UsGovernmentBondsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_UsGovernmentBondsMember" substitutionGroup="xbrli:item" />
<element name="DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" substitutionGroup="xbrli:item" />
<element name="PrimeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_PrimeMember" substitutionGroup="xbrli:item" />
<element name="HighGradeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_HighGradeMember" substitutionGroup="xbrli:item" />
<element name="UpperMediumGradeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_UpperMediumGradeMember" substitutionGroup="xbrli:item" />
<element name="LowerMediumGradeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_LowerMediumGradeMember" substitutionGroup="xbrli:item" />
<element name="ZeroCouponMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ZeroCouponMember" substitutionGroup="xbrli:item" />
<element name="Statement1Table" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_Statement1Table" substitutionGroup="xbrldt:hypercubeItem" />
<element name="Statement1LineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_Statement1LineItems" substitutionGroup="xbrli:item" />
<element name="LeaseTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_LeaseTerm" substitutionGroup="xbrli:item" />
<element name="LeasesOptionToExtendAndTerminationTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_LeasesOptionToExtendAndTerminationTerm" substitutionGroup="xbrli:item" />
<element name="DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfMaturityAnalysisOfLeaseLiabilityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems" substitutionGroup="xbrli:item" />
<element name="LeaseLiabilitiesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_LeaseLiabilitiesAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="LeaseLiabilitiesDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_LeaseLiabilitiesDomain" substitutionGroup="xbrli:item" />
<element name="NonadjustingEventsAfterReportingPeriodMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_NonadjustingEventsAfterReportingPeriodMember" substitutionGroup="xbrli:item" />
<element name="ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>asnd-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 27-August-2021 [01:11:57] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimStatementsOfFinancialPosition" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimCashFlowStatements" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail" roleURI="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail" roleURI="http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossAlternate1" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossAlternate1" />
<calculationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="loc_ifrs-full_ProfitLossBeforeTax" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_Revenue" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense" use="optional" order="4" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" use="optional" order="5" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax" xlink:to="loc_ifrs-full_FinanceIncome" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax" xlink:to="loc_ifrs-full_FinanceCosts" use="optional" order="8" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" use="optional" order="9" weight="-1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="loc_ifrs-full_ComprehensiveIncome" use="optional" order="10" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossAlternate1">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="loc_ifrs-full_ProfitLoss" use="optional" order="13" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="loc_ifrs-full_Equity" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity" xlink:to="loc_ifrs-full_IssuedCapital" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DistributableEquity" xlink:label="loc_ASND_DistributableEquity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity" xlink:to="loc_ASND_DistributableEquity" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="loc_ifrs-full_Liabilities" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities" xlink:to="loc_ifrs-full_CurrentLiabilities" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentContractLiabilities" xlink:label="loc_ifrs-full_CurrentContractLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_CurrentContractLiabilities" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_OtherCurrentPayables" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTaxLiabilities" xlink:label="loc_ifrs-full_CurrentTaxLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_CurrentTaxLiabilities" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities" xlink:to="loc_ifrs-full_NoncurrentLiabilities" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentPayables" xlink:label="loc_ifrs-full_OtherNoncurrentPayables" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="loc_ifrs-full_OtherNoncurrentPayables" use="optional" order="13" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets" xlink:to="loc_ifrs-full_CurrentAssets" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_CurrentTradeReceivables" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_OtherCurrentReceivables" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentPrepayments" xlink:label="loc_ifrs-full_CurrentPrepayments" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_CurrentPrepayments" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_CashAndCashEquivalents" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentFinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_CurrentFinancialAssetsAvailableforsale" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_CurrentFinancialAssetsAvailableforsale" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets" xlink:to="loc_ifrs-full_NoncurrentAssets" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_GoodwillAndOtherIntangibleAssets" xlink:label="loc_ASND_GoodwillAndOtherIntangibleAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ASND_GoodwillAndOtherIntangibleAssets" use="optional" order="21" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment" use="optional" order="22" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-full_InvestmentsInAssociates" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_InvestmentsInAssociates" use="optional" order="23" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LongtermDeposits" xlink:label="loc_ifrs-full_LongtermDeposits" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_LongtermDeposits" use="optional" order="24" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentFinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAvailableforsale" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAvailableforsale" use="optional" order="25" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperations" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ifrs-full_ProfitLoss" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NoncashConsideration" xlink:label="loc_ASND_NoncashConsideration" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ASND_NoncashConsideration" use="optional" order="4" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" use="optional" order="5" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ifrs-full_FinanceIncome" use="optional" order="6" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ifrs-full_FinanceCosts" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationExpense" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" xlink:label="loc_ASND_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ASND_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AdjustmentsForIncreaseDecreaseInPrepayments" xlink:label="loc_ASND_AdjustmentsForIncreaseDecreaseInPrepayments" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ASND_AdjustmentsForIncreaseDecreaseInPrepayments" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForAmortisationExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="loc_ifrs-full_AdjustmentsForAmortisationExpense" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" use="optional" order="16" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" use="optional" order="18" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets" xlink:label="loc_ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfAvailableforsaleFinancialAssets" xlink:label="loc_ifrs-full_PurchaseOfAvailableforsaleFinancialAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-full_PurchaseOfAvailableforsaleFinancialAssets" use="optional" order="21" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:label="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure" use="optional" order="22" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" use="optional" order="23" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfInterestsInAssociates" xlink:label="loc_ifrs-full_PurchaseOfInterestsInAssociates" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-full_PurchaseOfInterestsInAssociates" use="optional" order="24" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" use="optional" order="25" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" use="optional" order="26" weight="-1" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" xlink:label="loc_ASND_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="loc_ASND_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" use="optional" order="27" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-full_RevenueFromRenderingOfServices" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue" xlink:to="loc_ifrs-full_RevenueFromRenderingOfServices" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_RevenueFromSaleOfClinicalSupply" xlink:label="loc_ASND_RevenueFromSaleOfClinicalSupply" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue" xlink:to="loc_ASND_RevenueFromSaleOfClinicalSupply" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue" xlink:to="loc_ifrs-full_LicenceFeeIncome" use="optional" order="3" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-full_GrossLeaseLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_LeaseLiabilities" xlink:to="loc_ifrs-full_GrossLeaseLiabilities" use="optional" order="1" weight="1" />
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>asnd-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 27-August-2021 [01:11:57] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimStatementsOfChangesInEquity" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#WarrantsAndShareBasedPaymentTables" roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SignificantEventsInTheReportingPeriodAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#RevenueAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/RevenueAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail" roleURI="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#WarrantsAndShareBasedPaymentAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail" roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#MarketableSecuritiesSummaryOfMarketableSecuritiesDetail" roleURI="http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#ShareCapitalAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#LeaseLiabilitiesAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail" roleURI="http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SubsequentEventsAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimCashFlowStatements" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail" roleURI="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SegmentInformationAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/SegmentInformationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#GeneralInformation" roleURI="http://ascendispharma.com/role/GeneralInformation" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty" roleURI="http://ascendispharma.com/role/CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#Revenue" roleURI="http://ascendispharma.com/role/Revenue" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SegmentInformation" roleURI="http://ascendispharma.com/role/SegmentInformation" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#WarrantsAndShareBasedPayment" roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPayment" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#LeaseLiabilities" roleURI="http://ascendispharma.com/role/LeaseLiabilities" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#LeaseLiabilitiesTables" roleURI="http://ascendispharma.com/role/LeaseLiabilitiesTables" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#ShareCapital" roleURI="http://ascendispharma.com/role/ShareCapital" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SubsequentEvents" roleURI="http://ascendispharma.com/role/SubsequentEvents" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimStatementsOfFinancialPosition" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SignificantEventsInTheReportingPeriod" roleURI="http://ascendispharma.com/role/SignificantEventsInTheReportingPeriod" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CoverPage" roleURI="http://ascendispharma.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#RevenueTables" roleURI="http://ascendispharma.com/role/RevenueTables" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#MarketableSecurities" roleURI="http://ascendispharma.com/role/MarketableSecurities" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#MarketableSecuritiesAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/MarketableSecuritiesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#MarketableSecuritiesTables" roleURI="http://ascendispharma.com/role/MarketableSecuritiesTables" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementLineItems" xlink:label="loc_asnd_StatementLineItems_36" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementTable" xlink:label="loc_asnd_StatementTable_37" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_asnd_StatementLineItems_36" xlink:to="loc_asnd_StatementTable_37" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_34" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_StatementTable_37" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_34" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_35" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_34" xlink:to="loc_ifrs-full_EquityMember_35" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_35_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_34" xlink:to="loc_ifrs-full_EquityMember_35_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Warrant1Member" xlink:label="loc_asnd_Warrant1Member_38" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_35" xlink:to="loc_asnd_Warrant1Member_38" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_1074310" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_StatementLineItems_36" xlink:to="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_1074310" use="optional" order="6" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementLineItems" xlink:label="loc_asnd_StatementLineItems_78" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_87" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_87" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_86" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_ifrs-full_ProfitLoss_86" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementTable" xlink:label="loc_asnd_StatementTable_79" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_asnd_StatementTable_79" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_76" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_StatementTable_79" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_76" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_77" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_76" xlink:to="loc_ifrs-full_EquityMember_77" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_77_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_76" xlink:to="loc_ifrs-full_EquityMember_77_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_82" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_77" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_82" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_83" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_77" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_83" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_84" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_77" xlink:to="loc_ifrs-full_RetainedEarningsMember_84" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_81" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_77" xlink:to="loc_ifrs-full_SharePremiumMember_81" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_80" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_77" xlink:to="loc_ifrs-full_IssuedCapitalMember_80" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TransactionsWithOwnersAbstract" xlink:label="loc_asnd_TransactionsWithOwnersAbstract_735736" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_asnd_TransactionsWithOwnersAbstract_735736" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_89" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_TransactionsWithOwnersAbstract_735736" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_89" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners_90" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_TransactionsWithOwnersAbstract_735736" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners_90" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_88" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_ifrs-full_ComprehensiveIncome_88" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_85" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_ifrs-full_Equity_85" use="optional" order="16" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementLineItems" xlink:label="loc_asnd_StatementLineItems_296" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_300" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_StatementLineItems_296" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_300" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementTable" xlink:label="loc_asnd_StatementTable_297" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_asnd_StatementLineItems_296" xlink:to="loc_asnd_StatementTable_297" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_298" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_StatementTable_297" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_298" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_295" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_298" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_295" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_295_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_298" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_295_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Warrant1Member" xlink:label="loc_asnd_Warrant1Member_299" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_295" xlink:to="loc_asnd_Warrant1Member_299" use="optional" order="6" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" xlink:to="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_767301" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_767301" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_767302" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_767301" xlink:to="loc_ifrs-full_EquityMember_767302" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_767302_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_767301" xlink:to="loc_ifrs-full_EquityMember_767302_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_767288" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_767288" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_767289" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_767288" xlink:to="loc_ifrs-full_NonadjustingEventsMember_767289" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_767289_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_767288" xlink:to="loc_ifrs-full_NonadjustingEventsMember_767289_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockAxis" xlink:label="loc_asnd_SaleOfStockAxis_767291" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_asnd_SaleOfStockAxis_767291" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockMember" xlink:label="loc_asnd_SaleOfStockMember_767292" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_asnd_SaleOfStockAxis_767291" xlink:to="loc_asnd_SaleOfStockMember_767292" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockMember" xlink:label="loc_asnd_SaleOfStockMember_767292_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_asnd_SaleOfStockAxis_767291" xlink:to="loc_asnd_SaleOfStockMember_767292_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_961849" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_961849" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_961850" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_961849" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_961850" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_961850_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_961849" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_961850_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" xlink:label="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis_961858" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis_961858" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" xlink:label="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember_961859" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis_961858" xlink:to="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember_961859" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" xlink:label="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember_961859_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis_961858" xlink:to="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember_961859_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis_961870" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_ifrs-full_MajorCustomersAxis_961870" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_961871" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MajorCustomersAxis_961870" xlink:to="loc_ifrs-full_MajorCustomersMember_961871" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_961871_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MajorCustomersAxis_961870" xlink:to="loc_ifrs-full_MajorCustomersMember_961871_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_VisenPharmaceuticalsMember" xlink:label="loc_asnd_VisenPharmaceuticalsMember_961875" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersMember_961871" xlink:to="loc_asnd_VisenPharmaceuticalsMember_961875" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_963366" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_963366" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_963368" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_963366" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_963368" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_963368_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_963366" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_963368_default" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_VisenSeriesBFinancingMember" xlink:label="loc_asnd_VisenSeriesBFinancingMember_963371" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_963368" xlink:to="loc_asnd_VisenSeriesBFinancingMember_963371" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ExpectedNonCashGainTowardsShares" xlink:label="loc_asnd_ExpectedNonCashGainTowardsShares_961868" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" xlink:to="loc_asnd_ExpectedNonCashGainTowardsShares_961868" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" xlink:label="loc_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate_961869" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" xlink:to="loc_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate_961869" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod_963361" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" xlink:to="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod_963361" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_963388" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_963388" use="optional" order="28" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/RevenueAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_735317" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_735314" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_735317" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_735314" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis_735318" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_735314" xlink:to="loc_ifrs-full_MajorCustomersAxis_735318" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_735319" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MajorCustomersAxis_735318" xlink:to="loc_ifrs-full_MajorCustomersMember_735319" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_735319_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MajorCustomersAxis_735318" xlink:to="loc_ifrs-full_MajorCustomersMember_735319_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_VisenPharmaceuticalsMember" xlink:label="loc_asnd_VisenPharmaceuticalsMember_735320" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersMember_735319" xlink:to="loc_asnd_VisenPharmaceuticalsMember_735320" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" xlink:label="loc_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue_735321" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_735317" xlink:to="loc_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue_735321" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_735322" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_735317" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_735322" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_RetainedPercentageOfIssuedAndOutstandingShares" xlink:label="loc_asnd_RetainedPercentageOfIssuedAndOutstandingShares_981541" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_735317" xlink:to="loc_asnd_RetainedPercentageOfIssuedAndOutstandingShares_981541" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_160" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_160" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_161" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_160" xlink:to="loc_ifrs-full_GeographicalAreasAxis_161" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_162" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_161" xlink:to="loc_ifrs-full_GeographicalAreasMember_162" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_162_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_161" xlink:to="loc_ifrs-full_GeographicalAreasMember_162_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NorthAmericaMember" xlink:label="loc_srt_NorthAmericaMember_167" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_162" xlink:to="loc_srt_NorthAmericaMember_167" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN" xlink:label="loc_country_CN_696910" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_162" xlink:to="loc_country_CN_696910" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis_735297" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_160" xlink:to="loc_ifrs-full_MajorCustomersAxis_735297" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_735300" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MajorCustomersAxis_735297" xlink:to="loc_ifrs-full_MajorCustomersMember_735300" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_735300_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MajorCustomersAxis_735297" xlink:to="loc_ifrs-full_MajorCustomersMember_735300_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_VisenPharmaceuticalsMember" xlink:label="loc_asnd_VisenPharmaceuticalsMember_735301" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersMember_735300" xlink:to="loc_asnd_VisenPharmaceuticalsMember_735301" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_OtherCollaborationPartnersMember" xlink:label="loc_asnd_OtherCollaborationPartnersMember_735304" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersMember_735300" xlink:to="loc_asnd_OtherCollaborationPartnersMember_735304" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome_166" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" xlink:to="loc_ifrs-full_LicenceFeeIncome_166" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_163" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" xlink:to="loc_ifrs-full_Revenue_163" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-full_RevenueFromRenderingOfServices_165" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" xlink:to="loc_ifrs-full_RevenueFromRenderingOfServices_165" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_RevenueFromSaleOfClinicalSupply" xlink:label="loc_asnd_RevenueFromSaleOfClinicalSupply_694786" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" xlink:to="loc_asnd_RevenueFromSaleOfClinicalSupply_694786" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfGeographicalAreasAbstract" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasAbstract_158" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasAbstract_158" use="optional" order="16" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" xlink:label="loc_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement_183" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement_183" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_184" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_184" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_521241" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_521241" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_961885" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_961885" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_185" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_185" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_186" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_186" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_182" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_182" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_188" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_ParValuePerShare_188" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_177" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_177" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_178" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_177" xlink:to="loc_ifrs-full_RangeAxis_178" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_179" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_178" xlink:to="loc_ifrs-full_RangesMember_179" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_179_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_178" xlink:to="loc_ifrs-full_RangesMember_179_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_190" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_179" xlink:to="loc_ifrs-full_BottomOfRangeMember_190" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_191" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_179" xlink:to="loc_ifrs-full_TopOfRangeMember_191" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_181" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_177" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_181" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_180" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_181" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_180" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_180_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_181" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_180_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Warrant1Member" xlink:label="loc_asnd_Warrant1Member_192" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_180" xlink:to="loc_asnd_Warrant1Member_192" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" xlink:label="loc_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement_187" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement_187" use="optional" order="19" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfWarrantActivityLineItems" xlink:label="loc_asnd_DisclosureOfWarrantActivityLineItems_196" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xlink:label="loc_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement_212" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement_212" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_521243" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_521243" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_521245" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_521245" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_521246" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_521246" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019_521247" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019_521247" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_195" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_195" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_198" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_195" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_198" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_197" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_198" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_197" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_197_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_198" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_197_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Warrant1Member" xlink:label="loc_asnd_Warrant1Member_213" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_197" xlink:to="loc_asnd_Warrant1Member_213" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_200" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_200" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_201" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_201" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_202" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_202" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_199" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_199" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xlink:label="loc_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement_205" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement_205" use="optional" order="15" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" xlink:label="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_FinancialAssetsAvailableforsale_767322" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" xlink:to="loc_ifrs-full_FinancialAssetsAvailableforsale_767322" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentFinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAvailableforsale_767323" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAvailableforsale_767323" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentFinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_CurrentFinancialAssetsAvailableforsale_767324" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" xlink:to="loc_ifrs-full_CurrentFinancialAssetsAvailableforsale_767324" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable" xlink:label="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" xlink:to="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_735323" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_735323" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_735324" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_735323" xlink:to="loc_ifrs-full_FinancialAssetsMember_735324" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_735324_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_735323" xlink:to="loc_ifrs-full_FinancialAssetsMember_735324_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UsTreasuryBillsMember" xlink:label="loc_asnd_UsTreasuryBillsMember_735325" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_735324" xlink:to="loc_asnd_UsTreasuryBillsMember_735325" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_CommercialPapersMember" xlink:label="loc_asnd_CommercialPapersMember_735326" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_735324" xlink:to="loc_asnd_CommercialPapersMember_735326" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_CorporateBondsMember" xlink:label="loc_asnd_CorporateBondsMember_767332" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_735324" xlink:to="loc_asnd_CorporateBondsMember_767332" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AgencyBondsMember" xlink:label="loc_asnd_AgencyBondsMember_767334" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_735324" xlink:to="loc_asnd_AgencyBondsMember_767334" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UsGovernmentBondsMember" xlink:label="loc_asnd_UsGovernmentBondsMember_961908" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_735324" xlink:to="loc_asnd_UsGovernmentBondsMember_961908" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_735302" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_735302" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_735303" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_735302" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_735303" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_735303_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_735302" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_735303_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostMember_735778" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_735303" xlink:to="loc_ifrs-full_FinancialAssetsAtAmortisedCostMember_735778" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtFairValueMember" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueMember_735305" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_735303" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueMember_735305" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_735306" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_735306" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_735308" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_735306" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_735308" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_735308_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_735306" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_735308_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExternalCreditGradesAxis" xlink:label="loc_ifrs-full_ExternalCreditGradesAxis_961887" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xlink:to="loc_ifrs-full_ExternalCreditGradesAxis_961887" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForExternalCreditGradesMember" xlink:label="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ExternalCreditGradesAxis_961887" xlink:to="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForExternalCreditGradesMember" xlink:label="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ExternalCreditGradesAxis_961887" xlink:to="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888_default" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_PrimeMember" xlink:label="loc_asnd_PrimeMember_961889" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" xlink:to="loc_asnd_PrimeMember_961889" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_HighGradeMember" xlink:label="loc_asnd_HighGradeMember_961890" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" xlink:to="loc_asnd_HighGradeMember_961890" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UpperMediumGradeMember" xlink:label="loc_asnd_UpperMediumGradeMember_1072721" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" xlink:to="loc_asnd_UpperMediumGradeMember_1072721" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LowerMediumGradeMember" xlink:label="loc_asnd_LowerMediumGradeMember_1072722" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" xlink:to="loc_asnd_LowerMediumGradeMember_1072722" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_961897" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_961897" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-full_InterestRateTypesMember_961898" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_961897" xlink:to="loc_ifrs-full_InterestRateTypesMember_961898" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-full_InterestRateTypesMember_961898_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_961897" xlink:to="loc_ifrs-full_InterestRateTypesMember_961898_default" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FixedInterestRateMember" xlink:label="loc_ifrs-full_FixedInterestRateMember_961899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_961898" xlink:to="loc_ifrs-full_FixedInterestRateMember_961899" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="loc_ifrs-full_FloatingInterestRateMember_961900" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_961898" xlink:to="loc_ifrs-full_FloatingInterestRateMember_961900" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ZeroCouponMember" xlink:label="loc_asnd_ZeroCouponMember_961903" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_961898" xlink:to="loc_asnd_ZeroCouponMember_961903" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_961909" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" xlink:to="loc_ifrs-full_FinancialAssets_961909" use="optional" order="34" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_695220" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_262" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_695220" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_262" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_260" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_695220" xlink:to="loc_ifrs-full_ParValuePerShare_260" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_695217" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_695220" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_695217" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_695221" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_695217" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_695221" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_695222" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_695221" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_695222" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_695222_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_695221" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_695222_default" use="optional" order="6" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Statement1LineItems" xlink:label="loc_asnd_Statement1LineItems_961932" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeaseTerm" xlink:label="loc_asnd_LeaseTerm_961929" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_Statement1LineItems_961932" xlink:to="loc_asnd_LeaseTerm_961929" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeasesOptionToExtendAndTerminationTerm" xlink:label="loc_asnd_LeasesOptionToExtendAndTerminationTerm_961930" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_Statement1LineItems_961932" xlink:to="loc_asnd_LeasesOptionToExtendAndTerminationTerm_961930" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Statement1Table" xlink:label="loc_asnd_Statement1Table_961931" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_asnd_Statement1LineItems_961932" xlink:to="loc_asnd_Statement1Table_961931" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_961933" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_Statement1Table_961931" xlink:to="loc_ifrs-full_RangeAxis_961933" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_961926" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_961933" xlink:to="loc_ifrs-full_RangesMember_961926" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_961926_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_961933" xlink:to="loc_ifrs-full_RangesMember_961926_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_961927" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_961926" xlink:to="loc_ifrs-full_BottomOfRangeMember_961927" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_961928" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_961926" xlink:to="loc_ifrs-full_TopOfRangeMember_961928" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems" xlink:label="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems_245" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_251" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems_245" xlink:to="loc_ifrs-full_LeaseLiabilities_251" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable" xlink:label="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable_246" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems_245" xlink:to="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable_246" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_247" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable_246" xlink:to="loc_ifrs-full_MaturityAxis_247" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_244" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_247" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_244" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_244_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_247" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_244_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_248" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_244" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_248" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_250" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_244" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_250" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_249" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_244" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_249" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeaseLiabilitiesAxis" xlink:label="loc_asnd_LeaseLiabilitiesAxis_961916" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable_246" xlink:to="loc_asnd_LeaseLiabilitiesAxis_961916" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeaseLiabilitiesDomain" xlink:label="loc_asnd_LeaseLiabilitiesDomain_961918" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_asnd_LeaseLiabilitiesAxis_961916" xlink:to="loc_asnd_LeaseLiabilitiesDomain_961918" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeaseLiabilitiesDomain" xlink:label="loc_asnd_LeaseLiabilitiesDomain_961918_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_asnd_LeaseLiabilitiesAxis_961916" xlink:to="loc_asnd_LeaseLiabilitiesDomain_961918_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_961919" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_LeaseLiabilitiesDomain_961918" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_961919" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DiscountedCashFlowMember" xlink:label="loc_ifrs-full_DiscountedCashFlowMember_961920" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_LeaseLiabilitiesDomain_961918" xlink:to="loc_ifrs-full_DiscountedCashFlowMember_961920" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_1072720" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems_245" xlink:to="loc_ifrs-full_GrossLeaseLiabilities_1072720" use="optional" order="14" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_735276" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_735264" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_735276" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_735264" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_735265" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_735264" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_735265" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_735266" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_735265" xlink:to="loc_ifrs-full_NonadjustingEventsMember_735266" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_735266_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_735265" xlink:to="loc_ifrs-full_NonadjustingEventsMember_735266_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NonadjustingEventsAfterReportingPeriodMember" xlink:label="loc_asnd_NonadjustingEventsAfterReportingPeriodMember_1078354" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_735266" xlink:to="loc_asnd_NonadjustingEventsAfterReportingPeriodMember_1078354" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockAxis" xlink:label="loc_asnd_SaleOfStockAxis_735268" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_735264" xlink:to="loc_asnd_SaleOfStockAxis_735268" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockMember" xlink:label="loc_asnd_SaleOfStockMember_735269" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_asnd_SaleOfStockAxis_735268" xlink:to="loc_asnd_SaleOfStockMember_735269" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockMember" xlink:label="loc_asnd_SaleOfStockMember_735269_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_asnd_SaleOfStockAxis_735268" xlink:to="loc_asnd_SaleOfStockMember_735269_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_735270" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_735264" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_735270" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_735271" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_735270" xlink:to="loc_ifrs-full_EquityMember_735271" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_735271_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_735270" xlink:to="loc_ifrs-full_EquityMember_735271_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" xlink:label="loc_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts_1078353" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_735276" xlink:to="loc_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts_1078353" use="optional" order="12" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>asnd-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 27-August-2021 [01:11:57] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract" xml:lang="en-US">Cover [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeStatementAbstract" xml:lang="en-US">Profit or loss [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncomeStatementAbstract" xml:lang="en-US">Income Statement Abstract</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract" xlink:to="lab_ifrs-full_IncomeStatementAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xml:lang="en-US">Tax expense (income)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xml:lang="en-US">Tax on profit / (loss) for the period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xml:lang="en-US">Reversal of tax charge</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare" xml:lang="en-US">Basic and diluted earnings (loss) per share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare" xml:lang="en-US">Basic and diluted earnings / (loss) per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:to="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceCosts" xml:lang="en-US">Finance costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinanceCosts" xml:lang="en-US">Finance expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinanceCosts" xml:lang="en-US">Reversal of finance expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts" xlink:to="lab_ifrs-full_FinanceCosts" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceIncome" xml:lang="en-US">Finance income</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinanceIncome" xml:lang="en-US">Finance income</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinanceIncome" xml:lang="en-US">Reversal of finance income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome" xlink:to="lab_ifrs-full_FinanceIncome" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xml:lang="en-US">Profit (loss) before tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xml:lang="en-US">Profit / (loss) before tax</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax" xlink:to="lab_ifrs-full_ProfitLossBeforeTax" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xml:lang="en-US">Profit (loss) from operating activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xml:lang="en-US">Operating profit / (loss)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Revenue" xml:lang="en-US">Revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Revenue" xml:lang="en-US">Revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Revenue" xml:lang="en-US">Total revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Revenue" xml:lang="en-US">Total revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue" xlink:to="lab_ifrs-full_Revenue" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xml:lang="en-US">Selling, general and administrative expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xml:lang="en-US">Selling, general and administrative expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xml:lang="en-US">Share of profit (loss) of associates accounted for using equity method</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xml:lang="en-US">Share of profit / (loss) of associate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xml:lang="en-US">Reversal of share of profit / (loss) of associate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageShares" xml:lang="en-US">Weighted average number of ordinary shares outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageShares" xml:lang="en-US">Number of shares used for calculation (basic and diluted)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares" xlink:to="lab_ifrs-full_WeightedAverageShares" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xml:lang="en-US">Profit (loss), attributable to owners of parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xml:lang="en-US">Attributable to owners of the Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xml:lang="en-US">Statement of comprehensive income [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xml:lang="en-US">Consolidated Interim Statement of Comprehensive Income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xml:lang="en-US">Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xml:lang="en-US">Other comprehensive income / (loss)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xml:lang="en-US">Exchange differences on translating foreign operations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, net of tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xml:lang="en-US">Other comprehensive income / (loss) for the period, net of tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xml:lang="en-US">Other comprehensive income / (loss), net of tax</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncome" xml:lang="en-US">Comprehensive income</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome" xml:lang="en-US">Total comprehensive income / (loss)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="lab_ifrs-full_ComprehensiveIncome" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLoss" xml:lang="en-US">Profit (loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLoss" xml:lang="en-US">Net profit / (loss) for the period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLoss" xml:lang="en-US">Net profit / (loss) for the period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLoss" xml:lang="en-US">Loss for the period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="lab_ifrs-full_ProfitLoss" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xml:lang="en-US">Comprehensive income, attributable to owners of parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xml:lang="en-US">Attributable to owners of the Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementTable" xlink:label="loc_asnd_StatementTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_StatementTable" xml:lang="en-US">Statement [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_StatementTable" xml:lang="en-US">Statement [table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_StatementTable" xlink:to="lab_asnd_StatementTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_StatementTable" xml:lang="en-US">Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders Equity and Other Comprehensive Income, or other statement as needed.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xml:lang="en-US">Components of equity [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xml:lang="en-US">Components of equity [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityMember" xml:lang="en-US">Equity [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityMember" xml:lang="en-US">Equity [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityMember" xlink:to="lab_ifrs-full_EquityMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Warrant1Member" xlink:label="loc_asnd_Warrant1Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_Warrant1Member" xml:lang="en-US">Warrant1 [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_Warrant1Member" xml:lang="en-US">Warrants [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_Warrant1Member" xlink:to="lab_asnd_Warrant1Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_Warrant1Member" xml:lang="en-US">Warrants.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementLineItems" xlink:label="loc_asnd_StatementLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_StatementLineItems" xml:lang="en-US">Statement [line items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_StatementLineItems" xml:lang="en-US">Statement [LineItems]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_StatementLineItems" xlink:to="lab_asnd_StatementLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_StatementLineItems" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xml:lang="en-US">Dilutive effect of convertible instruments on number of ordinary shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xml:lang="en-US">Warrants outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:to="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" xlink:label="loc_asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" xml:lang="en-US">Non Current Assets Finance Liabilities [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" xlink:to="lab_asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" xml:lang="en-US">Non current assets finance liabilities abstract.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xml:lang="en-US">Equity and liabilities [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xml:lang="en-US">Equity and liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAbstract" xml:lang="en-US">Equity [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityAbstract" xml:lang="en-US">Equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract" xlink:to="lab_ifrs-full_EquityAbstract" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DistributableEquity" xlink:label="loc_asnd_DistributableEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DistributableEquity" xml:lang="en-US">Distributable equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_DistributableEquity" xml:lang="en-US">Distributable equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DistributableEquity" xlink:to="lab_asnd_DistributableEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DistributableEquity" xml:lang="en-US">Distributable equity.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Equity" xml:lang="en-US">Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Equity" xml:lang="en-US">Total equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Equity" xml:lang="en-US">Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Equity" xml:lang="en-US">Equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity" xlink:to="lab_ifrs-full_Equity" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapital" xml:lang="en-US">Issued capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssuedCapital" xml:lang="en-US">Share capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital" xlink:to="lab_ifrs-full_IssuedCapital" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilities" xml:lang="en-US">Equity and liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityAndLiabilities" xml:lang="en-US">Total equity and liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="lab_ifrs-full_EquityAndLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract" xml:lang="en-US">Current liabilities [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract" xml:lang="en-US">Current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTaxLiabilities" xlink:label="loc_ifrs-full_CurrentTaxLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxLiabilities" xml:lang="en-US">Current tax liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTaxLiabilities" xml:lang="en-US">Income taxes payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxLiabilities" xlink:to="lab_ifrs-full_CurrentTaxLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentContractLiabilities" xlink:label="loc_ifrs-full_CurrentContractLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentContractLiabilities" xml:lang="en-US">Current contract liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentContractLiabilities" xml:lang="en-US">Contract liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentContractLiabilities" xlink:to="lab_ifrs-full_CurrentContractLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xml:lang="en-US">Current lease liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xml:lang="en-US">Lease liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilities" xml:lang="en-US">Current liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentLiabilities" xml:lang="en-US">Total current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="lab_ifrs-full_CurrentLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherCurrentPayables" xml:lang="en-US">Other current payables</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherCurrentPayables" xml:lang="en-US">Other payables</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentPayables" xlink:to="lab_ifrs-full_OtherCurrentPayables" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xml:lang="en-US">Current trade payables</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xml:lang="en-US">Trade payables&#160;and accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xml:lang="en-US">Non-current liabilities [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xml:lang="en-US">Non-current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentPayables" xlink:label="loc_ifrs-full_OtherNoncurrentPayables" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherNoncurrentPayables" xml:lang="en-US">Other non-current payables</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherNoncurrentPayables" xml:lang="en-US">Other payables</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentPayables" xlink:to="lab_ifrs-full_OtherNoncurrentPayables" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xml:lang="en-US">Non-current lease liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xml:lang="en-US">Lease liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xml:lang="en-US">Non-current liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xml:lang="en-US">Total non-current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="lab_ifrs-full_NoncurrentLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Liabilities" xml:lang="en-US">Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Liabilities" xml:lang="en-US">Total liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities" xlink:to="lab_ifrs-full_Liabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAbstract" xml:lang="en-US">Assets [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AssetsAbstract" xml:lang="en-US">Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract" xlink:to="lab_ifrs-full_AssetsAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Assets" xml:lang="en-US">Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Assets" xml:lang="en-US">Total assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets" xlink:to="lab_ifrs-full_Assets" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsAbstract" xml:lang="en-US">Current assets [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentAssetsAbstract" xml:lang="en-US">Current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract" xlink:to="lab_ifrs-full_CurrentAssetsAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTradeReceivables" xml:lang="en-US">Current trade receivables</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTradeReceivables" xml:lang="en-US">Trade receivables</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables" xlink:to="lab_ifrs-full_CurrentTradeReceivables" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xml:lang="en-US">Cash and cash equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xml:lang="en-US">Cash and cash equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xml:lang="en-US">Cash and cash equivalents at January 1</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xml:lang="en-US">Cash and cash equivalents at June 30</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents" xlink:to="lab_ifrs-full_CashAndCashEquivalents" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssets" xml:lang="en-US">Current assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentAssets" xml:lang="en-US">Total current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="lab_ifrs-full_CurrentAssets" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentPrepayments" xlink:label="loc_ifrs-full_CurrentPrepayments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentPrepayments" xml:lang="en-US">Current prepayments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentPrepayments" xml:lang="en-US">Prepayments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepayments" xlink:to="lab_ifrs-full_CurrentPrepayments" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentFinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_CurrentFinancialAssetsAvailableforsale" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentFinancialAssetsAvailableforsale" xml:lang="en-US">Current financial assets available-for-sale</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentFinancialAssetsAvailableforsale" xml:lang="en-US">Marketable securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentFinancialAssetsAvailableforsale" xml:lang="en-US">Current financial assets available-for-sale</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentFinancialAssetsAvailableforsale" xlink:to="lab_ifrs-full_CurrentFinancialAssetsAvailableforsale" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherCurrentReceivables" xml:lang="en-US">Other current receivables</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherCurrentReceivables" xml:lang="en-US">Other receivables</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentReceivables" xlink:to="lab_ifrs-full_OtherCurrentReceivables" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xml:lang="en-US">Non-current assets [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xml:lang="en-US">Non-current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_GoodwillAndOtherIntangibleAssets" xlink:label="loc_asnd_GoodwillAndOtherIntangibleAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_GoodwillAndOtherIntangibleAssets" xml:lang="en-US">Goodwill and Other Intangible Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_GoodwillAndOtherIntangibleAssets" xml:lang="en-US">Intangible assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_GoodwillAndOtherIntangibleAssets" xlink:to="lab_asnd_GoodwillAndOtherIntangibleAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_GoodwillAndOtherIntangibleAssets" xml:lang="en-US">Goodwill and other intangible assets.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-full_InvestmentsInAssociates" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InvestmentsInAssociates" xml:lang="en-US">Investments in associates</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InvestmentsInAssociates" xml:lang="en-US">Investment in associate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInAssociates" xlink:to="lab_ifrs-full_InvestmentsInAssociates" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LongtermDeposits" xlink:label="loc_ifrs-full_LongtermDeposits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LongtermDeposits" xml:lang="en-US">Long-term deposits</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LongtermDeposits" xml:lang="en-US">Deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermDeposits" xlink:to="lab_ifrs-full_LongtermDeposits" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentFinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAvailableforsale" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentFinancialAssetsAvailableforsale" xml:lang="en-US">Non-current financial assets available-for-sale</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentFinancialAssetsAvailableforsale" xml:lang="en-US">Marketable securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentFinancialAssetsAvailableforsale" xml:lang="en-US">Non-current financial assets available-for-sale</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentFinancialAssetsAvailableforsale" xlink:to="lab_ifrs-full_NoncurrentFinancialAssetsAvailableforsale" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssets" xml:lang="en-US">Non-current assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentAssets" xml:lang="en-US">Total non-current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="lab_ifrs-full_NoncurrentAssets" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xml:lang="en-US">Property, plant and equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xml:lang="en-US">Property, plant and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract" xml:lang="en-US">Statement of changes in equity [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TransactionsWithOwnersAbstract" xlink:label="loc_asnd_TransactionsWithOwnersAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_TransactionsWithOwnersAbstract" xml:lang="en-US">Transactions With Owners [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_TransactionsWithOwnersAbstract" xml:lang="en-US">Transactions with Owners</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_TransactionsWithOwnersAbstract" xlink:to="lab_asnd_TransactionsWithOwnersAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_TransactionsWithOwnersAbstract" xml:lang="en-US">Transactions with owners.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xml:lang="en-US">Share-based payment (Note 7)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners" xml:lang="en-US">Increase (decrease) through transactions with owners, equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners" xml:lang="en-US">Capital increase</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xml:lang="en-US">Reserve of exchange differences on translation [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xml:lang="en-US">Foreign Currency Translation Reserve [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember" xml:lang="en-US">Reserve of share-based payments [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember" xml:lang="en-US">Share-based Payment Reserve [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:to="lab_ifrs-full_ReserveOfSharebasedPaymentsMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarningsMember" xml:lang="en-US">Retained earnings [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarningsMember" xml:lang="en-US">Accumulated Deficit [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember" xlink:to="lab_ifrs-full_RetainedEarningsMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharePremiumMember" xml:lang="en-US">Share premium [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SharePremiumMember" xml:lang="en-US">Share Premium [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremiumMember" xlink:to="lab_ifrs-full_SharePremiumMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapitalMember" xml:lang="en-US">Issued capital [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssuedCapitalMember" xml:lang="en-US">Issued Capital [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember" xlink:to="lab_ifrs-full_IssuedCapitalMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of cash flows [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xml:lang="en-US">Operating activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ChangesInWorkingCapitalAbstract" xlink:label="loc_asnd_ChangesInWorkingCapitalAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_ChangesInWorkingCapitalAbstract" xml:lang="en-US">Changes in working capital [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_ChangesInWorkingCapitalAbstract" xml:lang="en-US">Changes in working capital:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_ChangesInWorkingCapitalAbstract" xlink:to="lab_asnd_ChangesInWorkingCapitalAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_ChangesInWorkingCapitalAbstract" xml:lang="en-US">Changes in working capital.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" xlink:label="loc_asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" xml:lang="en-US">Adjustment For Decrease Increase In Trade Receivables Other Receivables And Other Short Term Deposits</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" xml:lang="en-US">Receivables</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" xlink:to="lab_asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" xml:lang="en-US">Adjustment for decrease increase in trade receivables other receivables and other short term deposits.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome" xml:lang="en-US">Adjustments for increase (decrease) in deferred income</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome" xml:lang="en-US">Contract liabilities (deferred income)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperations" xml:lang="en-US">Cash flows from (used in) operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperations" xml:lang="en-US">Cash flows generated from / (used in) operations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperations" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xml:lang="en-US">Income taxes paid (refund), classified as operating activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xml:lang="en-US">Income taxes received / (paid)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AdjustmentsForIncreaseDecreaseInPrepayments" xlink:label="loc_asnd_AdjustmentsForIncreaseDecreaseInPrepayments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_AdjustmentsForIncreaseDecreaseInPrepayments" xml:lang="en-US">Adjustments for Increase Decrease in Prepayments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_AdjustmentsForIncreaseDecreaseInPrepayments" xml:lang="en-US">Prepayments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_AdjustmentsForIncreaseDecreaseInPrepayments" xlink:to="lab_asnd_AdjustmentsForIncreaseDecreaseInPrepayments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_AdjustmentsForIncreaseDecreaseInPrepayments" xml:lang="en-US">Adjustments for Increase Decrease in Prepayments</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xml:lang="en-US">Adjustments for increase (decrease) in trade and other payables</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xml:lang="en-US">Trade payables and other payables</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xml:lang="en-US">Cash flows from (used in) operating activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xml:lang="en-US">Cash flows from / (used in) operating activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xml:lang="en-US">Interest received, classified as operating activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xml:lang="en-US">Finance income received</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xml:lang="en-US">Interest paid, classified as operating activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xml:lang="en-US">Finance expenses paid</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xml:lang="en-US">Adjustments to reconcile profit (loss) [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xml:lang="en-US">Adjustments for non-cash items:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationExpense" xml:lang="en-US">Adjustments for depreciation expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationExpense" xml:lang="en-US">Depreciation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationExpense" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationExpense" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NoncashConsideration" xlink:label="loc_asnd_NoncashConsideration" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_NoncashConsideration" xml:lang="en-US">Non-cash consideration</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_asnd_NoncashConsideration" xml:lang="en-US">Reversal of non-cash consideration relating to revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_NoncashConsideration" xlink:to="lab_asnd_NoncashConsideration" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_NoncashConsideration" xml:lang="en-US">Non-cash consideration</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xml:lang="en-US">Adjustments for share-based payments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xml:lang="en-US">Share-based payment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForAmortisationExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForAmortisationExpense" xml:lang="en-US">Adjustments for amortisation expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForAmortisationExpense" xml:lang="en-US">Amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForAmortisationExpense" xlink:to="lab_ifrs-full_AdjustmentsForAmortisationExpense" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xml:lang="en-US">Financing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xml:lang="en-US">Effect of exchange rate changes on balances held in foreign currencies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xml:lang="en-US">Increase (decrease) in cash and cash equivalents before effect of exchange rate changes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xml:lang="en-US">Increase / (decrease) in cash and cash equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xml:lang="en-US">Cash flows from (used in) financing activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xml:lang="en-US">Cash flows from / (used in) financing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xml:lang="en-US">Payment of principal portion of lease liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" xlink:label="loc_asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" xml:lang="en-US">Proceeds From Exercise Of Warrants Classified As Financing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" xml:lang="en-US">Proceeds from exercise of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" xlink:to="lab_asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" xml:lang="en-US">Proceeds from exercise of warrants classified as financing activities.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xml:lang="en-US">Investing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xml:lang="en-US">Cash flows from (used in) investing activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xml:lang="en-US">Cash flows from / (used in) investing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:label="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsForDevelopmentProjectExpenditure" xml:lang="en-US">Payments for development project expenditure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsForDevelopmentProjectExpenditure" xml:lang="en-US">Development expenditures (software)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:to="lab_ifrs-full_PaymentsForDevelopmentProjectExpenditure" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfAvailableforsaleFinancialAssets" xlink:label="loc_ifrs-full_PurchaseOfAvailableforsaleFinancialAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfAvailableforsaleFinancialAssets" xml:lang="en-US">Purchase of available-for-sale financial assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfAvailableforsaleFinancialAssets" xml:lang="en-US">Purchase of marketable securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfAvailableforsaleFinancialAssets" xlink:to="lab_ifrs-full_PurchaseOfAvailableforsaleFinancialAssets" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets" xlink:label="loc_ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets" xml:lang="en-US">Proceeds from disposal or maturity of available-for-sale financial assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets" xml:lang="en-US">Settlement of marketable securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets" xlink:to="lab_ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xml:lang="en-US">Acquisition of property, plant and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfInterestsInAssociates" xlink:label="loc_ifrs-full_PurchaseOfInterestsInAssociates" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfInterestsInAssociates" xml:lang="en-US">Purchase of interests in associates</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfInterestsInAssociates" xml:lang="en-US">Investment in associate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInterestsInAssociates" xlink:to="lab_ifrs-full_PurchaseOfInterestsInAssociates" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_CashDeposits" xlink:label="loc_asnd_CashDeposits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_CashDeposits" xml:lang="en-US">Cash Deposits</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_CashDeposits" xml:lang="en-US">Bank deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_CashDeposits" xlink:to="lab_asnd_CashDeposits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_CashDeposits" xml:lang="en-US">Bank deposits.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ShortTermMarketableSecurities" xlink:label="loc_asnd_ShortTermMarketableSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_ShortTermMarketableSecurities" xml:lang="en-US">Short Term Marketable Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_ShortTermMarketableSecurities" xml:lang="en-US">Short-term marketable securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_ShortTermMarketableSecurities" xlink:to="lab_asnd_ShortTermMarketableSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_ShortTermMarketableSecurities" xml:lang="en-US">Short-term marketable securities.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_TextBlockAbstract" xml:lang="en-US">Text block [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_TextBlockAbstract" xlink:to="lab_asnd_TextBlockAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_TextBlockAbstract" xml:lang="en-US">Text block [abstract]</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xml:lang="en-US">Disclosure of general information about financial statements [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xml:lang="en-US">General Information</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xml:lang="en-US">Disclosure of significant accounting policies [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xml:lang="en-US">Summary of Significant Accounting Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xml:lang="en-US">Critical Accounting Judgements and Key Sources of Estimation Uncertainty</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SignificantEventsInTheReportingPeriodTextBlock" xlink:label="loc_asnd_SignificantEventsInTheReportingPeriodTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_SignificantEventsInTheReportingPeriodTextBlock" xml:lang="en-US">Significant Events In The Reporting Period [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_SignificantEventsInTheReportingPeriodTextBlock" xml:lang="en-US">Significant Events In The Reporting Period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_SignificantEventsInTheReportingPeriodTextBlock" xlink:to="lab_asnd_SignificantEventsInTheReportingPeriodTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_SignificantEventsInTheReportingPeriodTextBlock" xml:lang="en-US">Significant events in the reporting period.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRevenueExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRevenueExplanatory" xml:lang="en-US">Disclosure of revenue [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfRevenueExplanatory" xml:lang="en-US">Revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRevenueExplanatory" xlink:to="lab_ifrs-full_DisclosureOfRevenueExplanatory" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xml:lang="en-US">Disclosure of entity's operating segments [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xml:lang="en-US">Segment Information</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xml:lang="en-US">Disclosure of employee benefits [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xml:lang="en-US">Warrants and Share-based Payment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract" xlink:label="loc_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract" xml:lang="en-US">Categories of current financial assets [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract" xml:lang="en-US">Categories of current financial assets [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract" xlink:to="lab_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory" xml:lang="en-US">Disclosure of available-for-sale financial assets [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory" xml:lang="en-US">Marketable Securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xml:lang="en-US">Share Capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory" xml:lang="en-US">Disclosure of leases [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory" xml:lang="en-US">Lease Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xml:lang="en-US">Disclosure of events after reporting period [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xml:lang="en-US">Subsequent Events</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xml:lang="en-US">Basis of Preparation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" xlink:label="loc_asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" xml:lang="en-US">Disclosure of New and Amended Standards Adoption [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" xml:lang="en-US">New and Amended IFRS Standards Adopted by the Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" xlink:to="lab_asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" xml:lang="en-US">Disclosure of New and Amended Standards Adoption [Policy Text Block].</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" xlink:label="loc_asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" xml:lang="en-US">Disclosure of revenue recognized in the statement of profit or loss explanatory</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" xml:lang="en-US">Schedule of Revenue Recognized in the Statement of Profit or Loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" xlink:to="lab_asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" xml:lang="en-US">Disclosure of revenue recognized in the statement of profit or loss explanatory.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xml:lang="en-US">Disclosure of number and weighted average exercise prices of other equity instruments [text block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xml:lang="en-US">Summary of Warrant Activity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharebasedPaymentArrangementsMember" xml:lang="en-US">Share-based payment arrangements [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SharebasedPaymentArrangementsMember" xml:lang="en-US">Share-based payment arrangements [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="lab_ifrs-full_SharebasedPaymentArrangementsMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock" xlink:label="loc_asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock" xml:lang="en-US">Disclosure Of Available For Sale Assets Explanatory [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock" xml:lang="en-US">Summary of Marketable Securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock" xlink:to="lab_asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock" xml:lang="en-US">Disclosure &#8203;of available for sale&#8203; assets&#8203; explanatory.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock" xlink:label="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock" xml:lang="en-US">Disclosure Of Maturity Analysis Of Lease Liability Explanatory [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock" xml:lang="en-US">Summary of Maturity Analysis for Lease Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock" xlink:to="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock" xml:lang="en-US">Disclosure of maturity analysis of lease liability explanatory.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" xml:lang="en-US">Disclosure of summary of significant accounting policies [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" xlink:to="lab_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" xml:lang="en-US">Disclosure of summary of significant accounting policies [abstract]</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable" xml:lang="en-US">Disclosure Of Summary Of Significant Accounting Policies [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable" xml:lang="en-US">Disclosure of summary of significant accounting policies [table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" xml:lang="en-US">Disclosure Of Summary Of Significant Accounting Policies [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" xml:lang="en-US">Disclosure of summary of significant accounting policies [line items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ExpectedNonCashGainTowardsShares" xlink:label="loc_asnd_ExpectedNonCashGainTowardsShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_ExpectedNonCashGainTowardsShares" xml:lang="en-US">Expected Non Cash Gain towards Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_ExpectedNonCashGainTowardsShares" xml:lang="en-US">Expected Non cash Gain recognised towards Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_ExpectedNonCashGainTowardsShares" xlink:to="lab_asnd_ExpectedNonCashGainTowardsShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_ExpectedNonCashGainTowardsShares" xml:lang="en-US">Expected Non Cash Gain towards Shares.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" xlink:label="loc_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" xml:lang="en-US">Proportion of interest Hold in Issued And Outstanding Shares of Associate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" xml:lang="en-US">Proportion of Interest retain in issued and Outstanding shares of Associate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" xlink:to="lab_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" xml:lang="en-US">Proportion of interest Hold in Issued And Outstanding Shares of Associate.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xml:lang="en-US">Investments in associates accounted for using equity method</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xml:lang="en-US">Equity Investment in Associates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xml:lang="en-US">Proceeds from borrowings, classified as financing activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xml:lang="en-US">Proceeds from Borrowings classified as Financing Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsMember" xml:lang="en-US">Non-adjusting events after reporting period [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NonadjustingEventsMember" xml:lang="en-US">Non-adjusting events after reporting period [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsMember" xlink:to="lab_ifrs-full_NonadjustingEventsMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockAxis" xlink:label="loc_asnd_SaleOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_SaleOfStockAxis" xml:lang="en-US">Sale Of Stock [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_SaleOfStockAxis" xml:lang="en-US">Sale Of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_SaleOfStockAxis" xlink:to="lab_asnd_SaleOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_SaleOfStockAxis" xml:lang="en-US">Sale Of Stock [Axis].</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockMember" xlink:label="loc_asnd_SaleOfStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_SaleOfStockMember" xml:lang="en-US">Sale Of Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_SaleOfStockMember" xml:lang="en-US">Sale Of Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_SaleOfStockMember" xlink:to="lab_asnd_SaleOfStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_SaleOfStockMember" xml:lang="en-US">Sale Of Stock [Member].</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" xml:lang="en-US">Associates [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" xml:lang="en-US">Associates [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:to="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForAssociatesMember" xml:lang="en-US">Entity's total for associates [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EntitysTotalForAssociatesMember" xml:lang="en-US">Entity's total for associates [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember" xlink:to="lab_ifrs-full_EntitysTotalForAssociatesMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" xlink:label="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" xml:lang="en-US">Statement of comprehensive income, profit or loss location [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" xml:lang="en-US">Statement of comprehensive income, profit or loss location [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" xlink:to="lab_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" xml:lang="en-US">Statement of comprehensive income, profit or loss location.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" xlink:label="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" xml:lang="en-US">Statement of comprehensive income, profit or loss location [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" xml:lang="en-US">Statement of comprehensive income, profit or loss location [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" xlink:to="lab_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" xml:lang="en-US">Statement of comprehensive income, profit or loss location 1.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MajorCustomersAxis" xml:lang="en-US">Major customers [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MajorCustomersAxis" xml:lang="en-US">Major customers [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorCustomersAxis" xlink:to="lab_ifrs-full_MajorCustomersAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MajorCustomersMember" xml:lang="en-US">Customers [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MajorCustomersMember" xml:lang="en-US">Customers [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorCustomersMember" xlink:to="lab_ifrs-full_MajorCustomersMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_VisenPharmaceuticalsMember" xlink:label="loc_asnd_VisenPharmaceuticalsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_VisenPharmaceuticalsMember" xml:lang="en-US">Visen Pharmaceuticals [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_asnd_VisenPharmaceuticalsMember" xml:lang="en-US">VISEN Pharmaceuticals [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_VisenPharmaceuticalsMember" xlink:to="lab_asnd_VisenPharmaceuticalsMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xml:lang="en-US">Liabilities arising from financing activities [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xml:lang="en-US">Liabilities arising from financing activities [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_VisenSeriesBFinancingMember" xlink:label="loc_asnd_VisenSeriesBFinancingMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_VisenSeriesBFinancingMember" xml:lang="en-US">VISEN Series B Financing [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_VisenSeriesBFinancingMember" xlink:to="lab_asnd_VisenSeriesBFinancingMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_VisenSeriesBFinancingMember" xml:lang="en-US">VISEN Series B Financing.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xml:lang="en-US">Disclosure of operating segments [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xml:lang="en-US">Disclosure of operating segments [table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xml:lang="en-US">Disclosure of operating segments [table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xml:lang="en-US">Disclosure of operating segments [line items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xml:lang="en-US">Disclosure of operating segments [line items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" xlink:label="loc_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" xml:lang="en-US">Upfront Payment Received Non Cash Consideration Towards License Revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" xml:lang="en-US">Upfront payment received non cash consideration towards license revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" xlink:to="lab_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" xml:lang="en-US">Upfront payment received non cash consideration towards license revenue.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" xml:lang="en-US">Proportion of ownership interest in associate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" xml:lang="en-US">Percentage of ownership in the customer company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_RetainedPercentageOfIssuedAndOutstandingShares" xlink:label="loc_asnd_RetainedPercentageOfIssuedAndOutstandingShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_RetainedPercentageOfIssuedAndOutstandingShares" xml:lang="en-US">Retained Percentage Of Issued And Outstanding Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_RetainedPercentageOfIssuedAndOutstandingShares" xml:lang="en-US">Retained percentage of issued and outstanding shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_RetainedPercentageOfIssuedAndOutstandingShares" xlink:to="lab_asnd_RetainedPercentageOfIssuedAndOutstandingShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_RetainedPercentageOfIssuedAndOutstandingShares" xml:lang="en-US">Retained percentage of issued and outstanding shares.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LicenceFeeIncome" xml:lang="en-US">Licence fee income</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LicenceFeeIncome" xml:lang="en-US">"Right-to-use" licenses (recognized at a point in time)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicenceFeeIncome" xlink:to="lab_ifrs-full_LicenceFeeIncome" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-full_RevenueFromRenderingOfServices" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromRenderingOfServices" xml:lang="en-US">Revenue from rendering of services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RevenueFromRenderingOfServices" xml:lang="en-US">Revenue from the rendering of services (recognized over time)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromRenderingOfServices" xlink:to="lab_ifrs-full_RevenueFromRenderingOfServices" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_RevenueFromSaleOfClinicalSupply" xlink:label="loc_asnd_RevenueFromSaleOfClinicalSupply" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_RevenueFromSaleOfClinicalSupply" xml:lang="en-US">Revenue From Sale Of Clinical Supply</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_RevenueFromSaleOfClinicalSupply" xml:lang="en-US">Sale of clinical supply (recognized at a point in time)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_RevenueFromSaleOfClinicalSupply" xlink:to="lab_asnd_RevenueFromSaleOfClinicalSupply" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_RevenueFromSaleOfClinicalSupply" xml:lang="en-US">Revenue from sale of clinical supply.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfGeographicalAreasAbstract" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasAbstract" xml:lang="en-US">Disclosure of geographical areas [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasAbstract" xml:lang="en-US">Revenue by geographical location</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasAbstract" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xml:lang="en-US">Geographical areas [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xml:lang="en-US">Geographical areas [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasAxis" xlink:to="lab_ifrs-full_GeographicalAreasAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeographicalAreasMember" xml:lang="en-US">Geographical areas [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GeographicalAreasMember" xml:lang="en-US">Geographical areas [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasMember" xlink:to="lab_ifrs-full_GeographicalAreasMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NorthAmericaMember" xlink:label="loc_srt_NorthAmericaMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_NorthAmericaMember" xml:lang="en-US">North America [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_NorthAmericaMember" xml:lang="en-US">North America [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NorthAmericaMember" xlink:to="lab_srt_NorthAmericaMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN" xlink:label="loc_country_CN" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_CN" xml:lang="en-US">CHINA</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_CN" xml:lang="en-US">China [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_OtherCollaborationPartnersMember" xlink:label="loc_asnd_OtherCollaborationPartnersMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_OtherCollaborationPartnersMember" xml:lang="en-US">Other Collaboration Partners [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_asnd_OtherCollaborationPartnersMember" xml:lang="en-US">Other collaboration partners [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_OtherCollaborationPartnersMember" xlink:to="lab_asnd_OtherCollaborationPartnersMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueAbstract" xml:lang="en-US">Revenue [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RevenueAbstract" xml:lang="en-US">Disclosure of Operating Segments [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueAbstract" xlink:to="lab_ifrs-full_RevenueAbstract" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DeferredRevenueFromAssociate" xlink:label="loc_asnd_DeferredRevenueFromAssociate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DeferredRevenueFromAssociate" xml:lang="en-US">Deferred revenue from associate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_DeferredRevenueFromAssociate" xml:lang="en-US">Deferred revenue from associate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DeferredRevenueFromAssociate" xlink:to="lab_asnd_DeferredRevenueFromAssociate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DeferredRevenueFromAssociate" xml:lang="en-US">Deferred revenue from associate.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NumberOfReportableOperatingSegments" xlink:label="loc_asnd_NumberOfReportableOperatingSegments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_NumberOfReportableOperatingSegments" xml:lang="en-US">Number of reportable operating segments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_NumberOfReportableOperatingSegments" xml:lang="en-US">Number of reportable segment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_NumberOfReportableOperatingSegments" xlink:to="lab_asnd_NumberOfReportableOperatingSegments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_NumberOfReportableOperatingSegments" xml:lang="en-US">Number of reportable operating segments.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" xlink:label="loc_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" xml:lang="en-US">Aggregate number of other equity instruments cancelled in sharebased payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" xml:lang="en-US">Aggregate number of other equity instruments cancelled</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" xlink:to="lab_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" xml:lang="en-US">Aggregate number of other equity instruments cancelled in sharebased payment arrangement.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xml:lang="en-US">Aggregate number of other equity instruments exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xml:lang="en-US">Exercise price of outstanding share options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:to="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xml:lang="en-US">Expense from share-based payment transactions with employees</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xml:lang="en-US">Warrant compensation costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xml:lang="en-US">Number of share options expired in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xml:lang="en-US">Aggregate number of other equity instruments expired</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xml:lang="en-US">Aggregate number of other equity instruments forfeited</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xml:lang="en-US">Number of share options granted in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xml:lang="en-US">Aggregate number of other equity instruments granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ParValuePerShare" xml:lang="en-US">Par value per share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ParValuePerShare" xml:lang="en-US">Share nominal value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare" xlink:to="lab_ifrs-full_ParValuePerShare" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" xlink:label="loc_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" xml:lang="en-US">Number Of Instruments Authorised In Share-Based Payment Arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" xml:lang="en-US">Number of other equity instruments authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" xlink:to="lab_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" xml:lang="en-US">Number Of Instruments Authorised In Share-Based Payment Arrangement</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangeAxis" xml:lang="en-US">Range [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RangeAxis" xml:lang="en-US">Range [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis" xlink:to="lab_ifrs-full_RangeAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesMember" xml:lang="en-US">Ranges [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RangesMember" xml:lang="en-US">Ranges [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesMember" xlink:to="lab_ifrs-full_RangesMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BottomOfRangeMember" xml:lang="en-US">Bottom of range [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BottomOfRangeMember" xml:lang="en-US">Bottom of range [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember" xlink:to="lab_ifrs-full_BottomOfRangeMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TopOfRangeMember" xml:lang="en-US">Top of range [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TopOfRangeMember" xml:lang="en-US">Top of range [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember" xlink:to="lab_ifrs-full_TopOfRangeMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfEmployeeCompensationCostsAbstract" xlink:label="loc_asnd_DisclosureOfEmployeeCompensationCostsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfEmployeeCompensationCostsAbstract" xml:lang="en-US">Disclosure of employee compensation costs [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfEmployeeCompensationCostsAbstract" xlink:to="lab_asnd_DisclosureOfEmployeeCompensationCostsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureOfEmployeeCompensationCostsAbstract" xml:lang="en-US">Disclosure of employees compensation costs.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfWarrantActivityLineItems" xlink:label="loc_asnd_DisclosureOfWarrantActivityLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfWarrantActivityLineItems" xml:lang="en-US">Disclosure Of Warrant Activity [line items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_DisclosureOfWarrantActivityLineItems" xml:lang="en-US">Disclosure Of Warrant Activity [line items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems" xlink:to="lab_asnd_DisclosureOfWarrantActivityLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureOfWarrantActivityLineItems" xml:lang="en-US">Disclosure Of Warrant Activity [line items]</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xlink:label="loc_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xml:lang="en-US">Weighted average exercise price of other equity instruments vested in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xml:lang="en-US">Vested at the balance sheet date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xlink:to="lab_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xml:lang="en-US">Weighted average exercise price of other equity instruments vested in share-based payment arrangement.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xml:lang="en-US">Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xml:lang="en-US">Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xml:lang="en-US">Ending balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xml:lang="en-US">Weighted average exercise price of other equity instruments granted in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xml:lang="en-US">Granted during the period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xml:lang="en-US">Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xml:lang="en-US">Exercised during the period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xml:lang="en-US">Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xml:lang="en-US">Forfeited during the period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xml:lang="en-US">Granted during the period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xml:lang="en-US">Number of other equity instruments exercised or vested in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xml:lang="en-US">Exercised during the period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xml:lang="en-US">Number of other equity instruments forfeited in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xml:lang="en-US">Forfeited during the period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xml:lang="en-US">Number of other equity instruments outstanding in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xml:lang="en-US">Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xml:lang="en-US">Ending balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xlink:label="loc_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xml:lang="en-US">Number of other equity instruments vested in share-based payment arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xml:lang="en-US">Vested at the balance sheet date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xlink:to="lab_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xml:lang="en-US">Number of other equity instruments vested in share-based payment arrangement.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_MarketableSecuritiesAbstract" xlink:label="loc_asnd_MarketableSecuritiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_MarketableSecuritiesAbstract" xml:lang="en-US">Marketable Securities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_asnd_MarketableSecuritiesAbstract" xml:lang="en-US">Marketable securities [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_MarketableSecuritiesAbstract" xlink:to="lab_asnd_MarketableSecuritiesAbstract" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent" xlink:label="loc_asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent" xml:lang="en-US">Weighted Average Duration Of Marketable Securities Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent" xml:lang="en-US">Weighted average duration of marketable securities non-current</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent" xlink:to="lab_asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent" xml:lang="en-US">Weighted average duration of marketable securities noncurrent.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_WeightedAverageDurationOfMarketableSecurities" xlink:label="loc_asnd_WeightedAverageDurationOfMarketableSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_WeightedAverageDurationOfMarketableSecurities" xml:lang="en-US">Weighted Average Duration Of Marketable Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_WeightedAverageDurationOfMarketableSecurities" xml:lang="en-US">Weighted average duration of marketable securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_WeightedAverageDurationOfMarketableSecurities" xlink:to="lab_asnd_WeightedAverageDurationOfMarketableSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_WeightedAverageDurationOfMarketableSecurities" xml:lang="en-US">Weighted average duration of marketable securities.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent" xlink:label="loc_asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent" xml:lang="en-US">Weighted Average Duration Of Marketable Securities Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent" xml:lang="en-US">Weighted average duration of marketable securities current</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent" xlink:to="lab_asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent" xml:lang="en-US">Weighted average duration of marketable securities current.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable" xlink:label="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable" xml:lang="en-US">Disclosure Detailed Information About Marketable Securities [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable" xml:lang="en-US">Disclosure detailed information about marketable securities [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable" xlink:to="lab_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable" xml:lang="en-US">Disclosure detailed information about marketable securities.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xml:lang="en-US">Classes of financial assets [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xml:lang="en-US">Classes of financial assets [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsMember" xml:lang="en-US">Financial assets, class [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinancialAssetsMember" xml:lang="en-US">Financial assets, class [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsMember" xlink:to="lab_ifrs-full_FinancialAssetsMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UsTreasuryBillsMember" xlink:label="loc_asnd_UsTreasuryBillsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_UsTreasuryBillsMember" xml:lang="en-US">US Treasury bills [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_UsTreasuryBillsMember" xml:lang="en-US">US Treasury bills [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_UsTreasuryBillsMember" xlink:to="lab_asnd_UsTreasuryBillsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_UsTreasuryBillsMember" xml:lang="en-US">U.S. Treasury bills [Member].</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_CommercialPapersMember" xlink:label="loc_asnd_CommercialPapersMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_CommercialPapersMember" xml:lang="en-US">Commercial papers [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_CommercialPapersMember" xml:lang="en-US">Commercial papers [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_CommercialPapersMember" xlink:to="lab_asnd_CommercialPapersMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_CommercialPapersMember" xml:lang="en-US">Commercial papers [Member].</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_CorporateBondsMember" xlink:label="loc_asnd_CorporateBondsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_CorporateBondsMember" xml:lang="en-US">Corporate bonds [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_CorporateBondsMember" xml:lang="en-US">Corporate bonds [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_CorporateBondsMember" xlink:to="lab_asnd_CorporateBondsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_CorporateBondsMember" xml:lang="en-US">Corporate bonds [Member].</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AgencyBondsMember" xlink:label="loc_asnd_AgencyBondsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_AgencyBondsMember" xml:lang="en-US">Agency bonds [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_AgencyBondsMember" xml:lang="en-US">Agency bonds [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_AgencyBondsMember" xlink:to="lab_asnd_AgencyBondsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_AgencyBondsMember" xml:lang="en-US">Agency bonds [Member].</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UsGovernmentBondsMember" xlink:label="loc_asnd_UsGovernmentBondsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_UsGovernmentBondsMember" xml:lang="en-US">US Government Bonds [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_UsGovernmentBondsMember" xml:lang="en-US">US Government bonds [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_UsGovernmentBondsMember" xlink:to="lab_asnd_UsGovernmentBondsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_UsGovernmentBondsMember" xml:lang="en-US">U.S. Government Bonds [Member].</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xml:lang="en-US">Categories of financial assets [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xml:lang="en-US">Categories of financial assets [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsCategoryMember" xml:lang="en-US">Financial assets, category [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinancialAssetsCategoryMember" xml:lang="en-US">Financial assets, category [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsCategoryMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsAtAmortisedCostMember" xml:lang="en-US">Financial assets at amortised cost, class [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinancialAssetsAtAmortisedCostMember" xml:lang="en-US">Financial assets at amortised cost, class [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:to="lab_ifrs-full_FinancialAssetsAtAmortisedCostMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtFairValueMember" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueMember" xml:lang="en-US">Financial assets at fair value, class [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueMember" xml:lang="en-US">Financial assets at fair value, class [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueMember" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" xml:lang="en-US">Levels of fair value hierarchy [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" xml:lang="en-US">Levels of fair value hierarchy [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember" xml:lang="en-US">All levels of fair value hierarchy [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember" xml:lang="en-US">All levels of fair value hierarchy [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:to="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" xlink:label="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" xml:lang="en-US">Disclosure Detailed Information About Marketable Securities [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" xlink:to="lab_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" xml:lang="en-US">Disclosure Detailed Information About Marketable Securities LineItems.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_FinancialAssetsAvailableforsale" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsAvailableforsale" xml:lang="en-US">Financial assets available-for-sale</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinancialAssetsAvailableforsale" xml:lang="en-US">Financial assets available-for-sale</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAvailableforsale" xlink:to="lab_ifrs-full_FinancialAssetsAvailableforsale" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssets" xml:lang="en-US">Financial assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinancialAssets" xml:lang="en-US">Financial assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssets" xlink:to="lab_ifrs-full_FinancialAssets" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExternalCreditGradesAxis" xlink:label="loc_ifrs-full_ExternalCreditGradesAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExternalCreditGradesAxis" xml:lang="en-US">External credit grades [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExternalCreditGradesAxis" xml:lang="en-US">External credit grades [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExternalCreditGradesAxis" xlink:to="lab_ifrs-full_ExternalCreditGradesAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForExternalCreditGradesMember" xlink:label="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForExternalCreditGradesMember" xml:lang="en-US">Entity's total for external credit grades [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EntitysTotalForExternalCreditGradesMember" xml:lang="en-US">Entity's total for external credit grades [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember" xlink:to="lab_ifrs-full_EntitysTotalForExternalCreditGradesMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_PrimeMember" xlink:label="loc_asnd_PrimeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_PrimeMember" xml:lang="en-US">Prime [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_PrimeMember" xml:lang="en-US">Prime [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_PrimeMember" xlink:to="lab_asnd_PrimeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_PrimeMember" xml:lang="en-US">Prime member.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_HighGradeMember" xlink:label="loc_asnd_HighGradeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_HighGradeMember" xml:lang="en-US">High grade [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_HighGradeMember" xml:lang="en-US">High grade [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_HighGradeMember" xlink:to="lab_asnd_HighGradeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_HighGradeMember" xml:lang="en-US">High grade member.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UpperMediumGradeMember" xlink:label="loc_asnd_UpperMediumGradeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_UpperMediumGradeMember" xml:lang="en-US">Upper Medium Grade [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_UpperMediumGradeMember" xml:lang="en-US">Upper Medium Grade [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_UpperMediumGradeMember" xlink:to="lab_asnd_UpperMediumGradeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_UpperMediumGradeMember" xml:lang="en-US">Upper medium grade [Member].</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LowerMediumGradeMember" xlink:label="loc_asnd_LowerMediumGradeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_LowerMediumGradeMember" xml:lang="en-US">Lower Medium Grade [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_LowerMediumGradeMember" xml:lang="en-US">Lower Medium Grade [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_LowerMediumGradeMember" xlink:to="lab_asnd_LowerMediumGradeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_LowerMediumGradeMember" xml:lang="en-US">Lower medium grade [Member].</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfInterestRatesAxis" xml:lang="en-US">Types of interest rates [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TypesOfInterestRatesAxis" xml:lang="en-US">Types of interest rates [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis" xlink:to="lab_ifrs-full_TypesOfInterestRatesAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-full_InterestRateTypesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestRateTypesMember" xml:lang="en-US">Interest rate types [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InterestRateTypesMember" xml:lang="en-US">Interest rate types [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestRateTypesMember" xlink:to="lab_ifrs-full_InterestRateTypesMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FixedInterestRateMember" xlink:label="loc_ifrs-full_FixedInterestRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FixedInterestRateMember" xml:lang="en-US">Fixed interest rate [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FixedInterestRateMember" xml:lang="en-US">Fixed interest rate [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixedInterestRateMember" xlink:to="lab_ifrs-full_FixedInterestRateMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="loc_ifrs-full_FloatingInterestRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FloatingInterestRateMember" xml:lang="en-US">Floating interest rate [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FloatingInterestRateMember" xml:lang="en-US">Floating interest rate [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FloatingInterestRateMember" xlink:to="lab_ifrs-full_FloatingInterestRateMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ZeroCouponMember" xlink:label="loc_asnd_ZeroCouponMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_ZeroCouponMember" xml:lang="en-US">Zero Coupon [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_ZeroCouponMember" xml:lang="en-US">Zero Coupon [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_ZeroCouponMember" xlink:to="lab_asnd_ZeroCouponMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_ZeroCouponMember" xml:lang="en-US">Zero Coupon [Member].</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xml:lang="en-US">Disclosure of classes of share capital [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xml:lang="en-US">Disclosure of classes of share capital [table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xml:lang="en-US">Disclosure of classes of share capital [table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xml:lang="en-US">Disclosure of classes of share capital [line items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xml:lang="en-US">Disclosure of classes of share capital [line items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding" xml:lang="en-US">Number of shares outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding" xml:lang="en-US">Number of shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Statement1Table" xlink:label="loc_asnd_Statement1Table" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_Statement1Table" xml:lang="en-US">Statement1 [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_Statement1Table" xml:lang="en-US">Statement [table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_Statement1Table" xlink:to="lab_asnd_Statement1Table" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_Statement1Table" xml:lang="en-US">Statement1 table.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Statement1LineItems" xlink:label="loc_asnd_Statement1LineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_Statement1LineItems" xml:lang="en-US">Statement1 [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_Statement1LineItems" xml:lang="en-US">Statement [line items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_Statement1LineItems" xlink:to="lab_asnd_Statement1LineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_Statement1LineItems" xml:lang="en-US">Statement1 line items.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeaseTerm" xlink:label="loc_asnd_LeaseTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_LeaseTerm" xml:lang="en-US">Lease Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_LeaseTerm" xml:lang="en-US">Lease term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_LeaseTerm" xlink:to="lab_asnd_LeaseTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_LeaseTerm" xml:lang="en-US">Lease Term.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeasesOptionToExtendAndTerminationTerm" xlink:label="loc_asnd_LeasesOptionToExtendAndTerminationTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_LeasesOptionToExtendAndTerminationTerm" xml:lang="en-US">Leases Option To Extend And Termination Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_LeasesOptionToExtendAndTerminationTerm" xml:lang="en-US">Lease extension and termination option term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_LeasesOptionToExtendAndTerminationTerm" xlink:to="lab_asnd_LeasesOptionToExtendAndTerminationTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_LeasesOptionToExtendAndTerminationTerm" xml:lang="en-US">Leases option to extend and termination term.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract" xlink:label="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract" xml:lang="en-US">Disclosure Of Maturity Analysis Of Lease Liability [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract" xlink:to="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract" xml:lang="en-US">Disclosure of maturity analysis of lease liability.</label>
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable" xlink:label="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable" xml:lang="en-US">Disclosure Of Maturity Analysis Of Lease Liability [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable" xlink:to="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable" xml:lang="en-US">Disclosure of maturity analysis of lease liability.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityAxis" xml:lang="en-US">Maturity [axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MaturityAxis" xml:lang="en-US">Maturity [axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis" xlink:to="lab_ifrs-full_MaturityAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AggregatedTimeBandsMember" xml:lang="en-US">Aggregated time bands [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AggregatedTimeBandsMember" xml:lang="en-US">Aggregated time bands [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember" xlink:to="lab_ifrs-full_AggregatedTimeBandsMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xml:lang="en-US">Not later than one year [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xml:lang="en-US">Within 1 year [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xml:lang="en-US">Later than five years [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xml:lang="en-US">After 5 years [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xml:lang="en-US">Later than one year and not later than five years [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xml:lang="en-US">Within 1 to 5 years [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems" xlink:label="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems" xml:lang="en-US">Disclosure Of Maturity Analysis Of Lease Liability [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [line items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems" xlink:to="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems" xml:lang="en-US">Disclosure of maturity analysis of lease liability.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilities" xml:lang="en-US">Lease liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_LeaseLiabilities" xml:lang="en-US">Total lease liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities" xlink:to="lab_ifrs-full_LeaseLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-full_GrossLeaseLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossLeaseLiabilities" xml:lang="en-US">Gross lease liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GrossLeaseLiabilities" xml:lang="en-US">Lease liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLeaseLiabilities" xlink:to="lab_ifrs-full_GrossLeaseLiabilities" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeaseLiabilitiesAxis" xlink:label="loc_asnd_LeaseLiabilitiesAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_LeaseLiabilitiesAxis" xml:lang="en-US">Lease Liabilities [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_LeaseLiabilitiesAxis" xlink:to="lab_asnd_LeaseLiabilitiesAxis" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeaseLiabilitiesDomain" xlink:label="loc_asnd_LeaseLiabilitiesDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_LeaseLiabilitiesDomain" xml:lang="en-US">Lease Liabilities [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_LeaseLiabilitiesDomain" xlink:to="lab_asnd_LeaseLiabilitiesDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xml:lang="en-US">Carrying amount [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember" xlink:to="lab_ifrs-full_GrossCarryingAmountMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DiscountedCashFlowMember" xlink:label="loc_ifrs-full_DiscountedCashFlowMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DiscountedCashFlowMember" xml:lang="en-US">Discounted cash flow [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DiscountedCashFlowMember" xml:lang="en-US">Total contractual cash-flows [member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DiscountedCashFlowMember" xlink:to="lab_ifrs-full_DiscountedCashFlowMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NonadjustingEventsAfterReportingPeriodMember" xlink:label="loc_asnd_NonadjustingEventsAfterReportingPeriodMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_NonadjustingEventsAfterReportingPeriodMember" xml:lang="en-US">Nonadjusting Events After Reporting Period [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_NonadjustingEventsAfterReportingPeriodMember" xlink:to="lab_asnd_NonadjustingEventsAfterReportingPeriodMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_NonadjustingEventsAfterReportingPeriodMember" xml:lang="en-US">Nonadjusting events after reporting period.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" xlink:label="loc_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" xml:lang="en-US">Reversal Of Prior Period Write Downs Of Inventories Expected Impact On Research And Development Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" xml:lang="en-US">Reversal of prior period write-downs of inventories expected to have a positive impact on research and development costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" xlink:to="lab_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" xml:lang="en-US">Reversal of prior period write downs of inventories expected impact on research and development costs.</label>
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>asnd-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 27-August-2021 [01:11:57] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CoverPage" roleURI="http://ascendispharma.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimStatementsOfFinancialPosition" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimStatementsOfChangesInEquity" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CondensedConsolidatedInterimCashFlowStatements" roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#GeneralInformation" roleURI="http://ascendispharma.com/role/GeneralInformation" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty" roleURI="http://ascendispharma.com/role/CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SignificantEventsInTheReportingPeriod" roleURI="http://ascendispharma.com/role/SignificantEventsInTheReportingPeriod" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#Revenue" roleURI="http://ascendispharma.com/role/Revenue" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SegmentInformation" roleURI="http://ascendispharma.com/role/SegmentInformation" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#WarrantsAndShareBasedPayment" roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPayment" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#MarketableSecurities" roleURI="http://ascendispharma.com/role/MarketableSecurities" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#ShareCapital" roleURI="http://ascendispharma.com/role/ShareCapital" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#LeaseLiabilities" roleURI="http://ascendispharma.com/role/LeaseLiabilities" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SubsequentEvents" roleURI="http://ascendispharma.com/role/SubsequentEvents" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#RevenueTables" roleURI="http://ascendispharma.com/role/RevenueTables" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#WarrantsAndShareBasedPaymentTables" roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#MarketableSecuritiesTables" roleURI="http://ascendispharma.com/role/MarketableSecuritiesTables" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#LeaseLiabilitiesTables" roleURI="http://ascendispharma.com/role/LeaseLiabilitiesTables" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SignificantEventsInTheReportingPeriodAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#RevenueAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/RevenueAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail" roleURI="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail" roleURI="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SegmentInformationAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/SegmentInformationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#WarrantsAndShareBasedPaymentAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail" roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#MarketableSecuritiesAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/MarketableSecuritiesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#MarketableSecuritiesSummaryOfMarketableSecuritiesDetail" roleURI="http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#ShareCapitalAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#LeaseLiabilitiesAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail" roleURI="http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="asnd-20210630.xsd#SubsequentEventsAdditionalInformationDetail" roleURI="http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail" />
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CoverPage">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_695384" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_695387" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_695384" xlink:to="loc_dei_DocumentType_695387" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_695388" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_695384" xlink:to="loc_dei_AmendmentFlag_695388" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_695389" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_695384" xlink:to="loc_dei_DocumentPeriodEndDate_695389" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_695390" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_695384" xlink:to="loc_dei_DocumentFiscalYearFocus_695390" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_695391" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_695384" xlink:to="loc_dei_DocumentFiscalPeriodFocus_695391" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_695392" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_695384" xlink:to="loc_dei_EntityRegistrantName_695392" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_695393" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_695384" xlink:to="loc_dei_EntityCentralIndexKey_695393" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_695394" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_695384" xlink:to="loc_dei_CurrentFiscalYearEndDate_695394" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_17" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_Revenue_17" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_18" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_18" use="optional" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_19" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_19" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_20" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_20" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_21" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_21" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_22" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_FinanceIncome_22" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_23" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_FinanceCosts_23" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_24" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_24" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_25" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_25" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_26" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_ProfitLoss_26" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_735272" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_735272" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare_30" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare_30" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_31" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_WeightedAverageShares_31" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_735280" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_12" xlink:to="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_735280" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_735599" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_735280" xlink:to="loc_ifrs-full_ProfitLoss_735599" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_13" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_735280" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_13" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_15" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_13" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_15" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_16" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_13" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_16" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_27" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_735280" xlink:to="loc_ifrs-full_ComprehensiveIncome_27" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_1072737" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_735280" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_1072737" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_33" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementTable" xlink:label="loc_asnd_StatementTable_37" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_33" xlink:to="loc_asnd_StatementTable_37" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_34" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementTable_37" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_34" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_35" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_34" xlink:to="loc_ifrs-full_EquityMember_35" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Warrant1Member" xlink:label="loc_asnd_Warrant1Member_38" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_35" xlink:to="loc_asnd_Warrant1Member_38" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementLineItems" xlink:label="loc_asnd_StatementLineItems_36" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementTable_37" xlink:to="loc_asnd_StatementLineItems_36" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_1074310" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementLineItems_36" xlink:to="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_1074310" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" xlink:label="loc_asnd_NonCurrentAssetsFinanceLiabilitiesAbstract_41" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_42" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_NonCurrentAssetsFinanceLiabilitiesAbstract_41" xlink:to="loc_ifrs-full_AssetsAbstract_42" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_47" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_42" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_47" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_GoodwillAndOtherIntangibleAssets" xlink:label="loc_asnd_GoodwillAndOtherIntangibleAssets_67" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_47" xlink:to="loc_asnd_GoodwillAndOtherIntangibleAssets_67" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_68" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_47" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_68" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-full_InvestmentsInAssociates_69" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_47" xlink:to="loc_ifrs-full_InvestmentsInAssociates_69" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LongtermDeposits" xlink:label="loc_ifrs-full_LongtermDeposits_70" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_47" xlink:to="loc_ifrs-full_LongtermDeposits_70" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentFinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAvailableforsale_767218" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_47" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAvailableforsale_767218" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_71" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_47" xlink:to="loc_ifrs-full_NoncurrentAssets_71" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_43" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_42" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_43" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_50" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_43" xlink:to="loc_ifrs-full_CurrentTradeReceivables_50" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_51" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_43" xlink:to="loc_ifrs-full_OtherCurrentReceivables_51" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentPrepayments" xlink:label="loc_ifrs-full_CurrentPrepayments_52" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_43" xlink:to="loc_ifrs-full_CurrentPrepayments_52" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentFinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_CurrentFinancialAssetsAvailableforsale_735261" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_43" xlink:to="loc_ifrs-full_CurrentFinancialAssetsAvailableforsale_735261" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_54" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_43" xlink:to="loc_ifrs-full_CashAndCashEquivalents_54" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_55" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_43" xlink:to="loc_ifrs-full_CurrentAssets_55" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_49" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_42" xlink:to="loc_ifrs-full_Assets_49" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_46" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_NonCurrentAssetsFinanceLiabilitiesAbstract_41" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_46" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_45" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_46" xlink:to="loc_ifrs-full_EquityAbstract_45" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_62" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_45" xlink:to="loc_ifrs-full_IssuedCapital_62" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DistributableEquity" xlink:label="loc_asnd_DistributableEquity_63" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_45" xlink:to="loc_asnd_DistributableEquity_63" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_64" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_45" xlink:to="loc_ifrs-full_Equity_64" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_48" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_46" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_48" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_72" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_48" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_72" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentPayables" xlink:label="loc_ifrs-full_OtherNoncurrentPayables_694781" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_48" xlink:to="loc_ifrs-full_OtherNoncurrentPayables_694781" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_73" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_48" xlink:to="loc_ifrs-full_NoncurrentLiabilities_73" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_44" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_46" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_44" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_56" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_44" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_56" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentContractLiabilities" xlink:label="loc_ifrs-full_CurrentContractLiabilities_57" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_44" xlink:to="loc_ifrs-full_CurrentContractLiabilities_57" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_58" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_44" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_58" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_59" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_44" xlink:to="loc_ifrs-full_OtherCurrentPayables_59" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTaxLiabilities" xlink:label="loc_ifrs-full_CurrentTaxLiabilities_60" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_44" xlink:to="loc_ifrs-full_CurrentTaxLiabilities_60" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_61" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_44" xlink:to="loc_ifrs-full_CurrentLiabilities_61" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_65" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_46" xlink:to="loc_ifrs-full_Liabilities_65" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_66" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_46" xlink:to="loc_ifrs-full_EquityAndLiabilities_66" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_75" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementTable" xlink:label="loc_asnd_StatementTable_79" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_75" xlink:to="loc_asnd_StatementTable_79" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_76" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementTable_79" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_76" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_77" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_76" xlink:to="loc_ifrs-full_EquityMember_77" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_80" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_77" xlink:to="loc_ifrs-full_IssuedCapitalMember_80" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_81" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_77" xlink:to="loc_ifrs-full_SharePremiumMember_81" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_82" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_77" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_82" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_83" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_77" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_83" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_84" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_77" xlink:to="loc_ifrs-full_RetainedEarningsMember_84" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementLineItems" xlink:label="loc_asnd_StatementLineItems_78" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementTable_79" xlink:to="loc_asnd_StatementLineItems_78" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_85" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_ifrs-full_Equity_85" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_86" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_ifrs-full_ProfitLoss_86" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_87" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_87" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_88" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_ifrs-full_ComprehensiveIncome_88" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TransactionsWithOwnersAbstract" xlink:label="loc_asnd_TransactionsWithOwnersAbstract_735736" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_asnd_TransactionsWithOwnersAbstract_735736" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_89" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TransactionsWithOwnersAbstract_735736" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_89" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners_90" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TransactionsWithOwnersAbstract_735736" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners_90" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_92" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementLineItems_78" xlink:to="loc_ifrs-full_Equity_92" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_94" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_98" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_94" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_98" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_112" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_98" xlink:to="loc_ifrs-full_ProfitLoss_112" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_98" xlink:to="loc_ifrs-full_FinanceIncome_115" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_116" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_98" xlink:to="loc_ifrs-full_FinanceCosts_116" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_117" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_98" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_117" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_95" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_94" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_95" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NoncashConsideration" xlink:label="loc_asnd_NoncashConsideration_113" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_95" xlink:to="loc_asnd_NoncashConsideration_113" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_114" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_95" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_114" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_100" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_95" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_100" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_101" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_95" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationExpense_101" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForAmortisationExpense_961810" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_95" xlink:to="loc_ifrs-full_AdjustmentsForAmortisationExpense_961810" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ChangesInWorkingCapitalAbstract" xlink:label="loc_asnd_ChangesInWorkingCapitalAbstract_99" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_94" xlink:to="loc_asnd_ChangesInWorkingCapitalAbstract_99" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits" xlink:label="loc_asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits_119" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_ChangesInWorkingCapitalAbstract_99" xlink:to="loc_asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits_119" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AdjustmentsForIncreaseDecreaseInPrepayments" xlink:label="loc_asnd_AdjustmentsForIncreaseDecreaseInPrepayments_121" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_ChangesInWorkingCapitalAbstract_99" xlink:to="loc_asnd_AdjustmentsForIncreaseDecreaseInPrepayments_121" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome_122" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_ChangesInWorkingCapitalAbstract_99" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome_122" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_123" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_ChangesInWorkingCapitalAbstract_99" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_123" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations_124" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_ChangesInWorkingCapitalAbstract_99" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperations_124" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_961819" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_ChangesInWorkingCapitalAbstract_99" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_961819" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_961820" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_ChangesInWorkingCapitalAbstract_99" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_961820" use="optional" order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_127" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_ChangesInWorkingCapitalAbstract_99" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_127" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_ChangesInWorkingCapitalAbstract_99" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_128" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_97" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_94" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_97" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfInterestsInAssociates" xlink:label="loc_ifrs-full_PurchaseOfInterestsInAssociates_961822" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_97" xlink:to="loc_ifrs-full_PurchaseOfInterestsInAssociates_961822" use="optional" order="23" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_110" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_97" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_110" use="optional" order="24" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:label="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure_735281" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_97" xlink:to="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure_735281" use="optional" order="25" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfAvailableforsaleFinancialAssets" xlink:label="loc_ifrs-full_PurchaseOfAvailableforsaleFinancialAssets_735282" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_97" xlink:to="loc_ifrs-full_PurchaseOfAvailableforsaleFinancialAssets_735282" use="optional" order="26" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets" xlink:label="loc_ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets_767251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_97" xlink:to="loc_ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets_767251" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_111" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_97" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_111" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_96" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_94" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_96" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_102" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_96" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_102" use="optional" order="30" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities" xlink:label="loc_asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities_1072723" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_96" xlink:to="loc_asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities_1072723" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_105" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_96" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_105" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_106" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_96" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_106" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_107" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_96" xlink:to="loc_ifrs-full_CashAndCashEquivalents_107" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_108" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_96" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_108" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_109" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_96" xlink:to="loc_ifrs-full_CashAndCashEquivalents_109" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_CashDeposits" xlink:label="loc_asnd_CashDeposits_695343" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_94" xlink:to="loc_asnd_CashDeposits_695343" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ShortTermMarketableSecurities" xlink:label="loc_asnd_ShortTermMarketableSecurities_695353" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_94" xlink:to="loc_asnd_ShortTermMarketableSecurities_695353" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_695354" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_94" xlink:to="loc_ifrs-full_CashAndCashEquivalents_695354" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/GeneralInformation">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_266" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_267" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_266" xlink:to="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_267" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/SummaryOfSignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_269" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_270" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_269" xlink:to="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_270" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_279" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_280" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_279" xlink:to="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_280" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/SignificantEventsInTheReportingPeriod">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_694970" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SignificantEventsInTheReportingPeriodTextBlock" xlink:label="loc_asnd_SignificantEventsInTheReportingPeriodTextBlock_694971" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_694970" xlink:to="loc_asnd_SignificantEventsInTheReportingPeriodTextBlock_694971" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/Revenue">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_282" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRevenueExplanatory_283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_282" xlink:to="loc_ifrs-full_DisclosureOfRevenueExplanatory_283" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/SegmentInformation">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_288" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_289" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_288" xlink:to="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_289" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/WarrantsAndShareBasedPayment">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_291" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_292" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_291" xlink:to="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_292" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/MarketableSecurities">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract" xlink:label="loc_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract_735287" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory_735288" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract_735287" xlink:to="loc_ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory_735288" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/ShareCapital">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_309" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_310" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_309" xlink:to="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_310" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/LeaseLiabilities">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_303" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_303" xlink:to="loc_ifrs-full_DisclosureOfLeasesExplanatory_304" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/SubsequentEvents">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_312" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_313" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_312" xlink:to="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_313" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_272" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_273" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_272" xlink:to="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_273" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" xlink:label="loc_asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock_694963" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_272" xlink:to="loc_asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock_694963" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/RevenueTables">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_285" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" xlink:label="loc_asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory_695649" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_285" xlink:to="loc_asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory_695649" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_294" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementTable" xlink:label="loc_asnd_StatementTable_297" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_294" xlink:to="loc_asnd_StatementTable_297" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_298" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementTable_297" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_298" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_295" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_298" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_295" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Warrant1Member" xlink:label="loc_asnd_Warrant1Member_299" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_295" xlink:to="loc_asnd_Warrant1Member_299" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementLineItems" xlink:label="loc_asnd_StatementLineItems_296" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementTable_297" xlink:to="loc_asnd_StatementLineItems_296" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_300" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementLineItems_296" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_300" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/MarketableSecuritiesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract" xlink:label="loc_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract_735294" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock" xlink:label="loc_asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock_983113" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract_735294" xlink:to="loc_asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock_983113" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/LeaseLiabilitiesTables">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_306" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock" xlink:label="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock_307" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_306" xlink:to="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock_307" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract_131" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract_131" xlink:to="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_767288" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_767288" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_767289" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_767288" xlink:to="loc_ifrs-full_NonadjustingEventsMember_767289" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockAxis" xlink:label="loc_asnd_SaleOfStockAxis_767291" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_asnd_SaleOfStockAxis_767291" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockMember" xlink:label="loc_asnd_SaleOfStockMember_767292" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_SaleOfStockAxis_767291" xlink:to="loc_asnd_SaleOfStockMember_767292" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_767301" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_767301" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_767302" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_767301" xlink:to="loc_ifrs-full_EquityMember_767302" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_961849" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_961849" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_961850" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_961849" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_961850" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" xlink:label="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis_961858" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis_961858" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" xlink:label="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember_961859" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis_961858" xlink:to="loc_asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember_961859" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis_961870" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_ifrs-full_MajorCustomersAxis_961870" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_961871" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersAxis_961870" xlink:to="loc_ifrs-full_MajorCustomersMember_961871" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_VisenPharmaceuticalsMember" xlink:label="loc_asnd_VisenPharmaceuticalsMember_961875" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersMember_961871" xlink:to="loc_asnd_VisenPharmaceuticalsMember_961875" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_963366" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_963366" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_963368" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_963366" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_963368" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_VisenSeriesBFinancingMember" xlink:label="loc_asnd_VisenSeriesBFinancingMember_963371" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_963368" xlink:to="loc_asnd_VisenSeriesBFinancingMember_963371" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable_767282" xlink:to="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod_963361" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" xlink:to="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod_963361" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_963388" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_963388" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate" xlink:label="loc_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate_961869" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" xlink:to="loc_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate_961869" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ExpectedNonCashGainTowardsShares" xlink:label="loc_asnd_ExpectedNonCashGainTowardsShares_961868" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems_767286" xlink:to="loc_asnd_ExpectedNonCashGainTowardsShares_961868" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/RevenueAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_735312" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_735314" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_735312" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_735314" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis_735318" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_735314" xlink:to="loc_ifrs-full_MajorCustomersAxis_735318" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_735319" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersAxis_735318" xlink:to="loc_ifrs-full_MajorCustomersMember_735319" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_VisenPharmaceuticalsMember" xlink:label="loc_asnd_VisenPharmaceuticalsMember_735320" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersMember_735319" xlink:to="loc_asnd_VisenPharmaceuticalsMember_735320" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_735317" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_735314" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_735317" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue" xlink:label="loc_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue_735321" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_735317" xlink:to="loc_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue_735321" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_735322" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_735317" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_735322" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_RetainedPercentageOfIssuedAndOutstandingShares" xlink:label="loc_asnd_RetainedPercentageOfIssuedAndOutstandingShares_981541" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_735317" xlink:to="loc_asnd_RetainedPercentageOfIssuedAndOutstandingShares_981541" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_157" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_160" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_157" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_160" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_161" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_160" xlink:to="loc_ifrs-full_GeographicalAreasAxis_161" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_162" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_161" xlink:to="loc_ifrs-full_GeographicalAreasMember_162" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NorthAmericaMember" xlink:label="loc_srt_NorthAmericaMember_167" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_162" xlink:to="loc_srt_NorthAmericaMember_167" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN" xlink:label="loc_country_CN_696910" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_162" xlink:to="loc_country_CN_696910" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis_735297" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_160" xlink:to="loc_ifrs-full_MajorCustomersAxis_735297" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_735300" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersAxis_735297" xlink:to="loc_ifrs-full_MajorCustomersMember_735300" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_VisenPharmaceuticalsMember" xlink:label="loc_asnd_VisenPharmaceuticalsMember_735301" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersMember_735300" xlink:to="loc_asnd_VisenPharmaceuticalsMember_735301" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_OtherCollaborationPartnersMember" xlink:label="loc_asnd_OtherCollaborationPartnersMember_735304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersMember_735300" xlink:to="loc_asnd_OtherCollaborationPartnersMember_735304" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_160" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-full_RevenueFromRenderingOfServices_165" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" xlink:to="loc_ifrs-full_RevenueFromRenderingOfServices_165" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_RevenueFromSaleOfClinicalSupply" xlink:label="loc_asnd_RevenueFromSaleOfClinicalSupply_694786" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" xlink:to="loc_asnd_RevenueFromSaleOfClinicalSupply_694786" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome_166" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" xlink:to="loc_ifrs-full_LicenceFeeIncome_166" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_163" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" xlink:to="loc_ifrs-full_Revenue_163" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfGeographicalAreasAbstract" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasAbstract_158" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_159" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasAbstract_158" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_521268" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasAbstract_158" xlink:to="loc_ifrs-full_Revenue_521268" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract_169" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DeferredRevenueFromAssociate" xlink:label="loc_asnd_DeferredRevenueFromAssociate_170" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_169" xlink:to="loc_asnd_DeferredRevenueFromAssociate_170" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/SegmentInformationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_172" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NumberOfReportableOperatingSegments" xlink:label="loc_asnd_NumberOfReportableOperatingSegments_173" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_172" xlink:to="loc_asnd_NumberOfReportableOperatingSegments_173" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_175" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_177" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_175" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_177" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_181" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_177" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_181" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_180" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_181" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_180" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Warrant1Member" xlink:label="loc_asnd_Warrant1Member_192" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_180" xlink:to="loc_asnd_Warrant1Member_192" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_178" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_177" xlink:to="loc_ifrs-full_RangeAxis_178" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_179" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_178" xlink:to="loc_ifrs-full_RangesMember_179" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_190" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_179" xlink:to="loc_ifrs-full_BottomOfRangeMember_190" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_191" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_179" xlink:to="loc_ifrs-full_TopOfRangeMember_191" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_177" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_182" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_182" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" xlink:label="loc_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement_183" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement_183" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_184" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_184" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_185" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_185" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_186" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_186" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" xlink:label="loc_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement_187" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement_187" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_188" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_ParValuePerShare_188" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_521241" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_521241" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_961885" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_176" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_961885" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfEmployeeCompensationCostsAbstract" xlink:label="loc_asnd_DisclosureOfEmployeeCompensationCostsAbstract_194" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfEmployeeCompensationCostsAbstract_194" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_195" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_198" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_195" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_198" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_197" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_198" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_197" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Warrant1Member" xlink:label="loc_asnd_Warrant1Member_213" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_197" xlink:to="loc_asnd_Warrant1Member_213" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfWarrantActivityLineItems" xlink:label="loc_asnd_DisclosureOfWarrantActivityLineItems_196" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_195" xlink:to="loc_asnd_DisclosureOfWarrantActivityLineItems_196" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_199" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_199" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_200" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_200" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_201" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_201" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_202" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_202" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_204" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_204" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xlink:label="loc_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement_205" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement_205" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_521243" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_521243" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_521245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_521245" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_521246" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_521246" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019_521247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019_521247" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_521244" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_521244" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" xlink:label="loc_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement_212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfWarrantActivityLineItems_196" xlink:to="loc_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement_212" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/MarketableSecuritiesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_MarketableSecuritiesAbstract" xlink:label="loc_asnd_MarketableSecuritiesAbstract_735346" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent" xlink:label="loc_asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent_767527" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_MarketableSecuritiesAbstract_735346" xlink:to="loc_asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent_767527" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent" xlink:label="loc_asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent_767528" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_MarketableSecuritiesAbstract_735346" xlink:to="loc_asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent_767528" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_WeightedAverageDurationOfMarketableSecurities" xlink:label="loc_asnd_WeightedAverageDurationOfMarketableSecurities_735350" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_MarketableSecuritiesAbstract_735346" xlink:to="loc_asnd_WeightedAverageDurationOfMarketableSecurities_735350" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract" xlink:label="loc_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract_735298" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable" xlink:label="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract_735298" xlink:to="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_735302" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_735302" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_735303" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_735302" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_735303" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostMember_735778" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_735303" xlink:to="loc_ifrs-full_FinancialAssetsAtAmortisedCostMember_735778" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtFairValueMember" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueMember_735305" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_735303" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueMember_735305" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_735323" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_735323" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_735324" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_735323" xlink:to="loc_ifrs-full_FinancialAssetsMember_735324" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UsTreasuryBillsMember" xlink:label="loc_asnd_UsTreasuryBillsMember_735325" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_735324" xlink:to="loc_asnd_UsTreasuryBillsMember_735325" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UsGovernmentBondsMember" xlink:label="loc_asnd_UsGovernmentBondsMember_961908" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_735324" xlink:to="loc_asnd_UsGovernmentBondsMember_961908" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_CommercialPapersMember" xlink:label="loc_asnd_CommercialPapersMember_735326" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_735324" xlink:to="loc_asnd_CommercialPapersMember_735326" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_CorporateBondsMember" xlink:label="loc_asnd_CorporateBondsMember_767332" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_735324" xlink:to="loc_asnd_CorporateBondsMember_767332" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_AgencyBondsMember" xlink:label="loc_asnd_AgencyBondsMember_767334" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_735324" xlink:to="loc_asnd_AgencyBondsMember_767334" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_735306" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_735306" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_735308" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_735306" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_735308" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_961897" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_961897" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-full_InterestRateTypesMember_961898" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_961897" xlink:to="loc_ifrs-full_InterestRateTypesMember_961898" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FixedInterestRateMember" xlink:label="loc_ifrs-full_FixedInterestRateMember_961899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_961898" xlink:to="loc_ifrs-full_FixedInterestRateMember_961899" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="loc_ifrs-full_FloatingInterestRateMember_961900" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_961898" xlink:to="loc_ifrs-full_FloatingInterestRateMember_961900" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ZeroCouponMember" xlink:label="loc_asnd_ZeroCouponMember_961903" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_961898" xlink:to="loc_asnd_ZeroCouponMember_961903" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExternalCreditGradesAxis" xlink:label="loc_ifrs-full_ExternalCreditGradesAxis_961887" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xlink:to="loc_ifrs-full_ExternalCreditGradesAxis_961887" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForExternalCreditGradesMember" xlink:label="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExternalCreditGradesAxis_961887" xlink:to="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_PrimeMember" xlink:label="loc_asnd_PrimeMember_961889" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" xlink:to="loc_asnd_PrimeMember_961889" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_HighGradeMember" xlink:label="loc_asnd_HighGradeMember_961890" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" xlink:to="loc_asnd_HighGradeMember_961890" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_UpperMediumGradeMember" xlink:label="loc_asnd_UpperMediumGradeMember_1072721" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" xlink:to="loc_asnd_UpperMediumGradeMember_1072721" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LowerMediumGradeMember" xlink:label="loc_asnd_LowerMediumGradeMember_1072722" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForExternalCreditGradesMember_961888" xlink:to="loc_asnd_LowerMediumGradeMember_1072722" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems" xlink:label="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable_735299" xlink:to="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_FinancialAssetsAvailableforsale_767322" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" xlink:to="loc_ifrs-full_FinancialAssetsAvailableforsale_767322" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentFinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAvailableforsale_767323" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAvailableforsale_767323" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentFinancialAssetsAvailableforsale" xlink:label="loc_ifrs-full_CurrentFinancialAssetsAvailableforsale_767324" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" xlink:to="loc_ifrs-full_CurrentFinancialAssetsAvailableforsale_767324" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_961909" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems_735311" xlink:to="loc_ifrs-full_FinancialAssets_961909" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_254" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_695217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_254" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_695217" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_695221" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_695217" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_695221" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_695222" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_695221" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_695222" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_695220" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_695217" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_695220" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_260" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_695220" xlink:to="loc_ifrs-full_ParValuePerShare_260" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_262" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_695220" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_262" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_TextBlockAbstract" xlink:label="loc_asnd_TextBlockAbstract_961922" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Statement1Table" xlink:label="loc_asnd_Statement1Table_961931" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_TextBlockAbstract_961922" xlink:to="loc_asnd_Statement1Table_961931" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_961933" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_Statement1Table_961931" xlink:to="loc_ifrs-full_RangeAxis_961933" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_961926" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_961933" xlink:to="loc_ifrs-full_RangesMember_961926" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_961927" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_961926" xlink:to="loc_ifrs-full_BottomOfRangeMember_961927" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_961928" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_961926" xlink:to="loc_ifrs-full_TopOfRangeMember_961928" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_Statement1LineItems" xlink:label="loc_asnd_Statement1LineItems_961932" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_Statement1Table_961931" xlink:to="loc_asnd_Statement1LineItems_961932" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeaseTerm" xlink:label="loc_asnd_LeaseTerm_961929" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_Statement1LineItems_961932" xlink:to="loc_asnd_LeaseTerm_961929" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeasesOptionToExtendAndTerminationTerm" xlink:label="loc_asnd_LeasesOptionToExtendAndTerminationTerm_961930" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_Statement1LineItems_961932" xlink:to="loc_asnd_LeasesOptionToExtendAndTerminationTerm_961930" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract" xlink:label="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract_243" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable" xlink:label="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable_246" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract_243" xlink:to="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable_246" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable_246" xlink:to="loc_ifrs-full_MaturityAxis_247" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_244" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_247" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_244" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_248" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_244" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_248" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_249" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_244" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_249" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_244" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_250" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeaseLiabilitiesAxis" xlink:label="loc_asnd_LeaseLiabilitiesAxis_961916" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable_246" xlink:to="loc_asnd_LeaseLiabilitiesAxis_961916" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_LeaseLiabilitiesDomain" xlink:label="loc_asnd_LeaseLiabilitiesDomain_961918" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_LeaseLiabilitiesAxis_961916" xlink:to="loc_asnd_LeaseLiabilitiesDomain_961918" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DiscountedCashFlowMember" xlink:label="loc_ifrs-full_DiscountedCashFlowMember_961920" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_LeaseLiabilitiesDomain_961918" xlink:to="loc_ifrs-full_DiscountedCashFlowMember_961920" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_961919" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_LeaseLiabilitiesDomain_961918" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_961919" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems" xlink:label="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems_245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable_246" xlink:to="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems_245" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_1072720" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems_245" xlink:to="loc_ifrs-full_GrossLeaseLiabilities_1072720" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems_245" xlink:to="loc_ifrs-full_LeaseLiabilities_251" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_735263" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_735264" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_735263" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_735264" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_735265" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_735264" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_735265" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_735266" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_735265" xlink:to="loc_ifrs-full_NonadjustingEventsMember_735266" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_NonadjustingEventsAfterReportingPeriodMember" xlink:label="loc_asnd_NonadjustingEventsAfterReportingPeriodMember_1078354" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_735266" xlink:to="loc_asnd_NonadjustingEventsAfterReportingPeriodMember_1078354" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockAxis" xlink:label="loc_asnd_SaleOfStockAxis_735268" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_735264" xlink:to="loc_asnd_SaleOfStockAxis_735268" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_SaleOfStockMember" xlink:label="loc_asnd_SaleOfStockMember_735269" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asnd_SaleOfStockAxis_735268" xlink:to="loc_asnd_SaleOfStockMember_735269" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_735270" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_735264" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_735270" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_735271" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_735270" xlink:to="loc_ifrs-full_EquityMember_735271" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_735276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_735264" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_735276" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="asnd-20210630.xsd#asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts" xlink:label="loc_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts_1078353" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_735276" xlink:to="loc_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts_1078353" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g206395g20i18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g206395g20i18.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1D^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &2*^9#0X0DE-!"4      !                      .$))300Z
M  $9    $     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!
M     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y"
M:71B;V]L      MP<FEN=&5R3F%M951%6%0    ; $( <@!O '0 : !E '(
M( !- $8 0P M $P ,@ W #4 , !$ %< ( !S &4 <@!I &4 <P      #W!R
M:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M    "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O
M9@    EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN
M=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M    4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L
M<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M     $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M            1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M     $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
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M8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P
M.$))30/M       0 [_^-0 "  $#O_XU  (  3A"24T$)@      #@
M       _@   .$))300-       $    'CA"24T$&0      !    !XX0DE-
M _,       D           $ .$))32<0       *  $          3A"24T#
M]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R
M     0!:    !@       0 U     0 M    !@       3A"24T#^
M<   _____________________________P/H     /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H   X0DE-! @      !     !   "0
M D      .$))300>       $     #A"24T$&@     #-0    8
M     WL   ;S          $                          0
M   &\P   WL                      0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   WL     4F=H=&QO;F<   ;S    !G-L:6-E<U9L3',    !3V)J
M8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R
M;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@
M  UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   -[     %)G
M:'1L;VYG   &\P    -U<FQ415A4     0       &YU;&Q415A4     0
M     $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L
M;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R
M>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV
M97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M"V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M  QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
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M^Q/OY/\ .X?M>,NQOKC8Z:.J9%+9/M/4,E^G
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M     /_A0(%H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME
M="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^
M"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L]
M(D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@,C Q,B\P,B\P
M-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H
M='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*
M(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @
M(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(CX*
M(" @(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y!9&]B92!0:&]T;W-H;W @0U,V
M("A7:6YD;W=S*3PO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.D-R
M96%T941A=&4^,C R,2TP."TR-E0Q,SHT-3HR.2TP-SHP,#PO>&UP.D-R96%T
M941A=&4^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR,#(Q+3 X+3(V5#$S
M.C0X.C0T+3 W.C P/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @/'AM<#I-
M971A9&%T841A=&4^,C R,2TP."TR-E0Q,SHT.#HT-"TP-SHP,#PO>&UP.DUE
M=&%D871A1&%T93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS
M.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^"B @(" @
M(" @(#QD8SIF;W)M870^:6UA9V4O97!S9CPO9&,Z9F]R;6%T/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O
M;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q+C O(CX*(" @(" @(" @/'!H;W1O
M<VAO<#I#;VQO<DUO9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @
M/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F
M.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @(" @("!X;6QN<SIS=$5V
M=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E
M179E;G0C(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(^"B @(" @(" @
M(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z04)$1#@P1D-!13 V14,Q,3E#
M139&.#DV.$%$0C-$1D(\+WAM<$U-.DEN<W1A;F-E240^"B @(" @(" @(#QX
M;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z03A$1#@P1D-!13 V14,Q,3E#139&
M.#DV.$%$0C-$1D(\+WAM<$U-.D1O8W5M96YT240^"B @(" @(" @(#QX;7!-
M33I/<FEG:6YA;$1O8W5M96YT240^>&UP+F1I9#I!.$1$.#!&0T%%,#9%0S$Q
M.4-%-D8X.38X041",T1&0CPO>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@
M(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI397$^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-R96%T960\
M+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A
M;F-E240^>&UP+FEI9#I!.$1$.#!&0T%%,#9%0S$Q.4-%-D8X.38X041",T1&
M0CPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T
M.G=H96X^,C R,2TP."TR-E0Q,SHT-3HR.2TP-SHP,#PO<W1%=G0Z=VAE;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@
M4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!I;6%G92]P
M;F<@=&\@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<#PO<W1%=G0Z
M<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I
M;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI
M:60Z03E$1#@P1D-!13 V14,Q,3E#139&.#DV.$%$0C-$1D(\+W-T179T.FEN
M<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C$M
M,#@M,C94,3,Z-#@Z,S<M,#<Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#
M4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I!041$.#!&0T%%,#9%
M0S$Q.4-%-D8X.38X041",T1&0CPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @
M(" @(" @(" @(" @/'-T179T.G=H96X^,C R,2TP."TR-E0Q,SHT.#HT-"TP
M-SHP,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O
M9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T
M179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC
M:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC;VYV
M97)T960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.G!A<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S
M:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYD97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IP87)A;65T97)S/F-O;G9E<G1E9"!F<F]M(&%P<&QI8V%T
M:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z
M<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I
M;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI
M:60Z04)$1#@P1D-!13 V14,Q,3E#139&.#DV.$%$0C-$1D(\+W-T179T.FEN
M<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C$M
M,#@M,C94,3,Z-#@Z-#0M,#<Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#
M4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@
M(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @(#QX;7!-33I$97)I
M=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z04%$1#@P1D-!13 V14,Q,3E#
M139&.#DV.$%$0C-$1D(\+W-T4F5F.FEN<W1A;F-E240^"B @(" @(" @(" @
M(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z03A$1#@P1D-!13 V14,Q,3E#
M139&.#DV.$%$0C-$1D(\+W-T4F5F.F1O8W5M96YT240^"B @(" @(" @(" @
M(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^>&UP+F1I9#I!.$1$.#!&0T%%
M,#9%0S$Q.4-%-D8X.38X041",T1&0CPO<W12968Z;W)I9VEN86Q$;V-U;65N
M=$E$/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB
M=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! ?_  !$( 54"J ,!$0 "$0$#$0'_Q  >   !! ,! 0$
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MAX9Y!81#/7$>Y7._"\K\6=_;B?"OR:<"1EV"]#OV&V4'PW;1C/\ M-*G9?\
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M:#_9=E&-VQI4_?\ HGRIE_W>XY#A[E<[LQ:5^+NG_G$1X5O3!\-V48_6:5.
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MS?.<[5-127M%+%<P35/-&%TQ32F-JY--0'G9[=TC[,!L;M#*4D24S3.W&-A
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M7<+?,XIIE<MAR9J481*>%-S[LZY)S:9F4FVVWYAAQQ"F$^ OI>E5MN.N,$A
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M#?ETWO?DSSOOPALOU4I3C:U-D9=R2$IT4OG$PC"8O:3E:H1BBB[<^!^>D(1
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MB>:!;5DQPM,$P&/K_!+Y993% \U%0ND+(44!0%%-$*U_/!M@+ DD"RT8$PP
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MOEU5$/\ P%VT/ZS4/UU2M_6_7=GB/ 9G[P?GH]<6'T0')6:TQ^8/_DN-#?\
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M[4<UXIA3K:D.%+C9-5(<EUK0376J4*0037QKC.XBWNAZ)@_;!RU3:2G;#I#
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MI;5Z?YY?3JIN5/)Z.I6Y3#1]\I91:<Y6G)5(4A,DCNB5V+F=U4$2PL=T[,9
MEF.54I"Q&A<S22TA<:!)CB.A^+(PN2E&1AK<_)C$FV,59Q'%I29E$SL\].-J
M;,NVDS*&E.I*I>94I*EM@E1"U1[">531EW2/&,5FU8^_@^*G 'YS1N;P#1?$
M\/Q-S"<'E<*?;F!/3"TR#DRB5*43L@VAQMI]20V"TV(T K;)DV*A;7)+.GF*
MG<Z2S(=3J;M)+#3*D4XM3K+4\N\Y."%M&HLVE$U)E!% U3<HEM])8#%<*E+
M:YH"B5RM2!G8K16;&,N3CJF)Z4F)W#\0=+V(8I*N-3$FU*-J<\!EJX?-+YV5
M3,-*>""%:K:R4)21XR>4W"_:FQA<LB>P;%)'",=P661*X%H[B<O,26*S.(NL
ML^S6(!.-8:T)?$5R4VB4+B5MI4^RE+SJP=/K/M'4WJ/0QJD93!-U0ZGI%LD
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M$ZW_ /J3V]/%B/;EI1\*'XM*?)X>Y3R<4'\7P*Y#PW$]_P#VRG&WGA0V"]D
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MXFE?\H\7IE_VOOLI%N#:UVIA$+[1]=>6]6)ZSW9!Z.VS\^8 -\9JT8T; -,
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MM!W /3QJX #;(:BS=XORWZCB#@6" $^Q&&6_N,KQK_FNCT[(NG3+2ZAKI1I
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MFER";-H486H1F*KWXNG&IV3\5)O$78\@1 \EM#NPBM-)&&+NA:8#(X AB&(
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M*HS6U/"68;BC3-9<;8]@YL..ORTL$F:DJAZ>D',1E$K(=("5R[9+JP5!DT2
MXHD)[%\DS299Z<]N&&*EY>3GY];B<-Q:\I@^-M8!B3K:3+A2E-S[J4RK:@@S
M* IQ2F$!*E8=RV&IS9CIW:7.>92(FN6GRNS3+\OE)7L^"<T6SJA3N50GA*[P
MH00LA)B XPV74COW)6Z'HU)"HMM 4IJG5O3&3=3).-R<T9=]K!77WU*92916
M/+4W(M*:#A6\0L)#ZFJI:"@4J<\8(Y7>2C$Y96*2S^+8<B?DIK2R6DI)*)I:
M<3:T-:0_C,RW,<T&I5):6I4FW,4<?6A:' R-13F[K>Q\S*WOY[215.3G-#+S
MU41@GMT2MCRB\%E].9-E>>%Q*<A]!H3/ICJTSBQI&\PEQ1(2W<Y0F6KDZ-/$
MXCQITX8=8#APV;;7,-2+\DVIQI?A*)Z;F)-)46.=4R&G95Y:P6U++24J0A2U
M<W'I/<CDZU.*ED:088^U)S6,R>+/H8FFC(/8+ADCBKJ4(FA+HFR_+XE*--*2
M^TTF86M#CJ6VU/1QE'LU*HIYK1++A4:2TTL4080F*9ZAM8N,SR^XM:]^EN6F
M UA3,"=8O<#79UFQF+.*++NU%>B(JHHCT/>Y_J'2! D\*?1(3:IC%WPQ+R+@
M;EGT.(9F)AX/J?4A"$M-RSI22?IBN;U:)7K)^=8T'<]E=)I![&L,1(Z+29G)
M[&6.>GI-YAV;DY&35*(E$./.JF'\0EDK2!]3I#W.>.WJ*]83YL$L#94J<SD<
M^L$F4\0UCF&597EEY<P43.Y21+$_L4EO1Z!>K4@>NF(J)W6GM+46WK37-,Q.
M9YJE,>+>E</FI/31YV0E0N2?FYY>%,3,S,,MZLNW.3,D]-M!:$I(0P0TD.NE
M: VIYM(2I.NIO]#Q7DEDV,;Q-3>+R>&8,UI).X?(2,T]KSSV%R&+R>&3*F77
M%A;LXDS+JY>7#+JGDRKZE.-JYEMZ&KFQY)4<P/:J2G9CIQ3F5IAJND>)H<5,
M\38M!ND^JLCT@9$:B7N\ECG&O&9YH*[Y4M1BA.J2QNCB!9!:9J;%,X9I3.!A
ME,VT]/S\RQAJFI9M,G*HYR:PV<Q1U8?UTH"/!Y=6JEQ*2E0:;JHJ<<3.D/)S
MA?ADVO#'Y7!<%PZ=Q]J8GGEXIB#O,X=C^%Z.RS:Y3FG7R]X=/IYQQ@K0XV7W
M@E(1+L.:_#L/JW]M9G--.,AR&WD2)($9SP]O;F+9,\YSH74=:A/4*)A)8XY9
M0J$<@JH%OX75 W1JFL2FX_N[E&V]'MP2PX\VJ4G9UPSDZ RTRWSLO*RBI!"T
MI3+EX3"TKG4E%T\X$.5<&JWSG(GDN<FV95].(X3A+*<*PDJF)F:?+$[B6)IQ
MIUI:USB94R+2V\)<2[XC@9+C&JRK7>+&*@V%ID.)EX4%2I06*UQM/#)H1 W3
M$3%)[546CDQ5L;',\^-!$G>Q1RK*4PE+43,8H/B7$MQ1,4?H@9WG<Z8L S&O
MA\VE*!/"77SC!$TY(8LQA+K:4A>LR%S,TP4+="0$EQ2J:GC\XY*YU:90LXUA
MSCCIP=4\US,XCV.E\9T;G-)V'UJ+11,EN0P^<2ZU*E:^>2RE&MSR@WADVR4>
M9+CG4-OJ++,PT[ER!X-?'P$S[*L!)J-MIXZRTRJC)C:R8V5?/7IC-;4UKEJ4
MYN0+6Y^6"8YM39"L5[*TF2'VY%<C,2\_,%H,L%3,P2%N3S;[J0PXKG427@+C
MKJ$*2M:'&$T;=<*$<R.3U9DW\89QF1G,&DA,JFIOFYJ0"5-,8/,24LX9UA!E
M7<5]F6)>7><0IIEUB<<J]+L<ZYP.H[7+[+.[RURN8C.944#840>VO:68FL]7
MZ$-\;L>T/*4]0"QG/=XEQK1WT8#HG;8TJ5X)3NI"U.5Z\BX^]*-.S(4EU?.$
MI<97+N!/.K#8=:4 $/):" ]J_2U.!2FBILI4?C\98DY7%)MB0+:I5L2Z4+8F
MD3C"G/!F3,+EYE"E<Y+KF"ZJ7YPAY#)0W,)1,(<0G3(0U#DMF(YYAO\ )XM;
MCCJCST[;[-]*W&WO>F8K%Z'0.8./)PY/>SMB":4Z1Y\AW^:P S_)J,\Z"I-,
MB.C<:DQ8#< YZ=.,=_"_H]/'SQT-[>KTQ9@_._[H6\_2 ].O+C)5=;JJ+"N>
MS?M(SI7(9C9.8Z1;K]';Y8NPWMGK?/K[M\N2P )-Z[\]HOT6%.G/B1&J<[_?
M?NL2,^)RVTH(L"'Q4/)>_#/VQQ5.WH/F^:U>G90[(RZ_0(LE?G>&>[.]QL/7
MS8K%E9'H/FBZ5ZL.CSAA$'WI_P!GIV;]L70S$ ]SV\5-Q0UO0; 3Z-E=FZQB
MZ?>'H3%B'U0>3=GR]/N6XY)S&W.V^W?UC..I-*',W34=??UWM8AU#G]O$4MY
M.^WHZ]T636AKO]6[/IZZQ9@]4'+UZWPBPI3K/IX=-ZW\^0)N%O\ 1'EUTW\O
MO8J?NL@;7KML03;]]-EXN/N<SGLV&U!?/._$;HN09 (<(A]K&,;18AT#K? Q
MNG+N*\:;.]+4B\7ZG?KOOU]O2]\L8JV99'*F\]]V=*7C=/W6>>WH'?LX1;AT
M#F]K%8T136'7V\?+UQ=@MQU"_FYN7CT7S@VI7::=?[Q&B<A;8/G[;'CMC(P!
ME?C;R!S>[PU <9K-Z;J^4]/JWY$187!.RV_N.ND62]/][W.?%(T3[W_Q#SIB
MX6.?0/+H/'W>;7"-(MP:<M@]NW/PXY#? BO?? &D6RN/*'+KD(\U];VME;@.
M2[T.\9=^]HZ(NE@(W  $1$0  #.XCN -XCEY,4/'U1HC.@ZK9\<Z5R&TY1M$
M4JS24,!9LMOY1D91QT$!C.XP1Q$INT[X-AAB3!%$40!I7=C  8"NZ0=T&'MX
M;\1F98E5)A@C6 )#K9NJNJ*A6:J&@S-#2M([_ )Y*@E<E-@D+4$JEWDDI136
M4*H%D!2=8Y)J*FX)K0MKCWNE6"A6@D6FBG1JA2G][JE$$7:QDIC^T[F>=#%\
M3$65'%&$06&$!Q;G$:RDZZ-9 UEIUAK)32M5"M4BEZF@I$AE[40OFG AQ10V
MO45J+4#0I0JFJI0-M5))&1 -HO0-SAW[Z&=X+/1+NX)O0_O4_O[OC*'N'>@P
M=W[O?+N7<^WOEVM\5#C?-<YKIYO4KKZPU:4]]K5I3C6FZT.9>YWF.:<Y[6U.
M9YM7.Z_WO-TU];\FE>$6E+>O;3P3.2%6WJ0A[IWNN3')#^TCOVD?<3X(# AB
MS&&+M;" #81MC)*T.#6;6E::D:R%!2:[JI)%MU;1LIEU@AMYIQE=*ZCJ%-KH
M2:'56 :'8:4,=8IC4>8I#;YV;94%Z23#.K2SL[8\R^Y+&YV:(T#^@>3S$HH"
MQ5GQ+DR,YMC)(/31"4ICBB$R (BH_-Q"28G%RJYCFE-2CCKKC3S:%M.!;*V@
M%:_BC44H.5*5738@T(^BP7&9O"F,29D#,MSF)2\M+,3,H\XS,2Y:FV9E2FRT
MGG%\ZAI3!2E2#JN$DJ *3U1-7EB@:VCOR2G)QFDB12Z;/3XNFH(TCA*RMW5N
M$Q&)6P&2$].^/:1>N;(G!:YN!*8M5&>"$TX![;SE82Z5NZLTVB75-F>::3+^
M,F82TAM@*<+VJIEI2$.:B6T%12!K 1[B=*98,2O.8:\]/)POV%F)IV?!;=D7
M)A;TXI#'@NNF;FFW7&.><?=2A*RKFE+SP]1ZV**G,1[6ZRPS-JHJ=%TT,R]G
M@A2=Y(W5"*)T:UQ/<HO1 ]5"C88P<0,2C"#3#!$FC V'N.DGA8D'==M]UQ)E
M$,.H<\;64TL*;6DU\1*2IXE%#7G/?"AKR8SI,K&Y=4O,2,LPXG$GI^6>EAS?
M-MOMJ:?8=30\\I:6Y7Z=5!'@X!00H:N>DRL"J2Y<:91"04:]H0()KBG")<5'
MZ+.9<\)(&E4K2+XD=V B)E!D0$B82MA/,3%GPF!WU 7!E,8:B:><F/#%MNK7
M+>#:A^EH,HHN!*D!5'B'0ZL^\*02#75)/9AFD2\-DV,.]B6G99IJ?.(EU*O"
M'ABC886XV]S9,F@RW@S224N!9;2NOTP)'8F^O,D(IM:B4X.XLA[5*YLPOQZ]
M8:$+A+5&7>343;+C5 S0+60R-Y?%25>X1&N4)YI"=<1"2C&(,>:O")M<NX3S
M?.AR8#+*4)%4/XHW-+<?<+I0Z TTE2$4;H"I*JKCZ%G2O"VL1EVTB8\&6Q(J
MG)M3SA =DM&IC#6F9*73+)<E5&9FG&W7BIY*E(0Z@(;J(T8_: 5-9K&W-LMN
M+>GE*8Z>KR4CL]F*%ZU!3UO7(H6N832FQO!6K7JUL2F(\$J<I!WNG()0Q 07
M%#U^PZ7$NK<>0M3[$ZDJ::"4)7.K0LN,@N+*4H2@) UE%>LI16*F/-5I:XRJ
M699DGFD8?-X2ZAN8F2MUUK!VG6PQ.*##0<<=<=*ROFT)9U$)2T=0$76_:%3L
MR@2&N65JEF22NH;&<M^?2W%W1S/#,SC-;+-2AQ):TA:B)@<75:2@0%I2 [T.
M."-5W10;%BCF"J<3K./I#BIA+CO,LZC:I<L(EW9<(+BB \AM)<65*.L 0F@I
M&K.ER)8ZC$DXN7;D%,2PFYL/S#<\)U^?EI];R)=M*S*/3#B66@V@<V55<)68
MR";:)+A;6) =+2D2T[26RS!"C7,K=$J3D2*XR&2M9EZ>61>$;F"%R-60J'9Q
M>2DY@1HB"(49H0EYJP4A;JN?34N%YG62ZX$E4XB;*74*?YI3>NWJZK;;14**
M42L5.C>F">9E&%2*Z(83+S?-NRS)<2C"GL*2[+O(D?"6WPT\IP+F'II*#5I*
M0T:#E<_SZ=.KMWTD*<FMIA:I<;(6A4[F.<,9DO,+<QP+E)T*=$2I5JBVXLXT
MX4A<81##!<88(!QW2<H)5.JHH<<*WG"XEL-TYYY;I2E.LHI2G7('C':=L>)B
MV**Q)_G$)>88#$FR)=R8+U3*2C,J'7%:C25NK2RE2EEI*JFF0$:67OZ./7Q9
M^3&ZLSTF/,%=8]/1E7<1NW$7O'UZV4JA/D]4Z[W?DRHQ3*BDEB(?#@$27E)
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MVF-<YF&=T[SI/C!<EW2^SSDHM"Y1?@<IK2I336#"N9UD)="0EY%2EU "% H
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MQY< ]*LX?W[S[POZY?O\F^/;UI0/Z1'Q22WTS\'Z#OV"IRD<C/)R*TP!5_\
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M9C>X<FF@AJ'%'M7V9[*&A-<Z[M]+"I (,. 0U$1SZ+@ "%\QUOGO'+(,(KN
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MK5J(:;T>T<6ZM=QJI;3@Q655&023PB6#LGNW(-PBK66$4.44,5+J.A$$6\!
M:?7 0&]P$+WRT ,45R>:'@BF$F_^L<4H>OPW;6E:T\\63RZ\JE:'2=.=ZX#H
MV".%#@XI2EQ2N>V+4'9.]N ;7K24.?T,*.WT"XY4^XWW<F(5R>Z( T&$G]8X
MI;.WV=NI'0GERY43GI,G]1:-Y4S/UGVFXINW5BS#V3;;=&_X])6_]#&C_G\
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M=UBVK-E*EU?JUG*J:5&KO.;;6&I4)J*H\WH:8TM0N:>='H#4JR3Y!-?)WFQ
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M"Q5Q V;B?FZNJ(.8X'JW;\[VSOTQODU?D\K]HA_G#CME,E](],>7B6;70O\
MY8UC'7'F1)"(VR"^OM"'('40SRQ!)V"O[K<-]?7:$/R\?)P&W#</'?OMA;MX
M;C3=L._;MI"#.W+RY[^CHRR'&2O?&OGX=77;*PA"]=W6WM<N-$^]'?;")8=
MZ?.._P =[!?%H0[+?E?KGNS$>GEP[]Z0@WWZ/'[HV\66$(//GK[W.'+B%9'H
M/FB4YCI'GA<81O!B1GW\G'=$'(]^WAOCP!MP[!#%MLG4V/>:DNU/HJ<E364G
MA;):1S #J$U1R[&:)PJGAJ%**,9?+" ( / [OF(8A+[D';_<Z&Z;/:(#$ UA
M[4][(&5*N<?4QS7@P?I34:<U@L/DDVU=6OW4?D'*GR22G*>K US.-3&$'!$X
MBE',23<X)CV0,GK:Q<F&2V6_! $@%6MSARU;^#@[ _(XC8-H^:\_^KAHY_7=
MC[3W:9L"GL!+&QOX>[D<\Y4=Q'Y&GZ$K"@!_'7$=H^TLMD0=V(4KWSM$\'8(
M9(A&_P""-FO++.G+1QW?);F ;KXCW9YO(8!+W_O[O$?BO&'\$O":4]NN(YBM
M<$E;ZM*D5Q#*]R.KC*'8)9(A_P"<9-0ARTY: _\ -@VQ7W9INM?8&6M_?W:[
M/[MOX1<?0FX2G_37$+ C[2RV1-;GV0-,CNC+M/80Y>85Z=U9-IZ>F=T2111I
M'%JD="W+DL<4(EQ1IUB2<2E!,41<4<$419D(C!%%"(C#$(8R=Y8'WT+;=T>E
M'&UT"VW)Q3B% 4("D+E2E0J*W!CJE_H69&4>3,RFG>+RTP@DH?E\*:9=0:%!
MU'6\12M!()!U5 D$C*L!W8/914J#E2K:.FY2I4FF'J5)]/VPY0>>=&,9IQQQ
MLVQF&FF1Q11F&&1B9'%%%%%$,0C=[L,VD!*<!E4I2 $I$ZZE*0* ) $L  D"
M@   I0"D0?H5L,<6IQS37$W%N*4M:W,)EU*6LDDK4HSY*E*-RHDE1-2:W#X.
MP?25 %@VAII'_P!W;5;=^RRW/;E$<5/+#.$U.!2WQ]WY+&B?H6,*2!_'&?/_
M )1+;.'A]CY2<LXLP=A$DO=M"3/G</S/6K\[S36/'R<<5/*]-G/ Y<4N*3[O
MR6WE\T7'T+F%BE=,)\Y9X/+W_P"/Z]W"D3P=A'DR$,MH.9QOH/I?-6_?\M/)
MS;A# \KTV:UP.7&5A/.;*_W;CNZXD?0O86*$:83_ .IY>]0?[_:W;0;8LP=A
M/DV&_P#; S-N#\SYJN-KAZZ@RX<F,U<K<VJGUDE[5_GSG#^[1H/H8,+!!]M\
M_;_5$O\ +HGA["I)L/Z/\S:Y?C?M7W46X=.(/*U-&A]A)?X\[\F._A&H^AEP
MP4_C;/FE?Z)EQ<BE?L[,?OB8.PMR:'Z/LS6_<"U<F[PHY..(]UF;I?!9>O\
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M#2,BB[$Q+S<?"J0UYFI&I@A,@@4)).0ICX(#BC"#H(329G@," X@TPDV$(@
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M=GDL*2XAA;*&FE.IN@N:KCA6E"O&U#JI4H)UPI&LE7K^]]V?/J&[0<L\P',
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M\;^JV5Z TI44N0#N >D1#G#4==;AH 97'?A%;$UXV R -#ELKD1>I)H#2A4
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MT(%U1IBD(UUEQ2Q)IME]X1R4GF4L"&V5W1\<FIO4*72FI0T)V4(%MF=R1:G
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MHJ[2S+$BMLK$O;W+,Q'OJNH:]<V+^YGN#U :4B/0*&Y0K*A(+-,?%8! 3 U
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MV'R F,D2 Q##" #$(QA#" !<1$1"P  9B(B.0!F(Y8P/W7^S^U&X!)H!4FP
MS)W1]/-F*@ZN3"BJ@S;"H2S$O11E-#*!D97H4VK2H0,/=(((@ QP6%Q $* X
M!+;R?BCX(E\?:(/A<<Q5,R3)RY"F$*!=<H#SCB":);.Q"#FL>_.7B"J_VG0K
M1=W#4HQ6>UD3CS9$O+:Q3X.PXD:RGP%5+S@_S2AJLCWPYXZK/LN$!$=^^VEL
MQ'[^N?-:_P W'Z(G, $5L"+UK0#A3=<6/$TAXY7W9B'77SCA&AM79<COGYS
M'O>;3J'/G84!\WFR[CIO0G)S^_Y UPB.'3\_D&<.@RB#E#W^/)[W!W[][Q=%
ME#B/GW\/FW2]?=Z[\1<<:#K]5:CR]NL&&P>KMJ./'KO"# ]/1Q.8W[O3LA!C
M->8Z/2808I"+&.B$&$(,9K\P[?1NXT/"$&*&E!ZL\[UJ?1"#&J;I&>_KK4]5
M?)"#$FX(X9G+OMX0BQT]0ZYXPA"#X_O\,(07MS99\H[O?TPA!OSXV#(>>WDU
M"WCP@,QT]]\2!TVL/$+9C$ ^( &P"%^.$:6-3MKTUR!%=U3MK;9L@OF&? +
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MQ3C$GBC\G3_23!#HHO!\&FL/(F9B6;$KARV=1MAEP3"U<W+^(VC69;1DFI4
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M*\#TT[D]0,:I2:6(.>T"_3\Q\D'<A_5"OX0,*[:$=]PJ>]XFE-HN?OAP&^)
M+$(?5E\X1PVU'CO\8:<N%>!K3<3LKT;:'*,U)))\9.S-0&P=]M-L.[F-[=L7
MK^G#KY\17;1665/1OMLWWX1J4H=9&S[H'R9]4+W/Z<OAZL/<\NF&M^2KLBX3
M>Q238^^ WYTVU.1))&<+W+_I"O9AAK?DJ[/G@!2H.K6I(N,AE4G8,@<MT'<O
M^D*]F&&M^2KL^>!!.T;-MR*FULAL\YO!W(?TY7LPPUOR5=D2$BHR!Z=F[H!H
M<J[3F8>!0@'JRQ_WPM[_ #W#0!W8M%]7\I/; )=_[Y!>V?QP-/)J%MP7RSXC
MW[WAJ_E)[8.Y7L/="A'?\<'H"^>_VM=1I6E10TX 4IU^7/JR$4/#M'KA82\_
M[H5?/+NF8#:P\]\\AO;C<;#!J1:IR%:9@U.T6I:^_,90H>':/7$G<_IR[Y#G
M$'MARZ6SUQ!RM6@M6O#I-MPKM(S-E#P[1ZX.Y9>K+]F&F6@:COO]_$='52E*
MY4Z"!M->FMU#O':/7"=S^G+]E[V+4.VNT"FK2@K8Y"W3YH4/#M'KB:&#+U9=
MP$;_ !0:WOY;\V*'AYZQ= MUUZ;6KPSL87M!_30>S#$1>UKY6H*9CHV\/16)
M(8+0^J@SS]5X\PY UOYL(S4*G,6%+F_7VPO:#OBAS$=X9<-VN09]%AU!$:OY
M2>V%""P6[:'+E\6[") V5%]E;CB,[T^>%[7Z:'QX1(30FXK3K&PD==O3O.U^
MFA\>$32V8I2F8H+]%SQL:]@ AS"T4/CPB*&HJ4UL,[UK6QM2QN<Z]-8?VHB
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M3MK:YR]-JGALIG%X.UY8?'A7AEGE0>8^2$':\L/CP/0=VR_EZMAOOR0!!?\
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M@WI#@XB&[.^@<<LQ&]A&XWO8,\(@;SG2IRMOX[,[Y6,/Z];81:#"$&$(/?\
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M6L(VOG?*P<=,LPUY<(BM34BAV7H:7K4T_=382*KPOSWW@.09WR&V07&UA'B
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M<12@)) 8.^IN:"AVQ<*[+SMQF####/4J&1Q;H:;RA$(@ 7BL$+9>X  B-@R
M!$>2AY+=#A_,IG>:S\W:O2YW[(LGZ([E64H@8KAYM44P3#C6P)L&":#=3*](
MM%]EVVW8Q !GN4PN&H4YE#/,0R_$W7>/WK1[EVA]0/ IJE3_ #^9H-M/?[>F
MM+QJGZ(SE2L!BN'7K7ZRX;LR_P SGO&X[B8R1/9;=MF+6>94'3]#N4=1W9MH
M6Y[:WOI;&1Y,-$ 0/ ID5.V>FMQ/W\;I^B)Y45$ XKAQV_:;#@;T&QG?6FX4
MV&^2A[+#MJC# ,<[2O"$< 1PWIW*</;!>W;0W;<X0&$0N%P 0$+W <8GDST2
MJ:2<Q95#]73)IP_E.CC>M-D=B/HA.4^@*L3D!5((K@L@*@U!(^DW%:BHMG7*
MUPOLKNV@(YSO*PZZ4^E/,;?[-ST#6]@XCGBGN:Z)&GU',"I.<],Y;_Y0='$[
MHT_A!\IM*^R>'6 _H?#[5)_L>OKRC(E]E6VS1A"**=98 (K]J/I?2J$(V$0'
MM1]#;#;> #D//?&:N3?1,%($I,9@'ZMF:[/[3OPC4<OW*82DG$Y  UH?8>0
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MRC'N&P:)=V.<Z)8*"0&7A<_SEVO_ -VW.-T<IVEQ-YR6-J_8,K_AQDB]MK:
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M4@424BH"B,R*FR:7H*B];Y;"(R 0DD%Y#A(<**@J;0I1312M8:I4H:UBDA)
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ME*J,:T@;3(HF)G%&F)F=DF%S)P1H8@7G,'GYK$I67D52 #S<I-L2X:>3*NJ
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M^;.^TVRKNW QDROSMAZYZ^V&X=+XYU&NM3;>F?DX^F.IL4%-F5>@#KOZ(RI
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M],.0 (>E8;:^6?R_:>UC-7+ DU^L"@3?[9#;?\2XBGHRCH3]"RY_79%J_P!
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MK>+Q>P(<7^BB6-K?,A'Y_"3(<NG/3&9TO233P Y@?9(-30 W+'"_3MBXY*%
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MX.]'/<-V*_PCIW^JDK3_ +V=\W@'IA[(_P!@G\[_ -D-B[*_-$0W*HS+T$(
M%P,FYQC&]QN/;0LA8 %K6#M=;YYY9.?1'XB"-31:2 (OKXF^HUX$2B12E+4Z
MXCV0.QE':?V1"?!7)L^@W+?UU.6?_P"T8A/T1V)D7T7D*[/KC,>4>#=P1#V0
M/X%':?5#P[*S-HA^8Y+8?OJ<A\OH3U\6(5]$?B8-!HO(=>(S'R;+TUA[('\"
MCM/JA?@K,V_0<EOZZG+E_P T[_;Q7^$CB?\ 5:0_64QG\6\GEA[('\"CM/JA
M\/95IL$+^D[+GUU.7]4<V'\)'$_ZK2&S^D9C;_NT/9 _@4=O_MA?@JLUC:U'
M9<S_ &4N?'_9'#QZZ8C^$CBFW1:0 I\)3!\@EMV?ISA[(*_ H[3^S#P[*E-D
M07"CTN!?C-#E_5(>]BA^B4Q0$CVJR%O]93'R6'LB?P*.WYN](7X*C-GT'Y;^
MNAR_JK#^$IBG]59#]93'R6(]D3^!1UDC;3=WZX/@J,V?0?EOZZ'+^J</X2F*
M?U6D/UE,?)HGV05^!1VGU0OP5&:_H/2Y;]U+ET?XIQ'\)3%?ZK8?^L9GY/$^
MR!V-(RO<]%,N_DAT/93YL&_XS\N!;]E+E_5. ^B4Q3^JV'GHQ*8^3&'LDO\
M!)_./JAWP4Z:_H02Y]=#E_5.)_A*8I_560_64Q\EBR9]9'\FD4MF8/@ITU_0
M@ESZZ'+^J</X2F*?U5D/UE,?)HMX<O[Q/:8D#LI<V6#\:&7 N%[>%#EOM?\
MQ5S7P_A*8I_560_64Q\EC,XBJI^E)-#]\=G5"_!2YL^A#+GUT.7]58H?HE\4
M!(]JDA^LYCY+Q'ESBPGE*%>;1?B3M@^"ES9]"&7?KH<M/J5R8C^$QBG]5)#A
M]<YCY+$^&J_!HWYGM\\+\%+FOZ$4N[]9H<L[_P#">0 'CEIB/X3&*_U5P_\
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MPG<5_JGA_3[)S'#9X+6M#E3,@;:P]DE_@D_G'U0OP3Z:L_QI9?R_9.Y!?_\
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M>R'^A+-\YVSD_"*3/_\ X^>W+C/P24_%I?\ 0M_LPUOR4]D+Z$L^7XD-MO\
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MTY&#" H57-]P-J@4.RMN/5MB34 WB&5P#AG?<(6N&8C;7+?A%X!#CP#AJ'(
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M'$.5$C,=(\\.'GT ./B"^>>NX-=UL(TONSK6E*5X[J'=?C40X-P6UTN&N\
M1L%A$;[AW#NNBI.T;*DTM39QH2 =^^UR%MJ B%QSL !>^5N W&^G"_&X(FN1
M - *5K;B=HH*<;TSH!"PVOD%AZ=>>_"^5MP\,(D5J+UK>U+BF= -X%Z[A'G^
MN<Z57E193U)2^5HG[T;F-.1,JP]D>WEM0-);Q+R52D4#+Z%Q5-RQ8UN3PO1+
MW.%GEXJ!D5BXS*W*0;FYY]S!I3#)E$\K$9GF.9849= >9:<6Z6GU)6.?6VE:
M$.MLH6ALNOGGD\W+.)YQQGY+2K$](,/=P=O I S?A4XE,\XN5FIEEJ73,R;:
MVUF3;=<8==8?F7FG7Q+R:1*N<_.LK#+,SYY;ZW;3IK4_)5\EPPSDSR@#HRM[
M=32=U+/.CS$X.A+\L3"YP,DS2JQ,#<E3G2L@FZ7&=WG1Y*<F9E4S' 0A<'/V
MUX5HV'V0B='@[DSJOE>(R29B3ERE'@X6ELO,3#LPX5IF'99]QF4:U'7DL$N-
MM_),Z2:>F3FE/82?#6)(KE4LX#BRY3%)Q+COAI:6^)2<D)>2EPTY)L8A)R\S
MB4P79:57.!++[V0*JAM=0MZ)U6R6U1(#9L;V!?$T4[G)2O1R,J2(71?4<ID=
MEC-,RU^:4!RM&;)\,O)HE3ZD.;D"1='$EA4P<.T7UUMIFW0L2KC[?.S\HE"I
MU"EMHD%.M)=ET,.K2A8FO"%:K*PXM2!K:MACO*(&6GW,,ERTK$691XRV#8FX
MZWA3C;4P[C*9:9=E9YR:EVEN-JPX2:"N;:4PTVZ2WKSTSFS:,8W.G[<_L<Q/
M[%,<V+DLS+GR7IP\* :%+7)@L\P=NM2G2O*3*WBLF51,3.^.<KO$)J0@EB0O
MCTE<VA;7$)7 7FIYQAYAA]B60J70R_*^#<ZEV;YUBB5IF9EYP)ETL.L-3+1"
MB7EL-*;=1I@F(:92K^$,SDK.SDI.XBZW.NS,GB/AXEG)?#?!INKB%R&'2K)<
MG7)V6FGY"9!;2B4:FIIM^7=_,/4:/:HJ-6RK#F]&*I%D8BIL_E%U3KQ-":F-
M.T[2BFET(+5(9HGYP;2WY.G2P%"6AE(A]<HB!+!(VFPC##C][D']%)#",-;0
M!-39P^3)D,)95/3BG52[94A4O*(7S)4JM5S)916NLX#>/Y!QC1GE.QS23''U
M.^!R!QC$RC%<?FE8?(-RXG7M18FIYQ)?2EHI^ER:'W=75U&E"@CW=V/6N.S3
M+^TY2NB--YI7;4=>YT6O9<RU6*;G"7:+TP89=EAZF.9 IJC?2$<SS@]J4C4I
M:H)I=6EG0Q%&D*6@"DZA6A7_ !>FDEBLW@6(8G-,HT?P>50T9;#><1,8KB3S
MS[3+!GULJ5+RK*5+#IEVG'56(<*E!*T?K7)8SA&!:3X/A4LX_IAI)/.O"?Q]
M;+TEH[@4HQ*OS$TG!F9E*9V?FW$M&7$[,-2[=%I6QJH4ZR[^GS'X)']=P80@
MPA' J:?+W47]U;UR?X6:' >N=\0,U= IEO[3MMZ(@[.F_GKLRI\QC?)J_)Y7
M[1#_ #AQW2OO5](\QXB/+Q+-KH7_ ,L:&^,K9,C*[RZ]IN_6=];%S.ZH^[*$
MX*VYR3&HUJ?NZ4TA41W=,<87W5.>4>7VW;E&P&!#$'5F*':.OCE3R1Y@)!!!
MN*$'B,CW$? 6*5I!HU(4]U+)-72@7)?946*GRV9U\U328D8J+2I5N4G 6-5$
MYO"I*7+;8C3&G*3S28C(TA9L"E2:1$9!%SD64=SI )-@ 1:YIU[+WCTJE:D)
ML:RFM2@NX002+9D;.P13VLYHAJ]5^N59Z1OK#-U-9&HKLXS615:6*C3LUS+(
M: BKU0V";)GHXVRT6$IS/,J.)D<B7E--KDUMQ ,9940KKG(XBC4J(N-5)K4F
MGC4)3QZ:6 W4$,C40VA8*5*<=&J4BBOI:2 LFX22135!S,>HG%:U4ZVAMJ:L
M],%4]JF"@U+")*"77&I%1YJEZJ.U36]:BF%D9T+%,TSOK"VEL);E)$NDHY=;
MVQM:G*?%B<M(5 TPD)!LI5*V  !K<F^\C=E3.UHRH5-M(6$ZSBRHG52"AIL$
M&I "KT4;U)"1??Y_7(9NI7MMT>I'!4"<'$9,?]DV5DY2V<)Q3S_,*!5)\W+:
MJ/U/Y&3KADV<Z0S8_P#<7"OLVS% +O+#C$X%("SS$;!W$"0I(J2:H%[VO6E\
MMYN:\*QH*+86O52*AXY)U4T(" I5*A8%0VD6(H;5,=!JK6"H*/;H(KZT,54U
MM'*.U:IQLO/4PH36@BC:>7)L;7EAJHY3"49,A3V=,;15FI-/2$S@1*2UK1HI
M)5B<]IAB-307*CKZWC42=6M/%X]!K:M#TQ5"$E@-DI"W$*= -=>H(**6I0MI
M4::P)*LCE&%1=D3V@X%JQ*XNU-H%2R0F:8IW1'T]?VP-F!X?]I>4Z/3$54&-
M7-$,<QM]*9*>E,RO J(F$Q0KC3NCJ:CEXU.897G%\,JY'Q:J OED"#UCKGP9
MO<OWQ"?&!YT!I2TZE$V*E #;M J;#89MVX-IH^5G=3)$R4V.32=3C;#G]%4I
M/3U8\2]6ADV;)PI^UR;,$J(89NA1,S//B*9'5L<EZ%RF%O-4-ZQREPP4QB",
MD7%4L1;6O3.A%#2NZ(##6L-8*&LIE.KK7;+J5U!-+E) .0K4 \<0Y;:-3:8/
M\U+65+(TLRT^;4E04TUHD[:9,\]S"61)VSBI0!+$I3A4B4PFDQ2=/+RC?&VG
MKH9-!,)3"LE^2U$"=W!Q%:KY4)-=]* FE]@[ <C%@RA6K4J)2V@I-:)%W+$A
M!U?>_="E:BN[V_L+3W4&;E&U,R5,JJFJ),D@;4=4I13,QC7 T.TGRVW/:DB7
M!C0"].AZ&6Y@;2"UDI-L1!"=&B2*8DR]X[X.5P0*WJ:FI^:G52*O #FRE.J%
M-I-:U!.W9F#6N_;3./?/'DZY8F,8^*'9?9!GN=E- XI,DJ;9NA;B*DPN$4L2
MX\/X((E1DC"EA6"U(U8)14@G/$@#^T$X"#NY]MW./M?P?EIP^?G7='O I&;F
M^:;Q,.>"RSS_ #94J2U=?FD+U-;55JZU-;5-,C&3R%J2@I2I0!7[T%0%D;A:
MO'MM'QJ2T(KC"/Q5&JKP[OBJ=S>&_E9^7/'X8< QVAI@N+9'^CIS_!CGYIPY
M-K/_ (%>J-F2T-K9#K1ZJ89CK3Z;0X7U:.'#SZ<3NCV/D&F!XP;#^C)T[?\
MX'7$H;<!'B+%/R3NZ#Y^N,^FHA6@.UO2&J 96SD";.(?YI#3VL]X8\Y>CFD-
M+8%C1O\ !<Z=^9#'77?LVQKS:ZUU%BWWIWV[TVV,9]-12L@:TCJ:&0ZR'-0<
M,A_$H+;LL_;QR.Z-Z1[, QK+X+GKY_V'9TF^Z$H7M2NHM4I/D-+U(Z;1G$]&
M*PAVOXT]2K!EG(DT!O#_ #4&[/DQRKT9TD('\7\<L#_14_\ E6^Q^@>2+%"_
MO5#H2?5&93T;J\%KTJJ0 <LC3.&O;9_E7;DW7RRQSJT8TE((&CV.'+^B9_?_
M -G[T,54VO5/B*).Y)V$6RKQVTO?*,L51^K8!G2VHN_62)FS^)X"V7S\>[7&
M!T8TEH?XO8Y^J9^_3]3^:+%MRWB+WUU54R.VE-O",HGI#5F$?BJ85##/?)4R
MA;(>+8'$<] OOSQSKT6TFJ?XN8Z;*RPC$-I%*?4]^YV1/-N?>+_-5ZHRA-)*
MK!#G3*H0:#G)<R!?,?\ -N?WL<J]%=)ZC^+F/='L1B/R?N1OK#FW/P:_S5>J
M+Q=):JA:],Z@AK\QDQY7O_FW&9T5TGH?XMX]E\#XA\G'G$6"%ZJO$4;C[E6P
M]'I[-MF"D]4[YTTJ &7K-F/^K<O)[N7M4TIH?XMX_F+>PV(\?[ML],76A=+(
M4;_>GU7\OJMETGJD A>FD_Z@-QDV8_ZMMT\! +XH=%-*:*_BUC_#ZS8CN']V
M[Y;(R+:Z^\5D/N3N W=73%@NDU53#("X*9S_ !F1Q!!"$,GS%>**(0"&$ ]#
M<Q$1  XY7T&V8T1TK40E.C&D!42  ,&Q*I)- /L;,DTAS;GX-?YJO5'U5V2]
MDLJGA2&HU2$!9T^'0@H8F%0$!Q4G%&06A5*80[8LR93((AS 8H&<N("RQ%>)
ML:;^NN1GD83H\F7TJTKED+Q]:><PW#7 %HP="AXK[Z;I5B2TFH3529,$:OU1
MK*:Z&VPBBE>_MQ":F@RS5QV=-Q]!(?4AT^<<?TKW_?W$0KWQZO,(7J(!GU\7
MOH@9CI'GA<(T(SL*4I6^0K8FM<QLX5.PF$18[B"!05(-!;9GE>E[94I!A$FM
M\Q:NPYT\QZ#8D5J:&$2+$#?T; ;9"E*]E-YI*-Q#,0L( %]]QMNS <^&FX<!
MD.COG%H0;V'?GEF.0@-AL&_/3?Q&^'3"&Z<@A>]^.5A#R#IH&_%<]U#3LO6N
MW*V9ONO"'0B%] XY7Y,N0.>X7TW8A0M4D[MG&],J\10TZX1)U]_3$96RJ+$5
MMM.6=J7% 3G6YA"\=>/W_=P/4+C:#45%S3/(UOOJ;"J$Q%;Y96INSH#78<JU
M%@:[X1-#ZD.GSCBISV]=SPBZ<K9UM>F0!/37(C+(P[EQ$7ME8Y URX #++9G
ME7.L20>IZ?:#Q\V?-A&:J5%,J>D]SQSO#^?3E]N^=[9>._#"*PH:9=?'A%AM
MX@CRCH[*]-H,(4Z\M_10"E:VS!%A3A!A"HL3NK;.HWF^9KE?(F@R,(D"XOM\
MII7<;C92QL;7+M SX<0R <\LP$!Y-^GYX,(OGEO[2+;C;YC44A<Q#< A;+2W
M ;!QSU"XYVU  0M>MP:[>T5--FXTMP)+@ ,AN&H!N$-+!;.^H!GKEPSPBI.8
MH:4)J;'.IKLI<\+[[0L-KY97&X<<]+\ WAIX[W1*2:B]-FZXK<$F],B;W[0^
MU\@Y<MP::9[],\N7@C2E;#C;8,LK[<KVX[C.WO\ CR\E^C"%Z?/VV\E>J#Q:
M!T#[HV$+>UA#LR'4?6:$4]$.A]4&_4-_ ;>]S81*??#;F-NXT^;HB;KUWY[M
MWEQ%/3EQ&P;+Y9^6-N_?OY(3 "EK;_-G4F_&^4(,3"#&2\^KUP@Q2$6,=$(,
M(08S72HR].WL%\\]NR$&*@T-<P*@#AYCGO\ )"#&B?>COM,(,6.1_=Y=D(GY
M0SOR^_;*WGY;\\(!]K/.V0[_ "#[H80A;]>B_CWX0@#(0'?QW>+,+WX[MXV'
M" %2!O-(<%PMSYA<,[7 ,QOON')8.0<(T-\LZ9]-*Y &XOE4W&\0H7O;7(0'
MFUL #80 <@TXB'(A44&S(@CLO<W&9'0":F%$!N&06Y^3/0 $+@ A>UK;M^$
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MOOB"+CU=Z9=S2-]FK\GE?M$/\X<=TKDOI3Z8\O$O?-="_P#EC6,=<>9$L 9
M/'7+E'WN3+IQ&VO5EW]7GA"AS#R9Y!;F&VN[/AI< @=!X7L*=!IGLONRJ @
M  !RWVSR =VF@ /)>X6O<<9JSZ-P IOI3M%=_7"'8T1[T=?G,(FA]2'7>.+0
MCAM-MFVCE))H?)RD:6%Z&8W]K-8%2]XG"=9NA;I=.?5TSFRS+*.;YB?4$HRT
M9,#DM=HY?E9,T-$2LTL12"6D1EIZA"020,[;[&Y%]E;_ #6C13KBP$J58'6L
M *JI36- "32U34]IKW*&&""&&""&&""$ AA@A (8888;0A##"%@  "P
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M#MSJ,J;=M1?,5XFD* [AOGQOEO ;COS +:7"^_-$$4N*>@["*"HI8G?GN-%
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M/TN(/9EY1TF-$DTK44!RU4].T6O3=EV.[K'QA]A!]CB(FIV7MG0$YG@0>L6
MM6EI(8XA#\[>X_G(/<Y>3DTPBJE*%K"VP)VWXTIEGD-Q@[80_2YZWAA ?,%L
MKZ6W#GA%==5[B_ >JW5#@C&P90],$%^GXG"+!:MI3UI3PW 7W;,[B#MAX0^P
M@^QP@5FFRXK4!.=N H+$6ZQO.V'A#["#['" 4LY$9G8D[S2XV[#7('.@@",;
MAE#[" /:PBQ4:BA%B:C5%Q7=2]+C;VF']O$-A"ULQM:$,@YX=+[].;$4''M/
MKBU3<6W5HG,Y;!PM0=<*$8C;.$-=80WZ!G#NN&@WW\N%.GM/KBNLH5M6F5D#
M9<]=R 0<NQ>W$ W#O]3" :"-M+Y6X .E\*#CVGUQ&LHG8-GO4DY@5RI>N\C.
MD*$0@-LLL[C#!?\ F^;R"&2G3VD^<Q*5J)!J.@)%K=%<Z;10[P08?V\68#;F
M&&'IU#Q!B8TUE9$]1 ]/<P=O%NMT0PZ &7YT<@Z\<(:Q_<!D,MF0[T@[>+D]
MC#R?2\GFX80UCW X<.'FW0Z&.(1#2V>7:P\O)?=[N$62HDB]KV[>O9ZXE[8>
M3?\ G8=^N[%:#=7;8YV]/$FNV-(.V'A#[&'W, D;AF;5[U&6>_JA"=L/)[&'
MW,-5.=!3]]Z[OFOE"'=O%]+[&'W,9J%"+4MZ^)\\(.Z1<0]C#[F*PB:X\GB#
MW,;T''M/KA!<>3Q![F%!Q[3ZX0O;"&@VZ ]S&:Q<=&9).T],36F[L!\X@[>+
MCY ]S$%/JVYB@\I.>0\D*GAV#U0=M%Q\@>YBZ0"!:^VYS'78]Q"IX=@]4';Q
M<?('N8G53N\I]<*GAV#U1-C&%3P[!ZH.OM]&6$*GAV#U080J>'8/5 %[AE;/
MDZCTVY;80J>'8/0*]EX?<>(6L(CE#KF&[>.5\QUPB]?0!;(6WBMKFIM4=(A;
MC?/FT >4+#8.<-=VN$!89;\QNZB36I!)H!<6A>VMJ.\-;6MT<][7$0R'2^$*
M;@*4.PUKUC>"*Y9Y&@@A'.V0#P"VZ_ -VX+W +W'")&8VB]Z4XU%]M;FE#80
M_"+P80@PA!A"#"$&$(,(080@PA' ::_+W47]UCS_ .+-Z^3$#-5=PI;B=_0<
MND9FL',=[#/OU[(WV:OR>5^T0_SAQW2F2^E/F,>5B/OFNA?_ "1SR9ID9).E
MYZFJ9%T+8P2ZV+'AY<(R5*F%$VH"(U"M3$G1DJ%9P$DEQQB6G(..CMVI9<<0
MA"/4: 5.0Z_63YR8\X DA(N20!TFPN?3'*Z0[2U#:\+7AOI'4%NG59+Y<1KR
M4W-SZEA0! KB0F0''.;4@($\E9#$G4)BS#%!!D(P'%P6$ J%!52DD@;@;G/=
M:YO8UMQ$76TXW373JURN#7L)CN^O0(>[YAY+Z#EBV?41Z_,>%<C:,X@4J4R)
M,H6+%!*1&D(-5*E:HTM.F3)DY<1IZA0>=%"60025!&:<:;'# 7!#%''&$,(B
M&2LZ=&^N0_=2_;>$<FI7M 49K>8^%4HJ)+L[G2V#>8]$-!YW?"1&[@JB9W2$
MA60F.5,CR")9$SOJ*!2S.H)%(MZY2!)@P70010$$C,=)M%UMN-TUTE(56A-*
M6SN#F-HS%;B.SP>I#I\^+Q2./3_7^CE+7WP;J!/K3*[V$MIIO%"XE. QPRTL
MFQHD5*ZQ')T1Z>$@^;7YH8RRQ.!0*I>5%W$$X&'%P5)%B:=Z>>+I;6L52DD5
M(M3, JIG7($QML_U(D*E<O1S94>;6*2Y<@6(VT':8' EO2G.3B:)*!M2]VB
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MVY95Z =E!6_ PB:@&U*$4.S::7K6]JU)I6AR @PB3;::9DC*N\&PO6_96#"
M-2#7:-PV=)-*[A0U)/!X7#?R6XYZ9W#01$;7 -^N$7MF;;<MMN@Y@6-">BD%
ML[\/*(W'7>(7"V6?"U\(7H0"!Y*4X; :&]>(.YV8Z7XY:V&VFZX[QR +Q6OG
MA%;#.AI4"O"N>9I>P%3E6E1"PCGH ;P]T;9](9"&EAU1*<P:W%C6O3GG;=F+
MC<0_R:<=??SOTY9!A&GDRWY_/>O7:PA-.O6V$1EW[TA;:[\N4 &V8^*PVY0#
M")IGMMQ -+GLH:<0(=#G$ B.?+OR'S==,Q]7G[]$63=0)-^.VQ\W?*\N(Z12
MM:;^VN9SMZ(U@PZ\N]_)NI4G=1!B;#OWVGRP@QDO/J]<(,4A%C'1"#"$&,UY
M] X5SWY[-@-.LP@Q&8J;IJ<R?54CHW&L(,73<#YQM[\-UK0@Q8]D(L=?'U^_
MCGA '-;KUTRPA"#UW>7EY RSY,(0 .=P'+7KPY+;P&^$2,QMN+;XDX#GQMEH
M-Q&P7RT'.]],M^$7!S&^@K0W( I<CM!&^^R$'2U@SWAG?@ ;PW!:]PWAGA"F
M=S:Y%Q0C:2*W(J:W)V0_?81T'I&UK:Y!GJ/$!W (X1&>0I;A;6)K7:;6' VN
M1  W&W*([N AG;??H&^FF$6 H0>%-O4!793A:E*YQYXKY21UJ:;(KFGG!!*[
M/(3R,T.T*EC3KEAIC<ZRZ\)W-M>P[5V9#VU"R.Z&,MI4H(W M[$Q2NA*;H4B
MSW,&Q9G#$3Z7)9;ZYM@L(4EY2$)2IJ8;6AUG^3>2M3K3E74N!!8HE!+A4CY/
M2G1N;TA>P=3&(-R36&SB9MU"I1MUUQQN9DWV79>:M,2JVD2S[)3+K9+PFM9;
MP2R&W?$S%2AI"&8I)(J<0; Y2@@998?E=+IBB=:<FO"UQ5E-R53&B1F.3O45
M,Y(2IG=YU9H'R>Y=7,B ]WFM0 J5OMN:5RRWV'_ '@6Y@/S*$S12U/*U4)2'
M6RE:I=,IJ!<DU+N!EAXJ6RVP%!*?D6>36>:E)R4]FI527I-4G(O+PX+F<(0'
M'7'3+O!UM,ZYB@=+&,3,ZRN;G99#;,V_.*0IQ>4246DV%M;SD57E[HZ)ID0N
MQY3A3Z=7>%PE%#$H2.-''1(SM[,:ED5ZF"4YB-,E-&T-B%/+R1:"*7(V]M%2
M,*TM;6M8,@4-JEW&AS+B4*;FE*<",41SB'B<0::6G5><<<=4ZG74]XQBR>3-
M]#313C7./MSK,PKPEA;K;^&MMLJ>T=>YEV52,%F9EI15*,,LRS<NX&42E$"N
MX2-2R6V!]I"M::G)DD4O3[$#>W&4VF!*R%E/K%()Q\EM#9,;<H02T:[-Z)"9
M+DPEFL#VB;GZ QJ5+$:QS;''GFM)FIEK$&ER;BO#9=+)<5,$/*>;<F5M3+SK
M26U.%)F IR7<#K#RD#62%I;<;[L/T F</F,%?:Q.70,*GW)H,HD4JED2KS.'
M-OR,I+S"WT2^L)%2&9QDR\U+(>5S:U(4\R]^0NK52]E63:YUF<*M5[G6>UB>
MK=1(AIM0>271$>!L$XN_=&:8*E5:(E!!+ZE+&$218JEJ1:@HA,+-B;U2DGN*
M@S^C9#$L:=PK#6,/PN2E0G#I-'AN+/MK%I9M(<:DI S"W@JRDA^:E#3WX2:@
M?REB7)-@BL=QG$,6Q7%9T/XOB$R,-P256VI0>G'7>:>Q+$PPB6(UM52V)&?3
M8E"B "?HYV++;X>=H3;)I#LWT&IU+FSSL^MA$X3_ #S+$JKULUSU/T,HRDZ'
MM"ZI]4'M.2_3%#X2GLQ/>+>GEYDA+6&(8VU0B[@E@^'TYP66DM'L1QC%9U['
M,;=\'E)28F6T2TI(A^8;#J,/PYE7,,'F [XZ^><JD+#B5ZRC^J\G+&)LZ28+
M@N!85+Z):)RKDQ/XC)2*G9K$,7=EY1[P9>-8U-)\,G )I35&6_!98)4IKF5M
M!*!^O?'\^1_4L&$(,(1P*FEO#NHW[JWK2VO?9H9];[L0,U=  RWU[/3V1!V9
M9USO;.F^T;Y-7Y/+_:(?YPX[I3)?2GTQY>)9M="_^6-8QUQYD2P^I"X\>3HU
M !'@.[HQ!IO\M/2+[MV<(4,LQW9:6R&PA?F\7-GB,K[A3*EK4KT=0%\J&$.Z
M^+W[8S5[X]7E'JK"$ <O=RZ<:IR&75?;")X?4AT^<>OWL3"'6ZY9>3?OPA"9
M^3AI[^8>(<(0<WW];=&(5D>@^:)3F.D>>#Q7TOYO+NOOUQA&\+A"/G'M][&D
M^[69U+39)F>49="12YQ+<@FDQY+%4,Q1RS$D%%Z$M3F$0$@RJ04=W$D0$PGN
M8&7C[3\OY1M!\3TP<PE4A,R4L,/;G [X6IY)69E4MJ<WS3+M:<RK6)('C"E;
MTHM <2D:VJ4J5F*UU@FULM75-0:&^V\?/E-V'NNQ(P]M4JDHVX*9P]N5=,@Y
MM=XV_,5\B6D:A3V2P;]).;LK2G'R&\9>#_VB?S5=>8IOV[-E1&?([$;7$L;Q
M5&I5D%LE$W< XRL'ERW99XXG.0G29=QBF""^UR=W<)(V\O"+):H*:Z:DVLK<
M. R\]K&,R1V)VM9.M0Z719#D"B;.(:WEGS#T[L<JN0'2@V&+8%GF7)[*_P#<
MN^RL6YH5KKC*F1]6VW1UF,P3V*ZLQ6M0*8#S*)JWA^YD-^.57T/>E9M[+8"+
MU_E)_P W@/7$%NN2DTJ/OMAKD$G=2,H5V+VL10!>?J:#:VBB:1Z ^1L-??Y,
M8J^AWTL53Z[X!;^UG_D,.9)(.ND4SH%<*[-PSZME8R)?8R*O0V$9\IQ<.!\S
MVOKE>70R\>_3/&2OH<]+3EC&C]>+L^/-('RUX;8MS7Y:#^>*]6J:=9C)D]C4
MJW!K/-.M=0.F:V_7Y'LM<^'FYU_0W:8*_IG1[C]-Q >;#^^VL.:%O''8O=M\
M7>:;MM;1>+[&U5B&PC/%.]+Y'3*.X WL'-[08R/T->F)'VXT<O7-[$?^G>J)
M" *T4#4@Y*V&N[;%B'L;]5@^;>GN?_33)NO_ )@]S&?\&C3+9C.CE?\ XV)?
M].B2FM#K"QL/&O<?DVRKMZ<HGA[')56$!#PWI]I8/CTQ^+\H>%_)EEBA^AFT
MS(2/9K1NUC].Q+_IW"*AK>M(ZE<.'>G5'IS9JV,X*0S(;.T]NC+,\QH [25D
M[3 MC;64PPLPM2ZFQN"9(8I<Q*,$A"'>W<F^$35,!ABN,@Q'^H\EG(7[3L77
MC^DDU(8IB,J G"&9,/KE9-:@H.SCBIAIDN3020B72&M1BJG0M;I;+-DI"*D&
MJL@0#0 BA(K0DG+(4%=I&K[QQ_1L3!A&J/>]_P!]?0!!A%L^/3WOOB:'U(<>
MFVH^/F\VN'?S1DKWQZO-"A;R!XL[<O7GQ&T<-M.]SP](B!F.D=]L+B8T-[\;
M7MG2QI0=%ZC96\&'?U0)RI0;-IOE<[C2E]E\Q8PB*7(R\M:[+C(94L,AG<G7
MK;#OWK%A2M!Y=U#85XB]/W2:6$1#0 T'2U_+RV$1N "%L(M (B(>*X:#;+A>
M][[[;\M+(0EL]U@$1SW!H-PO?6UKA<=_#%:VVU(I;;N-:==B0(0L/JK\HY[P
MUL.66?$+9^6#84J1:W'90#.M\C7//:E$O73KTXK8G(D[16M:4O79U9Y;:0A,
M*TL<[G>"*UR'"I&5,]IA"^/KEY_<RPWT-;$ 6 V5I0T-!P&_,4A$L.@;OO\
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6#"$&$(,(080@PA!A"#"$&$(,(1__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>d206395d6k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:asnd="http://ascendispharma.com/20210630"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="asnd-20210630.xsd" xlink:type="simple"/>
    <context id="P04_01_2021To06_30_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2020To06_30_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2020To06_30_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="PAsOn06_30_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="P06_30_2021To06_30_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
        </entity>
        <period>
            <startDate>2021-06-30</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To03_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="PAsOn12_31_2019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="P04_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2021To06_30_2021_OtherCollaborationPartnersMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">asnd:OtherCollaborationPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2021To06_30_2021_NorthAmericaMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2021To06_30_2021_CNifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">asnd:Warrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2020To06_30_2020_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2020To06_30_2020_NorthAmericaMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2020To06_30_2020_CNifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2020To06_30_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">asnd:Warrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">asnd:Warrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_OtherCollaborationPartnersMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">asnd:OtherCollaborationPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_NorthAmericaMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_CNifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_SharePremiumMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_BottomOfRangeMemberifrsfullRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_TopOfRangeMemberifrsfullRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2021To06_30_2021_Warrant1MemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">asnd:Warrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2020To06_30_2020_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2020To06_30_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2020To06_30_2020_NorthAmericaMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2020To06_30_2020_CNifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2020To06_30_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2020To06_30_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2020To06_30_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2020To06_30_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2020To06_30_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">asnd:Warrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2020To06_30_2020_Warrant1MemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">asnd:Warrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="asnd:LeaseLiabilitiesAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanOneYearAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="asnd:LeaseLiabilitiesAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanFiveYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="asnd:LeaseLiabilitiesAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="asnd:LeaseLiabilitiesAxis">ifrs-full:DiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_GrossCarryingAmountMemberASNDLeaseLiabilitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="asnd:LeaseLiabilitiesAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">asnd:Warrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_BottomOfRangeMemberifrsfullRangeAxis_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">asnd:Warrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_TopOfRangeMemberifrsfullRangeAxis_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">asnd:Warrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:UsTreasuryBillsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:UsTreasuryBillsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:UsGovernmentBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:UsGovernmentBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:CommercialPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:CommercialPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:CorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:CorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:AgencyBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:AgencyBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:UpperMediumGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:UpperMediumGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_LowerMediumGradeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:LowerMediumGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_LowerMediumGradeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:LowerMediumGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">asnd:ZeroCouponMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">asnd:ZeroCouponMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:PrimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:PrimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:HighGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:HighGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:UsTreasuryBillsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:UsTreasuryBillsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:UsGovernmentBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:UsGovernmentBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:CommercialPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:CommercialPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:CorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:CorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:AgencyBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">asnd:AgencyBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:UpperMediumGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:UpperMediumGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">asnd:ZeroCouponMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">asnd:ZeroCouponMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:PrimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:PrimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:HighGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">asnd:HighGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="P01_08_2021To01_08_2021_VisenSeriesBFinancingMemberifrsfullLiabilitiesArisingFromFinancingActivitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">asnd:VisenSeriesBFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-08</startDate>
            <endDate>2021-01-08</endDate>
        </period>
    </context>
    <context id="P01_08_2021To01_08_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-08</startDate>
            <endDate>2021-01-08</endDate>
        </period>
    </context>
    <context id="PAsOn01_08_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">asnd:VisenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-08</instant>
        </period>
    </context>
    <context id="P08_25_2021To08_25_2021_NonadjustingEventsAfterReportingPeriodMemberifrsfullNonadjustingEventsAfterReportingPeriodAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">asnd:NonadjustingEventsAfterReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-25</startDate>
            <endDate>2021-08-25</endDate>
        </period>
    </context>
    <context id="PAsOn12_31_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">asnd:Warrant1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_SharePremiumMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2019_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2019_SharePremiumMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2019_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2019_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2019_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612042</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <unit id="Unit_EUR">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="Unit_shares">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Month">
        <measure>utr:Month</measure>
    </unit>
    <unit id="Unit_Year">
        <measure>utr:Year</measure>
    </unit>
    <unit id="Unit_Segment">
        <measure>asnd:Segment</measure>
    </unit>
    <unit id="Unit_DKK_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:DKK</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_EUR_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="P01_01_2021To06_30_2021">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="P01_01_2021To06_30_2021">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="P01_01_2021To06_30_2021">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="P01_01_2021To06_30_2021">0001612042</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="P01_01_2021To06_30_2021">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="P01_01_2021To06_30_2021">6-K</dei:DocumentType>
    <dei:DocumentFiscalYearFocus contextRef="P01_01_2021To06_30_2021">2021</dei:DocumentFiscalYearFocus>
    <dei:EntityRegistrantName contextRef="P01_01_2021To06_30_2021">Ascendis Pharma A/S</dei:EntityRegistrantName>
    <asnd:LeaseTerm
      contextRef="P01_01_2021To06_30_2021_BottomOfRangeMemberifrsfullRangeAxis"
      id="hidden25486367">P2Y</asnd:LeaseTerm>
    <asnd:LeasesOptionToExtendAndTerminationTerm
      contextRef="P01_01_2021To06_30_2021_BottomOfRangeMemberifrsfullRangeAxis"
      id="hidden25486370">P2Y</asnd:LeasesOptionToExtendAndTerminationTerm>
    <ifrs-full:Revenue
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1022000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">1436000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1767000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">3661000</ifrs-full:Revenue>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">83306000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">63578000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">171455000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">121093000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">35345000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">20805000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">72591000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">38720000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-117629000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-82947000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-242279000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-156152000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-4817000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-1885000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">23289000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-3400000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:FinanceIncome
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">145000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">86000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">23268000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">1996000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">12141000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">10292000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1703000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">876000</ifrs-full:FinanceCosts>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-134442000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-95038000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-197425000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-158432000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-68000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-106000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-259000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-183000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-134374000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-94932000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-197166000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-158249000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-134374000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-94932000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-197166000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-158249000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:BasicAndDilutedEarningsLossPerShare
      contextRef="P04_01_2021To06_30_2021"
      decimals="2"
      unitRef="Unit_EUR_per_Share">-2.50</ifrs-full:BasicAndDilutedEarningsLossPerShare>
    <ifrs-full:BasicAndDilutedEarningsLossPerShare
      contextRef="P04_01_2020To06_30_2020"
      decimals="2"
      unitRef="Unit_EUR_per_Share">-1.97</ifrs-full:BasicAndDilutedEarningsLossPerShare>
    <ifrs-full:BasicAndDilutedEarningsLossPerShare
      contextRef="P01_01_2021To06_30_2021"
      decimals="2"
      unitRef="Unit_EUR_per_Share">-3.66</ifrs-full:BasicAndDilutedEarningsLossPerShare>
    <ifrs-full:BasicAndDilutedEarningsLossPerShare
      contextRef="P01_01_2020To06_30_2020"
      decimals="2"
      unitRef="Unit_EUR_per_Share">-3.29</ifrs-full:BasicAndDilutedEarningsLossPerShare>
    <ifrs-full:WeightedAverageShares
      contextRef="P04_01_2021To06_30_2021"
      decimals="0"
      id="Fact_25469810"
      unitRef="Unit_shares">53848166</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="P04_01_2020To06_30_2020"
      decimals="0"
      id="Fact_25469811"
      unitRef="Unit_shares">48207661</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="P01_01_2021To06_30_2021"
      decimals="0"
      id="Fact_25469854"
      unitRef="Unit_shares">53804300</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="P01_01_2020To06_30_2020"
      decimals="0"
      id="Fact_25469855"
      unitRef="Unit_shares">48096749</ifrs-full:WeightedAverageShares>
    <ifrs-full:ProfitLoss
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-134374000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-94932000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-197166000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-158249000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">77000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-147000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1765000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-61000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">77000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-147000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1765000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-61000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:ComprehensiveIncome
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-134297000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-95079000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-195401000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-158310000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-134297000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-95079000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-195401000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-158310000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullComponentsOfEquityAxis"
      decimals="0"
      unitRef="Unit_shares">6065823</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares
      contextRef="P01_01_2020To06_30_2020_Warrant1MemberifrsfullComponentsOfEquityAxis"
      decimals="0"
      unitRef="Unit_shares">5788390</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
    <asnd:GoodwillAndOtherIntangibleAssets
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">5495000</asnd:GoodwillAndOtherIntangibleAssets>
    <asnd:GoodwillAndOtherIntangibleAssets
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">5717000</asnd:GoodwillAndOtherIntangibleAssets>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">123924000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">108112000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:InvestmentsInAssociates
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">45783000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">9176000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:LongtermDeposits
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1702000</ifrs-full:LongtermDeposits>
    <ifrs-full:LongtermDeposits
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">1375000</ifrs-full:LongtermDeposits>
    <ifrs-full:NoncurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">90693000</ifrs-full:NoncurrentFinancialAssetsAvailableforsale>
    <ifrs-full:NoncurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">115280000</ifrs-full:NoncurrentFinancialAssetsAvailableforsale>
    <ifrs-full:NoncurrentAssets
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">267597000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">239660000</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentTradeReceivables
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">394000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">387000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">11398000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">6957000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:CurrentPrepayments
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">21826000</ifrs-full:CurrentPrepayments>
    <ifrs-full:CurrentPrepayments
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">13994000</ifrs-full:CurrentPrepayments>
    <ifrs-full:CurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">166094000</ifrs-full:CurrentFinancialAssetsAvailableforsale>
    <ifrs-full:CurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">134278000</ifrs-full:CurrentFinancialAssetsAvailableforsale>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">384539000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">584517000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentAssets
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">584251000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">740133000</ifrs-full:CurrentAssets>
    <ifrs-full:Assets
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">851848000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">979793000</ifrs-full:Assets>
    <ifrs-full:IssuedCapital
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">7237000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">7217000</ifrs-full:IssuedCapital>
    <asnd:DistributableEquity
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">680250000</asnd:DistributableEquity>
    <asnd:DistributableEquity
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">831494000</asnd:DistributableEquity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">687487000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">838711000</ifrs-full:Equity>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">94059000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">85116000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:OtherNoncurrentPayables
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">3162000</ifrs-full:OtherNoncurrentPayables>
    <ifrs-full:NoncurrentLiabilities
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">94059000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">88278000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">6950000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">6859000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentContractLiabilities
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">145000</ifrs-full:CurrentContractLiabilities>
    <ifrs-full:CurrentContractLiabilities
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">363000</ifrs-full:CurrentContractLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">44207000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">21897000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:OtherCurrentPayables
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">18623000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">23384000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:CurrentTaxLiabilities
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">377000</ifrs-full:CurrentTaxLiabilities>
    <ifrs-full:CurrentTaxLiabilities
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">301000</ifrs-full:CurrentTaxLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">70302000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">52804000</ifrs-full:CurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">164361000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">141082000</ifrs-full:Liabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">851848000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">979793000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">7217000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">1728747000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-76000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">133101000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-1030278000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">838711000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2021To06_30_2021_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-197166000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-197166000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2021To06_30_2021_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">1765000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1765000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2021To06_30_2021_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">1765000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2021To06_30_2021_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-197166000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-195401000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="P01_01_2021To06_30_2021_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">39396000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">39396000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners
      contextRef="P01_01_2021To06_30_2021_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">20000</ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners>
    <ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners
      contextRef="P01_01_2021To06_30_2021_SharePremiumMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">4761000</ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners>
    <ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">4781000</ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2021_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">7237000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2021_SharePremiumMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">1733508000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2021_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">1689000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2021_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">172497000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2021_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-1227444000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">687487000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2019_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">6443000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2019_SharePremiumMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">1122097000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2019_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-34000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2019_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">79931000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2019_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-611323000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2019"
      decimals="-3"
      unitRef="Unit_EUR">597114000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2020To06_30_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-158249000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-158249000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2020To06_30_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-61000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-61000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2020To06_30_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-61000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2020To06_30_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-158249000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-158310000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="P01_01_2020To06_30_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">28364000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">28364000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners
      contextRef="P01_01_2020To06_30_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">48000</ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners>
    <ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners
      contextRef="P01_01_2020To06_30_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">9928000</ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners>
    <ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners
      contextRef="P01_01_2020To06_30_2020"
      unitRef="Unit_EUR"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">6491000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">1132025000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2020_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-95000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2020_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">108295000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-3"
      unitRef="Unit_EUR">-769572000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">477144000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-197166000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-158249000</ifrs-full:ProfitLoss>
    <ifrs-full:FinanceIncome
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">23268000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">1996000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1703000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">876000</ifrs-full:FinanceCosts>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-259000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-183000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <asnd:NoncashConsideration
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1155000</asnd:NoncashConsideration>
    <asnd:NoncashConsideration
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">2215000</asnd:NoncashConsideration>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">23289000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-3400000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">39396000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">28364000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">7112000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">4192000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">222000</ifrs-full:AdjustmentsForAmortisationExpense>
    <asnd:AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-4035000</asnd:AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits>
    <asnd:AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-944000</asnd:AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits>
    <asnd:AdjustmentsForIncreaseDecreaseInPrepayments
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-7832000</asnd:AdjustmentsForIncreaseDecreaseInPrepayments>
    <asnd:AdjustmentsForIncreaseDecreaseInPrepayments
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-5385000</asnd:AdjustmentsForIncreaseDecreaseInPrepayments>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-218000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-858000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">10902000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">8008000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-197887000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-124990000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1915000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">1776000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">699000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">798000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">149000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-615000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-196820000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-123397000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfInterestsInAssociates
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">10187000</ifrs-full:PurchaseOfInterestsInAssociates>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">7607000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">10725000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PaymentsForDevelopmentProjectExpenditure
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">530000</ifrs-full:PaymentsForDevelopmentProjectExpenditure>
    <ifrs-full:PaymentsForDevelopmentProjectExpenditure
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">311000</ifrs-full:PaymentsForDevelopmentProjectExpenditure>
    <ifrs-full:PurchaseOfAvailableforsaleFinancialAssets
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">76358000</ifrs-full:PurchaseOfAvailableforsaleFinancialAssets>
    <ifrs-full:PurchaseOfAvailableforsaleFinancialAssets
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">233446000</ifrs-full:PurchaseOfAvailableforsaleFinancialAssets>
    <ifrs-full:ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">75600000</ifrs-full:ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-19082000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-244482000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">3371000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">2306000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <asnd:ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">4782000</asnd:ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities>
    <asnd:ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">9976000</asnd:ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1411000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">7670000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">-214491000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">-360209000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_EUR">584517000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn12_31_2019"
      decimals="-3"
      unitRef="Unit_EUR">598106000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">14513000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">2708000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">384539000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">240605000</ifrs-full:CashAndCashEquivalents>
    <asnd:CashDeposits
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">383073000</asnd:CashDeposits>
    <asnd:CashDeposits
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">183153000</asnd:CashDeposits>
    <asnd:ShortTermMarketableSecurities
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1466000</asnd:ShortTermMarketableSecurities>
    <asnd:ShortTermMarketableSecurities
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">57452000</asnd:ShortTermMarketableSecurities>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">384539000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">240605000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 1&#x2014;General Information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Ascendis Pharma A/S, together with its subsidiaries, is a biopharmaceutical company applying its innovative TransCon technologies to build a leading, fully integrated biopharmaceutical company. Ascendis Pharma A/S was incorporated in 2006 and is headquartered in Hellerup, Denmark. Unless the context otherwise requires, references to the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d; refer to Ascendis Pharma A/S and its subsidiaries. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The address of the Company&#x2019;s registered office is Tuborg Boulevard 12, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;DK-2900,&lt;/div&gt; Hellerup, Denmark. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On February 2, 2015, the Company completed an initial public offering which resulted in the listing of American Depositary Shares, or ADSs, representing the Company&#x2019;s ordinary shares, under the symbol &#x201c;ASND&#x201d; in the United States on The Nasdaq Global Select Market. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&#x2019;s Board of Directors approved these unaudited condensed consolidated interim financial statements on August&#160;25, 2021. &lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 2&#x2014;Summary of Significant Accounting Policies &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Basis of Preparation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The unaudited condensed consolidated interim financial statements of the Company are prepared in accordance with International Accounting Standard 34, &#x201c;Interim Financial Reporting.&#x201d; Certain information and disclosures normally included in the annual consolidated financial statements prepared in accordance with International Financial Reporting Standards (&#x201c;IFRS&#x201d;) have been condensed or omitted. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with the Company&#x2019;s audited annual consolidated financial statements for the year ended December 31, 2020 and accompanying notes, which have been prepared in accordance with IFRS as issued by the International Accounting Standards Board, and as adopted by the European Union. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The accounting policies applied are consistent with those of the previous financial year. A description of our accounting policies is provided in the &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accounting Policies section of the audited consolidated financial statements as of and for the year ended December 31, 2020. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The preparation of financial statements in conformity with IFRS requires the use of certain significant accounting estimates and requires management to exercise its judgement in the process of applying the Company&#x2019;s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the unaudited condensed consolidated interim financial statements are disclosed in Note 3. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;New and Amended IFRS Standards Adopted by the Company &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Several new amendments and interpretations became applicable for the current reporting period, but do not have an impact on the accounting policies applied by the Company. &lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Basis of Preparation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The unaudited condensed consolidated interim financial statements of the Company are prepared in accordance with International Accounting Standard 34, &#x201c;Interim Financial Reporting.&#x201d; Certain information and disclosures normally included in the annual consolidated financial statements prepared in accordance with International Financial Reporting Standards (&#x201c;IFRS&#x201d;) have been condensed or omitted. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with the Company&#x2019;s audited annual consolidated financial statements for the year ended December 31, 2020 and accompanying notes, which have been prepared in accordance with IFRS as issued by the International Accounting Standards Board, and as adopted by the European Union. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The accounting policies applied are consistent with those of the previous financial year. A description of our accounting policies is provided in the &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accounting Policies section of the audited consolidated financial statements as of and for the year ended December 31, 2020. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The preparation of financial statements in conformity with IFRS requires the use of certain significant accounting estimates and requires management to exercise its judgement in the process of applying the Company&#x2019;s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the unaudited condensed consolidated interim financial statements are disclosed in Note 3. &lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <asnd:DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;New and Amended IFRS Standards Adopted by the Company &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Several new amendments and interpretations became applicable for the current reporting period, but do not have an impact on the accounting policies applied by the Company. &lt;/div&gt;&lt;/div&gt;</asnd:DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 3&#x2014;Critical Accounting Judgements and Key Sources of Estimation Uncertainty &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In the application of the Company&#x2019;s accounting policies, management is required to make judgements, estimates and assumptions about the carrying amount&#160;of assets and liabilities that are not readily apparent from other sources. Judgements and estimates applied are based on historical experience and other factors that are relevant, and which are available at the reporting date. Uncertainty concerning judgements and estimates could result in outcomes, that require a material adjustment to assets and liabilities in future periods. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. While the application of significant accounting estimates is subject to material estimation uncertainties, management&#x2019;s ongoing revisions of significant accounting estimates have not revealed any material impact in the consolidated interim statements of profit or loss for any of the periods presented. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The unaudited condensed consolidated interim financial statements do not include all disclosures for significant accounting judgements, estimates and assumptions, that are required in the annual consolidated financial statements, and therefore, should be read in conjunction with the Company&#x2019;s audited consolidated financial statements as of and for the year ended December 31, 2020. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Significant judgements made in the process of applying our accounting policies and that have the most significant effect on the amounts recognized in the unaudited condensed consolidated interim financial statements relate to revenue recognition, share-based payment, internally generated intangible assets related to drug development, classification of collaboration agreements and recognition principles related to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-launch&lt;/div&gt; inventories. For the six months ended June 30, 2021, the Company has for the first time, in connection with determining the grant date fair value of warrants and accordingly, warrant compensation costs, applied its own share price as input for expected volatility. Details are provided in section &#x201c;Warrant Compensation Costs&#x201d;. Until December 31, 2020, the expected volatility was calculated using a simple average of daily historical data of comparable publicly traded companies, as the Company did not have sufficient data for the volatility of the Company&#x2019;s own share price. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The key sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities within the next financial year, primarily relate to recognition and measurement of accruals and prepayments for manufacturing and clinical trial activities. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other than as set out below, there have been no other changes to the application of significant accounting judg&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;e&lt;/div&gt;ments, or estimation uncertainties regarding accounting estimates compared to December&#160;31, 2020. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Warrant Compensation Costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;IFRS 2, &#x201c;Share-Based Payment&#x201d; requires an entity to reflect in its consolidated statement of profit or loss and financial position, the effects of share-based payment transactions. Warrant compensation costs are recognized over the vesting period as research and development costs or selling, general and administrative expenses, as appropriate, based on management&#x2019;s best estimate of the number of warrants that will ultimately vest, which is subject to uncertainty. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Warrant compensation costs are measured according to the grant date fair values of the warrants granted. Estimating fair values requires the Company to apply generally accepted valuation models and apply these models consistently according to the terms and conditions of the specific warrant program. Under all warrant programs, the Black-Scholes option-pricing model has been applied to determine the fair value of warrants granted. Subjective judgements and assumptions, which are subject to estimation uncertainties, need to be exercised in determining the appropriate input to the valuation model. These inputs include expected volatility of the Company&#x2019;s share price for a historic period equaling the expected lifetime of the warrants, reflecting the assumption that the historical volatility over a period similar to the life of the warrants is indicative of future trends. For the six months ended June&#160;30, 2021, the expected volatility has been calculated using the Company&#x2019;s own share price. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <asnd:SignificantEventsInTheReportingPeriodTextBlock contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 4&#x2014;Significant Events in the Reporting Period &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Impact from &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; pandemic &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;A novel strain of coronavirus, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(&#x201c;COVID-19&#x201d;)&lt;/div&gt; was reported to have surfaced in Wuhan, China, in December 2019. Since then, COVID-19 has spread around the world into a pandemic, including into countries where we are operating, where we have planned or have ongoing clinical trials, and where we rely on third-parties to manufacture preclinical and clinical supplies, as well as commercial supply. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;We monitor these risks closely, and work with relevant stakeholders to avoid disruptions, and to develop and establish working measures. However, while &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; continues to impact global societies, the uncertainty related to the duration and direction of the pandemic makes the future impact from &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19,&lt;/div&gt; including the magnitude of any impact on our operational results, highly uncertain and unpredictable. At the reporting date, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; did not have a direct impact on the &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;consolidated &lt;/div&gt;interim financial statements&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;VISEN Pharmaceuticals Investment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;On January 8, 2021, the Company entered into an equity investment of $12.5&#160;million in its associate, VISEN Pharmaceuticals, or VISEN, as part of VISEN&#x2019;s $150&#160;million Series B financing. Following VISEN&#x2019;s Series B financing, the Company retains approximately 44% of VISEN&#x2019;s issued and outstanding shares. As a result, the Company has recognized a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-cash&lt;/div&gt; gain in the first quarter of 2021 of &#x20ac;42.3&#160;million, which is presented as part of &#x201c;Share of profit / (loss) of associate&#x201d; in the consolidated interim statement of profit or loss. The Series B financing has not changed the Company&#x2019;s accounting treatment of VISEN. &lt;/div&gt;</asnd:SignificantEventsInTheReportingPeriodTextBlock>
    <ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod
      contextRef="PAsOn01_08_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis"
      decimals="-5"
      unitRef="Unit_USD">12500000</ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="P01_08_2021To01_08_2021_VisenSeriesBFinancingMemberifrsfullLiabilitiesArisingFromFinancingActivitiesAxis"
      decimals="-6"
      unitRef="Unit_USD">150000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <asnd:ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate
      contextRef="P01_08_2021To01_08_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis"
      decimals="2"
      unitRef="Unit_pure">0.44</asnd:ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate>
    <asnd:ExpectedNonCashGainTowardsShares
      contextRef="P01_01_2021To03_31_2021"
      decimals="-5"
      unitRef="Unit_EUR">42300000</asnd:ExpectedNonCashGainTowardsShares>
    <ifrs-full:DisclosureOfRevenueExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 5&#x2014;Revenue &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;The Company&#x2019;s revenue is primarily generated from three license agreements, which were entered into in 2018. The licenses grant VISEN exclusive rights to develop and commercialize TransCon hGH, TransCon PTH and TransCon CNP in Greater China. As consideration for the granting of such rights, the Company has received &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;up-front,&lt;/div&gt; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable,&lt;/div&gt; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-cash&lt;/div&gt; consideration of $40.0&#160;million in the form of 50% ownership in VISEN. At the reporting date, the Company retains approximately 44% of VISEN&#x2019;s issued and outstanding shares. &lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Consideration received is recognized partly as license revenue, and partly as rendering of services over time. In addition to granting exclusive rights, the Company will provide clinical trial supply and development services to VISEN. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 68%;"/&gt;
&lt;td style="width: 2%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 2%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 2%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 2%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three&#160;Months&#160;Ended&lt;br/&gt; June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six&#160;Months&#160;Ended&lt;br/&gt; June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(EUR&#x2019;000)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(EUR&#x2019;000)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Revenue from external customers&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Revenue from the rendering of services (recognized over time)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;226&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;779&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;395&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,091&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Sale of clinical supply (recognized at a point in time)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;217&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;217&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;246&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x201c;Right-to-use&#x201d;&lt;/div&gt;&lt;/div&gt; licenses (recognized at a point in time)&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;579&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;657&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,155&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,324&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total revenue &lt;div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px"&gt;(1)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,022&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,436&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,767&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,661&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Attributable to&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;VISEN Pharmaceuticals&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;913&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,436&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,550&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,661&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other collaboration partners&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;109&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;217&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total revenue&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,022&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,436&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,767&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,661&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Revenue by geographical location&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;North America&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;688&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;657&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,373&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,324&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;China&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;334&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;779&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;394&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,337&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total revenue&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,022&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,436&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,767&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,661&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"/&gt; &lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"/&gt; &lt;div style="clear: both; max-height: 0px;"/&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px"&gt;(1)&lt;/div&gt;&#160;&lt;/td&gt;
&lt;td style="text-align:left;;vertical-align:top;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For the three months ended June&#160;30, 2021 and 2020, and for the six months ended June&#160;30, 2021 and 2020, &#x201c;Total revenue&#x201d; includes recognition of previously deferred revenue/internal profit from associate of &#x20ac;579&#160;thousand and &#x20ac;1,013&#160;thousand, and of &#x20ac;1,155&#160;thousand and &#x20ac;2,215&#160;thousand, respectively. &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  </ifrs-full:DisclosureOfRevenueExplanatory>
    <asnd:UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue
      contextRef="P01_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis"
      decimals="-5"
      unitRef="Unit_USD">40000000.0</asnd:UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="P01_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis"
      decimals="2"
      unitRef="Unit_pure">0.50</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <asnd:RetainedPercentageOfIssuedAndOutstandingShares
      contextRef="PAsOn06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis"
      decimals="2"
      unitRef="Unit_pure">0.44</asnd:RetainedPercentageOfIssuedAndOutstandingShares>
    <asnd:DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 68%;"/&gt;
&lt;td style="width: 2%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 2%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 2%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 2%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three&#160;Months&#160;Ended&lt;br/&gt; June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six&#160;Months&#160;Ended&lt;br/&gt; June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(EUR&#x2019;000)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(EUR&#x2019;000)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Revenue from external customers&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt;
&lt;td style="vertical-align: bottom;"/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Revenue from the rendering of services (recognized over time)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;226&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;779&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;395&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,091&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Sale of clinical supply (recognized at a point in time)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;217&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;217&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;246&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x201c;Right-to-use&#x201d;&lt;/div&gt;&lt;/div&gt; licenses (recognized at a point in time)&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;579&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;657&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,155&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,324&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total revenue &lt;div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px"&gt;(1)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,022&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,436&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,767&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,661&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Attributable to&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;VISEN Pharmaceuticals&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;913&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,436&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,550&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,661&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other collaboration partners&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;109&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;217&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total revenue&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,022&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,436&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,767&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,661&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Revenue by geographical location&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;North America&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;688&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;657&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,373&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,324&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 68%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;China&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;334&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;779&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;394&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,337&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total revenue&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,022&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,436&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,767&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,661&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 68%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"/&gt; &lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"/&gt; &lt;div style="clear: both; max-height: 0px;"/&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px"&gt;(1)&lt;/div&gt;&#160;&lt;/td&gt;
&lt;td style="text-align:left;;vertical-align:top;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For the three months ended June&#160;30, 2021 and 2020, and for the six months ended June&#160;30, 2021 and 2020, &#x201c;Total revenue&#x201d; includes recognition of previously deferred revenue/internal profit from associate of &#x20ac;579&#160;thousand and &#x20ac;1,013&#160;thousand, and of &#x20ac;1,155&#160;thousand and &#x20ac;2,215&#160;thousand, respectively. &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </asnd:DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">226000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">779000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">395000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">2091000</ifrs-full:RevenueFromRenderingOfServices>
    <asnd:RevenueFromSaleOfClinicalSupply
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">217000</asnd:RevenueFromSaleOfClinicalSupply>
    <asnd:RevenueFromSaleOfClinicalSupply
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">217000</asnd:RevenueFromSaleOfClinicalSupply>
    <asnd:RevenueFromSaleOfClinicalSupply
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">246000</asnd:RevenueFromSaleOfClinicalSupply>
    <ifrs-full:LicenceFeeIncome
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">579000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">657000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1155000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">1324000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:Revenue
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1022000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">1436000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1767000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">3661000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis"
      decimals="-3"
      unitRef="Unit_EUR">913000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2020To06_30_2020_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis"
      decimals="-3"
      unitRef="Unit_EUR">1436000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis"
      decimals="-3"
      unitRef="Unit_EUR">1550000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2020To06_30_2020_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis"
      decimals="-3"
      unitRef="Unit_EUR">3661000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2021To06_30_2021_OtherCollaborationPartnersMemberifrsfullMajorCustomersAxis"
      decimals="-3"
      unitRef="Unit_EUR">109000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2021To06_30_2021_OtherCollaborationPartnersMemberifrsfullMajorCustomersAxis"
      decimals="-3"
      unitRef="Unit_EUR">217000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1022000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">1436000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1767000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">3661000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2021To06_30_2021_NorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-3"
      unitRef="Unit_EUR">688000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2020To06_30_2020_NorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-3"
      unitRef="Unit_EUR">657000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2021To06_30_2021_NorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-3"
      unitRef="Unit_EUR">1373000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2020To06_30_2020_NorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-3"
      unitRef="Unit_EUR">1324000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2021To06_30_2021_CNifrsfullGeographicalAreasAxis"
      decimals="-3"
      unitRef="Unit_EUR">334000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2020To06_30_2020_CNifrsfullGeographicalAreasAxis"
      decimals="-3"
      unitRef="Unit_EUR">779000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2021To06_30_2021_CNifrsfullGeographicalAreasAxis"
      decimals="-3"
      unitRef="Unit_EUR">394000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2020To06_30_2020_CNifrsfullGeographicalAreasAxis"
      decimals="-3"
      unitRef="Unit_EUR">2337000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1022000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">1436000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1767000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">3661000</ifrs-full:Revenue>
    <asnd:DeferredRevenueFromAssociate
      contextRef="P04_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">579000</asnd:DeferredRevenueFromAssociate>
    <asnd:DeferredRevenueFromAssociate
      contextRef="P04_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">1013000</asnd:DeferredRevenueFromAssociate>
    <asnd:DeferredRevenueFromAssociate
      contextRef="P01_01_2021To06_30_2021"
      decimals="-3"
      unitRef="Unit_EUR">1155000</asnd:DeferredRevenueFromAssociate>
    <asnd:DeferredRevenueFromAssociate
      contextRef="P01_01_2020To06_30_2020"
      decimals="-3"
      unitRef="Unit_EUR">2215000</asnd:DeferredRevenueFromAssociate>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 6&#x2014;Segment Information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company is managed and operated as one business unit. No separate business areas or separate business units have been identified in relation to product candidates or geographical markets. Accordingly, no additional information on business segments or geographical areas is disclosed. &lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <asnd:NumberOfReportableOperatingSegments
      contextRef="P01_01_2021To06_30_2021"
      decimals="INF"
      unitRef="Unit_Segment">1</asnd:NumberOfReportableOperatingSegments>
    <ifrs-full:DisclosureOfEmployeeBenefitsExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 7&#x2014;Warrants and Share-based Payment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Share-based&lt;/div&gt; Payment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Ascendis Pharma A/S has established warrant programs and equity-settled share-based payment transactions, as an incentive for all its employees, members of its Board of Directors and select external consultants. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Warrants are granted by the Company&#x2019;s Board of Directors in accordance with authorizations given to it by the shareholders of the Company. As of June&#160;30, 2021, 11,023,308 warrants have been granted, of which 19,580 warrants have been cancelled, 4,327,249 warrants have been exercised, 2,168 warrants have expired without being exercised, and 608,488 warrants have been forfeited. As of June&#160;30, 2021, the Company&#x2019;s Board of Directors was authorized to grant up to 2,603,979 additional warrants to employees, board members and select consultants without preemptive subscription rights for the shareholders of the Company. Each warrant carries the right to subscribe for one ordinary share of a nominal value of DKK 1. The exercise price is fixed at the fair market value of the Company&#x2019;s ordinary shares at the time of grant as determined by the Company&#x2019;s Board of Directors. The exercise prices of outstanding warrants under the Company&#x2019;s warrant programs range from &#x20ac;6.48 to &#x20ac;145.5 depending on the grant dates. Vested warrants may be exercised in two or four annual exercise periods. Apart from exercise prices and exercise periods, the programs are similar. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; font-size: 10pt;;font-weight:bold;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Warrant Activity&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table specifies the warrant activity during the six months ended June&#160;30, 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 74%;"/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;Average&lt;br/&gt; Exercise Price&lt;br/&gt; EUR&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="color: white; line-height: 0pt; visibility: hidden;"&gt;
&lt;td style="width: 74%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Outstanding at January&#160;1, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,148,004&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;69.97&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 74%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Granted during the period&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;158,590&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;120.15&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercised during the period&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(150,604&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;33.51&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 74%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Forfeited during the period&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(90,167&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;121.80&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; width: 74%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 1%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Outstanding at June&#160;30, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,065,823&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;71.04&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Vested at June&#160;30, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,565,573&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;46.23&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"/&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Warrant Compensation Costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Warrant compensation costs are determined with a basis in the grant date fair value of the warrants granted and recognized over the vesting period as research and development costs or as selling, general and administrative expenses. For the three months ended June &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;30&lt;/div&gt;, 2021 and 2020, and for the six months ended June&#160;30, 2021 and 2020, warrant compensation costs recognized in the consolidated interim statement of profit or loss was &#x20ac;16,320&#160;thousand and &#x20ac;13,415&#160;thousand, and &#x20ac;39,396&#160;thousand and &#x20ac;28,364&#160;thousand, respectively. &lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfEmployeeBenefitsExplanatory>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_pure">11023308</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <asnd:AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement
      contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_shares">19580</asnd:AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_pure">4327249</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_pure">2168</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_pure">608488</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <asnd:NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement
      contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_pure">2603979</asnd:NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement>
    <ifrs-full:ParValuePerShare
      contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_DKK_per_Share">1</ifrs-full:ParValuePerShare>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="PAsOn06_30_2021_BottomOfRangeMemberifrsfullRangeAxis_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_EUR_per_Share">6.48</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="PAsOn06_30_2021_TopOfRangeMemberifrsfullRangeAxis_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_EUR_per_Share">145.5</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table specifies the warrant activity during the six months ended June&#160;30, 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 74%;"/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;Average&lt;br/&gt; Exercise Price&lt;br/&gt; EUR&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="color: white; line-height: 0pt; visibility: hidden;"&gt;
&lt;td style="width: 74%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Outstanding at January&#160;1, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,148,004&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;69.97&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 74%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Granted during the period&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;158,590&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;120.15&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercised during the period&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(150,604&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;33.51&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 74%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Forfeited during the period&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(90,167&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;121.80&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; width: 74%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 1%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Outstanding at June&#160;30, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,065,823&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;71.04&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Vested at June&#160;30, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,565,573&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;46.23&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="PAsOn12_31_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_pure">6148004</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="PAsOn12_31_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="2"
      unitRef="Unit_EUR_per_Share">69.97</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_pure">158590</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="2"
      unitRef="Unit_EUR_per_Share">120.15</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_pure">150604</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="2"
      unitRef="Unit_EUR_per_Share">33.51</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_pure">90167</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="2"
      unitRef="Unit_EUR_per_Share">121.80</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      unitRef="Unit_pure">6065823</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="2"
      unitRef="Unit_EUR_per_Share">71.04</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <asnd:NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement
      contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="0"
      unitRef="Unit_pure">3565573</asnd:NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement>
    <asnd:WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement
      contextRef="PAsOn06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="2"
      unitRef="Unit_EUR_per_Share">46.23</asnd:WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="P04_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="-3"
      unitRef="Unit_EUR">16320000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="P04_01_2020To06_30_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="-3"
      unitRef="Unit_EUR">13415000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="-3"
      unitRef="Unit_EUR">39396000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="P01_01_2020To06_30_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="-3"
      unitRef="Unit_EUR">28364000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 8&#x2014;Marketable Securities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Marketable securities are measured at amortized cost, and fair values are determined based on quoted market prices (Level 1 in the fair value hierarchy). &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The composition of the portfolio is specified in the following table&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 48%;"/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&#160;amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&#160;amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="14" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(EUR&#x2019;000)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Marketable securities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;U.S. Treasury bills&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;46,243&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;46,245&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;U.S. Government bonds&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;85,049&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;85,049&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;62,088&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;62,101&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Commercial papers&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8,832&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8,833&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,583&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,581&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Corporate bonds&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;144,830&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;144,734&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;121,282&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;121,234&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Agency bonds&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;18,076&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;18,077&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9,362&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9,369&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total marketable securities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,787&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,693&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,558&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,530&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Classified based on maturity profiles&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Non-current&lt;/div&gt; assets&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;90,693&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;90,623&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;115,280&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;115,277&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Current assets&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;166,094&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;166,070&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;134,278&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;134,253&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total marketable securities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,787&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,693&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,558&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,530&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Specified by rate structure&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Fixed rate&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;231,342&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;231,249&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;175,757&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;175,732&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Floating rate&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,613&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,611&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,975&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,972&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Zero-coupon&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;8,832&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;8,833&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;56,826&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;56,826&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total marketable securities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,787&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,693&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,558&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,530&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Specified by investment grade credit rating&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Prime&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6,398&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6,398&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,716&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,714&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;High grade&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;127,690&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;127,678&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;142,339&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;142,352&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Upper medium grade&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;119,785&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;119,706&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;99,503&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;99,464&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Lower medium grade&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,914&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,911&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total marketable securities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,787&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,693&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,558&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,530&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"/&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"/&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Company&#x2019;s marketable securities are all denominated in U.S. Dollars. At June&#160;30, 2021, the portfolio has a weighted average duration of 6.6 and 17.5 months, for current and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; positions, respectively. The entire portfolio has a weighted average duration of 10.4 months. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;All marketable securities have investment grade ratings, and accordingly, the risk from probability of default is low. The risk of expected credit loss over marketable securities has been considered, including the hypothetical impact arising from the probability of default which is considered in conjunction with the expected loss given default from securities with similar credit ratings and attributes. This assessment did not reveal a material expected credit loss, and accordingly, no provision for expected credit loss has been recognized. &lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory>
    <asnd:DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The composition of the portfolio is specified in the following table&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 48%;"/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 1%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&#160;amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&#160;amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="14" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(EUR&#x2019;000)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Marketable securities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;U.S. Treasury bills&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;46,243&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;46,245&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;U.S. Government bonds&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;85,049&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;85,049&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;62,088&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;62,101&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Commercial papers&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8,832&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8,833&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,583&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,581&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Corporate bonds&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;144,830&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;144,734&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;121,282&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;121,234&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Agency bonds&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;18,076&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;18,077&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9,362&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9,369&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total marketable securities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,787&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,693&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,558&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,530&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Classified based on maturity profiles&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Non-current&lt;/div&gt; assets&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;90,693&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;90,623&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;115,280&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;115,277&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Current assets&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;166,094&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;166,070&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;134,278&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;134,253&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total marketable securities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,787&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,693&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,558&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,530&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Specified by rate structure&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Fixed rate&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;231,342&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;231,249&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;175,757&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;175,732&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Floating rate&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,613&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,611&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,975&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,972&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Zero-coupon&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;8,832&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;8,833&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;56,826&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;56,826&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total marketable securities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,787&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,693&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,558&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,530&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Specified by investment grade credit rating&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Prime&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6,398&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6,398&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,716&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,714&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;High grade&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;127,690&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;127,678&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;142,339&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;142,352&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Upper medium grade&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;119,785&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;119,706&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;99,503&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;99,464&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Lower medium grade&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,914&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,911&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 48%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total marketable securities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,787&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;256,693&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,558&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;249,530&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 48%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"/&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"/&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; </asnd:DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">0</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">0</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">46243000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsTreasuryBillsMemberifrsfullClassesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">46245000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">85049000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">85049000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">62088000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UsGovernmentBondsMemberifrsfullClassesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">62101000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">8832000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">8833000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">10583000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_CommercialPapersMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">10581000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">144830000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">144734000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">121282000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_CorporateBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">121234000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">18076000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">18077000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">9362000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_AgencyBondsMemberifrsfullClassesOfFinancialAssetsAxis_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">9369000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">256787000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">256693000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">249558000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">249530000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:NoncurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">90693000</ifrs-full:NoncurrentFinancialAssetsAvailableforsale>
    <ifrs-full:NoncurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">90623000</ifrs-full:NoncurrentFinancialAssetsAvailableforsale>
    <ifrs-full:NoncurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">115280000</ifrs-full:NoncurrentFinancialAssetsAvailableforsale>
    <ifrs-full:NoncurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">115277000</ifrs-full:NoncurrentFinancialAssetsAvailableforsale>
    <ifrs-full:CurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">166094000</ifrs-full:CurrentFinancialAssetsAvailableforsale>
    <ifrs-full:CurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">166070000</ifrs-full:CurrentFinancialAssetsAvailableforsale>
    <ifrs-full:CurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">134278000</ifrs-full:CurrentFinancialAssetsAvailableforsale>
    <ifrs-full:CurrentFinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">134253000</ifrs-full:CurrentFinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">256787000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">256693000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">249558000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssetsAvailableforsale
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">249530000</ifrs-full:FinancialAssetsAvailableforsale>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">231342000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">231249000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">175757000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">175732000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">16613000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">16611000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">16975000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_FloatingInterestRateMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">16972000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">8832000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">8833000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">56826000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_ZeroCouponMemberifrsfullTypesOfInterestRatesAxis"
      decimals="-3"
      unitRef="Unit_EUR">56826000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">256787000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">256693000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">249558000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">249530000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">6398000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">6398000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">7716000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_PrimeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">7714000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">127690000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">127678000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">142339000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_HighGradeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">142352000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">119785000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">119706000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">99503000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_UpperMediumGradeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">99464000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_LowerMediumGradeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">2914000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis_LowerMediumGradeMemberifrsfullExternalCreditGradesAxis"
      decimals="-3"
      unitRef="Unit_EUR">2911000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">256787000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn06_30_2021_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">256693000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">249558000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueMemberifrsfullCategoriesOfFinancialAssetsAxis"
      decimals="-3"
      unitRef="Unit_EUR">249530000</ifrs-full:FinancialAssets>
    <asnd:WeightedAverageDurationOfMarketableSecuritiesCurrent contextRef="P06_30_2021To06_30_2021">P6M18D</asnd:WeightedAverageDurationOfMarketableSecuritiesCurrent>
    <asnd:WeightedAverageDurationOfMarketableSecuritiesNoncurrent contextRef="P06_30_2021To06_30_2021">P17M15D</asnd:WeightedAverageDurationOfMarketableSecuritiesNoncurrent>
    <asnd:WeightedAverageDurationOfMarketableSecurities contextRef="P06_30_2021To06_30_2021">P10M12D</asnd:WeightedAverageDurationOfMarketableSecurities>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 9&#x2014;Share Capital &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The share capital of Ascendis Pharma A/S consists of 53,900,990 outstanding shares at a nominal value of DKK 1, all in the same share class. &lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="PAsOn06_30_2021"
      decimals="INF"
      unitRef="Unit_shares">53900990</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:ParValuePerShare
      contextRef="PAsOn06_30_2021"
      decimals="INF"
      unitRef="Unit_DKK_per_Share">1</ifrs-full:ParValuePerShare>
    <ifrs-full:DisclosureOfLeasesExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 10 &#x2014;Lease Liabilities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"&gt;The Company primarily leases office and laboratory facilities. Lease arrangements contain a range of different terms and conditions and are typically entered into for fixed periods. Generally, the lease terms are determined according to the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-cancellable&lt;/div&gt; period and are between &lt;span style="-sec-ix-hidden:hidden25486367"&gt;two&lt;/span&gt; and twelve years. In addition, in order to improve flexibility to the Company&#x2019;s operations, lease terms may provide the Company with options to extend the lease or to terminate the lease within the enforceable lease term. In the Company&#x2019;s current lease portfolio, extension and termination options range between &lt;span style="-sec-ix-hidden:hidden25486370"&gt;two&lt;/span&gt; to ten years, in addition to the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-cancellable&lt;/div&gt; period. &lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Maturity analysis for lease liabilities recognized in the consolidated statements of financial position at June&#160;30, 2021 is specified below. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"&gt;
&lt;tr style="color: white; line-height: 0pt; visibility: hidden;"&gt;
&lt;td style="width: 69%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;lt;&#160;1&#160;year&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1-5&#160;years&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;gt;5&#160;years&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;br/&gt; contractual&lt;br/&gt; cash-flows&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&lt;br/&gt; amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="18" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(EUR&#x2019;000)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;June&#160;30, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 69%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Lease liabilities&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,051&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;45,162&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;71,397&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;123,610&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;101,009&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 69%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,051&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;45,162&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;71,397&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;123,610&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;101,009&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 69%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"/&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; </ifrs-full:DisclosureOfLeasesExplanatory>
    <asnd:LeaseTerm contextRef="P01_01_2021To06_30_2021_TopOfRangeMemberifrsfullRangeAxis">P12Y</asnd:LeaseTerm>
    <asnd:LeasesOptionToExtendAndTerminationTerm contextRef="P01_01_2021To06_30_2021_TopOfRangeMemberifrsfullRangeAxis">P10Y</asnd:LeasesOptionToExtendAndTerminationTerm>
    <asnd:DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Maturity analysis for lease liabilities recognized in the consolidated statements of financial position at June&#160;30, 2021 is specified below. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"&gt;
&lt;tr style="color: white; line-height: 0pt; visibility: hidden;"&gt;
&lt;td style="width: 69%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;lt;&#160;1&#160;year&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1-5&#160;years&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;gt;5&#160;years&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;br/&gt; contractual&lt;br/&gt; cash-flows&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&lt;br/&gt; amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 1pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="18" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(EUR&#x2019;000)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;June&#160;30, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="width: 69%;;vertical-align:top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Lease liabilities&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,051&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;45,162&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;71,397&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;123,610&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;101,009&lt;/td&gt;
&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 69%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;"&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,051&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;45,162&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;71,397&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;123,610&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;101,009&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; width: 69%;;vertical-align:bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"/&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; </asnd:DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-3"
      unitRef="Unit_EUR">7051000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanOneYearAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis"
      decimals="-3"
      unitRef="Unit_EUR">45162000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanFiveYearsMemberifrsfullMaturityAxis"
      decimals="-3"
      unitRef="Unit_EUR">71397000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis"
      decimals="-3"
      unitRef="Unit_EUR">123610000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="PAsOn06_30_2021_GrossCarryingAmountMemberASNDLeaseLiabilitiesAxis"
      decimals="-3"
      unitRef="Unit_EUR">101009000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-3"
      unitRef="Unit_EUR">7051000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanOneYearAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis"
      decimals="-3"
      unitRef="Unit_EUR">45162000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis_LaterThanFiveYearsMemberifrsfullMaturityAxis"
      decimals="-3"
      unitRef="Unit_EUR">71397000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis"
      decimals="-3"
      unitRef="Unit_EUR">123610000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="PAsOn06_30_2021_GrossCarryingAmountMemberASNDLeaseLiabilitiesAxis"
      decimals="-3"
      unitRef="Unit_EUR">101009000</ifrs-full:LeaseLiabilities>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="P01_01_2021To06_30_2021">&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Note 11&#x2014;Subsequent Events &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"&gt;&lt;div style="display:inline;"&gt;O&lt;/div&gt;n August&#160;25, 2021, the Company announced that the U.S. Food and Drug Administration, or FDA, has approved SKYTROFA (lonapegsomatropin-tcgd) for the treatment of pediatric patients one year and older who weigh at least 11.5&#160;kg (25.4&#160;lb) and have growth failure due to inadequate secretion of endogenous growth hormone (GH). In order to accommodate market demands, the Company has initiated manufacturing of inventories prior to obtaining marketing approval, or pre-launch inventories, for SKYTROFA. However, since pre-launch inventories are not realizable prior to obtaining marketing approval, pre-launch inventories are immediately written down to zero through research and development costs. As a result of the marketing approval received on August&#160;25, 2021, the Company will reverse prior periods&#x2019; write-downs of pre-launch inventories through research and development costs, at the lower of cost and net-realizable value. Subsequent to the reporting date, reversal of prior periods&#x2019; write-downs is expected to have a positive impact on research and development costs of approximately &#x20ac;&lt;/div&gt;&lt;/div&gt;50&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No other events have occurred after the reporting date that would influence the evaluation of these unaudited condensed consolidated interim financial statements. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <asnd:ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts
      contextRef="P08_25_2021To08_25_2021_NonadjustingEventsAfterReportingPeriodMemberifrsfullNonadjustingEventsAfterReportingPeriodAxis"
      decimals="-6"
      unitRef="Unit_USD">50000000</asnd:ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact_25469810"
          xlink:label="Fact_25469810"
          xlink:type="locator"/>
        <link:footnote id="FN_86136" xlink:label="FN_86136" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">A total of 6,065,823 warrants outstanding as of June 30, 2021 can potentially dilute earnings per share in the future but have not been included in the calculation of diluted earnings per share because they are antidilutive for the periods presented. Similarly, a total of 5,788,390 warrants outstanding as of June 30, 2020 are also considered antidilutive for the periods presented and have not been included in the calculation. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_25469810"
          xlink:to="FN_86136"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_25469811"
          xlink:label="Fact_25469811"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_25469811"
          xlink:to="FN_86136"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_25469854"
          xlink:label="Fact_25469854"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_25469854"
          xlink:to="FN_86136"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_25469855"
          xlink:label="Fact_25469855"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_25469855"
          xlink:to="FN_86136"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711613456648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">6-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Ascendis Pharma A/S<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001612042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601195928">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 1,022<span></span>
</td>
<td class="nump">&#8364; 1,436<span></span>
</td>
<td class="nump">&#8364; 1,767<span></span>
</td>
<td class="nump">&#8364; 3,661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(83,306)<span></span>
</td>
<td class="num">(63,578)<span></span>
</td>
<td class="num">(171,455)<span></span>
</td>
<td class="num">(121,093)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(35,345)<span></span>
</td>
<td class="num">(20,805)<span></span>
</td>
<td class="num">(72,591)<span></span>
</td>
<td class="num">(38,720)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating profit / (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(117,629)<span></span>
</td>
<td class="num">(82,947)<span></span>
</td>
<td class="num">(242,279)<span></span>
</td>
<td class="num">(156,152)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod', window );">Share of profit / (loss) of associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,817)<span></span>
</td>
<td class="num">(1,885)<span></span>
</td>
<td class="nump">23,289<span></span>
</td>
<td class="num">(3,400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">145<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">23,268<span></span>
</td>
<td class="nump">1,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,141)<span></span>
</td>
<td class="num">(10,292)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">(876)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Profit / (loss) before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(134,442)<span></span>
</td>
<td class="num">(95,038)<span></span>
</td>
<td class="num">(197,425)<span></span>
</td>
<td class="num">(158,432)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Tax on profit / (loss) for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">68<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net profit / (loss) for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(134,374)<span></span>
</td>
<td class="num">(94,932)<span></span>
</td>
<td class="num">(197,166)<span></span>
</td>
<td class="num">(158,249)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Attributable to owners of the Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (134,374)<span></span>
</td>
<td class="num">&#8364; (94,932)<span></span>
</td>
<td class="num">&#8364; (197,166)<span></span>
</td>
<td class="num">&#8364; (158,249)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicAndDilutedEarningsLossPerShare', window );">Basic and diluted earnings / (loss) per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (2.50)<span></span>
</td>
<td class="num">&#8364; (1.97)<span></span>
</td>
<td class="num">&#8364; (3.66)<span></span>
</td>
<td class="num">&#8364; (3.29)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Number of shares used for calculation (basic and diluted)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">53,848,166<span></span>
</td>
<td class="nump">48,207,661<span></span>
</td>
<td class="nump">53,804,300<span></span>
</td>
<td class="nump">48,096,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Consolidated Interim Statement of Comprehensive Income</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net profit / (loss) for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (134,374)<span></span>
</td>
<td class="num">&#8364; (94,932)<span></span>
</td>
<td class="num">&#8364; (197,166)<span></span>
</td>
<td class="num">&#8364; (158,249)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Other comprehensive income / (loss)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translating foreign operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Other comprehensive income / (loss) for the period, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income / (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(134,297)<span></span>
</td>
<td class="num">(95,079)<span></span>
</td>
<td class="num">(195,401)<span></span>
</td>
<td class="num">(158,310)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Attributable to owners of the Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (134,297)<span></span>
</td>
<td class="num">&#8364; (95,079)<span></span>
</td>
<td class="num">&#8364; (195,401)<span></span>
</td>
<td class="num">&#8364; (158,310)<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">A total of 6,065,823 warrants outstanding as of June 30, 2021 can potentially dilute earnings per share in the future but have not been included in the calculation of diluted earnings per share because they are antidilutive for the periods presented. Similarly, a total of 5,788,390 warrants outstanding as of June 30, 2020 are also considered antidilutive for the periods presented and have not been included in the calculation.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicAndDilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of earnings per share when the basic and diluted measurements are equal. [Refer: Basic earnings (loss) per share; Diluted earnings (loss) per share]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicAndDilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2020-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2020-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2020-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2020-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2020-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2020-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2020-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2020-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2020-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601147640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss) (Parenthetical) - shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=asnd_Warrant1Member', window );">Warrants [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_StatementLineItems', window );"><strong>Statement [LineItems]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares', window );">Warrants outstanding</a></td>
<td class="nump">6,065,823<span></span>
</td>
<td class="nump">5,788,390<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2020-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=asnd_Warrant1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=asnd_Warrant1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601306824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Financial Position - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_GoodwillAndOtherIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">&#8364; 5,495<span></span>
</td>
<td class="nump">&#8364; 5,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">123,924<span></span>
</td>
<td class="nump">108,112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investment in associate</a></td>
<td class="nump">45,783<span></span>
</td>
<td class="nump">9,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LongtermDeposits', window );">Deposits</a></td>
<td class="nump">1,702<span></span>
</td>
<td class="nump">1,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAvailableforsale', window );">Marketable securities</a></td>
<td class="nump">90,693<span></span>
</td>
<td class="nump">115,280<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">267,597<span></span>
</td>
<td class="nump">239,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables</a></td>
<td class="nump">394<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables</a></td>
<td class="nump">11,398<span></span>
</td>
<td class="nump">6,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepayments', window );">Prepayments</a></td>
<td class="nump">21,826<span></span>
</td>
<td class="nump">13,994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAvailableforsale', window );">Marketable securities</a></td>
<td class="nump">166,094<span></span>
</td>
<td class="nump">134,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">384,539<span></span>
</td>
<td class="nump">584,517<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">584,251<span></span>
</td>
<td class="nump">740,133<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">851,848<span></span>
</td>
<td class="nump">979,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">7,237<span></span>
</td>
<td class="nump">7,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DistributableEquity', window );">Distributable equity</a></td>
<td class="nump">680,250<span></span>
</td>
<td class="nump">831,494<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">687,487<span></span>
</td>
<td class="nump">838,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">94,059<span></span>
</td>
<td class="nump">85,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentPayables', window );">Other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,162<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">94,059<span></span>
</td>
<td class="nump">88,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">6,950<span></span>
</td>
<td class="nump">6,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentContractLiabilities', window );">Contract liabilities</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Trade payables&#160;and accrued expenses</a></td>
<td class="nump">44,207<span></span>
</td>
<td class="nump">21,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Other payables</a></td>
<td class="nump">18,623<span></span>
</td>
<td class="nump">23,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilities', window );">Income taxes payable</a></td>
<td class="nump">377<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">70,302<span></span>
</td>
<td class="nump">52,804<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">164,361<span></span>
</td>
<td class="nump">141,082<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total equity and liabilities</a></td>
<td class="nump">&#8364; 851,848<span></span>
</td>
<td class="nump">&#8364; 979,793<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_DistributableEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Distributable equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_DistributableEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_GoodwillAndOtherIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_GoodwillAndOtherIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current contract liabilities. [Refer: Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialAssetsAvailableforsale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Current financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 8<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_d&amp;doctype=Standard&amp;book=b<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialAssetsAvailableforsale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments. [Refer: Prepayments]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of long-term deposits held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssetsAvailableforsale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Non-current financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 8<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_d&amp;doctype=Standard&amp;book=b<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssetsAvailableforsale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 70<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601342584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Changes in Equity - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Issued Capital [member]</div></th>
<th class="th"><div>Share Premium [member]</div></th>
<th class="th"><div>Foreign Currency Translation Reserve [member]</div></th>
<th class="th"><div>Share-based Payment Reserve [member]</div></th>
<th class="th"><div>Accumulated Deficit [member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at Dec. 31, 2019</a></td>
<td class="nump">&#8364; 597,114<span></span>
</td>
<td class="nump">&#8364; 6,443<span></span>
</td>
<td class="nump">&#8364; 1,122,097<span></span>
</td>
<td class="num">&#8364; (34)<span></span>
</td>
<td class="nump">&#8364; 79,931<span></span>
</td>
<td class="num">&#8364; (611,323)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_StatementLineItems', window );"><strong>Statement [LineItems]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">(158,249)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158,249)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Other comprehensive income / (loss), net of tax</a></td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income / (loss)</a></td>
<td class="num">(158,310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158,249)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TransactionsWithOwnersAbstract', window );"><strong>Transactions with Owners</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payment (Note 7)</a></td>
<td class="nump">28,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners', window );">Capital increase</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">9,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at Jun. 30, 2020</a></td>
<td class="nump">477,144<span></span>
</td>
<td class="nump">6,491<span></span>
</td>
<td class="nump">1,132,025<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="nump">108,295<span></span>
</td>
<td class="num">(769,572)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at Dec. 31, 2020</a></td>
<td class="nump">838,711<span></span>
</td>
<td class="nump">7,217<span></span>
</td>
<td class="nump">1,728,747<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="nump">133,101<span></span>
</td>
<td class="num">(1,030,278)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_StatementLineItems', window );"><strong>Statement [LineItems]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">(197,166)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(197,166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Other comprehensive income / (loss), net of tax</a></td>
<td class="nump">1,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income / (loss)</a></td>
<td class="num">(195,401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(197,166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TransactionsWithOwnersAbstract', window );"><strong>Transactions with Owners</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payment (Note 7)</a></td>
<td class="nump">39,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners', window );">Capital increase</a></td>
<td class="nump">4,781<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">4,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at Jun. 30, 2021</a></td>
<td class="nump">&#8364; 687,487<span></span>
</td>
<td class="nump">&#8364; 7,237<span></span>
</td>
<td class="nump">&#8364; 1,733,508<span></span>
</td>
<td class="nump">&#8364; 1,689<span></span>
</td>
<td class="nump">&#8364; 172,497<span></span>
</td>
<td class="num">&#8364; (1,227,444)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TransactionsWithOwnersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transactions with owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TransactionsWithOwnersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from transactions with owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2020-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2020-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2020-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601355176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Interim Cash Flow Statements - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net profit / (loss) for the period</a></td>
<td class="num">&#8364; (197,166)<span></span>
</td>
<td class="num">&#8364; (158,249)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Reversal of finance income</a></td>
<td class="num">(23,268)<span></span>
</td>
<td class="num">(1,996)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Reversal of finance expenses</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="nump">876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Reversal of tax charge</a></td>
<td class="num">(259)<span></span>
</td>
<td class="num">(183)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments for non-cash items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_NoncashConsideration', window );">Reversal of non-cash consideration relating to revenue</a></td>
<td class="num">(1,155)<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod', window );">Reversal of share of profit / (loss) of associate</a></td>
<td class="num">(23,289)<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based payment</a></td>
<td class="nump">39,396<span></span>
</td>
<td class="nump">28,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationExpense', window );">Depreciation</a></td>
<td class="nump">7,112<span></span>
</td>
<td class="nump">4,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForAmortisationExpense', window );">Amortization</a></td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_ChangesInWorkingCapitalAbstract', window );"><strong>Changes in working capital:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits', window );">Receivables</a></td>
<td class="num">(4,035)<span></span>
</td>
<td class="num">(944)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_AdjustmentsForIncreaseDecreaseInPrepayments', window );">Prepayments</a></td>
<td class="num">(7,832)<span></span>
</td>
<td class="num">(5,385)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome', window );">Contract liabilities (deferred income)</a></td>
<td class="num">(218)<span></span>
</td>
<td class="num">(858)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Trade payables and other payables</a></td>
<td class="nump">10,902<span></span>
</td>
<td class="nump">8,008<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperations', window );">Cash flows generated from / (used in) operations</a></td>
<td class="num">(197,887)<span></span>
</td>
<td class="num">(124,990)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities', window );">Finance income received</a></td>
<td class="nump">1,915<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities', window );">Finance expenses paid</a></td>
<td class="num">(699)<span></span>
</td>
<td class="num">(798)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income taxes received / (paid)</a></td>
<td class="num">(149)<span></span>
</td>
<td class="nump">615<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Cash flows from / (used in) operating activities</a></td>
<td class="num">(196,820)<span></span>
</td>
<td class="num">(123,397)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInterestsInAssociates', window );">Investment in associate</a></td>
<td class="num">(10,187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisition of property, plant and equipment</a></td>
<td class="num">(7,607)<span></span>
</td>
<td class="num">(10,725)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsForDevelopmentProjectExpenditure', window );">Development expenditures (software)</a></td>
<td class="num">(530)<span></span>
</td>
<td class="num">(311)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfAvailableforsaleFinancialAssets', window );">Purchase of marketable securities</a></td>
<td class="num">(76,358)<span></span>
</td>
<td class="num">(233,446)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets', window );">Settlement of marketable securities</a></td>
<td class="nump">75,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Cash flows from / (used in) investing activities</a></td>
<td class="num">(19,082)<span></span>
</td>
<td class="num">(244,482)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payment of principal portion of lease liabilities</a></td>
<td class="num">(3,371)<span></span>
</td>
<td class="num">(2,306)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities', window );">Proceeds from exercise of warrants</a></td>
<td class="nump">4,782<span></span>
</td>
<td class="nump">9,976<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Cash flows from / (used in) financing activities</a></td>
<td class="nump">1,411<span></span>
</td>
<td class="nump">7,670<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges', window );">Increase / (decrease) in cash and cash equivalents</a></td>
<td class="num">(214,491)<span></span>
</td>
<td class="num">(360,209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at January 1</a></td>
<td class="nump">584,517<span></span>
</td>
<td class="nump">598,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of exchange rate changes on balances held in foreign currencies</a></td>
<td class="nump">14,513<span></span>
</td>
<td class="nump">2,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at June 30</a></td>
<td class="nump">384,539<span></span>
</td>
<td class="nump">240,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_CashDeposits', window );">Bank deposits</a></td>
<td class="nump">383,073<span></span>
</td>
<td class="nump">183,153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_ShortTermMarketableSecurities', window );">Short-term marketable securities</a></td>
<td class="nump">1,466<span></span>
</td>
<td class="nump">57,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at June 30</a></td>
<td class="nump">&#8364; 384,539<span></span>
</td>
<td class="nump">&#8364; 240,605<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment for decrease increase in trade receivables other receivables and other short term deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_AdjustmentsForIncreaseDecreaseInPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for Increase Decrease in Prepayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_AdjustmentsForIncreaseDecreaseInPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_CashDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bank deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_CashDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_ChangesInWorkingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Changes in working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_ChangesInWorkingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_NoncashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_NoncashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from exercise of warrants classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_ShortTermMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-term marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_ShortTermMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in deferred income to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash from (used in) the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2020-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForDevelopmentProjectExpenditure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for expenditure related to development projects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForDevelopmentProjectExpenditure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the disposal or maturity of available-for-sale financial assets. [Refer: Financial assets available-for-sale]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2021-01-01<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_16&amp;doctype=Standard&amp;book=b<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2020-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2020-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2020-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfAvailableforsaleFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of available-for-sale financial assets. [Refer: Financial assets available-for-sale]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2021-01-01<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_16&amp;doctype=Standard&amp;book=b<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfAvailableforsaleFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInterestsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of interests in associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInterestsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711604832120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">General Information</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 1&#8212;General Information </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ascendis Pharma A/S, together with its subsidiaries, is a biopharmaceutical company applying its innovative TransCon technologies to build a leading, fully integrated biopharmaceutical company. Ascendis Pharma A/S was incorporated in 2006 and is headquartered in Hellerup, Denmark. Unless the context otherwise requires, references to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Ascendis Pharma A/S and its subsidiaries. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The address of the Company&#8217;s registered office is Tuborg Boulevard 12, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">DK-2900,</div> Hellerup, Denmark. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 2, 2015, the Company completed an initial public offering which resulted in the listing of American Depositary Shares, or ADSs, representing the Company&#8217;s ordinary shares, under the symbol &#8220;ASND&#8221; in the United States on The Nasdaq Global Select Market. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s Board of Directors approved these unaudited condensed consolidated interim financial statements on August&#160;25, 2021. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 51<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711613563928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 2&#8212;Summary of Significant Accounting Policies </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Basis of Preparation </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The unaudited condensed consolidated interim financial statements of the Company are prepared in accordance with International Accounting Standard 34, &#8220;Interim Financial Reporting.&#8221; Certain information and disclosures normally included in the annual consolidated financial statements prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;) have been condensed or omitted. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with the Company&#8217;s audited annual consolidated financial statements for the year ended December 31, 2020 and accompanying notes, which have been prepared in accordance with IFRS as issued by the International Accounting Standards Board, and as adopted by the European Union. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accounting policies applied are consistent with those of the previous financial year. A description of our accounting policies is provided in the </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Policies section of the audited consolidated financial statements as of and for the year ended December 31, 2020. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with IFRS requires the use of certain significant accounting estimates and requires management to exercise its judgement in the process of applying the Company&#8217;s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the unaudited condensed consolidated interim financial statements are disclosed in Note 3. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">New and Amended IFRS Standards Adopted by the Company </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Several new amendments and interpretations became applicable for the current reporting period, but do not have an impact on the accounting policies applied by the Company. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711613553336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Critical Accounting Judgements and Key Sources of Estimation Uncertainty<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">Critical Accounting Judgements and Key Sources of Estimation Uncertainty</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 3&#8212;Critical Accounting Judgements and Key Sources of Estimation Uncertainty </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the application of the Company&#8217;s accounting policies, management is required to make judgements, estimates and assumptions about the carrying amount&#160;of assets and liabilities that are not readily apparent from other sources. Judgements and estimates applied are based on historical experience and other factors that are relevant, and which are available at the reporting date. Uncertainty concerning judgements and estimates could result in outcomes, that require a material adjustment to assets and liabilities in future periods. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. While the application of significant accounting estimates is subject to material estimation uncertainties, management&#8217;s ongoing revisions of significant accounting estimates have not revealed any material impact in the consolidated interim statements of profit or loss for any of the periods presented. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The unaudited condensed consolidated interim financial statements do not include all disclosures for significant accounting judgements, estimates and assumptions, that are required in the annual consolidated financial statements, and therefore, should be read in conjunction with the Company&#8217;s audited consolidated financial statements as of and for the year ended December 31, 2020. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Significant judgements made in the process of applying our accounting policies and that have the most significant effect on the amounts recognized in the unaudited condensed consolidated interim financial statements relate to revenue recognition, share-based payment, internally generated intangible assets related to drug development, classification of collaboration agreements and recognition principles related to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-launch</div> inventories. For the six months ended June 30, 2021, the Company has for the first time, in connection with determining the grant date fair value of warrants and accordingly, warrant compensation costs, applied its own share price as input for expected volatility. Details are provided in section &#8220;Warrant Compensation Costs&#8221;. Until December 31, 2020, the expected volatility was calculated using a simple average of daily historical data of comparable publicly traded companies, as the Company did not have sufficient data for the volatility of the Company&#8217;s own share price. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The key sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities within the next financial year, primarily relate to recognition and measurement of accruals and prepayments for manufacturing and clinical trial activities. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other than as set out below, there have been no other changes to the application of significant accounting judg<div style="letter-spacing: 0px; top: 0px;;display:inline;">e</div>ments, or estimation uncertainties regarding accounting estimates compared to December&#160;31, 2020. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant Compensation Costs </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">IFRS 2, &#8220;Share-Based Payment&#8221; requires an entity to reflect in its consolidated statement of profit or loss and financial position, the effects of share-based payment transactions. Warrant compensation costs are recognized over the vesting period as research and development costs or selling, general and administrative expenses, as appropriate, based on management&#8217;s best estimate of the number of warrants that will ultimately vest, which is subject to uncertainty. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant compensation costs are measured according to the grant date fair values of the warrants granted. Estimating fair values requires the Company to apply generally accepted valuation models and apply these models consistently according to the terms and conditions of the specific warrant program. Under all warrant programs, the Black-Scholes option-pricing model has been applied to determine the fair value of warrants granted. Subjective judgements and assumptions, which are subject to estimation uncertainties, need to be exercised in determining the appropriate input to the valuation model. These inputs include expected volatility of the Company&#8217;s share price for a historic period equaling the expected lifetime of the warrants, reflecting the assumption that the historical volatility over a period similar to the life of the warrants is indicative of future trends. For the six months ended June&#160;30, 2021, the expected volatility has been calculated using the Company&#8217;s own share price. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711604935240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Events In The Reporting Period<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_SignificantEventsInTheReportingPeriodTextBlock', window );">Significant Events In The Reporting Period</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 4&#8212;Significant Events in the Reporting Period </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Impact from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">A novel strain of coronavirus, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(&#8220;COVID-19&#8221;)</div> was reported to have surfaced in Wuhan, China, in December 2019. Since then, COVID-19 has spread around the world into a pandemic, including into countries where we are operating, where we have planned or have ongoing clinical trials, and where we rely on third-parties to manufacture preclinical and clinical supplies, as well as commercial supply. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">We monitor these risks closely, and work with relevant stakeholders to avoid disruptions, and to develop and establish working measures. However, while <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> continues to impact global societies, the uncertainty related to the duration and direction of the pandemic makes the future impact from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19,</div> including the magnitude of any impact on our operational results, highly uncertain and unpredictable. At the reporting date, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> did not have a direct impact on the <div style="letter-spacing: 0px; top: 0px;;display:inline;">consolidated </div>interim financial statements<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">VISEN Pharmaceuticals Investment </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On January 8, 2021, the Company entered into an equity investment of $12.5&#160;million in its associate, VISEN Pharmaceuticals, or VISEN, as part of VISEN&#8217;s $150&#160;million Series B financing. Following VISEN&#8217;s Series B financing, the Company retains approximately 44% of VISEN&#8217;s issued and outstanding shares. As a result, the Company has recognized a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain in the first quarter of 2021 of &#8364;42.3&#160;million, which is presented as part of &#8220;Share of profit / (loss) of associate&#8221; in the consolidated interim statement of profit or loss. The Series B financing has not changed the Company&#8217;s accounting treatment of VISEN. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_SignificantEventsInTheReportingPeriodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant events in the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_SignificantEventsInTheReportingPeriodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711598684776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueExplanatory', window );">Revenue</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 5&#8212;Revenue </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company&#8217;s revenue is primarily generated from three license agreements, which were entered into in 2018. The licenses grant VISEN exclusive rights to develop and commercialize TransCon hGH, TransCon PTH and TransCon CNP in Greater China. As consideration for the granting of such rights, the Company has received <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">up-front,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> consideration of $40.0&#160;million in the form of 50% ownership in VISEN. At the reporting date, the Company retains approximately 44% of VISEN&#8217;s issued and outstanding shares. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Consideration received is recognized partly as license revenue, and partly as rendering of services over time. In addition to granting exclusive rights, the Company will provide clinical trial supply and development services to VISEN. </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 68%;"/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three&#160;Months&#160;Ended<br/> June&#160;30,</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30,</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue from external customers</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue from the rendering of services (recognized over time)</div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">226</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">779</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">395</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,091</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Sale of clinical supply (recognized at a point in time)</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">217</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">217</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">246</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Right-to-use&#8221;</div></div> licenses (recognized at a point in time)</div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">579</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">657</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,155</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,324</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total revenue <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,022</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,436</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,767</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,661</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Attributable to</div></div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">VISEN Pharmaceuticals</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">913</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,436</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,550</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,661</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other collaboration partners</div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">109</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">217</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total revenue</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,022</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,436</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,767</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,661</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Revenue by geographical location</div></div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">North America</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">688</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">657</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,373</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,324</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">China</div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">334</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">779</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">394</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,337</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total revenue</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,022</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,436</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,767</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,661</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="margin-top: 1em; margin-bottom: 1em"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;">
<tr style="page-break-inside: avoid;">
<td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div>&#160;</td>
<td style="text-align:left;;vertical-align:top;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended June&#160;30, 2021 and 2020, and for the six months ended June&#160;30, 2021 and 2020, &#8220;Total revenue&#8221; includes recognition of previously deferred revenue/internal profit from associate of &#8364;579&#160;thousand and &#8364;1,013&#160;thousand, and of &#8364;1,155&#160;thousand and &#8364;2,215&#160;thousand, respectively. </div></div> </td> </tr> </table>  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601132840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">Segment Information</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 6&#8212;Segment Information </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is managed and operated as one business unit. No separate business areas or separate business units have been identified in relation to product candidates or geographical markets. Accordingly, no additional information on business segments or geographical areas is disclosed. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711604933800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants and Share-based Payment<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory', window );">Warrants and Share-based Payment</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 7&#8212;Warrants and Share-based Payment </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Share-based</div> Payment </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ascendis Pharma A/S has established warrant programs and equity-settled share-based payment transactions, as an incentive for all its employees, members of its Board of Directors and select external consultants. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants are granted by the Company&#8217;s Board of Directors in accordance with authorizations given to it by the shareholders of the Company. As of June&#160;30, 2021, 11,023,308 warrants have been granted, of which 19,580 warrants have been cancelled, 4,327,249 warrants have been exercised, 2,168 warrants have expired without being exercised, and 608,488 warrants have been forfeited. As of June&#160;30, 2021, the Company&#8217;s Board of Directors was authorized to grant up to 2,603,979 additional warrants to employees, board members and select consultants without preemptive subscription rights for the shareholders of the Company. Each warrant carries the right to subscribe for one ordinary share of a nominal value of DKK 1. The exercise price is fixed at the fair market value of the Company&#8217;s ordinary shares at the time of grant as determined by the Company&#8217;s Board of Directors. The exercise prices of outstanding warrants under the Company&#8217;s warrant programs range from &#8364;6.48 to &#8364;145.5 depending on the grant dates. Vested warrants may be exercised in two or four annual exercise periods. Apart from exercise prices and exercise periods, the programs are similar. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; font-size: 10pt;;font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant Activity</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table specifies the warrant activity during the six months ended June&#160;30, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 74%;"/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;Average<br/> Exercise Price<br/> EUR</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="color: white; line-height: 0pt; visibility: hidden;">
<td style="width: 74%; font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding at January&#160;1, 2021</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">6,148,004</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">69.97</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 74%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted during the period</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">158,590</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">120.15</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercised during the period</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(150,604</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">33.51</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 74%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited during the period</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(90,167</td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">121.80</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 74%;">&#160;</td>
<td style="vertical-align: bottom; width: 1%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 1%;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding at June&#160;30, 2021</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">6,065,823</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">71.04</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Vested at June&#160;30, 2021</div></div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,565,573</div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">46.23</div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Warrant Compensation Costs </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant compensation costs are determined with a basis in the grant date fair value of the warrants granted and recognized over the vesting period as research and development costs or as selling, general and administrative expenses. For the three months ended June <div style="letter-spacing: 0px; top: 0px;;display:inline;">30</div>, 2021 and 2020, and for the six months ended June&#160;30, 2021 and 2020, warrant compensation costs recognized in the consolidated interim statement of profit or loss was &#8364;16,320&#160;thousand and &#8364;13,415&#160;thousand, and &#8364;39,396&#160;thousand and &#8364;28,364&#160;thousand, respectively. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2020-01-01<br> -Section Scope<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IAS19_g2-7_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711604702728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract', window );"><strong>Categories of current financial assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory', window );">Marketable Securities</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 8&#8212;Marketable Securities </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable securities are measured at amortized cost, and fair values are determined based on quoted market prices (Level 1 in the fair value hierarchy). </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The composition of the portfolio is specified in the following table<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 48%;"/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2020</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying&#160;amount</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying&#160;amount</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="14" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable securities</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U.S. Treasury bills</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">46,243</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">46,245</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">U.S. Government bonds</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">85,049</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">85,049</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">62,088</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">62,101</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Commercial papers</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8,832</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8,833</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,583</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,581</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Corporate bonds</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">144,830</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">144,734</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">121,282</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">121,234</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Agency bonds</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">18,076</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">18,077</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9,362</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9,369</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,787</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,693</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,558</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,530</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Classified based on maturity profiles</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Non-current</div> assets</div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">90,693</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">90,623</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">115,280</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">115,277</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current assets</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">166,094</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">166,070</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">134,278</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">134,253</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,787</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,693</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,558</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,530</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Specified by rate structure</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Fixed rate</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">231,342</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">231,249</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">175,757</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">175,732</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Floating rate</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,613</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,611</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,975</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,972</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Zero-coupon</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">8,832</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">8,833</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">56,826</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">56,826</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,787</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,693</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,558</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,530</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Specified by investment grade credit rating</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prime</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6,398</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6,398</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,716</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,714</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">High grade</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">127,690</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">127,678</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">142,339</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">142,352</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upper medium grade</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">119,785</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">119,706</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">99,503</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">99,464</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Lower medium grade</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,914</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,911</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,787</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,693</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,558</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,530</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company&#8217;s marketable securities are all denominated in U.S. Dollars. At June&#160;30, 2021, the portfolio has a weighted average duration of 6.6 and 17.5 months, for current and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> positions, respectively. The entire portfolio has a weighted average duration of 10.4 months. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All marketable securities have investment grade ratings, and accordingly, the risk from probability of default is low. The risk of expected credit loss over marketable securities has been considered, including the hypothetical impact arising from the probability of default which is considered in conjunction with the expected loss given default from securities with similar credit ratings and attributes. This assessment did not reveal a material expected credit loss, and accordingly, no provision for expected credit loss has been recognized. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial assets classified as available for sale. [Refer: Financial assets available-for-sale]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2021-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_10_e&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711604703112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Share Capital</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 9&#8212;Share Capital </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The share capital of Ascendis Pharma A/S consists of 53,900,990 outstanding shares at a nominal value of DKK 1, all in the same share class. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601145160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">Lease Liabilities</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 10 &#8212;Lease Liabilities </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;">The Company primarily leases office and laboratory facilities. Lease arrangements contain a range of different terms and conditions and are typically entered into for fixed periods. Generally, the lease terms are determined according to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancellable</div> period and are between <span style="-sec-ix-hidden:hidden25486367">two</span> and twelve years. In addition, in order to improve flexibility to the Company&#8217;s operations, lease terms may provide the Company with options to extend the lease or to terminate the lease within the enforceable lease term. In the Company&#8217;s current lease portfolio, extension and termination options range between <span style="-sec-ix-hidden:hidden25486370">two</span> to ten years, in addition to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancellable</div> period. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Maturity analysis for lease liabilities recognized in the consolidated statements of financial position at June&#160;30, 2021 is specified below. </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="color: white; line-height: 0pt; visibility: hidden;">
<td style="width: 69%;">&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td> </tr>
<tr style="font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&lt;&#160;1&#160;year</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1-5&#160;years</div></div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&gt;5&#160;years</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total<br/> contractual<br/> cash-flows</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying<br/> amount</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="18" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">June&#160;30, 2021</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 69%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lease liabilities</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,051</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">45,162</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">71,397</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">123,610</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">101,009</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 69%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total lease liabilities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">7,051</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">45,162</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">71,397</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">123,610</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">101,009</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 69%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Section Presentation<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601577112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Subsequent Events</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 11&#8212;Subsequent Events </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="display:inline;">O</div>n August&#160;25, 2021, the Company announced that the U.S. Food and Drug Administration, or FDA, has approved SKYTROFA (lonapegsomatropin-tcgd) for the treatment of pediatric patients one year and older who weigh at least 11.5&#160;kg (25.4&#160;lb) and have growth failure due to inadequate secretion of endogenous growth hormone (GH). In order to accommodate market demands, the Company has initiated manufacturing of inventories prior to obtaining marketing approval, or pre-launch inventories, for SKYTROFA. However, since pre-launch inventories are not realizable prior to obtaining marketing approval, pre-launch inventories are immediately written down to zero through research and development costs. As a result of the marketing approval received on August&#160;25, 2021, the Company will reverse prior periods&#8217; write-downs of pre-launch inventories through research and development costs, at the lower of cost and net-realizable value. Subsequent to the reporting date, reversal of prior periods&#8217; write-downs is expected to have a positive impact on research and development costs of approximately &#8364;</div></div>50<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">No other events have occurred after the reporting date that would influence the evaluation of these unaudited condensed consolidated interim financial statements. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2020-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601589736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of Preparation</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Basis of Preparation </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The unaudited condensed consolidated interim financial statements of the Company are prepared in accordance with International Accounting Standard 34, &#8220;Interim Financial Reporting.&#8221; Certain information and disclosures normally included in the annual consolidated financial statements prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;) have been condensed or omitted. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with the Company&#8217;s audited annual consolidated financial statements for the year ended December 31, 2020 and accompanying notes, which have been prepared in accordance with IFRS as issued by the International Accounting Standards Board, and as adopted by the European Union. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accounting policies applied are consistent with those of the previous financial year. A description of our accounting policies is provided in the </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Policies section of the audited consolidated financial statements as of and for the year ended December 31, 2020. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with IFRS requires the use of certain significant accounting estimates and requires management to exercise its judgement in the process of applying the Company&#8217;s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the unaudited condensed consolidated interim financial statements are disclosed in Note 3. </div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock', window );">New and Amended IFRS Standards Adopted by the Company</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">New and Amended IFRS Standards Adopted by the Company </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Several new amendments and interpretations became applicable for the current reporting period, but do not have an impact on the accounting policies applied by the Company. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of New and Amended Standards Adoption [Policy Text Block].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711604900552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory', window );">Schedule of Revenue Recognized in the Statement of Profit or Loss</a></td>
<td class="text"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 68%;"/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three&#160;Months&#160;Ended<br/> June&#160;30,</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30,</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue from external customers</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/>
<td style="vertical-align: bottom;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue from the rendering of services (recognized over time)</div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">226</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">779</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">395</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,091</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Sale of clinical supply (recognized at a point in time)</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">217</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">217</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">246</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Right-to-use&#8221;</div></div> licenses (recognized at a point in time)</div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">579</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">657</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,155</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,324</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total revenue <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,022</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,436</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,767</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,661</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Attributable to</div></div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">VISEN Pharmaceuticals</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">913</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,436</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,550</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,661</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other collaboration partners</div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">109</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">217</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total revenue</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,022</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,436</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,767</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,661</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Revenue by geographical location</div></div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">North America</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">688</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">657</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,373</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,324</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 68%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">China</div></div> </td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">334</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">779</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">394</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,337</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 68%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total revenue</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,022</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,436</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,767</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,661</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 68%;;vertical-align:bottom;">&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="margin-top: 1em; margin-bottom: 1em"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;">
<tr style="page-break-inside: avoid;">
<td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div>&#160;</td>
<td style="text-align:left;;vertical-align:top;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended June&#160;30, 2021 and 2020, and for the six months ended June&#160;30, 2021 and 2020, &#8220;Total revenue&#8221; includes recognition of previously deferred revenue/internal profit from associate of &#8364;579&#160;thousand and &#8364;1,013&#160;thousand, and of &#8364;1,155&#160;thousand and &#8364;2,215&#160;thousand, respectively. </div></div> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of revenue recognized in the statement of profit or loss explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711604735592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants and Share-based Payment (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_Warrant1Member', window );">Warrants [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_StatementLineItems', window );"><strong>Statement [LineItems]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory', window );">Summary of Warrant Activity</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table specifies the warrant activity during the six months ended June&#160;30, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 74%;"/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;Average<br/> Exercise Price<br/> EUR</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="color: white; line-height: 0pt; visibility: hidden;">
<td style="width: 74%; font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="font-family: &quot;Times New Roman&quot;;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding at January&#160;1, 2021</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">6,148,004</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">69.97</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 74%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted during the period</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">158,590</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">120.15</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercised during the period</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(150,604</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">33.51</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 74%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited during the period</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(90,167</td>
<td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">121.80</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 74%;">&#160;</td>
<td style="vertical-align: bottom; width: 1%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 1%;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding at June&#160;30, 2021</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">6,065,823</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">71.04</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Vested at June&#160;30, 2021</div></div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,565,573</div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">46.23</div></td>
<td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0); width: 74%;;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_Warrant1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_Warrant1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711604901608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract', window );"><strong>Categories of current financial assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock', window );">Summary of Marketable Securities</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The composition of the portfolio is specified in the following table<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="font-size: 0px;">
<td style="width: 48%;"/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2020</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying&#160;amount</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying&#160;amount</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="14" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable securities</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U.S. Treasury bills</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">46,243</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">46,245</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">U.S. Government bonds</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">85,049</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">85,049</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">62,088</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">62,101</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Commercial papers</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8,832</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8,833</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,583</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,581</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Corporate bonds</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">144,830</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">144,734</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">121,282</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">121,234</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Agency bonds</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">18,076</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">18,077</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9,362</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9,369</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,787</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,693</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,558</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,530</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Classified based on maturity profiles</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Non-current</div> assets</div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">90,693</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">90,623</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">115,280</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">115,277</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current assets</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">166,094</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">166,070</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">134,278</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">134,253</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,787</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,693</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,558</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,530</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Specified by rate structure</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Fixed rate</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">231,342</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">231,249</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">175,757</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">175,732</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Floating rate</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,613</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,611</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,975</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,972</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Zero-coupon</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">8,832</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">8,833</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">56,826</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">56,826</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,787</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,693</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,558</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,530</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Specified by investment grade credit rating</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prime</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6,398</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6,398</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,716</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,714</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">High grade</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">127,690</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">127,678</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">142,339</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">142,352</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upper medium grade</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">119,785</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">119,706</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">99,503</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">99,464</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 48%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Lower medium grade</div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,914</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,911</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 48%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total marketable securities</div></div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,787</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">256,693</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,558</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">249,530</div></td>
<td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 48%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure &#8203;of available for sale&#8203; assets&#8203; explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711603141064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_TextBlockAbstract', window );"><strong>Text block [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock', window );">Summary of Maturity Analysis for Lease Liabilities</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Maturity analysis for lease liabilities recognized in the consolidated statements of financial position at June&#160;30, 2021 is specified below. </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;">
<tr style="color: white; line-height: 0pt; visibility: hidden;">
<td style="width: 69%;">&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td>
<td style="width: 1%; vertical-align: bottom;">&#160;</td>
<td>&#160;</td>
<td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div></td>
<td>&#160;</td> </tr>
<tr style="font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&lt;&#160;1&#160;year</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1-5&#160;years</div></div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&gt;5&#160;years</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total<br/> contractual<br/> cash-flows</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying<br/> amount</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="18" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(EUR&#8217;000)</div></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">June&#160;30, 2021</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="width: 69%;;vertical-align:top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lease liabilities</div></div> </td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,051</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">45,162</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">71,397</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">123,610</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td>
<td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">101,009</td>
<td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 69%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;;background-color:#cceeff;">
<td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total lease liabilities</div></div></div> </td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">7,051</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">45,162</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">71,397</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">123,610</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td>
<td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">101,009</div></td>
<td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="font-family: &quot;Times New Roman&quot;; width: 69%;;vertical-align:bottom;">&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align:bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of maturity analysis of lease liability explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block [abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711599224600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Events in the Reporting Period - Additional Information (Detail)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 08, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Disclosure of summary of significant accounting policies [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_ExpectedNonCashGainTowardsShares', window );">Expected Non cash Gain recognised towards Shares | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 42.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=asnd_VisenSeriesBFinancingMember', window );">VISEN Series B Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Disclosure of summary of significant accounting policies [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from Borrowings classified as Financing Activities</a></td>
<td class="nump">$ 150.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=asnd_VisenPharmaceuticalsMember', window );">VISEN Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Disclosure of summary of significant accounting policies [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod', window );">Equity Investment in Associates</a></td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate', window );">Proportion of Interest retain in issued and Outstanding shares of Associate</a></td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_ExpectedNonCashGainTowardsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected Non Cash Gain towards Shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_ExpectedNonCashGainTowardsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proportion of interest Hold in Issued And Outstanding Shares of Associate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=asnd_VisenSeriesBFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=asnd_VisenSeriesBFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=asnd_VisenPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=asnd_VisenPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711599212232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Additional Information (Detail) - Visen Pharmaceuticals [Member]<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue', window );">Upfront payment received non cash consideration towards license revenue</a></td>
<td class="nump">$ 40.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Percentage of ownership in the customer company</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_RetainedPercentageOfIssuedAndOutstandingShares', window );">Retained percentage of issued and outstanding shares</a></td>
<td class="nump">44.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_RetainedPercentageOfIssuedAndOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Retained percentage of issued and outstanding shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_RetainedPercentageOfIssuedAndOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Upfront payment received non cash consideration towards license revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=asnd_VisenPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=asnd_VisenPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601515096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServices', window );">Revenue from the rendering of services (recognized over time)</a></td>
<td class="nump">&#8364; 226<span></span>
</td>
<td class="nump">&#8364; 779<span></span>
</td>
<td class="nump">&#8364; 395<span></span>
</td>
<td class="nump">&#8364; 2,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_RevenueFromSaleOfClinicalSupply', window );">Sale of clinical supply (recognized at a point in time)</a></td>
<td class="nump">217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LicenceFeeIncome', window );">"Right-to-use" licenses (recognized at a point in time)</a></td>
<td class="nump">579<span></span>
</td>
<td class="nump">657<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">1,436<span></span>
</td>
<td class="nump">1,767<span></span>
</td>
<td class="nump">3,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasAbstract', window );"><strong>Revenue by geographical location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">1,436<span></span>
</td>
<td class="nump">1,767<span></span>
</td>
<td class="nump">3,661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=asnd_VisenPharmaceuticalsMember', window );">VISEN Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">913<span></span>
</td>
<td class="nump">1,436<span></span>
</td>
<td class="nump">1,550<span></span>
</td>
<td class="nump">3,661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasAbstract', window );"><strong>Revenue by geographical location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">913<span></span>
</td>
<td class="nump">1,436<span></span>
</td>
<td class="nump">1,550<span></span>
</td>
<td class="nump">3,661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=asnd_OtherCollaborationPartnersMember', window );">Other collaboration partners [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasAbstract', window );"><strong>Revenue by geographical location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember', window );">North America [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">688<span></span>
</td>
<td class="nump">657<span></span>
</td>
<td class="nump">1,373<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasAbstract', window );"><strong>Revenue by geographical location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">688<span></span>
</td>
<td class="nump">657<span></span>
</td>
<td class="nump">1,373<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_CN', window );">China [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">779<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">2,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasAbstract', window );"><strong>Revenue by geographical location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">&#8364; 334<span></span>
</td>
<td class="nump">&#8364; 779<span></span>
</td>
<td class="nump">&#8364; 394<span></span>
</td>
<td class="nump">&#8364; 2,337<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_RevenueFromSaleOfClinicalSupply">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from sale of clinical supply.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_RevenueFromSaleOfClinicalSupply</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LicenceFeeIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from licence fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LicenceFeeIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2020-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRenderingOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the rendering of services. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRenderingOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=asnd_VisenPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=asnd_VisenPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=asnd_OtherCollaborationPartnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=asnd_OtherCollaborationPartnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711613387704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Parenthetical) (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DeferredRevenueFromAssociate', window );">Deferred revenue from associate</a></td>
<td class="nump">&#8364; 579<span></span>
</td>
<td class="nump">&#8364; 1,013<span></span>
</td>
<td class="nump">&#8364; 1,155<span></span>
</td>
<td class="nump">&#8364; 2,215<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_DeferredRevenueFromAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred revenue from associate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_DeferredRevenueFromAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711613559160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_NumberOfReportableOperatingSegments', window );">Number of reportable segment</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_NumberOfReportableOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reportable operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_NumberOfReportableOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711598528376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants and Share-based Payment - Additional Information (Detail)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>kr / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Share nominal value | kr / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">kr 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_Warrant1Member', window );">Warrants [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Aggregate number of other equity instruments granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,023,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement', window );">Aggregate number of other equity instruments cancelled | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,580<span></span>
</td>
<td class="nump">19,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Aggregate number of other equity instruments exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,327,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement', window );">Aggregate number of other equity instruments expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Aggregate number of other equity instruments forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">608,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement', window );">Number of other equity instruments authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,603,979<span></span>
</td>
<td class="nump">2,603,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Share nominal value | kr / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">kr 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Warrant compensation costs | &#8364;</a></td>
<td class="nump">&#8364; 16,320<span></span>
</td>
<td class="nump">&#8364; 13,415<span></span>
</td>
<td class="nump">&#8364; 39,396<span></span>
</td>
<td class="nump">&#8364; 28,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_Warrant1Member', window );">Warrants [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6.48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_Warrant1Member', window );">Warrants [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 145.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of other equity instruments cancelled in sharebased payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Instruments Authorised In Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of outstanding share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_Warrant1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_Warrant1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711598712968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants and Share-based Payment - Schedule of Warrant Activity (Detail) - Warrants [member]<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>&#8364; / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfWarrantActivityLineItems', window );"><strong>Disclosure Of Warrant Activity [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Beginning balance</a></td>
<td class="nump">6,148,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the period</a></td>
<td class="nump">158,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Exercised during the period</a></td>
<td class="num">(150,604)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement', window );">Forfeited during the period</a></td>
<td class="num">(90,167)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Ending balance</a></td>
<td class="nump">6,065,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement', window );">Vested at the balance sheet date</a></td>
<td class="nump">3,565,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019', window );">Beginning balance</a></td>
<td class="nump">&#8364; 69.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Granted during the period</a></td>
<td class="nump">120.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019', window );">Exercised during the period</a></td>
<td class="nump">33.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019', window );">Forfeited during the period</a></td>
<td class="nump">121.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019', window );">Ending balance</a></td>
<td class="nump">71.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement', window );">Vested at the balance sheet date</a></td>
<td class="nump">&#8364; 46.23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_DisclosureOfWarrantActivityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Warrant Activity [line items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_DisclosureOfWarrantActivityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of other equity instruments vested in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of other equity instruments vested in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_Warrant1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_Warrant1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601163368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Additional information (Detail)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_MarketableSecuritiesAbstract', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent', window );">Weighted average duration of marketable securities current</a></td>
<td class="text">6 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent', window );">Weighted average duration of marketable securities non-current</a></td>
<td class="text">17 months 15 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_WeightedAverageDurationOfMarketableSecurities', window );">Weighted average duration of marketable securities</a></td>
<td class="text">10 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_WeightedAverageDurationOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average duration of marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_WeightedAverageDurationOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average duration of marketable securities current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average duration of marketable securities noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711597657112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Summary of Marketable Securities (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAvailableforsale', window );">Non-current financial assets available-for-sale</a></td>
<td class="nump">&#8364; 90,693<span></span>
</td>
<td class="nump">&#8364; 115,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAvailableforsale', window );">Current financial assets available-for-sale</a></td>
<td class="nump">166,094<span></span>
</td>
<td class="nump">134,278<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">256,787<span></span>
</td>
<td class="nump">249,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAvailableforsale', window );">Non-current financial assets available-for-sale</a></td>
<td class="nump">90,693<span></span>
</td>
<td class="nump">115,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAvailableforsale', window );">Current financial assets available-for-sale</a></td>
<td class="nump">166,094<span></span>
</td>
<td class="nump">134,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">256,787<span></span>
</td>
<td class="nump">249,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Prime [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">6,398<span></span>
</td>
<td class="nump">7,716<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | High grade [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">127,690<span></span>
</td>
<td class="nump">142,339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Upper Medium Grade [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">119,785<span></span>
</td>
<td class="nump">99,503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Lower Medium Grade [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">2,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Fixed interest rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">231,342<span></span>
</td>
<td class="nump">175,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Floating interest rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">16,613<span></span>
</td>
<td class="nump">16,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Zero Coupon [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">8,832<span></span>
</td>
<td class="nump">56,826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | US Treasury bills [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">46,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | US Government bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">85,049<span></span>
</td>
<td class="nump">62,088<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Commercial papers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">8,832<span></span>
</td>
<td class="nump">10,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Corporate bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">144,830<span></span>
</td>
<td class="nump">121,282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Agency bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">18,076<span></span>
</td>
<td class="nump">9,362<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">256,693<span></span>
</td>
<td class="nump">249,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAvailableforsale', window );">Non-current financial assets available-for-sale</a></td>
<td class="nump">90,623<span></span>
</td>
<td class="nump">115,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAvailableforsale', window );">Current financial assets available-for-sale</a></td>
<td class="nump">166,070<span></span>
</td>
<td class="nump">134,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">256,693<span></span>
</td>
<td class="nump">249,530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Prime [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">6,398<span></span>
</td>
<td class="nump">7,714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | High grade [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">127,678<span></span>
</td>
<td class="nump">142,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Upper Medium Grade [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">119,706<span></span>
</td>
<td class="nump">99,464<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Lower Medium Grade [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">2,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Fixed interest rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">231,249<span></span>
</td>
<td class="nump">175,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Floating interest rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">16,611<span></span>
</td>
<td class="nump">16,972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Zero Coupon [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">8,833<span></span>
</td>
<td class="nump">56,826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | US Treasury bills [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">46,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | US Government bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">85,049<span></span>
</td>
<td class="nump">62,101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Commercial papers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">8,833<span></span>
</td>
<td class="nump">10,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Corporate bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">144,734<span></span>
</td>
<td class="nump">121,234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Agency bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems', window );"><strong>Disclosure Detailed Information About Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAvailableforsale', window );">Financial assets available-for-sale</a></td>
<td class="nump">&#8364; 18,077<span></span>
</td>
<td class="nump">&#8364; 9,369<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Detailed Information About Marketable Securities LineItems.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialAssetsAvailableforsale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Current financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 8<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_d&amp;doctype=Standard&amp;book=b<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialAssetsAvailableforsale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35H<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35I<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAvailableforsale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-derivative financial assets that are designated as available for sale or are not classified as (a) loans and receivables; (b) held-to-maturity investments; or (c) financial assets at fair value through profit or loss. [Refer: Derivative financial assets; Financial assets at fair value through profit or loss; Held-to-maturity investments]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 8<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_d&amp;doctype=Standard&amp;book=b<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAvailableforsale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssetsAvailableforsale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Non-current financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 8<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_d&amp;doctype=Standard&amp;book=b<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssetsAvailableforsale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExternalCreditGradesAxis=asnd_PrimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExternalCreditGradesAxis=asnd_PrimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExternalCreditGradesAxis=asnd_HighGradeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExternalCreditGradesAxis=asnd_HighGradeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExternalCreditGradesAxis=asnd_UpperMediumGradeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExternalCreditGradesAxis=asnd_UpperMediumGradeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExternalCreditGradesAxis=asnd_LowerMediumGradeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExternalCreditGradesAxis=asnd_LowerMediumGradeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FixedInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FixedInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=asnd_ZeroCouponMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=asnd_ZeroCouponMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=asnd_UsTreasuryBillsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=asnd_UsTreasuryBillsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=asnd_UsGovernmentBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=asnd_UsGovernmentBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=asnd_CommercialPapersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=asnd_CommercialPapersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=asnd_CorporateBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=asnd_CorporateBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=asnd_AgencyBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=asnd_AgencyBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711604619064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share Capital - Additional Information (Detail)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>kr / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Share nominal value | kr / shares</a></td>
<td class="nump">kr 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding | shares</a></td>
<td class="nump">53,900,990<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601177144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease Liabilities - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_Statement1LineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_LeaseTerm', window );">Lease term</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_LeasesOptionToExtendAndTerminationTerm', window );">Lease extension and termination option term</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_Statement1LineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_LeaseTerm', window );">Lease term</a></td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_LeasesOptionToExtendAndTerminationTerm', window );">Lease extension and termination option term</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_LeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_LeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_LeasesOptionToExtendAndTerminationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases option to extend and termination term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_LeasesOptionToExtendAndTerminationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_Statement1LineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Statement1 line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_Statement1LineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711601430568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lease Liabilities - Summary of Maturity Analysis for Lease Liabilities (Detail)<br> &#8364; in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_LeaseLiabilitiesAxis=ifrs-full_DiscountedCashFlowMember', window );">Total contractual cash-flows [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">&#8364; 123,610<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Total lease liabilities</a></td>
<td class="nump">123,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_LeaseLiabilitiesAxis=ifrs-full_GrossCarryingAmountMember', window );">Carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">101,009<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Total lease liabilities</a></td>
<td class="nump">101,009<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Within 1 year [member] | Total contractual cash-flows [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">7,051<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Total lease liabilities</a></td>
<td class="nump">7,051<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Within 1 to 5 years [member] | Total contractual cash-flows [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">45,162<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Total lease liabilities</a></td>
<td class="nump">45,162<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">After 5 years [member] | Total contractual cash-flows [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">71,397<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Total lease liabilities</a></td>
<td class="nump">&#8364; 71,397<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of maturity analysis of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 58<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_58&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph B11D<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B11D_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_LeaseLiabilitiesAxis=ifrs-full_DiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_LeaseLiabilitiesAxis=ifrs-full_DiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_LeaseLiabilitiesAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_LeaseLiabilitiesAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140711604599992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events - Additional information (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Aug. 25, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=asnd_NonadjustingEventsAfterReportingPeriodMember', window );">Nonadjusting Events After Reporting Period [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts', window );">Reversal of prior period write-downs of inventories expected to have a positive impact on research and development costs</a></td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reversal of prior period write downs of inventories expected impact on research and development costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=asnd_NonadjustingEventsAfterReportingPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=asnd_NonadjustingEventsAfterReportingPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>46
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MZ\;=Z>TW[.H) @O=V/"%;9<;1U"LK=.R Y,"*53[Y\_=.>P!B.=M0-(!DM>
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M#&9-PQ.-3Z#U2FNW<_P&_3C._P!02P,$%     @ X*P:4[X<V,9A!0  BA8
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M99Y[0,L!M P*Q?I<D0#)J,])>.R";*@NF!5ECV::W&J:6,-!Y73KN8RP1R;
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M2, 'S8GLXHB/B3F1710F?D)"TP@M0,C=G$@+6P#-R>P\-C+L!9Y/^DIR?YS
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M"R8T .XO.91R,] O/-J7=)-_ 5!+ P04    " #@K!I3MXP+YD4'  !N'0
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M/U[X0V+G3KZ!(\F->>3%UW*>3)@0*BP\(PCZV>$-*L5 1.-IP$R.+MGP]/N
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M-%!3L?&JVS<Y=<A!Z>7F=GV0>B#S0-2)VL93[A"2CGK>"E>*)_BL3$Y1;>)
M@&^4*NA[P5\R6!E6D ):4Z84WEC'E6'-CJ#)"V51T"*4T15E6$DCJO]R1LER
M2%MZ(=G ED+1!:OIF!--,Q]Y+4-%O1VRB[[%C>&U9I2>M'62MHK#RY&CH'W?
MX8^[Q_FX[,?"O]?[X4KA5E([*M0MF4[&'R\2L/W ZA?>M'%(Y,;3R(F?7&MH
M^0*=;PTUI&'!#H[_-2S^ 5!+ P04    " #@K!I3BK7BJXP$  "X"P  &
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M!8U?="Q ]VM+J6@.;*!=UA?_ E!+ P04    " #@K!I3Y?L9[<4'  !Q%
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M-[QNG&X*RT*AH<!<D7]]JVMIG7:&#1MH+;PX8)TIFP+8EZ4J;#30C^AD$\[
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M(_1S^<"5'Y*OY:,2KBO)5_)SC2&3 F_ ^M+[U#VP@OXKX\V_ %!+ P04
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M(+N:MH5*'^Y;M]Z/TM%>P-N('4,<CV \/H7D= AQ-SR-.@^L0(ML ^%#L"^
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M.B8G*=86^_/K%!1*^&ZG\>H5U13:>[BX&T?#/1Q='!6ZETSQTH/WKK/^WF.
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MVG'AG/=S]NS>;ZNOPE;*.-"XX=!L\NXX =MO@%[PU,:I6Y/G&8['FI<FVN#
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M@BM^C_MNDV*J)2EU%$5)7&1AD16>)C2X:B4S-LL<=XRVXL23V))ED7E"@S]
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MQ?4=62O9V>)<,>QIME 1USCDV*Z,'=BW;\>,9W"/>64=&C.HE1I?V*V]Q">
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MG<=L8>%RU(5TL.)()6 1KR$WO"^.G(^?C0?3)!E,IPGP.CH2G*QW+8\#02!
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M[A?<US/W?(51+OS#KO?-L@B*K2/3[,&<02-UOXK'_3D< <Z39P#9'I"%O/M
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M8@(  !L%   9    >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;*64W6_3,!#
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M%[K@P/;*\G4/FW# ^![FOP!02P,$%     @ X*P:4[K"BE*?!   - P  !D
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M=9XBXZB%,36A/F-[E.7K*1V)M>5&37%@=GN_;!B\@4)L$5:(II, Z\"6*E!
M_:B2RPE([WL<MO_9G/G"UCHGE\"#F3F1[;?:I,D7275RRG&.WEUY.+A\M6J4
MD0BT1^$ N97A/4HL5^A@,HK-.(S)8DFC+U;+V("^![M"R:*CS<D4D)P@/"CO
M:]JQVD>W/ZPU#PM+/[T4 Q',;16>[#_4CDXS8>"K(8A^;!;QA%(=)IVH*JU8
M%ZI]%D7Y0/0/.EI*5],D1&&K;.T[:K$TE&$Z&;QTJHH)H-VV=D==*2Y%NU6=
M&CXV>WUSB#5^.[7R@XR)V- LQVMRER2I.O.$C(_BIA+C#E5AW\F9P^^UXA9E
M5W522C8=[3L'3$<+]$%1G[/N%&8+4 I#MP+V!L$"/J*3BO 4.?]6Y\U*(QE)
M*-$GJI2[6'5'"_Z_&6BJ@/J&26VMWO*J@(*.<U(FQXW#R.+)*0G)U:WQD;CW
M^#69[\B H*ADRYCW1*A#CU:[&A"M\-/CFD&;T9A*Z#-U&TSZ<.+P.F\/K_.3
MA]=GNE0QA>LRU4O,\%.O73_OKD;L8Z?;23?'3[?_Y1N6N$5' AFV9LM&)-.H
M2/A!I-RL4-*.U.M2K#2V'2)KYSC/KIWW%>EO::RLZ@"YY8&6YAB-$D6.)=5$
M<_Z<F";/0SV>H$'G)E>BV\3[JH<(FBYU[=?V2GR=;H)/V]-]^I-P&T4\-:[)
M=-A_1TEPZ8Z:7H*MXKUP90/=,N-C0:<'.MY ZVM+E=2\L(/V'X7YOU!+ P04
M    " #@K!I3=+17I]0#  !4"   &0   'AL+W=O<FMS:&5E=',O<VAE970Q
M.2YX;6R-5MMNXS80??=7#%2@2 !O=+-E.[$-)&F*;M'=->SL]J'H RV-+2(2
MJ9*4G?3K=TC)BKV(@WV(/+R<P[F<(3/=2_6D<T0#SV4A],S+C:FN?5^G.99,
M7\D*!:ULI"J9H:':^KI2R#('*@L_"H+$+QD7WGSJYA9J/I6U*;C A0)=ER53
M+W=8R/W,"[W#Q))O<V,G_/FT8EM<H?E:+12-_(XEXR4*S:4 A9N9=QM>WPWL
M?K?A&\>]/K+!1K*6\LD./F8S+[ .88&IL0R,?G9XCT5AB<B-_UI.KSO2 H_M
M _OO+G:*9<TTWLOB;YZ9?.:-/<APP^K"+.7^#VSC&5J^5!;:?6'?[$T2#]):
M&UFV8/*@Y*+Y9<]M'HX X^ ,(&H!D?.[.<AY^1LS;#Y5<@_*[B8V:[A0'9J<
MX\(69644K7+"F?D2=RAJA(M'MBY07TY]0ZQVS4];AKN&(3K#D, G*4RNX4%D
MF)WB??*F<RDZN'07O4OX9RVN( [Z$ 51^ Y?W(48.[[X#-\C/AM8%S)]@G_8
M6AM%2OCW'=Y!QSMPO(,SO"MJD*PN$.0&#FE<8BJW@O^/&7 !)D=8&6:05&SL
MMH62&TZ6@K^DUF_E^MTC;8=>ZXJE./.H!36J'7KSQUPAGA0!5OSY9*)G4VGS
M&4!G]2X>OBY__64<A:.;( @NX8=Q[Q#31LD2*(>H!"M:3:+2I^LV5(5TEN)B
M:T.USO$4-5RHUYS('2HPU-27$$4)C$83B"=#B/K!).RM6)/+E*+F*1VEZZHJ
M7DX(F $&E>243IO?ABD<@?,[NG%V-$AZ=AP%-^Z.^6#DAUJCFPIO8$B')L,1
MA/UP.*1O' UZC]+0>>K0"^$ES0=11-]!G-!WE(P@[B=)V+LU1O%U;6RW@)&]
M;Q]7#Y]AD3.Z(5*LC75<PR2,.^QP&+38+Y0D!=2Q!5M+Q=RM5#%E!&43PF!R
M$D5K_^#:.;<.M5B_P!;E5K$J=RDDU;MS>I^E,CG<4N%H'I+QN,U!/(K;'-SG
M7#"(XT%;E@&5)8Y'/^F S1E=DTX'Q@FR;/2'3I#4T]CU-#"1.0GVG;5I89I$
M^U.@MK@GCAVJRT5:U!G)KA6-2S*)BMIEQV6M24]T9Z-2Q-]"?5)3H^VJ:4\G
M:*:U3#GUKD43>YP,;JQT3$XLUA?[U\Y34JC@AY4FJE=4([2W<%$_"H='.&KI
M"MTS5;Q<P5M7E']TTU,MM^X]TZ2I6ICFTN]FNR?SMGDI7K<W[^TGIK9<:"AP
M0]#@:C3T0#5O6#,PLG+OQEH:ZGAGYO3LH[(;:'TCI3D,[ '=/Q+S[U!+ P04
M    " #@K!I3(/.]<\\"   R!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6R%5=]/VS 0?N]?<<H32%U^-FU!;:7"V 8:&J(,'M >W.;26"1V9SL4
M_ON=G9!UHG0OC<^^[[OO?+[K9"O5DRX0#;Q4I=!3KS!F<QH$>E5@Q;0O-RCH
M))>J8H9,M0[T1B'+'*@J@S@,AT'%N/!F$[=WHV8369N2"[Q1H.NJ8NKU#$NY
MG7J1][9QR]>%L1O!;+)A:UR@^;FY460%'4O&*Q2:2P$*\ZDWCT[/4NOO'.XY
M;O7.&FPF2RF?K'&93;W0"L(25\8R,/H\XSF6I24B&;];3J\+:8&[ZS?V+RYW
MRF7)-)[+\H%GIIAZ8P\RS%E=FENY_89M/D[@2I;:_<*V\1W$'JQJ;635@DE!
MQ47S92_M/>P QN$'@+@%Q$YW$\BI_,P,FTV4W(*RWL1F%RY5AR9Q7-BB+(RB
M4TXX,WM@2C%A-#"1P:)@"C_9)#.X8:]T]P:.[MBR1'T\"0R%LZ!@U5*?-=3Q
M!]1#N);"%!HN1(;9O_B 9'9:XS>M9_%!PJM:^)"$?8C#.#K EW2Y)XYO\+_<
M'RNLEJA^'> <=)P#QYE\P+DPS*"[N,?O='1)AC[$FW:\Z4&MBZ9I0.;0RH:Y
M?=#<O.ZKS&&RNP(AER4U)!=K,+; H#>XXCE'#89.MVT,UL: K%;.E\XT?X&J
MJ2S:R@+5!;NZG/;NI&$E=)?[X!J#W.;/J*C/>S]JHPT]-\O'#%PQ4=O,H@8/
MPWXT&/?#< ##$_]DU/MJ:0B^HV"#BLL,HG3<3T]"B.+0C]+>Q0NJ%==[78^B
M-.P/B?,8DL1/HQZU=(Y\/^_12=B/AB/RC>+('X?O%._F2WK#8=H?QPF,(C\<
M].Y16]IW?DD_);]TE,!@Z,?)OC<1[/1QA6KMII6&E:R%:5JZV^T&XKR9 W_=
MFVEZS=2:"PTEY@0-_1&]"-5,J,8P<N.FPE(:FC%N6=!01V4=Z#R7TKP9-D#W
M-S'[ U!+ P04    " #@K!I3_E2&G_H#  #T"   &0   'AL+W=O<FMS:&5E
M=',O<VAE970R,2YX;6RM5FUOVS80_JY?07C T *J35'OK6,@29MUPSH$<;(!
M&_:!ELXV$4E422I._OV.I*QY19(OW1<^(GGWW N//"T/4MWK/8 ACVW3Z;/9
MWIC^_6*AJSVT7,]E#QWN;*5JN<&IVBUTKX#73JEM%HS2;-%RT<U62[=VK59+
M.9A&='"MB![:EJNG"VCDX6P6S8X+-V*W-W9AL5KV? =K,'?]M<+98F*I10N=
M%K(C"K9GL_/H_45BY9W [P(.^N2;V$@V4M[;R<_UV8Q:AZ"!RE@&CO  E] T
ME@C=^#IRSB:35O'T^\A^Y6+'6#9<PZ5L_A"UV9_-BAFI8<N'QMS(PV<8XTDM
M7R4;[49R\+(IG9%JT$:VHS)ZT(K.(W\<\W"B4+RDP$8%YOSVAIR7'[GAJZ62
M!Z*L-++9#Q>JTT;G1&</96T4[@K4,ZLO7-V#X9L&R!JJ00DC0),WMW9%OUTN
M#-JPDHMJY+OP?.P%OHQ\D9W9:_*IJZ'^K_X"?9L<9$<'+]BKA+\,W9S$-"2,
MLN@5OG@*.'9\\0M\E]S 3BH;I=QBAI6"SI"MZ'A7"=X0KC483?[B&VT4ULS?
MK]A,)IN)LYF\8'/M*]X:?#;?SZ7Y=<;;/9!*MKW4PA4W,AM<ZJ4R6]D(280F
MNH=*; 741'1N%W?P#HIN1[P#\P"3"U-RR4>HH-V (G'D5FAPR95ZL@J\E0.F
MZ8H+11YX,P!Y>2MX\^GNYL<?"A;E'RBE;X.3F/44<W W7\_)+3XD>L#4;$33
M:.*TV(<)DRQD2>PA]1H_R0=076L/;2.[6I,B#6E2'B%C(2T*"Q&-@DO9MJ#<
MN?:\!X7281$S-\8DHF%:C&!E%:8/JV/DC9($I:C#/$Y(Q**0%<QCG 3G.^BJ
MIZ-P$=(\\Y"3,HPSYL8RN)4&K;?/I8"P- OS(G>8E3%A21FF:>$QQO0W6(W^
M".W+4Q,\:7R(K/H3Z97<"KRDP6^R>W>LXY(Z(@L,(XM2=)EZS//@<I0::SS*
MLI"6B<<<Q>($Q0J/:?Q=KJ^GXML\$9=5O$Y#A;Y#<"4><=TM,BRU.&$.495$
M>1KF:>XQ9L%5([FQ5>:D([05Q1XB"V6>>F#!GZ#DNTH./>;H])#1OX)E(_Q_
M(8GN ;1Q9;A3O,;;J* 6QOJ)[@;7"CL7R<*X+,8Q#_,H<V,2?,96,:I%+$=C
MU*/-?<+"."X]IBRXZ[%L28O<0WM4B4KT,_5(,U*B>S2VD&1)\*L\?*O PC)*
MW!A]>\.^)R'//8R+DTZ$-V_G^JW&IPJ?"-^4IM6II9_[3O:ON/\?P%=C)SI-
M&MBB*IWGZ8PHWV/]Q,C>];6---@EW><>?TM 60'<WTIICA-K8/K16?T#4$L#
M!!0    ( ."L&E/P_RV#G@(  *\%   9    >&PO=V]R:W-H965T<R]S:&5E
M=#(R+GAM;(U466_;, Q^SZ\@/*!H@2P^<O5( C3=AFUH@:+']C#L0;9I1Z@L
M>1*S-/OUD^3$2]$FV(M%4OP^'C(Y62G]9!:(!,^5D&8:+(CJ\S TV0(K9GJJ
M1FEO"J4K1E;596AJC2SWH$J$212-PHIQ&<PFWG:K9Q.U),$EWFHPRZIB>CU'
MH5;3( ZVACM>+L@9PMFD9B7>(SW6M]IJ8<N2\PJEX4J"QF(:7,;G\X'S]P[?
M.*[,C@RNDE2I)Z=\R:=!Y!)"@1DY!F:/WWB%0C@BF\:O#6?0AG3 77G+_LG7
M;FM)F<$K);[SG!;3X#2 ' NV%'2G5I]Q4\_0\65*&/^%5>,[M!&SI2%5;<!6
MK[AL3O:\Z<,.X#3: T@V@,3GW03R67Y@Q&83K5:@G;=E<X(OU:-M<ERZ1[DG
M;6^YQ='L&FU)<,U9R@4GC@:.'U@JT)Q,0K+\SBO,-ESSABO9PS6"&R5I8>"C
MS#%_B0]M7FURR3:Y>7*0\.M2]J ?=2&)DO@ 7[\MMN_Y^GOX'O"9(!4J>X(?
M+#6D[3_Q\P#OH.4=>-[!'M[[YH\&5< -HZ7FM(9+R<3:< -V<.!5E]]J[N$8
M+3';)1:>6.P\G\9,E9+_P1RX!%H@9$H:)7C.R-H,V<,.%1F7;<$EDQEG FIE
M>#,F!+;MV+8=;"138\8+;N&IF^)>YTC0!<2P1J8A?C_T@H&CDBZV\H,BRWK%
MM%YS67:./S[>';T[3>+Q111%)YT7(3K7KZH8=Z-A#(-A-QXE,(Z[_;,QQ$F_
M.XHCB*.X&T5GG2;$ZP[\!_:M-P]WAJA"7?I586SWEI*:>6JM[3:Z;(;PGWNS
MRFZ8+KDT-K?"0J/>>!B ;M9#HY"J_4BFBNR >W%A-RIJYV#O"Z5HJ[@ [8Z>
M_0502P,$%     @ X*P:4W^#MR4X P  HP@  !D   !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&ULQ59M;]LX#/XKA*]WZ( N=IRD3;<D0-]VUP'=@@;=?1CV
M0;696)@L>1*==,!^_"C;\1D'-^NW 4$L6>+#AP]%T;.=L5]=ADCPE"OMYD%&
M5+P)0Y=DF LW, 5J7ED;FPOBJ=V$KK HTLHH5V$<1:=A+J0.%K/JW=(N9J8D
M)34N+;@RSX7]?HG*[.;!,-B_N)>;C/R+<#$KQ 972 _%TO(L;%%2F:-VTFBP
MN)X'%\,W5\/(&U0[/DG<N<X8?"B/QGSUD]MT'D2>$2I,R$,(?FSQ"I7R2,SC
M6P,:M#Z]87>\1W]7!<_!/ J'5T;]*U/*YL$T@!37HE1T;W;_8!/0Q.,E1KGJ
M'W;-WBB I'1D\L:8&>12UT_QU C1,8B'SQC$C4'\4H-18S"J JV956%="Q*+
MF34[L'XWH_E!I4UES=%([=.X(LNKDNUHL9(;+=<R$9K@9HN:'$@-E"'<8V$L
M2;V!)5II4G@-%VDJO?A"P:VNCY!/Q?$UDI#J%?SUQW1T.G[K$>ZD4KSF3N"H
M.YV%Q*2]ZS!I"%[6!.-G"+X7>@#1] 3B*!X^K*[A^.A5#\K5890[80<P&M8H
M-P_W<-QP_1]6R/*U&L:MAG$%/GH&_%JZ1!E76@2SWA=$->R(*Y+$E+K2LS!*
M)A(=?/9(( ES]^4 CU'+8U3Q&#_#X^:IX.+ %#YP4A+A,OB;ZYB++3',P_$"
MF9VPJ8-5)BS[_['/6)^@M:]IY<M?!MO%.!Z,9N&VA^&X93@^R/#3[>KF ZSX
M/+'W2W@GM=")E^3S'>:/: ^I,&E]3'YK-DY;'J<'8UU:DR"RV&MK<K@TENW9
MGX-$">>8".=#N(X&%_Y&X_K"WBJIG9UWTC&<1/W9.&L9GKT@&TL^"[E(L"26
M1KF7I&+:.IC^UE2<MSS.#Q?&MU+2=[ZSMNB(>Q#Y*^G".9-(0?URUX#<GCIZ
MQX-)O^##Z+_;-OK5H:AN52Y0EN%6$W(=$I<H^4KU/^=*?S!T"A]+<L0#KXRK
M"Y9M6MJ]5^EA[^/Q((K^[!,T['00W[[YOMQ([4#AFI&BP1G7G*T[8CTA4U1-
MY=$0MZAJF/%7!%J_@=?7QM!^XOM4^UVR^ E02P,$%     @ X*P:4^RO9R.M
M @  '@8  !D   !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL?55M;]HP$/XK
MIVB36FDC(;QLJP)2*9O624B(JMV'J1],<A"KCIW9#FG__<Y.R*@$^4+L\[T\
M]]P+2:WTB\D1+;P60II9D%M;WH2A27,LF!FH$B6][)0NF*6KWH>FU,@R;U2(
M,(ZB:5@P+H-YXF5K/4]49067N-9@JJ)@^FV!0M6S8!@<!1N^SZT3A/.D9'M\
M0/M8KC7=PLY+Q@N4ABL)&G>SX'9XLY@Z?:_PQ+$V)V=PF6R5>G&7^VP61 X0
M"DRM\\#H<\ [%,(Y(AA_6Y]!%](9GIZ/WG_XW"F7+3-XI\1OGME\%GP-(,,=
MJX3=J/HGMOE,G+]4">-_H6YUHP#2REA5M,:$H."R^;+7EH<3@WAXP2!N#6*/
MNPGD42Z99?-$JQJTTR9O[N!3]=8$CDM7E >KZ963G9UO\("R0O@,MUG&'5%,
MP+ULJNUHNUJB95Q<D\83-RAAG3-Z2[&R/&7"P)\5%EO4S_ !N(05%X+,3!):
M0N=BA&F+9-$@B2\@F<)*29L;^"XSS-[;AY15EUI\3&T1]SK\5<D!C*)/$$?Q
M\/%A"5<?KGO<CCK&1M[MZ(+;)3>I4*;2"&H'-!V:B))[,+BG9K5$B+, ;K$P
MSSWQQEV\L8\WOA#OL=QI(@9*]N;\TR2D2(V<@:3JI,SDD!+?//,X2&15S71F
M0/"49@=)WU?X7$&:P-]\8#>]A_DX2L+#&;"3#NRD%^P:-46U-,Z>G%JB-CDO
M76?8'-N&1DV0BY+)MW.@^@-,HD$4?>RA==HAG?8ZVKBVED1C^0XR-Z8B(9,9
MT HSE@Z^N-3T>+:I^Z.,QY?@AB<S2XSL_68R1$PE;3.^G;1;?K?-S/]7;S;G
MBND]EU1QW)%I-/A"%.IF&S47JTJ_ ;;*$OW^F-,"1^T4Z'VGE#U>7(#N+V'^
M#U!+ P04    " #@K!I3L(O!;=P$  "=%@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6R]6%UOVS84_2N$!@PML$0B]6$[<PPDMH=V6+H@;KN'8@^T
M1%M")=$C*;O9KQ\IR9(MTHHQ(WF))>K<>WG/O3QD.-Y1]IW'A CP(TMS?FO%
M0FQN;)N',<DPOZ8;DLLO*\HR+.0K6]M\PPB.2J,LM9'C!':&D]R:C,NQ1S89
MTT*D24X>&>!%EF'V?$]2NKNUH+4?>$K6L5 #]F2\P6NR(.++YI')-[OQ$B49
MR7E"<\#(ZM:Z@S=S-%(&)>)K0G;\X!FH5):4?E<O'Z-;RU$S(BD)A7*!Y<^6
M3$F:*D]R'O_43JTFIC(\?-Y[_ZU,7B:SQ)Q,:?I7$HGXUAI:("(K7*3BB>X^
MD#HA7_D+:<K+OV!78QT+A 47-*N-Y0RR)*]^\8^:B ,#Z<=L@&H#U#7P3ABX
MM8%[;@2O-O#.C>#7!F7J=I5[2=P,"SP9,[H#3*&E-_50LE]:2[Z27#7*0C#Y
M-9%V8O)$MB0O"+@""]F#49$20%=@/_I$0KK.DW])!)(<+ 061#:)X KSR.@J
M$8 R\ ?E'+R;$8&3]+WT-/_R!-[]_-/0#;Q?WX/Z03GX'-."XSSB8UO(N:L9
MV&$]S_MJGNC$/%WP0',1<S#/(Q(9[&?]]D&/O2TY:XA#>^+N4:_#WXO\&KC.
M+P Y"!KF,SW?W#&E<UGT^?^.?D2&VW216_IS3_B;)3Q,*2]8V3U2Q1@62;X&
MG*RK?OFF+$ BVX?_W1//:^)Y93SOA:Y=,9H!$1,I6;*L3(64\3EAVR0DLB=9
MV[]T2Q@04N/>FYJO"N>7X92V;B<(!6-[>UA0'3,8C(XQ,QWCCOQCS-P0RQG!
M!G1$B-\0XO<2LL#5P@WEAR3$J13^S29]/F( "X#!AB:Y4&OQ)!55H.!P>G#0
M2?,,S-R \0)SED&39=";I57N8U>"7A6<6""51<YYI\YG9AEHL_.[Q9SJF,#O
M,J%C(/2[%3> 7.29N1@T7 QZN?A,A2PSJQ:"*<.!'M1!J).B >2YG<:?&4"#
MH%MN'>0&P8FN'C8Y#GME9;_,E\]@3>B:X4U<-G=*0ZR.&3U*,FI"C"ZC<70.
MC0:03J,!I-.H@T[3")UVDW=ZL_SZ<3'_!!YC+(]6(2F$8E&*\@/)EH3U"3(\
M.$? -]D"(&HCHLM*5]L?DCF";J=T!I"A=B:4[SN=XAE0/=5K-U?8O[M>L Q@
MNZ/"_BWU93:]<]C4028V#2@#FSJJA\UVIX3]6^6?\KS @#PWIWA)64D@V& F
M<L+.6Q+M;@6#MUD2[9X +]P4H&E7Z!YB#*##[?UX;JV6PU<3<]BJ.;Q0SJ%)
MSS4"=-!) E KPJA?A#]1)F)PE\ES:HC!M^S%3D.M^**W$5_4BB^Z4'R1KH7!
M<-B1"Q-(.V(90- ==)1G;D2=.F2A5GO1JVDO:K477:B]2)=" YD&D$ZF07H-
M9)I0)\ELI1?U2^\T3O+S.K_56/0V&HM:C447:BPR'(5=KULL':3_-VGR-/*Z
MM3*HM>N>4JM6KM&KR35JY1I=*->UO=_/I0XR<&GPI'.I@PQ<V@?7;5+-U^4]
M)Y='BB(7U9U),]K<I=Z5-XB=\7MX,X6&\1F\F5<WI:W[ZN+V ;-UDG.0DI4,
MY5P/Y%19=1=:O0BZ*2_[EE0(FI6/,<$180H@OZ\H%?L7%:"YD9[\!U!+ P04
M    " #@K!I3S3%E_)<"  #9!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6RE56UOTS 0_BNG(*%-8LMKMS'22.L+ L2DJF7P ?'!32Z-M<0NMM,.
M?CVVDV;=EI4)OC3G\_,\]]++)=YR<2L+1 5W5<GDT"F46E^ZKDP+K(@\Y6MD
M^B;GHB)*'\7*E6N!)+.DJG0#SSMS*T*9D\36-Q-)S&M54H8S ;*N*B)^C;#D
MVZ'C.SO'G*X*91QN$J_)"A>H;M8SH4]NIY+1"IFDG(' ?.A<^9?3R. MX"O%
MK=RSP52RY/S6'#YF0\<S"6&)J3(*1#\V.,:R-$(ZC9^MIM.%-,1]>Z?^WM:N
M:UD2B6->?J.9*H;.A0,9YJ0NU9QO/V!;S\#HI;R4]A>V+=9S(*VEXE5+UAE4
ME#5/<M?V88^@=?H)04L('A.B9PAA2PA?&B%J"=%+(PQ:@BW=;6JWC9L019)8
M\"T(@]9JQK#=MVS=+\K,G"R4T+=4\U0RQPVR&N$$%GH$L[I$X#GLO'-,^8K1
MWY@!9;!01*&>$24-9B9X3A5P 9^YE' T(T)?%:AH2LIC.)J@(E0;)S"]F</1
MZU<7X5GT[AA:PPA^*7@M"<MD["I=B\G(3=N\1TW>P3-YAW#-=30)4Y9AUL.?
M'.:?'>"[NH==(X-=(T?!0<%/-3N%T'L#@1?X/?F,7T[W^LKYO^C3?X[^H!EA
M-U6AU0O_,E7?R5(JH9?!CP.B42<:6='H&=$)YBB$'D71JN>"5T"DY"G5@]DW
M0XW@P J:C;E)!N=O8W>S_[\\Q?B>'SX$37I _F#P$#1]"@H"_Q[4%.WNO:L5
MBI5=DA)27C/5-+CS=GOXRJZ?1_Z1?SGV>_P3O;>;-7LOWRS]:R)6E$DH,=>A
MO--SG:IH%FES4'QM-\62*[UWK%GH;P\* ]#W.>=J=S !NJ]9\@=02P,$%
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M;-;1QXB44+%>X*,:OL!8S]+Q%4H8_R1#R%TN(E+T!E4[@JV#ELOP9L]C'\X
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MF%^PL6O=$8A*(5ENP8I!3FCUCQZL(UH #_8 / OP]@7X%N#O"P@L(-@7,+:
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M#UA)9744K6?KZX93\Y&],W\&C\]AQ_P2'J^ZYB_@\65UR="HK>X\OB*>J X
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M:1>8YRLA]-W$.NB[R<5O4$L#!!0    ( ."L&E,Z.E :%P(  )(%   9
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;*U4;6O;,!#^*\*?-ECCE[PT%,>0
MM(QM,"@-6S^,?5#L<RPB2YYT;MI_OY/L>!DT'H-^L>ZDNWN>Y\Y2>M3F8"L
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M]F9%CR88%T#GI=9X<MQ%'I[A[#=02P,$%     @ X*P:4Y4Z$HF%!P  OC<
M !D   !X;"]W;W)K<VAE971S+W-H965T,S$N>&ULQ5MM;]LV$/XKA <,+=#4
MXCO5)0':='T9VB%HV@U8L0^R32=")=&3Y*0%]N-'R:[/E2A-M!,(!1K).E)'
M/N)SI^>HTSN3?RENM"[1US3)BK/)35FNGDVGQ?Q&IU'QU*QT9J\L39Y&I3W-
MKZ?%*M?1HFZ4)E,2!&*:1G$V.3^M?[O,ST_-NDSB3%_FJ%BG:91_>Z$3<W<V
MP9/O/WR(KV_*ZH?I^>DJNM97NORTNLSMV737RR).=5;$)D.Y7IY-GN-G%TI5
M#6J+/V)]5^P=HVHH,V.^5"=O%V>3H/)()WI>5EU$]L^MOM!)4O5D_?AGV^ED
M=\^JX?[Q]]Y?U8.W@YE%A;XPR9_QHKPYFZ@)6NAEM$[*#^;NC=X.B%?]S4U2
MU/^CNZUM,$'S=5&:=-O8>I#&V>9O]'4[$7L-,.MH0+8-R- &=-N U@/=>%8/
MZV541N>GN;E#>65M>ZL.ZKFI6]O1Q%D%XU69VZNQ;5>>OX_R+[J,9HE&5WJ^
MSN,RU@4Z05<;6)%9(K?)HY?VMSAY;&U__?0!/?KY)T4%^^4QVAZ@.$,?;\RZ
MB+)%<3HMK:_5':?SK5\O-GZ1#K]^6V=/$0V>(!(0[&A^T=_\I9[;YKAN'OS8
M?&IG:#=-9#=-I.Z/=O47%_/$%.M<H\VX]0*]S3:KJ'H:G\_L$NF8J<_O;&?H
M;:G3XN\>5^C.%5J[PCI<^=UD)[;O7&<E6L99E,WC*$%14>BR0-&M]:URX,3Z
M=E)$B79-_>8&O+Y!M<YOS\- A/1T>KL_PVTKC#E1P<[L!_?9SGW6Z_[%<:YO
M.A?[3@D1A*SAN\.,,B*5VW>^\YWW^OZJY7.)HM3D95S8YV%NBO()FB?V&OJ<
MZG2F\SZ\Q>ZF8NQ'3^Y<D9[C'X29;(%!N)!*-C!SF+&0\P[,U,YG]=#+1;4<
M<RV7ME7?<@EW[H</N5S"8<O%8=:S7'  P27P>F"<<2 8]GBX['J>#[P7 ?$]
MKVKT+[K,;3(S9)EC"#%X]!B#(<C@_B@S"#G:0D304#5Q:UM)B44':A!&<'\<
M.0BU-S:I0]=YM!@&'<0%S$>'#N(%%L=#)]HKGD@1!DWP'':,4!IVP >1!/N&
MD@'P?5JM=([>ZT6\3M'KP3!"J,!J=!B!^'$_\P^"T4'<.)2*-V%LVX4A#Z@;
M10+\3OSX?1"*[\S= 2@2X'."QT:1[+TWD*-1W';Q0V0+,>L !RB<^%'X('!>
MQ5_MQ3@K=:Z+$N51:=%Y___H &\3-CHZP-O$+Z%WHL/;Z- J/6JL,8<=EMS^
MZ\ 1^)SX\?DP'!-CYS.[/@!*X' B1X<2N)OTY_F#H'3DZ$+@9B;O- LE[P 2
M&)WX,?H@(/_2N4$79KVR$SH /0K<38.QT:/ V=0O!W>J%K@%BU*TN0P=5EPH
MTI%O4B!RZD?DPQ*6*_0QUY&=Y&]H%B=),0C"/26(C@XA$#OU3<B':5%MJ::9
MA#I,F""L(WNAP/[TON6<#:2OS:W.L[1Z+9^9;#$,5*![.KK>0X'BZ8,H/K2M
MY2@>L+ );-M,D$!UO-%3B 74+Q8, O;"I*G.ZU:KR+YG#(,5R)^&8\/*@/N9
M;]X^3'QM2S .!G98X8"KCN7*($:P!]!I+DR^,G7J,WBI,H@);'3%AD$P8+[I
M_C!,V_(,9DS1)@F[[ @FBG3 NE</>  AY_FUSN;?/#"%H,!&EW(8Q +FF_H/
MP]2AVJA BB:D;;.0BBY (68P?VEG&<4YNHV2M?:HD# @?#:Z<,. Z9EOFC\,
MM+9&0[AHUQE<=BSDM*/0P"$H\/Z@< ^5$MZF_C 0I#D$AUE5*Y$=K\H<0@3O
M#Q%'5DMX^]VA*I?()A>Z["@CO"/$<0@H_'BUB#O4(M=SXK+K>TX@T'!_7:E[
M??O42C@$#3ZZBL3WJL+'JTB\K0XY:B4.*RF[E$ .883[*TB]B/G523B$!CZZ
M8L0A:/#C%2/ND(*(%+(%G,..$<H[@BF'8,+]-:->Z ZKD0B($F)TV4@ WXOC
M92/A(&L<RJ"9#3GLPI")CL4G@-.%OW#4B^!A]1$!_"U&5XT$$+GPR_Z="+;U
M'Q)BW $,T+;PEW]Z@3FP-B+V=OJ,+OT(X&KAE\8[D7'LV:&8M(0>AUU5&Z$=
M]"B PX6_TM./X<%U$0&<+4:7>B3PM3Q^"XYTY.-"[*VP[08MEUDH.T"4P.+2
M7]CI!=&S)B*!J^7H@HX$GI;';\&1;55&*=I\%7!8]=1$))"W])=N^I.30^HA
M$AA=CJ[=2"!S^2#:C6R+,LW73X=)50_IJ$_*O=V=]RG<'%X+D4#O<G1=1P*M
MRP?1=61;KW'50AQF@N"@(\M1P/_*?XM.+Z@'U4$4D+T:?7>. KY7OKGYL W!
M;6G%P;H.JZH.TH4HQ 5US_K+ 340!3% C:[$* @ RC>E'X:G8^L.8Y(VMTF[
M[ @FM.,=44&L4/<LT/C6/Q0$ 36Z1*/V]N[[IO?#\-ST^L.G*RJ0S1WE#K.0
MBN;6UNG>QU75EVUVZ-=Q5J!$+VVSX&F5D^2;C\4V)Z59U=];S4Q9FK0^O-'V
M+3ZO#.SUI3'E]Y/J$Z[=)WOG_P%02P,$%     @ X*P:4S:)CAX< @  BP0
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M;]LP#/XKA-%#"ZRUXR9[%(Z!M-FP'3($";H=AAT4FXZUZN%*<MS]^U&RXV7
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MQOW?277HWW7C]L/R>7/R00TX6SA@W?\"4$L#!!0    ( ."L&E/?(2<;D@$
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MR'K5?\2C8Y"^^GS43CNG_$SO<+V?VBZ[>3C6+=??\?<9'_4OS"% <J0@.6Y
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ X*P:4YE<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" #@K!I34V4,.J4"  !)"   &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ X*P:4X*ZBA;K!@  ZQL  !@
M             ("!Z0H  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4
M Q0    ( ."L&E/AR9^)90(  )H%   8              " @0H2  !X;"]W
M;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #@K!I3OAS8QF$%  "*
M%@  &               @(&E%   >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL
M4$L! A0#%     @ X*P:4_G=*"3K!   L!,  !@              ("!/!H
M 'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( ."L&E.WC OF
M10<  &X=   8              " @5T?  !X;"]W;W)K<VAE971S+W-H965T
M-BYX;6Q02P$"% ,4    " #@K!I3?N94.^8#  !!"   &
M@('8)@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ X*P:
M4XJUXJN,!   N L  !@              ("!]"H  'AL+W=O<FMS:&5E=',O
M<VAE970X+GAM;%!+ 0(4 Q0    ( ."L&E/E^QGMQ0<  '$4   8
M      " @;8O  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ."L&E-39B^B?@4  )@,   9              "
M@;)(  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ X*P:
M4_A6VNU, @  [00  !D              ("!9TX  'AL+W=O<FMS:&5E=',O
M<VAE970Q-2YX;6Q02P$"% ,4    " #@K!I3J[;\!"T#  "_!@  &0
M        @('J4   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0
M   ( ."L&E.EV#3%8@(  !L%   9              " @4Y4  !X;"]W;W)K
M<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ X*P:4[K"BE*?!   - P
M !D              ("!YU8  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q0
M2P$"% ,4    " #@K!I3=+17I]0#  !4"   &0              @(&]6P
M>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( ."L&E,@\[US
MSP(  #(&   9              " @<A?  !X;"]W;W)K<VAE971S+W-H965T
M,C N>&UL4$L! A0#%     @ X*P:4_Y4AI_Z P  ] @  !D
M ("!SF(  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #@
MK!I3\/\M@YX"  "O!0  &0              @('_9@  >&PO=V]R:W-H965T
M<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( ."L&E-_@[<E. ,  *,(   9
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M970R-RYX;6Q02P$"% ,4    " #@K!I3>.1)L5X$  #8$0  &0
M    @(%3>@  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    (
M ."L&E/^TSY7,0,  %D*   9              " @>A^  !X;"]W;W)K<VAE
M971S+W-H965T,CDN>&UL4$L! A0#%     @ X*P:4SHZ4!H7 @  D@4  !D
M             ("!4((  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"
M% ,4    " #@K!I3E3H2B84'  "^-P  &0              @(&>A   >&PO
M=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( ."L&E,VB8X>' (
M (L$   9              " @5J,  !X;"]W;W)K<VAE971S+W-H965T,S(N
M>&UL4$L! A0#%     @ X*P:4\% ;R5@ @  00<  !D              ("!
MK8X  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #@K!I3
M]6]@'2X#   T#0  &0              @(%$D0  >&PO=V]R:W-H965T<R]S
M:&5E=#,T+GAM;%!+ 0(4 Q0    ( ."L&E,E@*)>8@(  .($   9
M      " @:F4  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%
M  @ X*P:4Q*#KP!! P  +!0   T              ( !0I<  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " #@K!I3EXJ[',     3 @  "P
M@ &NF@  7W)E;',O+G)E;'-02P$"% ,4    " #@K!I3&+)P/E,#  #(%P
M#P              @ &7FP  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
MX*P:4TN*H MS 0  <!4  !H              ( !%Y\  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ X*P:4]\A)QN2 0  ^14  !,
M             ( !PJ   %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     "L
,*P"D"P  A:(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>126</ContextCount>
  <ElementCount>228</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>34</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>1001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1002 - Statement - Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss</Role>
      <ShortName>Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1003 - Statement - Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical</Role>
      <ShortName>Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1004 - Statement - Condensed Consolidated Interim Statements of Financial Position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition</Role>
      <ShortName>Condensed Consolidated Interim Statements of Financial Position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity</Role>
      <ShortName>Condensed Consolidated Interim Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1006 - Statement - Condensed Consolidated Interim Cash Flow Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements</Role>
      <ShortName>Condensed Consolidated Interim Cash Flow Statements</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007 - Disclosure - General Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/GeneralInformation</Role>
      <ShortName>General Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1009 - Disclosure - Critical Accounting Judgements and Key Sources of Estimation Uncertainty</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty</Role>
      <ShortName>Critical Accounting Judgements and Key Sources of Estimation Uncertainty</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>1010 - Disclosure - Significant Events In The Reporting Period</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/SignificantEventsInTheReportingPeriod</Role>
      <ShortName>Significant Events In The Reporting Period</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>1011 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>1012 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>1013 - Disclosure - Warrants and Share-based Payment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/WarrantsAndShareBasedPayment</Role>
      <ShortName>Warrants and Share-based Payment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>1014 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/MarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>1015 - Disclosure - Share Capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/ShareCapital</Role>
      <ShortName>Share Capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>1016 - Disclosure - Lease Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/LeaseLiabilities</Role>
      <ShortName>Lease Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>1017 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>1018 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://ascendispharma.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>1019 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ascendispharma.com/role/Revenue</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>1020 - Disclosure - Warrants and Share-based Payment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables</Role>
      <ShortName>Warrants and Share-based Payment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ascendispharma.com/role/WarrantsAndShareBasedPayment</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>1021 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/MarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ascendispharma.com/role/MarketableSecurities</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>1022 - Disclosure - Lease Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/LeaseLiabilitiesTables</Role>
      <ShortName>Lease Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ascendispharma.com/role/LeaseLiabilities</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>1023 - Disclosure - Significant Events in the Reporting Period - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail</Role>
      <ShortName>Significant Events in the Reporting Period - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>1024 - Disclosure - Revenue - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/RevenueAdditionalInformationDetail</Role>
      <ShortName>Revenue - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>1025 - Disclosure - Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail</Role>
      <ShortName>Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>1026 - Disclosure - Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail</Role>
      <ShortName>Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>1027 - Disclosure - Segment Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/SegmentInformationAdditionalInformationDetail</Role>
      <ShortName>Segment Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>1028 - Disclosure - Warrants and Share-based Payment - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail</Role>
      <ShortName>Warrants and Share-based Payment - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>1029 - Disclosure - Warrants and Share-based Payment - Schedule of Warrant Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail</Role>
      <ShortName>Warrants and Share-based Payment - Schedule of Warrant Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>1030 - Disclosure - Marketable Securities - Additional information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/MarketableSecuritiesAdditionalInformationDetail</Role>
      <ShortName>Marketable Securities - Additional information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>1031 - Disclosure - Marketable Securities - Summary of Marketable Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail</Role>
      <ShortName>Marketable Securities - Summary of Marketable Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>1032 - Disclosure - Share Capital - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail</Role>
      <ShortName>Share Capital - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>1033 - Disclosure - Lease Liabilities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail</Role>
      <ShortName>Lease Liabilities - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>1034 - Disclosure - Lease Liabilities - Summary of Maturity Analysis for Lease Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail</Role>
      <ShortName>Lease Liabilities - Summary of Maturity Analysis for Lease Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="d206395d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>1035 - Disclosure - Subsequent Events - Additional information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail</Role>
      <ShortName>Subsequent Events - Additional information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="6-K" original="d206395d6k.htm">d206395d6k.htm</File>
    <File doctype="6-K" original="d206395dex991.htm">d206395dex991.htm</File>
    <File>asnd-20210630.xsd</File>
    <File>asnd-20210630_cal.xml</File>
    <File>asnd-20210630_def.xml</File>
    <File>asnd-20210630_lab.xml</File>
    <File>asnd-20210630_pre.xml</File>
    <File>d206395dex992.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>52
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d206395d6k.htm d206395dex991.htm": {
   "axisCustom": 1,
   "axisStandard": 12,
   "contextCount": 126,
   "dts": {
    "calculationLink": {
     "local": [
      "asnd-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "asnd-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d206395d6k.htm",
      "d206395dex991.htm"
     ]
    },
    "labelLink": {
     "local": [
      "asnd-20210630_lab.xml",
      "doc_full_ifrs-en_2020-03-16.xml",
      "dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "asnd-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "local": [
      "ref_ifrs_3_2020-03-16.xml",
      "ref_ias_1_2020-03-16.xml",
      "ref_ias_7_2020-03-16.xml",
      "dei-ref-2020-01-31.xml",
      "ref_ias_12_2020-03-16.xml",
      "ref_ifrs_5_2020-03-16.xml",
      "ref_ifrs_4_2020-03-16.xml",
      "ref_ifrs_13_2020-03-16.xml",
      "ref_ias_29_2020-03-16.xml",
      "ref_ifric_2_2020-03-16.xml",
      "ref_ifrs_14_2020-03-16.xml",
      "ref_ias_8_2020-03-16.xml",
      "ref_ifrs_12_2020-03-16.xml",
      "ref_ifrs_15_2020-03-16.xml",
      "ref_ifrs_2_2020-03-16.xml",
      "ref_ias_27_2020-03-16.xml",
      "ref_ias_2_2020-03-16.xml",
      "ref_ifrs_17_2020-03-16.xml",
      "ref_ias_36_2020-03-16.xml",
      "ref_ias_23_2020-03-16.xml",
      "ref_ias_41_2020-03-16.xml",
      "ref_ifrs_7_2020-03-16.xml",
      "ref_ias_33_2020-03-16.xml",
      "ref_ifrs_1_2020-03-16.xml",
      "ref_ifrs_8_2020-03-16.xml",
      "ref_ias_19_2020-03-16.xml",
      "ref_ias_24_2020-03-16.xml",
      "ref_ias_10_2020-03-16.xml",
      "ref_ias_40_2020-03-16.xml",
      "ref_ifrs_16_2020-03-16.xml",
      "ref_ias_34_2020-03-16.xml",
      "ref_ifric_5_2020-03-16.xml",
      "ref_ias_26_2020-03-16.xml",
      "ref_ias_20_2020-03-16.xml",
      "ref_ifrs_6_2020-03-16.xml",
      "ref_ias_21_2020-03-16.xml",
      "ref_ias_37_2020-03-16.xml",
      "ref_ias_38_2020-03-16.xml",
      "ref_sic_29_2020-03-16.xml",
      "ref_ias_16_2020-03-16.xml"
     ]
    },
    "schema": {
     "local": [
      "asnd-20210630.xsd",
      "xbrl-linkbase-2003-12-31.xsd",
      "xl-2003-12-31.xsd",
      "xlink-2003-12-31.xsd",
      "dei-2020-01-31.xsd",
      "xbrl-instance-2003-12-31.xsd",
      "xbrldt-2005.xsd",
      "nonNumeric-2009-12-16.xsd",
      "numeric-2009-12-16.xsd",
      "full_ifrs-cor_2020-03-16.xsd",
      "srt-2020-01-31.xsd",
      "ref-2006-02-27.xsd",
      "srt-types-2020-01-31.xsd",
      "country-2020-01-31.xsd",
      "negated-2009-12-16.xsd",
      "net-2009-12-16.xsd",
      "currency-2020-01-31.xsd",
      "exch-2020-01-31.xsd",
      "naics-2017-01-31.xsd",
      "sic-2020-01-31.xsd",
      "stpr-2018-01-31.xsd",
      "factExplanatory-2009-12-16.xsd",
      "us-types-2020-01-31.xsd",
      "reference-2009-12-16.xsd",
      "deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 258,
   "entityCount": 1,
   "hidden": {
    "http://ascendispharma.com/20210630": 2,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 7
   },
   "keyCustom": 30,
   "keyStandard": 198,
   "memberCustom": 15,
   "memberStandard": 18,
   "nsprefix": "asnd",
   "nsuri": "http://ascendispharma.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395d6k.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "1001 - Document - Cover Page",
     "role": "http://ascendispharma.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395d6k.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:SignificantEventsInTheReportingPeriodTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1010 - Disclosure - Significant Events In The Reporting Period",
     "role": "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriod",
     "shortName": "Significant Events In The Reporting Period",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:SignificantEventsInTheReportingPeriodTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1011 - Disclosure - Revenue",
     "role": "http://ascendispharma.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1012 - Disclosure - Segment Information",
     "role": "http://ascendispharma.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1013 - Disclosure - Warrants and Share-based Payment",
     "role": "http://ascendispharma.com/role/WarrantsAndShareBasedPayment",
     "shortName": "Warrants and Share-based Payment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1014 - Disclosure - Marketable Securities",
     "role": "http://ascendispharma.com/role/MarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1015 - Disclosure - Share Capital",
     "role": "http://ascendispharma.com/role/ShareCapital",
     "shortName": "Share Capital",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1016 - Disclosure - Lease Liabilities",
     "role": "http://ascendispharma.com/role/LeaseLiabilities",
     "shortName": "Lease Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1017 - Disclosure - Subsequent Events",
     "role": "http://ascendispharma.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1018 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1019 - Disclosure - Revenue (Tables)",
     "role": "http://ascendispharma.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P04_01_2021To06_30_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002 - Statement - Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss)",
     "role": "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss",
     "shortName": "Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P04_01_2021To06_30_2021",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1020 - Disclosure - Warrants and Share-based Payment (Tables)",
     "role": "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables",
     "shortName": "Warrants and Share-based Payment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1021 - Disclosure - Marketable Securities (Tables)",
     "role": "http://ascendispharma.com/role/MarketableSecuritiesTables",
     "shortName": "Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1022 - Disclosure - Lease Liabilities (Tables)",
     "role": "http://ascendispharma.com/role/LeaseLiabilitiesTables",
     "shortName": "Lease Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "asnd:SignificantEventsInTheReportingPeriodTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To03_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "asnd:ExpectedNonCashGainTowardsShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1023 - Disclosure - Significant Events in the Reporting Period - Additional Information (Detail)",
     "role": "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail",
     "shortName": "Significant Events in the Reporting Period - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "asnd:SignificantEventsInTheReportingPeriodTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To03_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "asnd:ExpectedNonCashGainTowardsShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "asnd:UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1024 - Disclosure - Revenue - Additional Information (Detail)",
     "role": "http://ascendispharma.com/role/RevenueAdditionalInformationDetail",
     "shortName": "Revenue - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021_VisenPharmaceuticalsMemberifrsfullMajorCustomersAxis",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "asnd:UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "asnd:DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P04_01_2021To06_30_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromRenderingOfServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1025 - Disclosure - Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Detail)",
     "role": "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail",
     "shortName": "Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "asnd:DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P04_01_2021To06_30_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromRenderingOfServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "asnd:DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P04_01_2021To06_30_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "asnd:DeferredRevenueFromAssociate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1026 - Disclosure - Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Parenthetical) (Detail)",
     "role": "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail",
     "shortName": "Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Parenthetical) (Detail)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "asnd:DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P04_01_2021To06_30_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "asnd:DeferredRevenueFromAssociate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "asnd:NumberOfReportableOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1027 - Disclosure - Segment Information - Additional Information (Detail)",
     "role": "http://ascendispharma.com/role/SegmentInformationAdditionalInformationDetail",
     "shortName": "Segment Information - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "asnd:NumberOfReportableOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Segment",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn06_30_2021",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ParValuePerShare",
      "reportCount": 1,
      "unitRef": "Unit_DKK_per_Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1028 - Disclosure - Warrants and Share-based Payment - Additional Information (Detail)",
     "role": "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail",
     "shortName": "Warrants and Share-based Payment - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis",
      "decimals": "INF",
      "lang": null,
      "name": "ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn12_31_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1029 - Disclosure - Warrants and Share-based Payment - Schedule of Warrant Activity (Detail)",
     "role": "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail",
     "shortName": "Warrants and Share-based Payment - Schedule of Warrant Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn12_31_2020_Warrant1MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021_Warrant1MemberifrsfullComponentsOfEquityAxis",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003 - Statement - Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss) (Parenthetical)",
     "role": "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical",
     "shortName": "Condensed Consolidated Interim Statements of Profit or Loss and Comprehensive Income / (Loss) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021_Warrant1MemberifrsfullComponentsOfEquityAxis",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P06_30_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:WeightedAverageDurationOfMarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1030 - Disclosure - Marketable Securities - Additional information (Detail)",
     "role": "http://ascendispharma.com/role/MarketableSecuritiesAdditionalInformationDetail",
     "shortName": "Marketable Securities - Additional information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P06_30_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:WeightedAverageDurationOfMarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn06_30_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NoncurrentFinancialAssetsAvailableforsale",
      "reportCount": 1,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1031 - Disclosure - Marketable Securities - Summary of Marketable Securities (Detail)",
     "role": "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail",
     "shortName": "Marketable Securities - Summary of Marketable Securities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "asnd:DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock",
       "ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn06_30_2021_FinancialAssetsAtAmortisedCostMemberifrsfullCategoriesOfFinancialAssetsAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:FinancialAssetsAvailableforsale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn06_30_2021",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ParValuePerShare",
      "reportCount": 1,
      "unitRef": "Unit_DKK_per_Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1032 - Disclosure - Share Capital - Additional Information (Detail)",
     "role": "http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail",
     "shortName": "Share Capital - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn06_30_2021",
      "decimals": "INF",
      "lang": null,
      "name": "ifrs-full:NumberOfSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021_TopOfRangeMemberifrsfullRangeAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:LeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1033 - Disclosure - Lease Liabilities - Additional Information (Detail)",
     "role": "http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail",
     "shortName": "Lease Liabilities - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021_TopOfRangeMemberifrsfullRangeAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "asnd:LeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "asnd:DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:GrossLeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1034 - Disclosure - Lease Liabilities - Summary of Maturity Analysis for Lease Liabilities (Detail)",
     "role": "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail",
     "shortName": "Lease Liabilities - Summary of Maturity Analysis for Lease Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "asnd:DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn06_30_2021_DiscountedCashFlowMemberASNDLeaseLiabilitiesAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:GrossLeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P08_25_2021To08_25_2021_NonadjustingEventsAfterReportingPeriodMemberifrsfullNonadjustingEventsAfterReportingPeriodAxis",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "asnd:ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1035 - Disclosure - Subsequent Events - Additional information (Detail)",
     "role": "http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail",
     "shortName": "Subsequent Events - Additional information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P08_25_2021To08_25_2021_NonadjustingEventsAfterReportingPeriodMemberifrsfullNonadjustingEventsAfterReportingPeriodAxis",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "asnd:ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn06_30_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "asnd:GoodwillAndOtherIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004 - Statement - Condensed Consolidated Interim Statements of Financial Position",
     "role": "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition",
     "shortName": "Condensed Consolidated Interim Statements of Financial Position",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn06_30_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "asnd:GoodwillAndOtherIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn12_31_2019",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity",
     "role": "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity",
     "shortName": "Condensed Consolidated Interim Statements of Changes in Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "PAsOn12_31_2019",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006 - Statement - Condensed Consolidated Interim Cash Flow Statements",
     "role": "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements",
     "shortName": "Condensed Consolidated Interim Cash Flow Statements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": "-3",
      "lang": null,
      "name": "asnd:NoncashConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_EUR",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1007 - Disclosure - General Information",
     "role": "http://ascendispharma.com/role/GeneralInformation",
     "shortName": "General Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1008 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://ascendispharma.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1009 - Disclosure - Critical Accounting Judgements and Key Sources of Estimation Uncertainty",
     "role": "http://ascendispharma.com/role/CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty",
     "shortName": "Critical Accounting Judgements and Key Sources of Estimation Uncertainty",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d206395dex991.htm",
      "contextRef": "P01_01_2021To06_30_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 34,
   "tag": {
    "asnd_AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 11.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment for decrease increase in trade receivables other receivables and other short term deposits.",
        "label": "Adjustment For Decrease Increase In Trade Receivables Other Receivables And Other Short Term Deposits",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "AdjustmentForDecreaseIncreaseInTradeReceivablesOtherReceivablesAndOtherShortTermDeposits",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_AdjustmentsForIncreaseDecreaseInPrepayments": {
     "auth_ref": [],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 12.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for Increase Decrease in Prepayments",
        "label": "Adjustments for Increase Decrease in Prepayments",
        "terseLabel": "Prepayments"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInPrepayments",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_AgencyBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency bonds [Member].",
        "label": "Agency bonds [Member]",
        "terseLabel": "Agency bonds [Member]"
       }
      }
     },
     "localname": "AgencyBondsMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of other equity instruments cancelled in sharebased payment arrangement.",
        "label": "Aggregate number of other equity instruments cancelled in sharebased payment arrangement",
        "terseLabel": "Aggregate number of other equity instruments cancelled"
       }
      }
     },
     "localname": "AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "asnd_CashDeposits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank deposits.",
        "label": "Cash Deposits",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "CashDeposits",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_ChangesInWorkingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes in working capital.",
        "label": "Changes in working capital [abstract]",
        "terseLabel": "Changes in working capital:"
       }
      }
     },
     "localname": "ChangesInWorkingCapitalAbstract",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_CommercialPapersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial papers [Member].",
        "label": "Commercial papers [Member]",
        "terseLabel": "Commercial papers [Member]"
       }
      }
     },
     "localname": "CommercialPapersMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_CorporateBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate bonds [Member].",
        "label": "Corporate bonds [Member]",
        "terseLabel": "Corporate bonds [Member]"
       }
      }
     },
     "localname": "CorporateBondsMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_DeferredRevenueFromAssociate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred revenue from associate.",
        "label": "Deferred revenue from associate",
        "terseLabel": "Deferred revenue from associate"
       }
      }
     },
     "localname": "DeferredRevenueFromAssociate",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_DisclosureDetailedInformationAboutMarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Detailed Information About Marketable Securities LineItems.",
        "label": "Disclosure Detailed Information About Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "DisclosureDetailedInformationAboutMarketableSecuritiesLineItems",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_DisclosureDetailedInformationAboutMarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure detailed information about marketable securities.",
        "label": "Disclosure Detailed Information About Marketable Securities [Table]",
        "terseLabel": "Disclosure detailed information about marketable securities [Table]"
       }
      }
     },
     "localname": "DisclosureDetailedInformationAboutMarketableSecuritiesTable",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure \u200bof available for sale\u200b assets\u200b explanatory.",
        "label": "Disclosure Of Available For Sale Assets Explanatory [Text Block]",
        "terseLabel": "Summary of Marketable Securities"
       }
      }
     },
     "localname": "DisclosureOfAvailableForSaleAssetsExplanatoryTextBlock",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "asnd_DisclosureOfEmployeeCompensationCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of employees compensation costs.",
        "label": "Disclosure of employee compensation costs [abstract]"
       }
      }
     },
     "localname": "DisclosureOfEmployeeCompensationCostsAbstract",
     "nsuri": "http://ascendispharma.com/20210630",
     "xbrltype": "stringItemType"
    },
    "asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of maturity analysis of lease liability.",
        "label": "Disclosure Of Maturity Analysis Of Lease Liability [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfLeaseLiabilityAbstract",
     "nsuri": "http://ascendispharma.com/20210630",
     "xbrltype": "stringItemType"
    },
    "asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of maturity analysis of lease liability explanatory.",
        "label": "Disclosure Of Maturity Analysis Of Lease Liability Explanatory [Text Block]",
        "terseLabel": "Summary of Maturity Analysis for Lease Liabilities"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfLeaseLiabilityExplanatoryTextBlock",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of maturity analysis of lease liability.",
        "label": "Disclosure Of Maturity Analysis Of Lease Liability [Line Items]",
        "terseLabel": "Disclosure of maturity analysis of operating lease payments [line items]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfLeaseLiabilityLineItems",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_DisclosureOfMaturityAnalysisOfLeaseLiabilityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of maturity analysis of lease liability.",
        "label": "Disclosure Of Maturity Analysis Of Lease Liability [Table]",
        "terseLabel": "Disclosure of maturity analysis of operating lease payments [table]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfLeaseLiabilityTable",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of New and Amended Standards Adoption [Policy Text Block].",
        "label": "Disclosure of New and Amended Standards Adoption [Policy Text Block]",
        "terseLabel": "New and Amended IFRS Standards Adopted by the Company"
       }
      }
     },
     "localname": "DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of revenue recognized in the statement of profit or loss explanatory.",
        "label": "Disclosure of revenue recognized in the statement of profit or loss explanatory",
        "terseLabel": "Schedule of Revenue Recognized in the Statement of Profit or Loss"
       }
      }
     },
     "localname": "DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of summary of significant accounting policies [abstract]",
        "label": "Disclosure of summary of significant accounting policies [abstract]"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract",
     "nsuri": "http://ascendispharma.com/20210630",
     "xbrltype": "stringItemType"
    },
    "asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Summary Of Significant Accounting Policies [Line Items]",
        "verboseLabel": "Disclosure of summary of significant accounting policies [line items]"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Summary Of Significant Accounting Policies [Table]",
        "verboseLabel": "Disclosure of summary of significant accounting policies [table]"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_DisclosureOfWarrantActivityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Warrant Activity [line items]",
        "label": "Disclosure Of Warrant Activity [line items]",
        "terseLabel": "Disclosure Of Warrant Activity [line items]"
       }
      }
     },
     "localname": "DisclosureOfWarrantActivityLineItems",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_DistributableEquity": {
     "auth_ref": [],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributable equity.",
        "label": "Distributable equity",
        "terseLabel": "Distributable equity"
       }
      }
     },
     "localname": "DistributableEquity",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_ExpectedNonCashGainTowardsShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected Non Cash Gain towards Shares.",
        "label": "Expected Non Cash Gain towards Shares",
        "terseLabel": "Expected Non cash Gain recognised towards Shares"
       }
      }
     },
     "localname": "ExpectedNonCashGainTowardsShares",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_GoodwillAndOtherIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 21.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and other intangible assets.",
        "label": "Goodwill and Other Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "GoodwillAndOtherIntangibleAssets",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_HighGradeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "High grade member.",
        "label": "High grade [Member]",
        "terseLabel": "High grade [member]"
       }
      }
     },
     "localname": "HighGradeMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_LeaseLiabilitiesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Liabilities [Axis]"
       }
      }
     },
     "localname": "LeaseLiabilitiesAxis",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_LeaseLiabilitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Liabilities [Domain]"
       }
      }
     },
     "localname": "LeaseLiabilitiesDomain",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_LeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Term.",
        "label": "Lease Term",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LeaseTerm",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "asnd_LeasesOptionToExtendAndTerminationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases option to extend and termination term.",
        "label": "Leases Option To Extend And Termination Term",
        "terseLabel": "Lease extension and termination option term"
       }
      }
     },
     "localname": "LeasesOptionToExtendAndTerminationTerm",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "asnd_LowerMediumGradeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower medium grade [Member].",
        "label": "Lower Medium Grade [Member]",
        "terseLabel": "Lower Medium Grade [member]"
       }
      }
     },
     "localname": "LowerMediumGradeMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_MarketableSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities [Abstract]",
        "verboseLabel": "Marketable securities [Abstract]"
       }
      }
     },
     "localname": "MarketableSecuritiesAbstract",
     "nsuri": "http://ascendispharma.com/20210630",
     "xbrltype": "stringItemType"
    },
    "asnd_NonCurrentAssetsFinanceLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non current assets finance liabilities abstract.",
        "label": "Non Current Assets Finance Liabilities [abstract]"
       }
      }
     },
     "localname": "NonCurrentAssetsFinanceLiabilitiesAbstract",
     "nsuri": "http://ascendispharma.com/20210630",
     "xbrltype": "stringItemType"
    },
    "asnd_NonadjustingEventsAfterReportingPeriodMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonadjusting events after reporting period.",
        "label": "Nonadjusting Events After Reporting Period [Member]"
       }
      }
     },
     "localname": "NonadjustingEventsAfterReportingPeriodMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_NoncashConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash consideration",
        "label": "Non-cash consideration",
        "negatedLabel": "Reversal of non-cash consideration relating to revenue"
       }
      }
     },
     "localname": "NoncashConsideration",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Instruments Authorised In Share-Based Payment Arrangement",
        "label": "Number Of Instruments Authorised In Share-Based Payment Arrangement",
        "terseLabel": "Number of other equity instruments authorized"
       }
      }
     },
     "localname": "NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of other equity instruments vested in share-based payment arrangement.",
        "label": "Number of other equity instruments vested in share-based payment arrangement",
        "terseLabel": "Vested at the balance sheet date"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "asnd_NumberOfReportableOperatingSegments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reportable operating segments.",
        "label": "Number of reportable operating segments",
        "terseLabel": "Number of reportable segment"
       }
      }
     },
     "localname": "NumberOfReportableOperatingSegments",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "asnd_OtherCollaborationPartnersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Collaboration Partners [Member]",
        "verboseLabel": "Other collaboration partners [Member]"
       }
      }
     },
     "localname": "OtherCollaborationPartnersMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_PrimeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prime member.",
        "label": "Prime [Member]",
        "terseLabel": "Prime [member]"
       }
      }
     },
     "localname": "PrimeMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 27.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from exercise of warrants classified as financing activities.",
        "label": "Proceeds From Exercise Of Warrants Classified As Financing Activities",
        "verboseLabel": "Proceeds from exercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfWarrantsClassifiedAsFinancingActivities",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proportion of interest Hold in Issued And Outstanding Shares of Associate.",
        "label": "Proportion of interest Hold in Issued And Outstanding Shares of Associate",
        "terseLabel": "Proportion of Interest retain in issued and Outstanding shares of Associate"
       }
      }
     },
     "localname": "ProportionOfInterestHoldInIssuedAndOutstandingSharesOfAssociate",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "asnd_RetainedPercentageOfIssuedAndOutstandingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retained percentage of issued and outstanding shares.",
        "label": "Retained Percentage Of Issued And Outstanding Shares",
        "terseLabel": "Retained percentage of issued and outstanding shares"
       }
      }
     },
     "localname": "RetainedPercentageOfIssuedAndOutstandingShares",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/RevenueAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "asnd_RevenueFromSaleOfClinicalSupply": {
     "auth_ref": [],
     "calculation": {
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail": {
       "order": 2.0,
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of clinical supply.",
        "label": "Revenue From Sale Of Clinical Supply",
        "terseLabel": "Sale of clinical supply (recognized at a point in time)"
       }
      }
     },
     "localname": "RevenueFromSaleOfClinicalSupply",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reversal of prior period write downs of inventories expected impact on research and development costs.",
        "label": "Reversal Of Prior Period Write Downs Of Inventories Expected Impact On Research And Development Costs",
        "terseLabel": "Reversal of prior period write-downs of inventories expected to have a positive impact on research and development costs"
       }
      }
     },
     "localname": "ReversalOfPriorPeriodWriteDownsOfInventoriesExpectedImpactOnResearchAndDevelopmentCosts",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_SaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock [Axis].",
        "label": "Sale Of Stock [Axis]",
        "terseLabel": "Sale Of Stock [Axis]"
       }
      }
     },
     "localname": "SaleOfStockAxis",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail",
      "http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_SaleOfStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock [Member].",
        "label": "Sale Of Stock [Member]",
        "terseLabel": "Sale Of Stock [Member]"
       }
      }
     },
     "localname": "SaleOfStockMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail",
      "http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_ShortTermMarketableSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term marketable securities.",
        "label": "Short Term Marketable Securities",
        "terseLabel": "Short-term marketable securities"
       }
      }
     },
     "localname": "ShortTermMarketableSecurities",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_SignificantEventsInTheReportingPeriodTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant events in the reporting period.",
        "label": "Significant Events In The Reporting Period [Text Block]",
        "terseLabel": "Significant Events In The Reporting Period"
       }
      }
     },
     "localname": "SignificantEventsInTheReportingPeriodTextBlock",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriod"
     ],
     "xbrltype": "textBlockItemType"
    },
    "asnd_Statement1LineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statement1 line items.",
        "label": "Statement1 [Line Items]",
        "terseLabel": "Statement [line items]"
       }
      }
     },
     "localname": "Statement1LineItems",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_Statement1Table": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statement1 table.",
        "label": "Statement1 [Table]",
        "terseLabel": "Statement [table]"
       }
      }
     },
     "localname": "Statement1Table",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [line items]",
        "terseLabel": "Statement [LineItems]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statement of comprehensive income, profit or loss location.",
        "label": "Statement of comprehensive income, profit or loss location [axis]",
        "terseLabel": "Statement of comprehensive income, profit or loss location [axis]"
       }
      }
     },
     "localname": "StatementOfComprehensiveIncomeProfitOrLossLocationAxis",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statement of comprehensive income, profit or loss location 1.",
        "label": "Statement of comprehensive income, profit or loss location [member]",
        "terseLabel": "Statement of comprehensive income, profit or loss location [member]"
       }
      }
     },
     "localname": "StatementOfComprehensiveIncomeProfitOrLossLocationMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Text block [abstract]",
        "label": "Text block [abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://ascendispharma.com/20210630",
     "xbrltype": "stringItemType"
    },
    "asnd_TransactionsWithOwnersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transactions with owners.",
        "label": "Transactions With Owners [Abstract]",
        "terseLabel": "Transactions with Owners"
       }
      }
     },
     "localname": "TransactionsWithOwnersAbstract",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "asnd_UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payment received non cash consideration towards license revenue.",
        "label": "Upfront Payment Received Non Cash Consideration Towards License Revenue",
        "verboseLabel": "Upfront payment received non cash consideration towards license revenue"
       }
      }
     },
     "localname": "UpfrontPaymentReceivedNonCashConsiderationTowardsLicenseRevenue",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/RevenueAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "asnd_UpperMediumGradeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper medium grade [Member].",
        "label": "Upper Medium Grade [Member]",
        "terseLabel": "Upper Medium Grade [member]"
       }
      }
     },
     "localname": "UpperMediumGradeMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_UsGovernmentBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Government Bonds [Member].",
        "label": "US Government Bonds [Member]",
        "terseLabel": "US Government bonds [Member]"
       }
      }
     },
     "localname": "UsGovernmentBondsMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_UsTreasuryBillsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Treasury bills [Member].",
        "label": "US Treasury bills [Member]",
        "terseLabel": "US Treasury bills [Member]"
       }
      }
     },
     "localname": "UsTreasuryBillsMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_VisenPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Visen Pharmaceuticals [Member]",
        "verboseLabel": "VISEN Pharmaceuticals [Member]"
       }
      }
     },
     "localname": "VisenPharmaceuticalsMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/RevenueAdditionalInformationDetail",
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail",
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_VisenSeriesBFinancingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VISEN Series B Financing.",
        "label": "VISEN Series B Financing [Member]"
       }
      }
     },
     "localname": "VisenSeriesBFinancingMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_Warrant1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants.",
        "label": "Warrant1 [member]",
        "terseLabel": "Warrants [member]"
       }
      }
     },
     "localname": "Warrant1Member",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables"
     ],
     "xbrltype": "domainItemType"
    },
    "asnd_WeightedAverageDurationOfMarketableSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average duration of marketable securities.",
        "label": "Weighted Average Duration Of Marketable Securities",
        "terseLabel": "Weighted average duration of marketable securities"
       }
      }
     },
     "localname": "WeightedAverageDurationOfMarketableSecurities",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "asnd_WeightedAverageDurationOfMarketableSecuritiesCurrent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average duration of marketable securities current.",
        "label": "Weighted Average Duration Of Marketable Securities Current",
        "terseLabel": "Weighted average duration of marketable securities current"
       }
      }
     },
     "localname": "WeightedAverageDurationOfMarketableSecuritiesCurrent",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "asnd_WeightedAverageDurationOfMarketableSecuritiesNoncurrent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average duration of marketable securities noncurrent.",
        "label": "Weighted Average Duration Of Marketable Securities Noncurrent",
        "terseLabel": "Weighted average duration of marketable securities non-current"
       }
      }
     },
     "localname": "WeightedAverageDurationOfMarketableSecuritiesNoncurrent",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price of other equity instruments vested in share-based payment arrangement.",
        "label": "Weighted average exercise price of other equity instruments vested in share-based payment arrangement",
        "terseLabel": "Vested at the balance sheet date"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "asnd_ZeroCouponMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zero Coupon [Member].",
        "label": "Zero Coupon [Member]",
        "terseLabel": "Zero Coupon [Member]"
       }
      }
     },
     "localname": "ZeroCouponMember",
     "nsuri": "http://ascendispharma.com/20210630",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "China [member]"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ascendispharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ascendispharma.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ascendispharma.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ascendispharma.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ascendispharma.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ascendispharma.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ascendispharma.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ascendispharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ifrs-full_AdjustmentsForAmortisationExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 15.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for amortisation expense",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentsForAmortisationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDepreciationExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for depreciation expense",
        "verboseLabel": "Depreciation"
       }
      }
     },
     "localname": "AdjustmentsForDepreciationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncome": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 13.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in deferred income to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in deferred income",
        "terseLabel": "Contract liabilities (deferred income)"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInDeferredIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 14.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade and other payables",
        "terseLabel": "Trade payables and other payables"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss) [abstract]",
        "terseLabel": "Adjustments for non-cash items:"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "terseLabel": "Share-based payment"
       }
      }
     },
     "localname": "AdjustmentsForSharebasedPayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "auth_ref": [
      "r17",
      "r104",
      "r108",
      "r109",
      "r121",
      "r134",
      "r138",
      "r154",
      "r156",
      "r157"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated time bands [member]",
        "terseLabel": "Aggregated time bands [member]"
       }
      }
     },
     "localname": "AggregatedTimeBandsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllLevelsOfFairValueHierarchyMember": {
     "auth_ref": [
      "r49",
      "r97"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "All levels of fair value hierarchy [member]",
        "terseLabel": "All levels of fair value hierarchy [member]"
       }
      }
     },
     "localname": "AllLevelsOfFairValueHierarchyMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r15",
      "r96",
      "r97",
      "r98",
      "r143",
      "r146"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BasicAndDilutedEarningsLossPerShare": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of earnings per share when the basic and diluted measurements are equal. [Refer: Basic earnings (loss) per share; Diluted earnings (loss) per share]"
       }
      },
      "en-us": {
       "role": {
        "label": "Basic and diluted earnings (loss) per share",
        "terseLabel": "Basic and diluted earnings / (loss) per share"
       }
      }
     },
     "localname": "BasicAndDilutedEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_BottomOfRangeMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r116",
      "r131",
      "r156"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Bottom of range [member]",
        "terseLabel": "Bottom of range [member]"
       }
      }
     },
     "localname": "BottomOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r13",
      "r78",
      "r93"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 18.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents at June 30",
        "periodStartLabel": "Cash and cash equivalents at January 1",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r64",
      "r79"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 25.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Cash flows from / (used in) financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities [abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r64",
      "r79"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 19.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Cash flows from / (used in) investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities [abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "auth_ref": [
      "r64",
      "r79"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Cash flows from / (used in) operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities [abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperations": {
     "auth_ref": [
      "r72",
      "r80"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash from (used in) the entity's operations."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operations",
        "totalLabel": "Cash flows generated from / (used in) operations"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CategoriesOfCurrentFinancialAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of current financial assets [abstract]",
        "terseLabel": "Categories of current financial assets [abstract]"
       }
      }
     },
     "localname": "CategoriesOfCurrentFinancialAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CategoriesOfFinancialAssetsAxis": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of financial assets [axis]",
        "terseLabel": "Categories of financial assets [axis]"
       }
      }
     },
     "localname": "CategoriesOfFinancialAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "auth_ref": [
      "r129",
      "r130",
      "r153",
      "r159",
      "r160"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]",
        "terseLabel": "Classes of financial assets [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]",
        "terseLabel": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical",
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail",
      "http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]",
        "verboseLabel": "Other comprehensive income / (loss)"
       }
      }
     },
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r3",
      "r31",
      "r82",
      "r84",
      "r86",
      "r91"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": 10.0,
       "parentTag": "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent",
       "weight": 1.0
      },
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossAlternate1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "totalLabel": "Total comprehensive income / (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "auth_ref": [
      "r3",
      "r33"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to owners of parent",
        "totalLabel": "Attributable to owners of the Company"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssets": {
     "auth_ref": [
      "r18",
      "r86",
      "r87"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 14.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "CurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets [abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentContractLiabilities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 7.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current contract liabilities. [Refer: Contract liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current contract liabilities",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "CurrentContractLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentFinancialAssetsAvailableforsale": {
     "auth_ref": [
      "r169"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 19.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Current financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current financial assets available-for-sale",
        "terseLabel": "Current financial assets available-for-sale",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "CurrentFinancialAssetsAvailableforsale",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition",
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 6.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current lease liabilities",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "CurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilities": {
     "auth_ref": [
      "r20",
      "r86",
      "r89"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 5.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentPrepayments": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 17.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current prepayments. [Refer: Prepayments]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepayments",
        "terseLabel": "Prepayments"
       }
      }
     },
     "localname": "CurrentPrepayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxLiabilities": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 10.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax liabilities",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "CurrentTaxLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTradeReceivables": {
     "auth_ref": [
      "r19",
      "r23"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 15.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current trade receivables",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "CurrentTradeReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of dilutive potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Dilutive effect of convertible instruments on number of ordinary shares",
        "terseLabel": "Warrants outstanding"
       }
      }
     },
     "localname": "DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of accounting judgements and estimates [text block]",
        "verboseLabel": "Critical Accounting Judgements and Key Sources of Estimation Uncertainty"
       }
      }
     },
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CriticalAccountingJudgementsAndKeySourcesOfEstimationUncertainty"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfAvailableforsaleAssetsExplanatory": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of financial assets classified as available for sale. [Refer: Financial assets available-for-sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of available-for-sale financial assets [text block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "DisclosureOfAvailableforsaleAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for the preparation of the financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of basis of preparation of financial statements [text block]",
        "terseLabel": "Basis of Preparation"
       }
      }
     },
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [abstract]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [line items]",
        "verboseLabel": "Disclosure of classes of share capital [line items]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [table]",
        "terseLabel": "Disclosure of classes of share capital [table]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for employee benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of employee benefits [text block]",
        "terseLabel": "Warrants and Share-based Payment"
       }
      }
     },
     "localname": "DisclosureOfEmployeeBenefitsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPayment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of entity's operating segments [text block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of events after reporting period [text block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of general information about financial statements [text block]",
        "terseLabel": "General Information"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/GeneralInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [abstract]",
        "terseLabel": "Revenue by geographical location"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "auth_ref": [
      "r110",
      "r111"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of leases [text block]",
        "terseLabel": "Lease Liabilities"
       }
      }
     },
     "localname": "DisclosureOfLeasesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [abstract]",
        "terseLabel": "Disclosure of non-adjusting events after reporting period [abstract]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [line items]",
        "terseLabel": "Disclosure of non-adjusting events after reporting period [line items]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]",
        "terseLabel": "Disclosure of non-adjusting events after reporting period [table]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]",
        "terseLabel": "Summary of Warrant Activity"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [abstract]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [line items]",
        "terseLabel": "Disclosure of operating segments [line items]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/RevenueAdditionalInformationDetail",
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsTable": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [table]",
        "terseLabel": "Disclosure of operating segments [table]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/RevenueAdditionalInformationDetail",
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfRevenueExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of revenue [text block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "DisclosureOfRevenueExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "terseLabel": "Share Capital"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/ShareCapital"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [text block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [abstract]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]",
        "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [line items]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]",
        "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DiscountedCashFlowMember": {
     "auth_ref": [
      "r99",
      "r101"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a specific valuation technique consistent with the income approach that involves analysing future cash flow amounts through the application of present value techniques and inputs (for example, weighted average cost of capital, long-term revenue growth rate, long-term pre-tax operating margin, discount for lack of marketability, control premium). [Refer: Income approach [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Discounted cash flow [member]",
        "terseLabel": "Total contractual cash-flows [member]"
       }
      }
     },
     "localname": "DiscountedCashFlowMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "auth_ref": [
      "r73",
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "terseLabel": "Effect of exchange rate changes on balances held in foreign currencies"
       }
      }
     },
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EntitysTotalForAssociatesMember": {
     "auth_ref": [
      "r55",
      "r57",
      "r95",
      "r162",
      "r166"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Associates' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for associates [member]",
        "terseLabel": "Entity's total for associates [member]"
       }
      }
     },
     "localname": "EntitysTotalForAssociatesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForExternalCreditGradesMember": {
     "auth_ref": [
      "r125",
      "r139",
      "r165",
      "r167",
      "r170"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'External credit grades' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for external credit grades [member]",
        "terseLabel": "Entity's total for external credit grades [member]"
       }
      }
     },
     "localname": "EntitysTotalForExternalCreditGradesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r15",
      "r24",
      "r81",
      "r83",
      "r96",
      "r97",
      "r98"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Equity",
        "periodStartLabel": "Equity",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [abstract]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total equity and liabilities"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and liabilities [abstract]",
        "terseLabel": "Equity and liabilities"
       }
      }
     },
     "localname": "EquityAndLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [member]",
        "terseLabel": "Equity [member]"
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossParenthetical",
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail",
      "http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The exercise price of outstanding share options."
       }
      },
      "en-us": {
       "role": {
        "label": "Exercise price of outstanding share options"
       }
      }
     },
     "localname": "ExercisePriceOfOutstandingShareOptions2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "auth_ref": [
      "r9"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions with employees",
        "verboseLabel": "Warrant compensation costs"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExternalCreditGradesAxis": {
     "auth_ref": [
      "r125",
      "r139",
      "r165",
      "r167",
      "r170"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "External credit grades [axis]",
        "terseLabel": "External credit grades [axis]"
       }
      }
     },
     "localname": "ExternalCreditGradesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_FinanceCosts": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      },
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": 8.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance costs",
        "negatedLabel": "Finance expenses",
        "terseLabel": "Reversal of finance expenses"
       }
      }
     },
     "localname": "FinanceCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncome": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0
      },
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": 7.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income",
        "negatedLabel": "Reversal of finance income",
        "terseLabel": "Finance income"
       }
      }
     },
     "localname": "FinanceIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssets": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r125",
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets",
        "terseLabel": "Financial assets"
       }
      }
     },
     "localname": "FinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsAtAmortisedCostMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets measured at amortised cost class. [Refer: Financial assets at amortised cost]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets at amortised cost, class [member]",
        "terseLabel": "Financial assets at amortised cost, class [member]"
       }
      }
     },
     "localname": "FinancialAssetsAtAmortisedCostMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsAtFairValueMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets measured at fair value class. [Refer: Financial assets; At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets at fair value, class [member]",
        "terseLabel": "Financial assets at fair value, class [member]"
       }
      }
     },
     "localname": "FinancialAssetsAtFairValueMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsAvailableforsale": {
     "auth_ref": [
      "r169"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-derivative financial assets that are designated as available for sale or are not classified as (a) loans and receivables; (b) held-to-maturity investments; or (c) financial assets at fair value through profit or loss. [Refer: Derivative financial assets; Financial assets at fair value through profit or loss; Held-to-maturity investments]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets available-for-sale",
        "terseLabel": "Financial assets available-for-sale"
       }
      }
     },
     "localname": "FinancialAssetsAvailableforsale",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsCategoryMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, category [member]",
        "terseLabel": "Financial assets, category [member]"
       }
      }
     },
     "localname": "FinancialAssetsCategoryMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsMember": {
     "auth_ref": [
      "r129",
      "r130",
      "r153",
      "r159",
      "r160"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, class [member]",
        "terseLabel": "Financial assets, class [member]"
       }
      }
     },
     "localname": "FinancialAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FixedInterestRateMember": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a fixed interest rate. [Refer: Interest rate risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Fixed interest rate [member]",
        "terseLabel": "Fixed interest rate [Member]"
       }
      }
     },
     "localname": "FixedInterestRateMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FloatingInterestRateMember": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a non-fixed interest rate. [Refer: Interest rate risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Floating interest rate [member]",
        "terseLabel": "Floating interest rate [Member]"
       }
      }
     },
     "localname": "FloatingInterestRateMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GeographicalAreasAxis": {
     "auth_ref": [
      "r48",
      "r105",
      "r150",
      "r158"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]",
        "terseLabel": "Geographical areas [axis]"
       }
      }
     },
     "localname": "GeographicalAreasAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GeographicalAreasMember": {
     "auth_ref": [
      "r48",
      "r105",
      "r150",
      "r158"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [member]",
        "terseLabel": "Geographical areas [member]"
       }
      }
     },
     "localname": "GeographicalAreasMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "auth_ref": [
      "r46",
      "r60",
      "r62",
      "r63",
      "r119",
      "r124",
      "r125",
      "r126",
      "r168",
      "r171"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount [member]"
       }
      }
     },
     "localname": "GrossCarryingAmountMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GrossLeaseLiabilities": {
     "auth_ref": [
      "r107",
      "r135"
     ],
     "calculation": {
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "ifrs-full_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross lease liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "GrossLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]",
        "terseLabel": "Income Statement Abstract"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "auth_ref": [
      "r36",
      "r43",
      "r44",
      "r45",
      "r52",
      "r94",
      "r142"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      },
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": 9.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income)",
        "negatedLabel": "Tax on profit / (loss) for the period",
        "terseLabel": "Reversal of tax charge"
       }
      }
     },
     "localname": "IncomeTaxExpenseContinuingOperations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r65",
      "r76"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 16.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes paid (refund), classified as operating activities",
        "negatedLabel": "Income taxes received / (paid)"
       }
      }
     },
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes",
        "totalLabel": "Increase / (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "auth_ref": [
      "r5"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through share-based payment transactions, equity",
        "terseLabel": "Share-based payment (Note 7)"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners": {
     "auth_ref": [
      "r6"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from transactions with owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transactions with owners, equity",
        "terseLabel": "Capital increase"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransactionsWithOwners",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestPaidClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 18.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as operating activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest paid, classified as operating activities",
        "negatedLabel": "Finance expenses paid"
       }
      }
     },
     "localname": "InterestPaidClassifiedAsOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestRateTypesMember": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest rate types [member]",
        "terseLabel": "Interest rate types [member]"
       }
      }
     },
     "localname": "InterestRateTypesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 17.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as operating activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest received, classified as operating activities",
        "terseLabel": "Finance income received"
       }
      }
     },
     "localname": "InterestReceivedClassifiedAsOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentsInAssociates": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 23.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in associates",
        "terseLabel": "Investment in associate"
       }
      }
     },
     "localname": "InvestmentsInAssociates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in associates accounted for using equity method",
        "terseLabel": "Equity Investment in Associates"
       }
      }
     },
     "localname": "InvestmentsInAssociatesAccountedForUsingEquityMethod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapital": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "IssuedCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapitalMember": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital [member]",
        "terseLabel": "Issued Capital [member]"
       }
      }
     },
     "localname": "IssuedCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "auth_ref": [
      "r108",
      "r109",
      "r134",
      "r137",
      "r140",
      "r157"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than five years [member]",
        "terseLabel": "After 5 years [member]"
       }
      }
     },
     "localname": "LaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r133",
      "r140"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one year and not later than five years [member]",
        "terseLabel": "Within 1 to 5 years [member]"
       }
      }
     },
     "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseLiabilities": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "auth_ref": [
      "r49",
      "r97"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]",
        "terseLabel": "Levels of fair value hierarchy [axis]"
       }
      }
     },
     "localname": "LevelsOfFairValueHierarchyAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_Liabilities": {
     "auth_ref": [
      "r15",
      "r96",
      "r97",
      "r98",
      "r143",
      "r147"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [member]"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LicenceFeeIncome": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail": {
       "order": 3.0,
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income arising from licence fees."
       }
      },
      "en-us": {
       "role": {
        "label": "Licence fee income",
        "terseLabel": "\"Right-to-use\" licenses (recognized at a point in time)"
       }
      }
     },
     "localname": "LicenceFeeIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LongtermDeposits": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 24.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of long-term deposits held by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Long-term deposits",
        "terseLabel": "Deposits"
       }
      }
     },
     "localname": "LongtermDeposits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MajorCustomersAxis": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Major customers [axis]",
        "terseLabel": "Major customers [axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/RevenueAdditionalInformationDetail",
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail",
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MajorCustomersMember": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Customers [member]",
        "terseLabel": "Customers [member]"
       }
      }
     },
     "localname": "MajorCustomersMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/RevenueAdditionalInformationDetail",
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail",
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MaturityAxis": {
     "auth_ref": [
      "r17",
      "r104",
      "r108",
      "r109",
      "r121",
      "r128",
      "r134",
      "r154",
      "r156",
      "r157"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Maturity [axis]",
        "terseLabel": "Maturity [axis]"
       }
      }
     },
     "localname": "MaturityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]",
        "terseLabel": "Non-adjusting events after reporting period [axis]"
       }
      }
     },
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail",
      "http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NonadjustingEventsMember": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [member]",
        "terseLabel": "Non-adjusting events after reporting period [member]"
       }
      }
     },
     "localname": "NonadjustingEventsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail",
      "http://ascendispharma.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r18",
      "r86",
      "r88"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 20.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets [abstract]",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentFinancialAssetsAvailableforsale": {
     "auth_ref": [
      "r169"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 25.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Non-current financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current financial assets available-for-sale",
        "terseLabel": "Marketable securities",
        "verboseLabel": "Non-current financial assets available-for-sale"
       }
      }
     },
     "localname": "NoncurrentFinancialAssetsAvailableforsale",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition",
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 12.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "NoncurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilities": {
     "auth_ref": [
      "r20",
      "r86",
      "r90"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 11.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities [abstract]",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "auth_ref": [
      "r16",
      "r108",
      "r109",
      "r134",
      "r140",
      "r157"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Not later than one year [member]",
        "terseLabel": "Within 1 year [member]"
       }
      }
     },
     "localname": "NotLaterThanOneYearMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesSummaryOfMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "auth_ref": [
      "r117",
      "r118"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments granted in share-based payment arrangement",
        "terseLabel": "Granted during the period"
       }
      }
     },
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments exercised or vested in share-based payment arrangement",
        "negatedLabel": "Exercised during the period"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments forfeited in share-based payment arrangement",
        "negatedLabel": "Forfeited during the period"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments outstanding in share-based payment arrangement",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options exercised in share-based payment arrangement",
        "terseLabel": "Aggregate number of other equity instruments exercised"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options expired in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options expired in share-based payment arrangement",
        "terseLabel": "Aggregate number of other equity instruments expired"
       }
      }
     },
     "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options forfeited in share-based payment arrangement",
        "terseLabel": "Aggregate number of other equity instruments forfeited"
       }
      }
     },
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options granted in share-based payment arrangement",
        "terseLabel": "Aggregate number of other equity instruments granted"
       }
      }
     },
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares outstanding",
        "terseLabel": "Number of shares outstanding"
       }
      }
     },
     "localname": "NumberOfSharesOutstanding",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "auth_ref": [
      "r21",
      "r39"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossAlternate1": {
       "order": 12.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, exchange differences on translation",
        "terseLabel": "Exchange differences on translating foreign operations"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": {
     "auth_ref": [
      "r37",
      "r40"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossAlternate1": {
       "order": 11.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax",
        "totalLabel": "Other comprehensive income / (loss) for the period, net of tax",
        "verboseLabel": "Other comprehensive income / (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentPayables": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 9.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other current payables",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "OtherCurrentPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentReceivables": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 16.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current receivables",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherCurrentReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentPayables": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 13.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current payables that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current payables",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "OtherNoncurrentPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ParValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Par value per share",
        "terseLabel": "Share nominal value"
       }
      }
     },
     "localname": "ParValuePerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_PaymentsForDevelopmentProjectExpenditure": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 22.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for expenditure related to development projects."
       }
      },
      "en-us": {
       "role": {
        "label": "Payments for development project expenditure",
        "negatedLabel": "Development expenditures (software)"
       }
      }
     },
     "localname": "PaymentsForDevelopmentProjectExpenditure",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 26.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Payment of principal portion of lease liabilities"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from borrowings, classified as financing activities",
        "terseLabel": "Proceeds from Borrowings classified as Financing Activities"
       }
      }
     },
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 20.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the disposal or maturity of available-for-sale financial assets. [Refer: Financial assets available-for-sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from disposal or maturity of available-for-sale financial assets",
        "terseLabel": "Settlement of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r30",
      "r70",
      "r82",
      "r84",
      "r86",
      "r143",
      "r145",
      "r155",
      "r161"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      },
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLossAlternate1": {
       "order": 13.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss)",
        "terseLabel": "Loss for the period",
        "totalLabel": "Net profit / (loss) for the period",
        "verboseLabel": "Net profit / (loss) for the period"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to owners of parent",
        "terseLabel": "Attributable to owners of the Company"
       }
      }
     },
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "auth_ref": [
      "r1",
      "r2",
      "r120",
      "r143",
      "r145"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) before tax",
        "totalLabel": "Profit / (loss) before tax"
       }
      }
     },
     "localname": "ProfitLossBeforeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "auth_ref": [
      "r38",
      "r58"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "totalLabel": "Operating profit / (loss)"
       }
      }
     },
     "localname": "ProfitLossFromOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r12",
      "r47"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 22.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "verboseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInAssociate": {
     "auth_ref": [
      "r54",
      "r56",
      "r85"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in associate",
        "verboseLabel": "Percentage of ownership in the customer company"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInAssociate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/RevenueAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PurchaseOfAvailableforsaleFinancialAssets": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 21.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of available-for-sale financial assets. [Refer: Financial assets available-for-sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of available-for-sale financial assets",
        "negatedLabel": "Purchase of marketable securities"
       }
      }
     },
     "localname": "PurchaseOfAvailableforsaleFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfInterestsInAssociates": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 24.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of interests in associates. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of interests in associates",
        "negatedLabel": "Investment in associate"
       }
      }
     },
     "localname": "PurchaseOfInterestsInAssociates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 23.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "negatedLabel": "Acquisition of property, plant and equipment"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RangeAxis": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r116",
      "r131",
      "r156"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Range [axis]",
        "terseLabel": "Range [axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r116",
      "r131",
      "r156"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges [member]",
        "terseLabel": "Ranges [member]"
       }
      }
     },
     "localname": "RangesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Research and development expense",
        "negatedLabel": "Research and development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "auth_ref": [
      "r8",
      "r51"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements of foreign operations recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation [member]",
        "terseLabel": "Foreign Currency Translation Reserve [member]"
       }
      }
     },
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ReserveOfSharebasedPaymentsMember": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from share-based payments."
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of share-based payments [member]",
        "terseLabel": "Share-based Payment Reserve [member]"
       }
      }
     },
     "localname": "ReserveOfSharebasedPaymentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r7",
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Accumulated Deficit [member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Revenue": {
     "auth_ref": [
      "r1",
      "r2",
      "r34",
      "r86",
      "r92",
      "r120",
      "r141",
      "r144",
      "r148",
      "r149",
      "r151"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      },
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue",
        "terseLabel": "Revenue",
        "totalLabel": "Total revenue",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "Revenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss",
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [abstract]",
        "terseLabel": "Disclosure of Operating Segments [abstract]"
       }
      }
     },
     "localname": "RevenueAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RevenueFromRenderingOfServices": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail": {
       "order": 1.0,
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the rendering of services. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from rendering of services",
        "terseLabel": "Revenue from the rendering of services (recognized over time)"
       }
      }
     },
     "localname": "RevenueFromRenderingOfServices",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": 5.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expense",
        "negatedLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0
      },
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss": {
       "order": 6.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share of profit (loss) of associates accounted for using equity method",
        "negatedLabel": "Reversal of share of profit / (loss) of associate",
        "terseLabel": "Share of profit / (loss) of associate"
       }
      }
     },
     "localname": "ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements",
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremiumMember": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share premium [member]",
        "terseLabel": "Share Premium [member]"
       }
      }
     },
     "localname": "SharePremiumMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]",
        "terseLabel": "Share-based payment arrangements [member]"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SignificantInvestmentsInAssociatesAxis": {
     "auth_ref": [
      "r55",
      "r57",
      "r95",
      "r162",
      "r166"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Associates [axis]",
        "terseLabel": "Associates [axis]"
       }
      }
     },
     "localname": "SignificantInvestmentsInAssociatesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/SignificantEventsInTheReportingPeriodAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [abstract]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of comprehensive income [abstract]",
        "verboseLabel": "Consolidated Interim Statement of Comprehensive Income"
       }
      }
     },
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TopOfRangeMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r116",
      "r131",
      "r156"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Top of range [member]",
        "terseLabel": "Top of range [member]"
       }
      }
     },
     "localname": "TopOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/LeaseLiabilitiesAdditionalInformationDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "auth_ref": [
      "r22",
      "r25"
     ],
     "calculation": {
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition": {
       "order": 8.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current trade payables",
        "terseLabel": "Trade payables\u00a0and accrued expenses"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TypesOfInterestRatesAxis": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of interest rates [axis]",
        "terseLabel": "Types of interest rates [axis]"
       }
      }
     },
     "localname": "TypesOfInterestRatesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]",
        "terseLabel": "Types of share-based payment arrangements [axis]"
       }
      }
     },
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentAdditionalInformationDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail",
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement",
        "terseLabel": "Exercised during the period"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement",
        "terseLabel": "Forfeited during the period"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of other equity instruments granted in share-based payment arrangement",
        "terseLabel": "Granted during the period"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageShares": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares outstanding",
        "terseLabel": "Number of shares used for calculation (basic and diluted)"
       }
      }
     },
     "localname": "WeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full",
     "presentation": [
      "http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "sharesItemType"
    },
    "srt_NorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "North America [Member]",
        "terseLabel": "North America [member]"
       }
      }
     },
     "localname": "NorthAmericaMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r1": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r10": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r100": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2020-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r101": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE63",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2020-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2020-01-01"
  },
  "r102": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "14",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2020-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r103": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "105",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2020-en-r&anchor=para_105&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r104": {
   "Clause": "i",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2020-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r105": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2020-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r106": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2020-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r107": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "58",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2020-en-r&anchor=para_58&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r108": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "94",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2020-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r109": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "97",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2020-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r11": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "51",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r110": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2020-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2020-01-01"
  },
  "r111": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Presentation",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2020-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2020-01-01"
  },
  "r112": {
   "Clause": "ii",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r113": {
   "Clause": "iii",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r114": {
   "Clause": "iv",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r115": {
   "Clause": "v",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b_v&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r116": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r117": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r118": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r119": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2020-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r12": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r120": {
   "Clause": "i",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2020-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r121": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r122": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r123": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r124": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r125": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r126": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35N",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r127": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r128": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r129": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r13": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r130": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r131": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r132": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_8&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r133": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r134": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r135": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11D",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_B11D_a&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r136": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B2",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_B2_a&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r137": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r138": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r139": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG20C",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_IG20C&doctype=Implementation%20Guidance",
   "URIDate": "2020-01-01"
  },
  "r14": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "n",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_54_n&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r140": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG31A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2020-01-01"
  },
  "r141": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r142": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r143": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r144": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r145": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r146": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r147": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r148": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r149": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r15": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r150": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r151": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r152": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2020-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2020-01-01"
  },
  "r153": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "9",
   "Paragraph": "7.2.34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2020-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r154": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Effective 2021-01-01",
   "Number": "17",
   "Paragraph": "109",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2020-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r155": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Effective 2021-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2020-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r156": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Effective 2021-01-01",
   "Number": "17",
   "Paragraph": "120",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2020-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r157": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Effective 2021-01-01",
   "Number": "17",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2020-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r158": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Effective 2021-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2020-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r159": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Effective 2021-01-01",
   "Number": "17",
   "Paragraph": "C32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2020-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2020-01-01"
  },
  "r16": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r160": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2020-en-b&anchor=para_39L_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r161": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2020-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r162": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39M",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2020-en-b&anchor=para_39M&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r163": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Note": "Expiry date 2021-01-01",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2017-en-b&anchor=para_10_e&doctype=Standard&forcepdf=true",
   "URIDate": "2020-01-01"
  },
  "r164": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Note": "Expiry date 2021-01-01",
   "Number": "7",
   "Paragraph": "16",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b",
   "URIDate": "2020-01-01"
  },
  "r165": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2021-01-01",
   "Number": "4",
   "Paragraph": "39G",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2020-en-b&anchor=para_39G_a&doctype=Standard&book=b",
   "URIDate": "2020-01-01"
  },
  "r166": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2021-01-01",
   "Number": "4",
   "Paragraph": "39J",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2020-en-b&anchor=para_39J&doctype=Standard&book=b",
   "URIDate": "2020-01-01"
  },
  "r167": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2021-01-01",
   "Number": "7",
   "Paragraph": "36",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_36_c&doctype=Standard&book=b",
   "URIDate": "2020-01-01"
  },
  "r168": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2021-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2020-01-01"
  },
  "r169": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2021-01-01",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_d&doctype=Standard&book=b",
   "URIDate": "2020-01-01"
  },
  "r17": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r170": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2021-01-01",
   "Number": "7",
   "Paragraph": "IG24",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG24_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2020-01-01"
  },
  "r171": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2021-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2020-01-01"
  },
  "r172": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r18": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r19": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "68",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r2": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r20": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r21": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r22": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "70",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r23": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r24": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r25": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r26": {
   "Clause": "iii",
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r27": {
   "Clause": "iv",
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r28": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r29": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r3": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r30": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r31": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r32": {
   "Clause": "ii",
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r33": {
   "Clause": "ii",
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r34": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r35": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r36": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r37": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_82A&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r38": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r39": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r4": {
   "Clause": "i",
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r40": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "IG6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2020-01-01"
  },
  "r41": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "21",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2020-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r42": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "10",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2020-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2020-01-01"
  },
  "r43": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2020-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r44": {
   "Clause": "i",
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2020-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r45": {
   "Clause": "ii",
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2020-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r46": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2020-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r47": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2020-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r48": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2020-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r49": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2020-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r5": {
   "Clause": "iii",
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r50": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "19",
   "Section": "Scope",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2020-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI",
   "URIDate": "2020-01-01"
  },
  "r51": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2020-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r52": {
   "Clause": "viii",
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2020-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r53": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "10",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2020-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r54": {
   "Clause": "iii",
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2020-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r55": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2020-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r56": {
   "Clause": "iii",
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2020-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r57": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2020-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r58": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "IE33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2020-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2020-01-01"
  },
  "r59": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2020-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r6": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r60": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2020-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r61": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2020-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r62": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2020-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r63": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2020-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r64": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r65": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r66": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r67": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r68": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r69": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r7": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r70": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r71": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r72": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r73": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r74": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r75": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r76": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r77": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44D",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r78": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r79": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r8": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r80": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "7",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2020-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI",
   "URIDate": "2020-01-01"
  },
  "r81": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2020-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r82": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2020-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r83": {
   "Clause": "i",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2020-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r84": {
   "Clause": "ii",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2020-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r85": {
   "Clause": "iv",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "21",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_21_a_iv&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r86": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r87": {
   "Clause": "i",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r88": {
   "Clause": "ii",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r89": {
   "Clause": "iii",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r9": {
   "IssueDate": "2020-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r90": {
   "Clause": "iv",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r91": {
   "Clause": "ix",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r92": {
   "Clause": "v",
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r93": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r94": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r95": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  },
  "r96": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2020-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r97": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2020-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r98": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2020-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2020-01-01"
  },
  "r99": {
   "IssueDate": "2020-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B11",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2020-en-r&anchor=para_B11_a&doctype=Appendix&subtype=B",
   "URIDate": "2020-01-01"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>53
<FILENAME>0001193125-21-257913-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-257913-xbrl.zip
M4$L#!!0    ( ."L&E-*OWU#<PX  "..   1    87-N9"TR,#(Q,#8S,"YX
M<V3M7=USV[@1?^],_P=63^F#+,MNDK/G?#>*[>3<.K''=BXW[70R$ E):"B
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M10,=CA=MP'5ABJXR>XV1M4D!UA?:9=ZM%;KZ=0.:&W4U]3 W!H'G!\+XG7C
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ML&[T;P>?&K^]']\U!A'C*/*@T2=>/(>(-UJ-&>>+RW;[\?'QS ]PQ$@8<_$
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M8@O-BJ9(W> Q*Q1E%=_D"D79$N9G7TX]"*2.<ACLWY2U/=)5-9@C:K5OX"@
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M ].LZZAUTGW?:9WXH%S?PK"/EC]:5H;=\:8M[-,ZWDZT\VKY=L_#F$Y#O!%
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MDG\QR&(\WHOA>'O\JX*,L@?9;:9N/B5:L45[A(L6#1WT0:<U; FN$4CB/L'
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M4?1X'V><JH<"_%&!O+QXI#F&;^><TS<L9?);59##ETOAQ]B,O@5S4GXVG]P
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M!,DAIK"X2-*?,VK2^?\YA/GS9Y)ODY6:F"/$NB7K&/M[$&?"V(;:OK4XI+_
MM4RZ-BR%\C/J Q.+")>+=EPPU.1@UJ8X%34&H!>;TM;F5FHVQ&['[FTTY04N
M;S3?8=W@5Q)NME3#!>U)O"'<'/4>EJ2&4^<ET[H+T*H<PD5!%!]V]R1EF$S2
M51CC]+D ;H:20\[N^K,L!U!^R-2J+[41I>Z'K'2J 8Z"0\2C2M#K^^YY/_!V
MEA)J?68I<>;+)O BS]/P_I#C^XC<)<M'.O&A'N :LUN,ACO!:A% V\$:NY1[
MPF\0;M1&>8(27I\/#EP"%,$&V[>0&L1"[<Z2W1['(#<KAV)2M6-L DC@N7L5
M8;M<L[9/R9:N*^@"HS@4-8KN-A7A=DYN:E=OTEE'3E-(!LVJY='VG.'@QEM)
M@\T[2UB^H'#%,PU=T@E5&NY0R^:6/'3IP7&^'48%$TLK@,+RD2F8Q%17ZB>6
MU".F HWOMCC_&D;1!W)#@HBN",)UR%+!%'YGF3+/\X50:^_PDQ&#Y_NH4\[/
MV'9]&E6?XA-@]C&QL\CI]] C_2"Z)RAM?)*-??O6/9,W*"9Y%:[M@Y-QV)Y+
M>0OZ<8 \-R_[7FMN4L+Z.9E%E;;G3\&6 H1\#-=K0J=+ <F6\5V*XZQ8DRG]
MV7CA3OW6!&UASJ>FEWF#2"F:KFMKV>PJ3'Z4#K7"F*%5SG76QANV]J>KY;@*
MQ*'3)5C',Q51^@YF*I;XZ4AL7.,@9V+W 2\<BF6;6 S2 Z<Y4*$"[AM(<JEP
MUL8PGNC!-8?*?C_\[! _8NYKAS@1^ 5JQPCMVK)7WOFRL*^Q:$77A2F4>S+3
MN @:\GS-)(&*>+DCP8DO)Q2&IQ!@)PVZTP2X 4:I(_5OSJ_>VP; >Z*V[=F,
M0&WV:XV>4*<M)B<J?O@$T3;RT.-+:UG0@Z?E@9]H8(4XUQP\]/[C'7 .A*_1
MH#W5D2?.XA5_K>+=[W]XQ^G'?G,\R[EC'Q 02UC* 67$VLE/%[_Q(HXS2EDK
MF0N5=(%616]7.)R[JU=E\C7AAK-Y:P9;LCI$;%MD'9&@N-O7/G*]+)UB^QP6
M9UMT$26/6></Q;7ED&6@3;*0Z=8IP.-[MDFT8GZGB)/CL4O%>EQTOON&;<X4
MIUA9+0EG='%.5F3UMMG_\ -O=2A26+9X"M43<UD5L*/)EM[J@\4RIO<;IH7!
MDL_-H3O<X5T?->JCMSYD8!E0Q;VRN$4E[ML%G:*]HV/O&*9$QHX7 ,/U."W=
M(EC4ZWW<BKI\Q%SK*TY9ZOCW4K )2[F::_6TZT4LEP6 @&:E9 :*,T5OM^9:
M,W:UT5S+N#6M9RRZU<95&)-+^J-HJB$MZ7S5T=12,:FG0NA"G)4#77X8:EL7
M\V 9TH.!>"DR#P;LEB.JUKVJ 4 7)70QD+&&7M?+BK)),K99$QWH H#^0)<L
M?"WX%MUM:?EC&795B5^:R!.T"K,@2C*VU-DG:;$#$L;K)-T5]RCJRTLK]!CF
M6[1*=IB*+CQ?AE:$ZE!\C<Z^V))DAV.Z='DB&9/.MD\*'?Q9C_#$B.P^YGI-
MEW8LOC1^(&D>4BW9RYTI[[!L&1?W3);K97E5QN!RT%C13F=\H]NAEYV]%(@(
MEU@$8]<R47@4R@)XI'>1H.:6D[='/4]07*YR.R6=!OK]2>PTN!\QZ'])XO+Q
MM$66D3PKT\1=A?@^C'C&'T50M;4$5Y,$*ZMZ9UV48]6#>$5U5.4H; A0!"T[
M&ZKM.Z\UA /UG-'0/KH'@[('<=&#5<;&J-&#50=Z-,26&S#QRHR IA4!-D2D
M-DBV'MB>;61$+[=;)B/M\&$G10TGV<Z*&DM>T,2"&*!4T(+&&[#K-/4"SJ8
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MC8&!?BV&E=BV7Q,K@>WKTMAX"F\JPI/%LF:>:G=^[]_ZV=(\P?+YQ1WDCSW
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M,DIMP;J[NGGT%*K3C9D+<>IH+&SK)7-@5>LCV#* ;U\^=84;]=$W3"6 >0)
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MTL=QQ 9JG7FD.YP93AR'XHU[K4S<9Q[-#)N[]I](LDGQ?LLT7:0$VP<E*"2
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MRVA???P[2JC+^QF-J!=<L3%65F)X+VHI-CU<$CG6/J;9WF3+F )/15+*%ZM
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M>%W^-M,0T]>9U%.EM;9I>._EN6OG)>+'-JWBK;F]HCI!<6#L],YMQ)ILI<D
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MAGEJ9)47B2[!9J*Y?5^B$9F OT7L-=DO?A"^1#]I+A4.1*8L>?4XZF9-*F;
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MT9R"Q+!MA1J[IA%;X_,1!R,:$)=)_;:9@MMG^V2W0EW1;X8%;[N50J\B12K
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MI TGHL\/5ACKCT.MMKSN9?>B#6G5:/&</\+,T(*&R]I0A6]1.+*H#?OF.$5
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M=E#/E1BGV+8'R**V!VW"0!PHPE&/,,1A?D W'"0Z!+4\X<&WIB=0![\0 +A
M34(<2#=MSR+6,"/(P_1L-95ELW[%5EC-33!D'B>RU #)!]!SJO)3:  (0=77
M4ZB!<HQPZ"ZQCE&#=JF-F3TX0G@LA=.C3V=G1\7S_+)2R/N-VMR52N,4IBET
M=+E.0#9K>4$<(Z7ID6HOU=<).F"D1:3!)?SRLV31,E>^"X (*8^G+("(OF0X
M[?9L2:_J68=)C$G/+3MTSX[['!R#7%#)D(]7KN89QGD,B!MFD:['&[RO/)-
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M4W/G##IOW=?#0V?XH/>/3LV=&IWQ1:?FSKGH1Y]8-] 6(US4(7/H!MK)#$F
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M'<DM5[35(HPX)A"0\PBLPFTLZ.S;G[2J=45Q)%SG<_9E]C!4VK6\2 !)U:O
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MB:V%2--ZV)L>P,SFFJXU@!(=T;4O_Q]02P,$%     @ X*P:4RLS^"]Y=0
M$F(* !$   !D,C V,SDU9&5X.3DQ+FAT;>R]:7/;2-(N^OU&W/]0H3X]QXZ
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MZ);AI]_!?X);M/[R+;YEI-\ /Z2\P0]FWH;KX1?V_,'R#2_V%O;\]^<$Q,+
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MU[-UU$J;[K&6_MV,>GH 0R*L>.S)"BPJV<F-V8E>4!\]'$#QG00KG^))#J!
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MA'Y8#484G9A'IU(E]/IBNN!.I,[.$(*G/;GV$_M5)Q,PI8#_)GWT*)_%XJ4
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M$)$F$=EBW^M/NF5S<TP7$UU884QJ7BRA#P0#_.&P'_^S:;@&#^R))"=SEH"
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MF^J69Y[/="^(6F<L0KI\6\;\*4O!73_D[I8(,SQ3\.!T'@6<,E<G_OVUQ$3
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MDMA%6M>SN+Z4KXFXNFI1/\J=HV#"=O2#J<>BJHD:T'@]/3.G?,ERXNTEM8%
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M-[YQ BMX];_1F>OQY]_3QRD8&O[-"P@V1P]<[S4C#BC09,9TAA?2+?)W=[G
MDA4UR&Z(R-BGY8L+,K,7G=X3T9;<.@(T#+=IZ?!\2->3C7(/H-NNW>E,=UZ)
MY</0'#"5Q*)V9]2#U0E_^&3+R@9$CZAW-U[ ]8[?"*^/<7N0T(IN3B[RVR^?
MYJM<75KEYSXUV$I_!L/0I\[9;ZY#UQ8Y&84^S-KW^9LNR!>7^'2FLTDN?M)9
M830!K;_^$[O+)Q/]";ZCU"$6L_ZML04DLAP0&;9 3^ R-6V&1D ,H*-EPD/X
M$Y>: @$(_J*!?T&N# ,&#=2R7Q6PG0BSJ=ESX!HK@4GXWWP@?D37M8>*P0,?
M32%.J'FQ N95J;3!?CW:]1CDY'KDM.XVC3]II!J465G5+<7!JI[9VY55V7<)
M7V=$ 3_,U[&?]5<_X7!.O)6(#/>:2&S!M]E($]D1K=M62/S/V\NS=\O#BIXQ
MN.A:SDHME1X&[OPK3SR=?Y?B'9P2K_=76#Z3*\P3^>[H(4@($#K7+HL_^.(3
M+U'DXOJ63<V:DD^6HSM@8-GD/H ?A,3(HMJDDP%[F$[3F>V^4OJ!.A0<)5DL
MICU()RO^2#\RF/[4/4]G4&(VPOT$5,[Y2&<@_*J_<DM*"NMI>VY[#:_L\WL+
MO'7+V'YY:DYY7^HGJ!812"K:E0/!*Q^$,'Q+Q&'AY.K=/=A6/BQ 9D1:_@0@
M]2RPQNPI,'*F G/T[Q#<([#X@L"&:_P$!&<1&0.XRQ=6GZ\P^U5W6-R%F6M@
MO+&8CFZ#>04@II' @,NFO&^!SWQT]LL'5_>XP_[1\L 5=#WQ=I_:\!<!.2(B
M,B!4_- .V(I8=11S\K9:LG%N(0$\2A[91R#]Z)5KI\B7X+*B?YE*1;"5=6[S
M@G:BY-D*)LPDF+B>]3_<U/7)(W")V]%6$#^7<WD"JSGB4.)=8$+SK]8C<LH&
MOV6A.V+GA:_(NQE__>]B1K<._Y(#*UJ>5VS>CU2X)5GVV$:4TI9;8CR\SJ@?
MO7/#XU.W9LY Q65SA]8".:QJMZVTU?4&5_$:2SHV$4\51E40>,9DF_]W]?CH
MT4<P,&):\L.,;_@BO75\T*-\0M>,V[:])UVO_#NG,'IR3/D'4G2H= =J)FH:
M\<P/@^/-"_4,RV\6(#M*N]576IWU2' :!6E,@D,I. /ATRCZM12MMW,M4S%O
M+F+=$$0I!?&>)";39X<0])/KC:G5,!G94P=*)Z4#8!H@QS$!MNF>C.KPF9DG
MD?X#9H'6X^*7A#/V.4/@+2%DK\1S]A46A4K98T#>4]O*,"5=E R2S=D#U$I8
M<R-.Z=BF2UAN"8-MOC)F'H5;N7'HAR/?\"P.=,(C%OXB";C-"+G104_&!JL!
M_[68SPY7\(>PT46/'@D+U'4HX8$_W7L53V:/U,&IF%IL7D^Z'?*O/O[[WSM7
MZ5?=^R]V_5?J<0:5R6 8WX\9]7Y$+SY(FZYQ^(*PR'0LJX!!%MB*X"R,K1<6
MD0XX9<>ZY46!U 6YTI;=,IW]^/X #&1VBUAPL Y-"H8PD'\?>S9MI!P= "QP
M91P6VEV -'0 /*E/7O-U.-5%JG=K?FV!@MA4^,K& (;88@!)Z=U2M>%V?'S@
M7L;=^!L;P3)(^%<,!3F#Z.;[MV-!U+OHI$AO6'<E4^_!G=6-=%JG>[&>%(5'
MS:C +TMK3")GC_"$Q@7Y+_#4%SXZRQV]@G9<V!?,T0N>79:D&+LAN-R.$X)<
M6ZP4F+IKL@S(3/>BFH;59<3]_94;A&9=A 0\5IT!?J_N%>2 9TMWIGK1JP^^
MW"\X=718;WM@*\(AN6*9;G#7UJ-/^T=@A55RY9A_\DE2\^J)>OHC75I=_B8O
M<=]X[=%+*6.X]_":J4UQM]0*PCQ97U[^>.S:MOO,Q(2H$F2E$RPM*LR?6*_I
M$<B(&7K\VFQ55>_W2%DLA<JV5ZP53?WD@(Y/@:S6868LOA03YZ^),G&B<%)\
M8X2>!]/G>;ZC6BSL6:BY3OMMI9N)MZDIVZ.BW&-?5&-NK#C74NHQ%YNZ$H7)
M&3X7\^AC.GH,]NH@NV&P) +4HC ZFXK+#.1=1>Z%#V33< "N\"3GU[/6V:ZA
M17A.C"RM-\S.3/,QXJ785!\O65T2/2-O)=U?[ #BY$*:+5(Y@B0>"((X@:'(
M]!2TB@Q0 >38#"7<#HV^^_Y->K2EJ(>H0(=GI%=*\+E:?K)\:V398'*])Q/+
M!'6[37MF-P!V[R+>HA)S>4TN0TU)Y)>)T:1*JN._.]8*H@G15#F:ZM<ECTEB
M[)(G3Y>\1!"8)0W^I3NA[KT*C&DB0%% [SP-^]<4WK]F>[5*@N][9U*UUH^V
MV+\D32:UIVB=@:*J::WX-W!/PN8YN*!D7E#;XOU'+[,-6;?"EMK&G%HKZXH;
M7@SKW7ZMA%956ZV=#&Z!7$U$9&D4?1JS1'P@/O9L,5/F^7QIH@W/Y\O U:CZ
M/IDE%G4?N^!\_+*OQ=E/*56?Z;951,AZ%>%JW8'2':[7U1=]8EC347.(<9YI
M'TR*85X*Q(XVT+66>I'2"*2, \OJ%7Y$K95;['&^E6=_[596N*-QQUR_.2X0
M.&?9G2?J79NTY47KJDHO-2A8!B[>'A=S0["78P;LN0)J:Q"TVQ?=M.;R9:,&
M?55)M7YJ8TFQ#?!DO=4CM6LC-Y(.545+/7KE.!9N5I<-P5(1RBLCP&JKM+26
M=I'2AJ ,+W9S'NCH8BVR5-6?-4P_?\]B/>P;Z2<-"X*?R#3S@,CI4>U$IEF5
M<8UU?U+VLENMZ%O;<(CU?+4L/RJNGD]"%Z.GJ+VN,FBM-YVO4X41+BB9%U05
M]7SR.EI][:+FU;-%UO.ESDQ_ Q/BLXK^43/:._NMW6VOR5M.I+TKF]E6W[.Z
MD"#'$@0177,&(D&V(KIJI_I@18..=8Z.==0.+&^?6EIA6+PKD#J<<MV!I4:C
MZ3;_ 64QI7K5:M;\O](%G[K;+\2GK@&R<%&5NJ@.<:]E6VI'>]6=WD4Q,:Q2
M08>>-?HAZ(=4[X<@HFO'0"1(!L_ZE\VGS"8&GL=Y]24ZEVGG&Q[4RK7PYJLE
M]Y&6UL$_L+DTZW-/'5^<8GKM^JF'$#;\K+.8%D:2%@:G!6M?GCAV0!R'!6:?
M;_&3LI:[KHL3#Y:..IBW7X\/XF(MTZ.CY=EY(NY3=-[ $S@/K.A!U">STPX\
MZH/(,";\%I,^4=N=\>/3Q,C8*6GLK%D;)O&HD$?J@*=B\XMU$T9K@5^B\S,S
MZ N;%>L)_RDZ*2.8>)2NMW8^JH]H6Q4H$2$E/@[6^4,<8S,_HF-W1^G$G<^;
M^9(@8<0&(WG(IA4=LNG'1VLR?LP\=VP%C'"VZXN373*?/< IR(Y%7_/"'A*'
MV?T)\(C/N%P[5KE33L7J84?)]Y1V:[U057 F^UGR!5%LZ:1Y62C65CH93JHO
MFV0EE44?1++V4&D/>[*!3),89*V! G38"3+0%#/*^O=3^Q5/%*_-*=/#&ITH
MGA@<GBY>JEV/IXMG/=OFZDFW;.:*PR+P0;I>^3[%,\;S0R$91&>,_\'/=.-'
MG=Q3(_2L@)TF<T(.8X( _H( S%><4IV!D2?:]:GK!=Q%83Y+Y C-/<0UWU*<
MD0UF#ALE?(I.SHN.VGKSF7F 1(O=G82K.;' \P-'\?7MZ@E;:6N'I[=2EPUX
MA_=IR^8!5LP'VS7^RG?]'%ZQL?',[0:=VL1\7M?GIVC&L809P&D,DMYE)RW&
MISC-_=^58YZ.F?9%]@@0GNQTVB<[=09U/]FIGH\^IJ@/SZ/*YSRJ'A[EDZ66
M4 )62C,0Q-1N3'VD!@^Z1;@2YSBHTN,*)7+UJP</5_OM6O>\5WBNH!6XH*$3
M2+]V$%62H^J3;D7RF(<<$% (*!13B"K94%4W,56YS5C%"BEE,6B=7:NAQC!_
M<_/]&T_%]"]557U[#,QE0O2.S:;9&C3L GY].Z>67#Y:829M<_I!"B&SZ\W[
M=ZPKXPZD!](#Z5%-"V^6)<,6W@>HA^\7]Q?DP>-%%:]D9-FVOTLAG$B[Y7F!
MERC76*U]VK[/>/7FX(J7JOC49#M EFM>K_6 /KJ>Q0I?5^][L?P?W_V8/Q\8
M>U9NMG6X,OW.@XMD_X=ZKJG[$T9\7H^TH4"V: 8CT/8'&O/0_XOYY@@R!-DQ
M($N<+5QO:;;6<T%I==*:+B# Y %8;:18&KCP5+WE;K5HG!=ZJAXWX7]G^UP=
MOA%SY#KF3B,>CQ@KZ(@QB=R&!28^,$B4+PT'747M#"4X4PRA7S_H'VP"(.P1
M]G+#OC#7JG+H]UJ*.A@@]!'Z93I],L!>4T_S\%1T[@[,O%R[TRGK>:K;0/,9
M]3#ODH,5N2#J5T[3[*(@3TV<FR&I#-HMC%0V%6"'Z;L\P85A\.K!E;"(FB6]
M-%7I#A!AC458M>*+H^M@D[MJ8QHS+77,M%R[WLSU6!]2S+'4*^RP9,%%3-PS
M5B"EBNUTP(I;;RN*\38$?H' KUCS ^C[[;3#2!'T"/HU@[=!TKZE*:W!P0$A
M!#X"OX;2GH%>"FF/N15)W;EU1^WJD3K&:S8O#<-&NTU'0<\FJ-"!HO;7.^1C
M3++^X*I833%@]1%8E0,K80(U1FH-E78/\\!-Q%:U0HOAZN ZU:-LYCR.AMUB
M))>!\4VW'7=R(Y DK65490<W-GN6B _$!^(#\8'X0'P4CH]FE).D<^C40Y"'
M5I3LUT+NP0UT.SJV:&='MRHK4HX+NN]'E!U-L7)/VNS7]*\FNX5S.T^SVU/Z
M@[0XV ;V%)"S*1\^N&+JNF*JC;^PU=(;II5(XVK!U5+-:BEF;W)N*Z8S5+K=
MM W&N&)PQ<BW8BK6+VRUI)8'UV>U8 9AS]A'>_9"3#=D[F&30SS23!,1@@A!
MA"!"$"&(D/IG$K 2.=]*Y#T/;6/%0^+0^9$.?C8!!P6,>Q;C?R4SSQU;=M90
M__&"(S.5]K>=Z_EH)"F25/Y'(TGS>'0SDO7U5=&ID:AB<O!?7.?<"#V/Q@>D
M$IU'XJI/HY_<CD=@1<2)IB7&A^J&3!]NW44@UR5?S4#<0A CB.N>1M:TKM(:
M8-\<1'*=T[L<Q8=O.L76"-)X.V6VG1;K8,G'.?GF"-?-=#JT7D]1AP?W3L&=
MPV7"I6)=PJ#2/]@B0JCD#17)#>AV!TR/@P]Z0;B4"9>*)0N#2K?8/N!8)%C3
M#9*G,4O$!^(#\8'X0'P@/NI<'(AM!K#- +89.(E-;7('-K'- *Z8.JT8;#.
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MYS#Q]S"@*=PW.?NM=]%;XXWNF'D-\XOK&#F-5.M?=->&RG_S%78;B5XDAI^
M5VJ1R;Z8AI>>1R^((#US?8M-'-[N47]&P7E[HO;K!6' @\LLKQID'$]H]:*S
M@= 79)/(R7WY5I1XN;(W)%* @T]TO6.V:)4-&&"HTPT#=!C\;;\*R>!9_E]D
M[+E3,O/<D3ZR;"MX9;PVZ5@/[8!8/K'=9X$9?C'\1E\8F  D43=NV_5]XCZQ
M4O(- _/)B%*'\9VEY> N!09JV"$;"A_'Y'4&2H5R14TLD(D&+!-X'_N=#X^+
ML?0APO(Q)FR@B\<SZ0A__2=T1%3FV0HF_!'SH?,Q/\*"<.;/X>])#)O?Y%O
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MI]0'F+5CLK>!P%V_J^PF2KG12*=JTS]X&G_Q(*TI?#D,1L[;_P!02P,$%
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M8XYVH6F<)7>E/CY0RC;Z.J/8UF"R1-9T7=/U?="UZ%^+,(7U3!:HPLN(M=D
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M55->37D+*.__%&,C.<S$6(HD4]F!2ZGO\F1C<T<37FYYJ)"H+0GK;FZUA;&
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MN7*"R8^$26SRNG/<4Q=^1UPR_2I*(E_W71]FWJ7L$S@>^WYT+1(O0U P50>
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M=;F%J]9>2,1U32:8_P0B7*%>2<2!"A3>OP"VX+6V>P?03QY<GW(G>I7N0<=
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M$A,5HJ$TF13V#T.+M7^I9N-%;/R1540X)77#O[6/L&O06J@Q-I-K7OY%)[7
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M'>M"?85F"1$&)AJG\GNZX5.M]9L-_>5:)^U7Q%?)I%'#U]ROL_,_OAY<K$
MU1?J/8TQ*O7B?<=M=[NW>OR/&N\6@E6N\_B'8,6G3V.J:(4,# LBR(N2-'D:
MI/=R;]/=;*^RF:^>"O6]W-ETMW?WUARR38 _K]B[E$% L=*A#"EMF0N8\I*B
M:T:8"A/Y5 AT<]O=W-I^5@0*%ME>>]TA5TA(:VLGW]\Z<_6.>] XUJ9/I;&1
M[8OJVO>RNI:;BS_^M?>GF?T\Z_0SGMCGNO*&$9%2Y[7S,HB2Y-4]RT+0X?6U
M1=U])?F"%D"GL^ON=/=7NQ_O>%7]PA\^D;VNN[^U>_MYU.<ZG>LCP=7W);HE
MKW*"/G&1/A%CY^66N]?9?5;G><?=V[N'X_QO3X4GE(F&:"X()?HTR*VSDN[X
M5$AM[PYF]<\K_33=/3'+I=-U.UN=YR7IVFYW?Q575&VYU);+4UVGG_'H!<WX
MHJ3ZZ1QW\5V'?Y^4XM_9W'*WMKK/WX+9WW;;FWOW8\'4XK,6GS]ZG6J=DEJI
MB.\.0Y,5A*K&'>,^.T]#T=Q9)1;R5%3,SDK!IEJ[K,7C$UVGGU2[/)/I4F'X
M1+7,S=VMOX&6N>7N;]Y!6Z[%:"U&?_1K*U+1WBV&>KC'K&J5\57(AW[ 5GSJ
M==S?E&!?*8=[S#G<LI3#O:ESN!'-\%__Z'3WWL*Z\F_P_(#;I.5-W**!NJK=
MVBI=93?7U4\J7N.L,Z0VEW=P]R>?*DK'\$>"T'<BH)',0@5BXR$$TE4U:7F!
M*G=Z\R(L>E#%%J:H79TN?4SUQ_%3@46A3PYB&H;4C@7OD0I@D4MMJGMQ<>LJ
MLVRXNJHT7J@6:6*,((S<W=A#[S&,CPF%*X+4:*DW%\)+();B8( U!KTI!CKH
MP68M+' >O1B%$EU\,PVL:B7TBVGBY@Y>2048PA"_I>DJ&)7GVWIEIX:AO;MT
MLW(-CZQ<PT/,-9Q;!'+_4F]1RB/W[V*AM+?9VKR]5.JXW+.T+ X[^ZW=DCR$
MIVYV?G$)_;HD&'<V6SMWD(P/7V5U_%W)QMFEM*JL@B@4$SE,X)XTCB8X F_8
MSX53LP&B2JU/^;PH'!<,-SK6"KT3B"2E+H@(2#,@9'Y$X .EE&10HN#-BN7!
MG(1 $$@,#>LZO2QEV)5%3Z&^RM6 MH\ 7;+:2E?U*\[/@'R56]T2$>;'I[4$
M^9WY*I1FS@75%6>*#<5;&B3,P/=*J+4K[?)3H>=B6]:*]2V+CCGK:TN(6:@+
M?NT<J&-#L>H!5,!:('.Z_<D0)M6*ZDY:LVT-[ 6:U[ &5V*-?M?WT5!D%<Y9
ML)^+F&9V4Y%7N.ZYHNT#-?2128*=(V/J,%P"?L8RZ*%2YDCK+$'?V6^TA=9#
M<M,YZ8+QXB.WDGV*IYZ+J&:://JQ#UHH=0XL+C=(BR0*0ZDYQYRY,P<YX5$N
MHY\P"C<\D9@>KPEFL&TX/1KJ1$QU3P]MYFP7WV&T>'6.A!E9"7!##LM%T(75
MBP-F619Z&E5/>'Z J!MS5ZQ37C%&5\<&D&E^BF$G:D]SY-QM,2\V9@F]2,!-
M*1!/KLJT]A8(N8#35.%%IU?*0(L&B/%(Y=@#*1]#-BW1]E3KE%L3PQQ:V%M%
M:4/@MGF:XZPBN-?J/&D]D'5\4[SQT2K>."@4;S0;QRH'ZK'\'.M4E-CZ_^;V
MO>K_S8;BFJV2I" #8+?]2]6VP];MW6G?T;F@!%!QCI8\58)J16&Z5:9$1M2Y
M5P;JEH7IH CF8.&65&RF&3I[<TH3 VE$,W*+0!=YRP33]@]A4VY6F-KQUXL-
M;H=D,#3,3+9+,VDYY_/D<;("G>:BN7 &S(CF[HS3;9%^K\L)"M*YV; $??EP
M&10/).L4K#AI?02*IO3')5<_0HN.Y6L,<EDSR@,=#[LE#\"Z<F563&R7E-+;
MG [SSN%[='!CA"[/ ?NLT_\/=/K_8YT(. Z,#Y)4-L4'EF=[ZRY2M[1#*$7,
MZPQ#[=]9JINGQG*"JAQ"3A$*L2ZTP L45AKY:Y6[^9'V6F<\GU*F/?&9_NJQ
M%0#U7NP32V/)][E]%ZVJ4\&(=WH@;&PY3]S61SK=VSZ\V9@SW,Z,O-:/M-TO
M<&CRZ X2 BF.".XR\?D@ DJ##?HF"=:)VUH0/"=;G" 3\P^(Y'<M B)5>.AO
MK<N6<X2!@IAQ<I%PQ6 @-92:_,[PP@YBDCF# +&/50<SBK/D:,)(^#;*,#<]
M\T/0-K,X:B&4TEJ:6^Z\JEH0R^M(W:MT_(58KCAHY%!9.5R</;^7E\!:4E@;
M'';!M6 0W.8ORF/@)\L2%C+B@5&H*TDW>K B#+S82UEC"Z<&K(Q6#MT8)*ID
MWP)9.SWY>NET=EP%G?49U9K$9; L6 (@FI@.8WY-SALIHF0C&G><(<PC;#9#
M<06^Z*%VLJQ+^CU*.\S%TY1RP43R2,(-WGR;""Z?2BD,VT-0MH(CHR1E9@^S
ME6Y;]T@3W^VFJ:M,A ,F'.D%)5]B U16IBO'5U*1-/I^'&43O.Q(A @&2+,-
MR<4Z$TP5]&0"/TZ4C3!G\@K7[:.,89.<).LE?M\7\?3Y1D!WZPCH_:/F7?K?
M:\R\.V/F[>[7F'GWETQ=GNV]8>8!L?/;:L2\RO6M$?-^DHVN$?,>)@?\B2'F
M[>ZL@B'Q5*I>-MV=G54JP7_R.H-G@9C7V>VX6]O/"Y&LT^VX[?W-.Q3V_[R"
M[QEBYNUVW>W]YX4\L;GG[J*J4B-//,%BC7J=GEAMX&VG^&#E@0N0\VY?%;AR
M%=WR\KGN5M?M[CX>7MX]#KVSO>-VMN^I].\G/L;G0>1A Q4=I7XB!WAWT^WN
M[3\C^^;EIKO5OH?3^V]/A4\1(@^I[7EA2+C[^S50WM\(*,_=;:]KF_[8$>_M
MK@N97YLJM:GRHU];FRH/AY-WGPK__JZ[U=U^GK;*GKM5PY0\??:OUZD&P_M;
M@N%UMY^3W=S96T7OK=7(6CX^T77Z>=7(AP7$NV=ULK.S\US5R>[6';SVM;BL
MQ>6/?NU/C7J7^-_7PKPK8QY48=Z5Z_NJ:C8WYU6!+A]0C7B7(]Y9I5I\LUX!
M"]"NV: 75U1T/ B^W2.PS#.#4NOL=JHJ^E=DOSE(:MNSR)+PS*UN-9):I]N9
M5Z&T L,]%>"I-8#4NK<%4JM$"J@AU99!JFW.H*&N!*EFO:BPI 2_<"T"A'_"
MS>N)U!NAN*X"3V.4!8/EL";NU%K@:T]@0PP^V!SPM?W5P.W6!5]K-FZ)OO;C
MQ<;MP=>:C2KTM>6 & \#OK8SHWU5<!;53T_@9-<;BB.OV)R"[E#F'M8/[P^V
MS;EGU+8'9</;PK9U9A&A[P+;MC<?MJW9N"\PENTRU,<=<=N<M6#;RD!'RV';
M4(V_(V[;]@P"[3S<-A=H3EQ+6QK.07%[2!FG]<QFXU%1W+K=>2@P*^FL%2KH
M;HD]5GP@P7<L5D'OT;A8 <.M&L'E(4V-VV*X[7;G0?'=WN[8W"Q;]Z"KQ<[>
M;B6"V^;>'>S\A\!OVRMC#]T&#!-TH<5"M0)6YI[QVRQO2QE[<T:@Y9KM+,K;
MNAAO+2T\'@7(;45=UE)?YJ*MS9PU"*I:$N8V9FKYQ?,PWSHS6,>DM91UT%[F
M!WT-?F,10"^#8<LB.E:19Y\O:,9>#9KQ2#+_UCK $DG6V;G3 5*A!)3997TW
MU#S=_V^*U*=\T/.P^KISVS2LO4-54'V;\UK3W'F[[D4W/EEGKJF"#30KFI>5
MF! "0D.MK4</!0(>&8C;K>Z,Y8:/56"$&OM&QF@\?]"X;71TJ=8S<,>_P0X6
M\90?LY<K9/TBR&$)5W&_I&&S E7QJA&,"%',&$N-'RH\#^,.9/V D$VU)*B!
M$V> $^_$=%4XQ[>SC%9!3;R]^MVIBB.TYT%W/A9B(K^=,0,?"35Q-5OIWC 3
M49K<!V0B__KS0"8R8J);0R:N YFX:OA_$?)A212N"I@X![-Y-;]  2YQ95FV
M,EAB2>E9!I;(NOEJP) *&Y'07PTRXMJ B[-HCM6 BVAY/3@Y?_:!X_IH&^,Z
M'(J)CT;\5YG F#PZKQ^<J,]A]H$]#-AP-8[8C$.3 !TN[NP1PY&2BJ/IX9V\
M!W0NSM%:8<2<$U+HC;95Z7D *P$.Q&0B/7_@([$CFP1!=).\*4_B9P1+W&O_
M$+#$M1[V$"F[SPS,[U#$\10T@W<?OKYGTG^&T'XGPH]Q B!>$):MQOBK,?[N
M(:U]]HRXUS1VZS>SF]LOUDJ^_FFQ(V94H1D5Y*&VZKY^>Y1WUR5[2"Q?JA3-
MIU*BM^/N[CTG^$X<\<Y*\(D_HC3J"5'=X3S_VM.@O,V]+7=[\SD5B-YJQ'75
M4UWU]*-?^T2*Z)]<V>@59: $CZC'?2"O[W+K:J;\<F>KXVYVUR@<7>D]CU W
MB@/OKH-"4GK/\Y6?F\R@_2A#Q>_Q!,,Z[WT:$O2YK=3/J$VBIRX02>(/?(\S
M"JGM>TCG#X57DA3^T9D$>;!51RYK>[BVAS4M+<NZ.<.LFRR.)3J#.?$&2$\^
M%=-EO[V^!?K#!]RM3>;E)C/3W),BMNUMV+S-YT1M-.)V;2<_2?NO7J?:3GX.
M=O(=S,VU[.25WE/;R;7U]P0DZ'-;J7<K(2S=2U)598A-I:$Z-Q+9##.DKF4,
M(MOI9[&IBMMI[9! Z^RVME5JH<N($DH9?.FW9 N3LZ)$PCA5O3JB_&"NX(T,
MKF6SH7(2Q2"5G*B8Y_.B=?QJC=K#HMUC$G\QVQ5SO3#/-YARNC]<YV.%)+QI
M .=;-#_A^J6>S;KC>*4',J+4T/)2-AOV6G;:K2VUA@^?1_>'Y/T=^4D:Q8@;
M$$RQVK"OBAPB;H.#.=-Y):$&)_"3)*-,>L)S0= GB7]1M46"\#I]/Q3QU'S!
M55<J/1O+!&!9T;D!'.%[F,=)<%/N\J7E#+T-](?PNNI[.2=1?L=B02["O1%Q
M+,*44$M"6.[4QTVE!.I\9Q5 %E=S4=ISECBX"&7D)C&,);EG'B,5_#1T3F0O
MQKH6Q,[:YO3],(PR6.4^@V8%4:( =7"WYJXHP6FI6A[0OOJ4/?G/3F<&9^DE
M\*PND^T@'?+WKUH.C$:7Y.) F@VB&TP1#62Z2B7=S*:51DEC.AA+I,+0.9+$
MM#AW:G0#W,?)ZP='ERIU_14F:^:9FST)CU^0M+ESZYS-^TV^M+(ZR\F?Y>10
MNP13ZR54K.G\ZLS3FXV&8F[^I<H(S1,M"SX$K5-QP2:N\W[5;9W2;14OL!\T
MZZ8H_+K.B;J637"*A358]S"'_KN[Y6QSB_ZQEM/0_UO''-%T(.OCN%G93+TF
MM9^4U';GDMK6=KD&P2*U[F:K4Y-:36KKD-K>/%+K;I6A&VQ2V]];0:HYSQ \
M8?_O#YY0L^[?@W7WY['N]N9^N90N9]VMO79KTV)=,D+KDZ(FMR7DAOC/U>2V
ML[U5ABO)R6T;R&W;LO^6D]J]&\!8I$BUR&!V9F@"B@*2E846-!?D3J"K)R^7
M7X -8UV)H$S9!!U"<Q_L(KJ(J6"W[D6G5P&[" &F[5))PHP4D]4*J._+QP/_
MHLLN*E1]QG[R#<MFQ\(/4_@?(4CVY7\S OC ?&><?7RMAM\3X3="FE7(3L9O
M0H](O1$A88RT>R^=,G!(P#!1>2X+QX4M9U"ELTW1+ YC X]?^%"X24/OY.\(
MBV7I..LH]%-5\TR310@3)QG!QM)J#,C3E3@9^5"$M3230(0AXQI&@4LXBA*!
MLF"$V6#@>[X"4(2;Q;7P QH\87FE:5"HCU=PGU-G((!6^IE\^/W^0-A$$9<X
M:Y=EE/>SAKF1*ZDG Q\H&H8G4KI6?@=V8/K4];XP[U4*?G&6<^IQ;T""((J
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MTL2+)M(U*)@YAKE*Q;$[RB0I6$VRU _&ZA%3ZN14\B9:"H/=*H:\-I2#@VZ
MGI2A;G_7+UMJ]KD1QL $0/NIKU%"!<Y)!NC$"]%?4=')IF:1FD56L-2D80,G
M!'LM23!["_M)]4@YB>4P"T0:P9=B@BB-2/^WHW#N[:*]$,1T$_BPD3L:-,_1
M0[PH"S!!3+O:^MS,,1].EHZBN'9*U*2^$JG/>JJ5EJ'\#<*#GPQ\<^ST_82,
MPJG=^'"YZ5>[(VJ:,S2G^HJAV"/50^5<%[K6Y71&^HH8*_%W0_USL1$E]J?,
MX@04[TAG"Z?R;;-1R[R:_I9HP%&*A1)(:;ET6ZT0 LOIM/\A3]A7;HA4>J,0
M.TURTVGMJD7ZY$!Q?2#7Q'D'W1/K?:*0&WH94LO;?**Z:.=U%*)<@RPF&K43
M2K!M">JKIK>I3< UK=:TNHQ6A3?"K N-\5)HS&R;)$3-INW9&'-<TBB4B7(Y
MJ 8X))I5*DSN2T/T_DIG&KS0@S'%Z&RPGYJ[Y[1=Q7X.[G)/H3?C"M:7+HNF
MU41?$[UV")N^QHID@9!01@\RN[FC_S^QNE+A11OPT''$J$BY4H&%A6/*3.A?
M"ZJ3J_ LZ+Y0<C"(8B[X4WQ8XCN8!><0I=Q24^5'5=EP\]-Q:T:H&<&X#K2[
M:N!SMT(@)4RC2^D/*Q/3!8H<2(YA4$UK"*3J\5]3]-]20^- ^&-%SD2AV,*'
MXBT9AO#@V1,94Z;G<%14;3 #9\CLEC=KQ@%&64K-N[2TSR^T;S?3L <YU>.!
M[_UP@,YL/N9Z5"Y,+5IHF(F"/0LE-37EA*-2IW/7\HJ3M3HK)XRGO<R,K14,
MVGO/NCPHI_]1@B Y+JT<46I3=2-5YN!(CAU2(6-MJE-W+I"-DU2GE&9428UY
MD"((6LZIE76@$E!C<I V&X5,U(PR8HUOOR<2/W%UWJ+M"279%XBIRZF$&-D0
M\(B>\+[1LG,WXVQ!@_<\7H'D+"?<HPH=N[G1.+-[[LH1D@4>8OBIV>"P('4)
MXQ@XDBVK_8FO(A]&X.NP^5B7\1/+R5"7L2_+6;/BYU:^..Z<6M>"\3%[D%00
MZ\,7DB/* 5=?4T2(<W>S,:;1_P^GA&G"Z-(<8-L;6F\)6JIN+):% C:'P EU
MWRC3;&QN#RQ<02P]6)24^O-TT=G=_R%==#H_61>=F2XJ:S:@N?2_\]N^4)(Y
M?SY&$B>$H%X\TT_DY^I2<]<&/WGSE956[ D-N_US;73=CNAA8. .K5,64YY>
M.R\SK-7QPU=6F4JN63P-\,R7G?T==P]Y8.D;7CT5^,R7G>ZFN[F_2D^65P_,
MN\^9*/WP6B9/E2C=]E[W6=%D=VO+W5I[S.]JN.LE5)KW:7]J5-IQMSJ=6SW^
MQXQWU]W9747.+Q:9UL8^9<S,YX6E6Z_3$^LK\>00AL]DBB[:F#QV(!_[DC^_
M(G?K_$9F3P%R^&6W V?C_HQY.!^Z]]5*;WJ,H6_NM-TN0K7?=NBU"*U%Z(]^
M[2+(X6>(!M9I__WAP!YL,:GUV2FKW"<%E?LWK7*?&V_%01X'>??Z]+T^3N8$
M-';N8WAXT-$QIBR 2M\)Q3$HUT!'+1:$*VY$8@#R=EI[14PDQ+@5*E26 S:6
M<+JLMQD@ZSFO:S/N-,(Q!5&RWD"C@1GG;AE0DL.SJT#Q$C0U+*!.G/!&L".,
MTZ.PQG9:NX6'N[0*L4\UI(3GO-$CF!F5#>0V&WV)$3T_S^$08P3OUN&^U3&S
MK8&%K-)$8VE'G]=^3"RO99C!,_!Y>9$@/YE#W^([05:;!2C#=>9[IL!C@.QN
MHI@1D70?!\JM\GL9!LM".10,,TZ1P-Q\[4WU%I9>X5K85JHV4H2Y1@<OI.BJ
ME:A%J5G7&,^S]J[3:>V7GBL<K0OB4S!F'\?$.3K4SW>V9P<D8D3 B0:#1%+\
M7N@MH:<AAK>3QJ)/"60T#A?#UW$F^XS<E4@[/4%?9 VV71KLP\,CW4UZ-!NS
M_&R+CQG)<&MF;UNKM+WW@,R^V2VAP-G,WFQ4<+M* <CY_0[LK89C\_?*7-J9
MN]8S3.I4\2CW!:CDT69#\\3>4B8M\(0SPQ(+&6"OU5[*<T4A8#,]P=9;0L$\
M=J>U6:07$LA+Q$ ^YS5X<N]Q%(Y3XXG^ 0J'Y7S40J/*,W[;D[P,0GXC8VFC
M&W+:<%YU46A0 0R:P["9A^[NE!44G>#%$'4Z_;@:S2U_S/:,:(#Q7,H8K_J@
M%H&>!4OR^^GE\5E!M)>/D^JYZ#0UEU#26+B@@T(GW.NQE(>""6X56) (%R='
M40#;-,8J4POB(G\J[E2FF!5&]%M("2Z7*0-=B7#>NB?1(+W!C"OKT-RN8)8'
MS>>Y?W*TSIKNUE89/KI,CVO28G>S?":Z%4]9D0HZBP2R-4;*V@7!%D3#J:-2
MX2,BVZHMI[>5:*)PD\HU_"ACV %'(6!.-:5@S?Y2,ME\<C+UQ,1-?JQ,I8%5
M!7%N*5#+HH_H5ZDTB(QIE/RRI0<[#T<Y)<XR2BZ-3+60,6UEB(2^8"JD"_]P
M<B&.1P%>SIS?^>F,&CR<MOZ$6OK&FEI(8A5 0W/=;$;#>4SI<A\;T[8E^.YJ
M&P-,WK[USAS TX+9G6DOV9D%F]#](;Q+RG2SL4"=/A\,0"\/,'=5:]27(P16
M/;"QG30S5X_W7GA9=Y'"=&=R8I& (?MUNMPJB&:F@48'SJ. 485)T/ X/-FI
M6Q!L]36(?=)=?'II0F]?CJI\7UOT?S(!I,+PT4=^@LV8&*:Z%V4I2@@L+OR*
MP,./(5 16=;B4#"_L==:EFA-)K>H$ N9:\'(2J*E1)^F/PP57K WA?N5#16;
M ]*L<LR)R[#M_2C?=-[R/BB'U[PF%IJ8'R9IG)GV6A8>-8T3<_P)=1M3MW%T
M+>>$BR^YZ17\S/.ALQULF+Z?,J0SCJL(:?U8)^N)6K%#O6)JIQ_G^/QC9E7T
M#N8;1^NC?'8D+Y%?(J (:Y-Y\1-;BZ)R#-4G3Q//;ZW+%LO (ZPLC%WZ]@.J
M>G!:7$09FI=L830;1R+$;_\31Z$D*B'AP':KM/JL =GA<QU^I.ZX1NGH=OFB
M5L@9A\D2_P0RR[;(D75,P6//4.U'O(1NN[/E+NJ-AE>7NJSI8H&U.YHA!*[J
M9>8J%3)%=NE)]:)_9\%4(_+CT5=: %HKPI)&%H$!CW790($9*X';R7EA^AQJ
M'59MM%)[3:4$NN9X;T$;R6*%VOY7%"M<2PL[M>#%H_*1;U:U*!>;<E='\_+'
M8L!3+8Z^XJ+,<-_#GW?-1A@9H;C1DUSX0KT%B6W\N$\Z!YU'Q?YY(Q^+@22=
M9B!!+:E)!]T,6CZ+N5PW&8.VDN$Q*\"6%7X,K!V@@QMWTI:H!9'-A%,VE\P!
M413OC -F@.#ME %&7ZIT':#<)KHQ#U/>)6+8F;7"G@+H2$32600OC\4U!*!/
MX/U(HDS"JC6E<L19QUGYJ%JD-=^GM<4GTP^@12"N:$(]1;4S@-LC1"#LILV&
M*;'CW9\B# SI!PPC@VT>+">I"]P?#'Q&"R\VC0A)_#+:S+6,$W\PU3!SK%:4
M@<2K26C^7C-$_LP4\M(M) >4C=G88;<]DRIJ&'Z:,4'0FTG<H73*.6W=P;B.
MU>5#!PFH0CC$2+,JKZ?".1Y%-?F.9-!OZ8#T\XNE=^I8^AWJ0H%XQL .,9=!
M9C@N=2B0!N=%E)*&LISUVAN0<*,IZ )T1G#1L$UMJ+=;"C#7'8+%!!/R!]@[
M->5CP+[(U/3Y(;"MW\^*8W'\Q!X'B-(>*"_1#?.B?9[8#ZT\2-9G]ZO26%7C
MDN+1  /4G2YZTA/HIB-5L[B@KK8.'6LUS$-<6F]\KA(0(W\X,J]FYGZI1<M2
MY>]@\_7!AFGL#%(/WLC @G3VA$(5 Q>>#PLQ9'V,Y\V#$>1>O?;E#?=M$0H(
M).:R71UMXY70^YTB (V*X/2YG3;N^A1.5E8?J6Z[L+2PG2&30;&Q-ME8>O\+
MW7+XE#6DR2%,&&%A<\IPHZ/I!*-=*17Q,D1OT0Q1FGS/0E+ORX'(@M15E>%_
M96&I-%R/I-F@,1 )T&JK._&CM;4)$ LN8'GUT4Q)5?R/E3(XXZ1N>0%[@.:1
MJFYUN:D,:F!)0D=1W^^3N8OY!*B;Y8R-T_1CN@C'I_H4>![UP!X&6 F.4[Z&
M55#)(I5+B_W!">@2C*4(*/A_LO\('K]+'ZN?R:.IK!.,BL=$#!8E+1-%LY2A
M RE*PY"Y?B%L_^<LNY-&@PO1;$P"X6EW4BYQR&P:(MA=R! #44@;%I->#*0
MR@OU_ 8MAU1?NJ",JC,1L-7S- Y7H93F\-(?(A&3E_+(A_WAECQ1"*,1 ;E+
MB^&P.:J N&9CT%PZI&!QD5"IO=A*$L42* <YN;DY%W.(N(K92E*?Y/W5"LP_
M;V**=/-'WD8PD(OW5I+!F2,8X%IKF.M(AZN5V;]JJ=:0 7".K2($'C(KYD2A
M+-C9!64M8H9>:(:WEVP,T_$L5>+N8I48[+[SHS_ART]77SZ___]02P$"% ,4
M    " #@K!I32K]]0W,.   CC@  $0              @ $     87-N9"TR
M,#(Q,#8S,"YX<V102P$"% ,4    " #@K!I3\<YC-H@*  !ND0  %0
M        @ &B#@  87-N9"TR,#(Q,#8S,%]C86PN>&UL4$L! A0#%     @
MX*P:4S)+7%51&@  FHT! !4              ( !71D  &%S;F0M,C R,3 V
M,S!?9&5F+GAM;%!+ 0(4 Q0    ( ."L&E.K:;87CCL  !:0 P 5
M      "  >$S  !A<VYD+3(P,C$P-C,P7VQA8BYX;6Q02P$"% ,4    " #@
MK!I3P6"ZL5LJ  !4LP( %0              @ &B;P  87-N9"TR,#(Q,#8S
M,%]P<F4N>&UL4$L! A0#%     @ X*P:4Z2W>73Y%P  JI<!  X
M     ( !,)H  &0R,#8S.35D-FLN:'1M4$L! A0#%     @ X*P:4RLS^"]Y
M=0  $F(* !$              ( !5;(  &0R,#8S.35D97@Y.3$N:'1M4$L!
M A0#%     @ X*P:4TLY7\2.40  @CL" !$              ( !_2<! &0R
E,#8S.35D97@Y.3(N:'1M4$L%!@     (  @ !0(  +IY 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
